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Definitions 
a) ART- antiretroviral treatment taken by HIV-infected patients  
b) ART access and adherence- availability of HIV treatment and the ability to use it as 
directed by health care workers 
c) HIV-disclosure- sharing of information about one’s seropositive HIV status with 
others 
d) HIV-infected person- a person infected with the human immunodeficiency virus 
(HIV) 
e) HIV-exposed but uninfected children- children born to HIV-infected mothers who 
were exposed to the HIV in utero but are not HIV-infected themselves 
f) HIV-affected persons- People, including, children who are affected by HIV through 
living with someone who is HIV-infected in their household  
g) Maternal HIV-disclosure- an HIV-infected mother disclosing her seropositive status 
to her children 
i. Full HIV-disclosure- full information about HIV is provided by a mother, for 
example using the words HIV or AIDS 
ii. Partial HIV-disclosure- a mother sharing some information about an illness 
with a child. For example, a mother may tell a child that she is taking 
medication for an illness or a virus but not divulge that she has HIV 
iii. No HIV-disclosure- a mother telling a child nothing about her own illness 
h) Social exposure to HIV- children being exposed to HIV in their household or 
community. This can also be extended to living in high HIV prevalence areas 
i) Social support- the financial, practical, emotional, spiritual or emotional assistance 
that is provided to an individual especially after they have disclosed their HIV status 
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Preface 
After completing a Master’s degree in International Community Health in June 2009, I 
returned to South Africa to pursue a PhD. My PhD supervisors had projects within which I 
could integrate my PhD. I could either nest it within with an HIV Treatment as Prevention 
Trial or a Maternal HIV-disclosure (Amagugu) study. I chose the latter due to my passion 
for, and experience in, maternal and child health. Further, I had worked previously on the 
Vertical Transmission Study (VTS) from which mother and child pairs for the Amagugu 
Study were to be recruited. I had occupied various roles in the VTS at Somkhele, including as 
a breastfeeding counsellor, HIV counsellor, infant feeding counsellor and a junior manager, 
as well as being a study coordinator in the peri-urban site at KwaDabeka Clinic outside 
Durban.  
While the VTS (2001-2006) enrolled both HIV-infected and HIV-uninfected women during 
the Prevention of Mother-to-Child Transmission programme, the Amagugu study intended to 
enrol only HIV-infected women with HIV-uninfected children with the aim of supporting 
them to disclose their own HIV status to their now 6-10 year old HIV-uninfected children. 
These women were last contacted more than six years ago, therefore they had to be traced 
and tracked before being offered enrolment into the maternal HIV-disclosure intervention 
(Amagugu study).  
Clinic staff were identified as stakeholders who needed to be trained in maternal disclosure in 
order to support these women. All clinics where women were receiving anti-retroviral 
therapy (ART) treatment and care were provided with training in maternal HIV-disclosure 
and child-friendliness.  
This PhD with publications comprises four first-authored papers attached as Appendix A. 
The first paper is a literature review on maternal HIV-disclosure. The second and third papers 
explore the women’s experiences of living with HIV in an ART-era and their experiences of 
participating in a maternal HIV-disclosure intervention (Amagugu). Lastly, the fourth paper 
addresses the role of primary health care clinics in facilitating maternal HIV-disclosure and 
supporting HIV-affected families. This integrating narrative will discuss three main themes 
across all four papers.  
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Abstract 
Introduction: As Prevention of Mother-to-Child Transmission and HIV treatment 
programmes have scaled-up, more women are being kept alive and fewer children are 
infected with HIV. One of the challenges that HIV-infected women face is how to disclose 
their own HIV status to their children. The disclosure literature suggests that the main reason 
for women’s HIV-disclosure is to obtain social support, including financial, practical and 
emotional assistance, to help women to manage their HIV infection. HIV-related stigma, lack 
of knowledge of how to disclose, uncertainty about a child’s reaction to disclosure, and a 
perception that a child lacks the developmental capacity to handle HIV-disclosure are factors 
that affect disclosure decisions. HIV-disclosure is considered a critical element in 
strengthening the capacity of families in the continuum of HIV care. 
In 2011, the World Health Organization published guidelines for parental HIV-disclosure to 
children. These guidelines recommended full disclosure to primary school-aged children 
(from 6 years up to 12 years) and partial disclosure to younger children. Globally, but 
particularly in sub-Saharan Africa, HIV-disclosure interventions are lacking. The Amagugu 
maternal HIV-disclosure intervention was developed, piloted and evaluated between 2010 
and 2012 to assist mothers to disclose their HIV status to their HIV-uninfected children. The 
intervention enrolled 281 mothers and their primary school-aged HIV-uninfected children, 
and aimed to increase maternal capacity to disclose their HIV status. This was implemented 
through six lay counsellor- led, home-based, sessions, including a health intervention at a 
primary health care clinic. The Amagugu intervention was acceptable and feasible in a high 
HIV prevalence, resource-poor, rural setting, and increased maternal HIV-disclosure to 
primary school-aged HIV-uninfected children.  
Methods: This PhD study was nested within the Amagugu study and was conducted at the 
Africa Centre for Population Health, now the Africa Health Research Institute (AHRI), in the 
Hlabisa sub-district of Umkhanyakude, northern KwaZulu-Natal, South Africa. The aim of 
this PhD was to explore, in more depth, the experiences of women enrolled in the Amagugu 
intervention, including their experiences of the health intervention.  
Both quantitative and qualitative methods were used. The sample for the PhD study 
comprised three groups: 1) all mothers from the Amagugu study (N=281); 2) a sub-sample of 
mothers from the Amagugu study (N=20) and 3) health care staff employed in the clinics 
where the Amagugu study took place (N=87). The quantitative data used in the PhD study 
 xvi 
 
were collected at different time points from the 281 women, using questionnaires specifically 
designed for the Amagugu study, including baseline and post-disclosure questionnaires. Data 
on the clinic experiences were collected from the 281 mothers using semi-structured 
questionnaires administered after the health intervention. Semi-structured questionnaires, 
specifically designed for this PhD study, were administered to the clinic staff during the 
health intervention. Qualitative data were collected using semi-structured questionnaires with 
the clinic staff (N=87), nine focus groups with clinic staff after the health intervention, and 
in-depth and semi-structured interviews with the sub-sample of women (N=20) who were 
enrolled after the Amagugu intervention had been completed.  
The University of KwaZulu-Natal Biomedical Research Ethics Committee (BREC Ref: BF 
144/010) and the University of Witwatersrand Human Research Ethics Committee (Ref: 
R14/49) granted ethical approval for the PhD study. 
Results: The results reported in this PhD are drawn from four papers written during the 
course of this PhD, (three published papers and one paper accepted for publication). The 
results have been integrated from the data collected from the women and health care staff that 
were used for the PhD, and a literature review that resulted in a publication.  
The three main themes that emerged from the PhD are:  
1. HIV-related stigma and HIV-disclosure: The literature review revealed that fear of 
HIV-related stigma was the most common reason for non-HIV-disclosure of HIV to 
both adults and children. In the sub-sample of 20 women, only two women had not 
disclosed to other adults due to fear of HIV-related stigma prior to the intervention. 
Those who had disclosed to only some, but not all other adults in their close social 
networks, reported HIV-related stigma at household (6/18), community (2/18) and 
clinic levels (1/18). Although HIV-related stigma was reported, there was also a 
normalisation of HIV and antiretroviral therapy (ART) in some communities due to 
the high social exposure to HIV in the study area. Qualitative data from the focus 
groups with clinic staff, and interviews with the sub-sample of 20 women, recognised 
that children’s exposure to HIV education has played a role in the normalisation of 
HIV. 
 
2. HIV-disclosure and family strengthening: The majority of women in the sub-sample 
had disclosed their HIV status to other adults including their partners, friends and 
 xvii 
 
other relatives, prior to the Amagugu intervention. Most women reported living 
positively with HIV and receiving necessary support from those to whom they had 
disclosed. Of those women who had disclosed to partners, about half had disclosed to 
their partners first before disclosing to any other adults. Their partners had mixed 
reactions to disclosure but were overall supportive. Whilst women’s original fear of 
disclosing their HIV status to their children had been that they would be stigmatised 
by their children, on the contrary, most children were supportive. The majority of 
women in the sub-sample expressed that they would advise other women in similar 
circumstances to disclose their HIV status to their children for social support, because 
disclosure increased family cohesion and improved antiretroviral therapy adherence. 
The health staff echoed the same sentiments regarding social support and family 
cohesion in the focus groups.  
 
3. HIV-disclosure and access and adherence to HIV treatment: The interviews with the 
sub-sample of 20 women, and the semi-structured questionnaires and focus groups 
with 87 clinic staff, all revealed that participants agreed that whilst maternal HIV-
disclosure was challenging, it was necessary for women to obtain social support from 
their children. Health care staff also agreed that maternal HIV-disclosure to their 
children was instrumental in supporting HIV-infected women to access and adhere to 
their HIV treatment. The clinic staff recognised the role they could play in health 
promotion and increasing opportunities for children to participate in activities at 
health facilities, but acknowledged that they needed support to address logistical 
constraints that hinder child-friendliness in health facilities, including heavy 
workloads, poor clinic infrastructure and staff shortages. The health intervention 
provided clinic staff with child-friendliness training and materials that were found to 
be acceptable and feasible, and yielded encouraging results.  
Discussion: This study contributes to the literature about the experiences of African, HIV-
infected, rural women with HIV-uninfected children living in an ART-era. In particular the 
experiences of women who have participated in a maternal HIV disclosure intervention in 
Africa have not been explored previously. The findings of this work indicate that a decade 
after being diagnosed with HIV, women in this resource-poor setting are generally living 
positively with HIV. However, HIV-disclosure to other adults does not necessarily translate 
 xviii 
 
to disclosure to children, and parents require specific interventions to assist them with this, 
and to understand the development and level of understanding of their children.  
Conclusion: Despite concerns raised by women prior to the intervention, including fear of 
HIV-related stigma and a perception that children lacked the developmental capacity to grasp 
knowledge about maternal HIV status, the women in this study reported no regrets in 
disclosing their status to children. They also reported receiving support from their children, 
which in turn, assisted them with adherence to their own HIV treatment. Future studies could 
test the same Amagugu intervention materials in a group of HIV-infected women with 
uninfected children not previously involved in research to explore whether similar results are 
found.  
 
Key words: Maternal HIV-disclosure, sub-Saharan Africa, HIV-uninfected children, primary 
school-aged, interventions, resource-poor setting 
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1. Introduction 
This PhD thesis explores the in-depth experiences of HIV-infected women who participated 
in a maternal HIV-disclosure intervention, the Amagugu study, conducted in a high HIV 
prevalence, resource-poor, and rural setting in South Africa. Three specific themes relating to 
maternal HIV-disclosure are explored:  
i. HIV-related stigma and HIV-disclosure 
ii. HIV-disclosure and family strengthening  
iii. HIV-disclosure and access and adherence to HIV treatment  
 
To answer my research question on where maternal HIV-disclosure studies have been 
conducted, with whom, and what lessons can be adapted to rural settings in sub-Saharan 
Africa, I reviewed the global literature on maternal/ parental HIV-disclosure. This led to an 
identification of the following main gaps in the literature: 
 
a) Maternal HIV-disclosure research is mostly descriptive and was conducted in 
resource-rich settings. 
b) Very few studies have been conducted with primary school-aged HIV-infected 
children. 
c) No maternal HIV-disclosure interventions had been conducted in Africa 
d) There is a lack of maternal HIV-disclosure interventions that consider the unique 
epidemiology of HIV and the socio-cultural factors such as HIV-related stigma, high 
social exposure to HIV, and the difficulty in discussing sex-related issues in the sub-
Sahara African context. 
 
Following the development and the implementation of the Amagugu intervention, I sought to 
answer the research question about the experiences of women living with HIV in an ART-
era, ten years after their diagnosis. This was done by enrolling a sub-sample of women who 
had been part of the Amagugu study. These women were selected because they were 
diagnosed with HIV during pregnancy in a pre-ART-era but had been living with HIV for 
almost a decade and had survived and lived through the ART-era. I explain the women’s 
 2 
 
journey through an in-depth exploration of their perspectives around their HIV diagnosis. 
Through in-depth interviews I was able to explore various issues that surround their HIV 
infection, including, their reasons for participating in a maternal HIV-disclosure intervention 
and the maternal HIV-disclosure lessons they learnt.  
 
A mixed methods approach has been used for this PhD study as it allowed for both 
descriptive data (including age, marital status, education, employment and health status) of 
the women and (age, profession, gender, and geographical areas) of the clinic staff to be 
collected. The interviews and the focus groups allowed for the qualitative exploration of 
women and health staff perspectives on various factors surrounding women’s HIV infection, 
access and adherence to HIV treatment. The semi-structured questionnaires captured and 
described women’s interactions with the clinic staff, the experiences of women and their 
children of a clinic intervention to support maternal HIV-disclosure, and examined how 
primary health care clinics can be supported to assist HIV-affected families with access and 
adherence to HIV treatment. 
 
The three themes which emerged from this PhD are intertwined in the daily existence of 
HIV-infected women and shape their relationships with their significant others, children, 
families, communities, and their interactions with their health care facilities. At the centre of 
HIV infection lies disclosure decisions - what to disclose, to whom, how and when to 
disclose? The World Health Organization (WHO) Parental HIV-Disclosure to Children 
Guidelines of 2011 recommend full disclosure to primary school-aged children (from 6 years 
up to 12 years) and partial disclosure to younger children. However, disclosure decisions are 
complex and even more so when they involve children. It is well established in the literature 
that the main reason for HIV-disclosure is to obtain support from the disclosure targets (1-4). 
Whilst HIV-disclosure might have positive consequences - from family strengthening to 
greater access and adherence to HIV treatment and care- a number of factors affect disclosure 
decisions, including the fear of HIV-related stigma.  
When investigating such complex HIV-related issues, it is important to first consider the 
origin of the Human Immunodeficiency Virus (HIV) because how HIV was introduced into 
populations impacts on how different communities, including those in sub-Saharan Africa, 
can be assisted to respond effectively to the HIV epidemic. This includes addressing issues of 
stigma that are associated with HIV infection which make it difficult for HIV-infected 
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individuals to disclose their status to others and in turn shy away from accessing and adhering 
to HIV treatment. 
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2. Background 
2.1 The origin of HIV and AIDS  
In 1981, AIDS was identified as a new disease associated with homosexual men in the United 
States (US) (5, 6). Thereafter, similar cases were identified in other groups in the US and 
Europe, including injection drug users (IDUs) (7), haemophiliacs (8), recipients of blood 
transfusions (9), travellers from central Africa visiting Europe for medical attention (10) and 
new-born infants (11). In years to come it would be determined that heterosexual contact was 
the dominant mode of transmission of HIV and is the main cause of AIDS in Africa (12).  
2.2 HIV infection in South Africa 
In South Africa, the first case of HIV infection was reported in 1981 (13). Almost a decade 
later, in 1990, the first anonymous antenatal HIV prevalence survey was conducted to project 
the national HIV prevalence (14). Since then, anonymous antenatal HIV surveys have been 
used to estimate national prevalence in South Africa. HIV prevalence in the first antenatal 
survey was reported to be 0.76% (14). By 1995 antenatal HIV prevalence had increased to an 
estimated 10%, and by the year 2000 it had more than doubled to 25% (14) in a survey that 
tested 16,548 blood samples from 400 sites in all nine provinces of the country (14). Figure 1 
illustrates the observed HIV epidemic curve among antenatal attendees in KwaZulu-Natal 
between 1990 and 2008. 
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Figure 1: HIV prevalence epidemic curve among antenatal attendees from 1990 to 2008 
in KwaZulu-Natal Province, South Africa 
 
Source: 2008 National Antenatal Sentinel HIV and Syphilis Prevalence Survey (15).  
It is predicted that HIV prevalence in South Africa will continue to increase as more people 
initiate antiretroviral therapy (ART), but will eventually stabilise as a result of effective HIV 
prevention programmes (16). This means that people live longer and thus the population of 
people living with HIV increases as the virus causes a chronic rather than a fatal disease. In 
2012, the HIV prevalence among 15-49 year olds was estimated to be 18%, an increase from 
the 15% reported in 2001 (17). Table 1 illustrates the prevalence and incidence estimates of 
HIV infection among antenatal clinic attendees, aged 15-49 years, in the Hlabisa health sub-
district (study area) in the period between 1992-1999 (18). 
Table 1: Prevalence and incidence estimates of HIV infection among antenatal clinic 
attendees, aged 15-49 years, in the Hlabisa sub-district in the period between 1992-1999 
(18) 
Year  N  
Prevalence of HIV  
(95% CI) 
Incidence per 100 
person-years 
1992 884 4.2% (3.0-5.7)  
1993 709 7.9% (6.0-10.1) 2.3 
1995 314 14.0% (10.4-18.4) 7.2 
1997 4731 27.2% (25.9-28.5) 8.2 
1998 3166 29.9% (28.4-31.6) 9.9 
1999 3014 34.0% (32.3-35.7) 15.0 
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2.3 HIV and women 
South African women bear the brunt of HIV and are socially vulnerable to HIV infection due 
to marginalisation and persisting inequalities (19). These inequalities are perpetuated by 
poverty and unemployment and are made manifest through gender-based violence (20). The 
epidemiology of the HIV epidemic in South Africa is unique due to institutionalised 
inequalities stemming from the previous apartheid regime (13). Together, this regime and the 
migrant labour system served as catalysts of HIV transmission and other sexually transmitted 
infections (13).  
2.4 The vertical transmission of HIV 
The high HIV prevalence rates observed in the adult population are reflected in the rates of 
vertical transmission of HIV in South Africa. In sub-Sahara Africa, the vertical transmission 
rates for breastfeeding populations before the implementation of Prevention of Mother-to-
Child Transmission (PMTCT) programmes were between 15-45% (21, 22). In 2001, the 
South African National Department of Health (NDoH) launched PMTCT programmes and, in 
keeping with policy at the time, single-dose Nevirapine was offered to HIV-infected women 
during labour and to their infants after delivery (23). Since then PMTCT regimens have 
evolved as illustrated in Table 2.  
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Table 2: Evolution of South Africa’s policy on the PMTCT of HIV, 2000–2011 (adapted 
from Barron 2013 in the Bulletin of the World Health Organization 91(1): 70-74) (16).  
2000 
Data presented at the 13th International AIDS Conference held in Durban, South 
Africa indicated that antiretroviral drug regimens were effective in reducing 
Mother-to-Child Transmission (MTCT) of HIV. 
2001 
The Ministry of Health endorsed the establishment of two research sites in all nine 
provinces for a period of two years to better understand the operational challenges 
of introducing antiretrovirals (ARVs) during pregnancy to reduce MTCT. 
2001 
In December, the government was ordered by the Constitutional Court to develop a 
fully capable and effective national programme to reduce MTCT of HIV by 2002. 
2002 
The government challenged the court order, but was unsuccessful. The PMTCT 
programme commenced. It included provision of free formula to infants for six 
months at any time during the first year of life.  
2003 
The government published a new operational plan for treating and caring for those 
who were HIV-infected. In addition, the plan included increased provision of 
Nevirapine, the extension of HIV treatment to all HIV-infected pregnant women 
and their infants and the expansion of related health-care services, such as 
voluntary counselling and testing. 
2004 
Introduction of comprehensive care management and treatment of HIV-infected 
individuals. Pregnant women with a CD4+ T-cell count < 200 cells/mm3 became 
eligible for lifetime Highly Active Antiretroviral Therapy (HAART). 
2008 
The NDoH updated the PMTCT policy to include: (i) dual prophylaxis with 
Zidovudine and Nevirapine from 28 weeks’ gestation; (ii) Nevirapine treatment for 
pregnant women during labour and for their babies within 72 hours of delivery; 
and (iii) HAART for pregnant women with a CD4+ T-cell count < 200 cells/mm3  
 
The Minister of Health launched the national PMTCT accelerated plan (A-plan) 
which aimed to reduce MTCT of HIV from 12% in 2008 to less than 5% by 2011, 
in accordance with the National Strategic Plan 2007–2011. 
2009 
President Zuma’s speech on World AIDS Day outlined changes to be implemented 
in 2010, giving a clear indication that the political leadership required to address 
the scale of the problem was available. 
2010 
The NDoH revised the PMTCT policy again to include lifelong HAART for HIV-
positive women with a CD4+ T-cell count ≤ 350 cells/mm3 and dual ART from 14 
weeks onwards in the pregnancy for HIV-positive women with a CD4+ T-cell 
count >350 cells/mm3, in line with Option A of World Health Organization 
guidelines. Nurse-initiated and managed ART (NIMART) was introduced by the 
NDoH in antenatal clinics (24). 
 
Infant prophylaxis was daily Nevirapine for 6 weeks for all infants. Daily 
Nevirapine was continued for all breastfeeding infants whose mothers were not on 
HAART, to reduce postnatal transmission of HIV. 
2011 
Following a national conference on breastfeeding, the Minister of Health endorsed 
a policy that breastfeeding should be exclusively recommended at public health 
facilities and formula milk be reserved for medically indicated cases, and that the 
provision of free formula milk should be phased out. KwaZulu-Natal was the first 
province to phase out free formula milk in its PMTCT programme. 
 
In line with a call from global agencies, the NDoH developed a national action 
framework for eliminating MTCT of HIV by 2015 (25). 
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In 2010, when the effect of the South African PMTCT programmes was evaluated in a 
national population-based survey, the overall transmission rate was 3.5% and further 
decreased to 2.7% when the survey was repeated in 2011 (16, 26, 27). Furthermore, the 
percentage of HIV-infected women receiving ART to reduce MTCT of HIV increased from 
83% in 2009 to 87% in 2011 (28).  
2.5 The progression of HIV treatment and care  
Providing free HIV treatment and care was rigorously debated by the national government in 
South Africa. In 2006, former South African President Thabo Mbeki was accused of being an 
AIDS denialist by the media when he was quoted as saying that there was no association 
between HIV and AIDS (http: //news.bbc. co.uk/2/hi/5265432.stm) (Page last accessed on 20 
December 2016). His late national Minister of Health, Dr Mantombazane Tshabalala-
Msimang was nicknamed “Dr Beetroot” when she ‘prescribed’ beetroot and garlic as 
alternative treatments for HIV, and escalated confusion in a population already bombarded by 
HIV/AIDS myths (http://www.nytimes.com/2009/12/02/world/africa/02safrica.html) (Page 
last accessed on 20 December 2016) (29, 30). The government’s reasons for initial resistance 
to providing HIV treatment included concerns about the side effects of HIV drugs, poor 
infrastructure for rolling out treatment, lack of human resources and the unaffordability of 
HIV medication (31). It took the combined influence of civil society movements such as the 
Treatment Action Campaign (TAC) and pressure from the international community to change 
the government’s stance and to ultimately provide free HIV treatment (29, 32). In 2004, HIV 
treatment and care was eventually rolled out in South African public health facilities, in a 
devolved programme that allowed patients to access HIV services at their nearest primary 
health care clinics (33-35).  
2.6 Children and HIV transmission 
As PMTCT and HIV treatment and care programmes were scaled up, more women were 
being kept alive and fewer children were being infected with HIV (36-38). Logistical 
constraints of initiating ART in pregnancy, such as a shortage of doctors in the public health 
care facilities, have been mitigated by the introduction of nurse-initiated and managed ART 
(NIMART) (39-41). Encouragingly, a substantial decline of 43% in the number of new HIV 
infections among children was reported in sub-Saharan Africa in 2013 (42). Globally in 2013, 
3.2 million children under the age of 15 years were living with HIV, 91% of whom were in 
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sub-Saharan Africa (42). However, only 22% of these infected children were receiving ART 
in 2013 (42). In 2012, over 18 million children were reported as HIV orphans whilst millions 
of children under the age of 18 years were HIV-affected through living with HIV-infected 
parents (43).  
2.7 Vulnerability of HIV-infected children 
Despite dramatic decreases in the MTCT of HIV, efforts still need to be focussed towards the 
care and support of over 3 million HIV-infected children globally (19, 44). HIV-infected 
children have higher morbidity and mortality rates compared to their HIV-uninfected 
counterparts (45). These children also have the double burden of dealing with their own HIV 
status and that of their parents (45). 
2.8 Disclosure to a child about their own HIV-infection 
For HIV-infected children, being disclosed to about their own status is challenging (46), 
possibly leading to discrimination and stigmatization (47). Conversely, lack of HIV-
disclosure to a child about their own HIV status may lead to poor ART adherence and 
possible drug resistance (48). The American Academy of Paediatrics (AAP) issued disclosure 
guidelines for HIV-infected children and adolescents in 1999 (47). The Academy strongly 
recommends disclosure to school-aged children, and suggested that disclosure decisions 
relating to an HIV diagnosis should be individualised to account for the child’s cognitive 
ability, their developmental stage, clinical status, and social circumstances. There is 
consensus in the literature that it is best to disclose children’s HIV status to them during the 
pre-adolescent years, before they become sexually active, and that the primary care-giver, 
usually the mother, is the best person to do this (49). Adherence to ART is one of the primary 
reasons for recommending disclosure to HIV-infected children (50). However, any efforts to 
increase HIV-disclosure must be cognisant of concerns regarding the negative impacts of 
disclosure such as psychological harm reported in some studies (50-53).  
2.9 Vulnerability of HIV-exposed but uninfected children 
Although HIV-uninfected themselves, children born to HIV-infected mothers face several 
risks including poverty, violence, ill health, inadequate medical care and other social 
problems (54). They are also at a higher risk of parental ill-health, hospitalisation and 
potential death (55). The existence of HIV in a home has the potential to seriously disrupt the 
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family system and child care (56, 57). Despite increasing numbers of these children who are 
themselves HIV-uninfected but living with HIV-infected parents, little research exists on the 
issue of disclosure within these families, particularly parental disclosure of their HIV status to 
their children (36, 37). Further, very few studies have specifically examined disclosure by 
fathers (58, 59), despite their involvement in a child’s life from conception to grand parenting 
(60). In dealing with HIV-affected families, disclosure is considered an essential aspect in the 
continuum of HIV care (61) and family-based interventions are needed to guide caregivers in 
assessing whether to disclose, what to disclose (full or partial), how to disclose and when to 
disclose (appropriate age of a child) (62). 
Most mothers struggle with disclosure decisions due to lack of knowledge about how to 
disclose their HIV infection to their HIV-uninfected children (52, 54, 55). Disclosure rates to 
school-aged and adolescent children vary; some studies have reported maternal HIV-
disclosure rates as low as 30-40% (53, 63, 64), others have reported rates as high as 60-77% 
(65, 66). Mixed reactions to maternal HIV-disclosure have been reported by both children 
and mothers after the disclosure process (53, 65, 67). 
 
2.10 Family-centred maternal HIV-disclosure interventions  
Family-centred approaches to HIV prevention and care have been promoted as important for 
improving overall family health (68-71). Given that there is little research to guide 
interventions in South Africa, developing an understanding of the factors that are associated 
with disclosure is an essential step towards designing family-centred interventions that will 
assist families to respond to HIV. While disclosure of HIV status by a parent to a child is a 
complex, challenging, psychological and social process, it is also considered a critical 
element of strengthening the capacity of families with children to respond to HIV in high 
HIV prevalent communities (72-74). The feasibility of maternal interventions in sub-Saharan 
Africa depends on where the intervention happens (75) (home or health facility), who the unit 
of the intervention is (child or extended family household structure), what human resources 
are available, and whether these can be scaled up.  
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2.11 The Amagugu intervention 
Amagugu is a home-based maternal HIV-disclosure intervention that was implemented in 
sub-Saharan Africa (73, 76, 77), and is explained in detail in the Methodology section (see 
page 36). The Amagugu intervention enrolled 281 HIV-infected women with their primary 
school-aged HIV-uninfected children. The current PhD study is nested within this larger 
Amagugu study. The Amagugu study explored whether a family-centred maternal HIV-
disclosure intervention was feasible and acceptable and whether the intervention package 
would increase maternal disclosure rates in a poor-resourced setting with very high HIV 
prevalence (73, 76, 77).  
2.12 Current PhD study 
The current study was conducted at the Africa Centre for Population Health 
(www.africacentre.ac.za), now the Africa Health Research Institute (AHRI) (www.ahri.org) 
in the Hlabisa sub-district of Umkhanyakude District in rural northern KwaZulu-Natal, South 
Africa. Using a mixed methods approach, this study explored in more depth the experiences 
of women involved in the Amagugu intervention. This includes their interaction with the 
clinic staff in their primary health care clinics where they access HIV treatment and care 
during the health intervention with their children described below (4.3.6.2 on page 43). The 
PhD study used:  
i. Quantitative data collected through semi-structured questionnaires from the 281 
women enrolled in the Amagugu study  
ii. Qualitative data collected through in-depth and semi-structured interviews from a sub-
sample of 20 women enrolled specifically for this PhD 
iii. Quantitative and qualitative data collected through semi-structured questionnaires and 
focus groups from 87 clinic staff from the Amagugu women’s primary health care 
clinics specifically enrolled for the PhD  
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3. Literature Review 
3.1 HIV-disclosure  
For the purpose of this thesis, HIV-disclosure is defined as sharing of information about 
one’s seropositive HIV status with others (78). Maternal HIV-disclosure refers to an HIV-
infected mother disclosing her seropositive status to her children. Maternal HIV-disclosure 
can be categorised into no disclosure, partial disclosure and full disclosure of HIV status (79). 
No disclosure refers to a mother telling a child nothing about her or the child’s HIV infection. 
During partial disclosure some information about an illness is shared with a child, for 
example a mother may tell her child that she is taking medication for an illness or a virus but 
not divulge the name of the virus. Full disclosure is when full information about the illness is 
provided, for example, a mother telling her child that she (the mother) is HIV-infected (77). 
HIV-infected women may decide to disclose their status to others, including their children, 
for various reasons including a need to obtain social support (80). 
3.2 Social support 
Social support refers to the financial, practical, emotional, spiritual or emotional assistance 
that is provided to an individual especially after they have disclosed their vulnerability in a 
particular aspect of their life, for example disclosure of an HIV infection (59). This could 
include money for transport in order to access health care and food to take with medication, 
reminders to take medication, and assistance in caring for children in case of hospitalisation 
or illness (81-84). Social support has the potential to be an important family strengthening 
activity in areas of high HIV prevalence, however, it is challenging for people living with 
HIV to receive the necessary support without disclosing their HIV status. (68). Social support 
is particularly important for HIV-infected individuals to access and adhere to HIV treatment 
(4, 85). Health care workers often encourage people infected with HIV to disclose to at least 
one person for social support (4, 86). 
3.3 Parental HIV-disclosure 
Three literature reviews (55, 87, 88) and a systematic review (89) demonstrate the lack of 
maternal HIV-disclosure intervention studies for primary school-aged children in sub-
Saharan Africa. Most studies on maternal HIV-disclosure have been conducted in the United 
States with low-income African-American families, and include adolescents (67, 90, 91) 
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rather than primary school-aged or younger children, as is now recommended by the World 
Health Organization Guidelines (46). In contrast there are numerous studies on HIV-infected 
women’s disclosures to partners and other adults in their lives (92-94). There is a dearth of 
literature providing guidance for interventions to support maternal HIV-disclosure (77, 88, 
95, 96), particularly in sub-Saharan Africa, where the number of HIV-affected children is 
increasing rapidly (36, 37). Limited literature suggests that disclosure of parental HIV status 
may potentially cause psychological harm as children may not be equipped to handle the 
implications of disclosure (52, 53). 
Murphy’s review (55) examined factors affecting maternal HIV-disclosure, including 
maternal health status, questions asked by children, child age and gender, fears regarding 
disclosure outcomes, maternal disclosure regrets and disclosure advice received by mothers. 
Other factors examined by Murphy included characteristics of children who were aware, and 
unaware of maternal HIV status, what influenced children’s reactions to disclosure, and 
child-coping and problem-solving skills and perceived HIV-related stigma.  
A review by Hawk (87) examined rates and predictors of disclosure, reasons for non-
disclosure, how mothers executed their disclosure plans and adjustment of families following 
disclosure. The author suggested further development of structured interventions to assist 
mothers and their families with the disclosure process. A comprehensive literature review 
conducted for the current study revealed that available research on maternal HIV-disclosure 
is mostly descriptive and from resource-rich settings (88). It further concluded that the key 
role played by the family should be considered when designing parental disclosure models 
for sub-Saharan Africa.  
Qiao and colleagues (89) examined disclosure rates, the disclosure process, and reasons for 
and impacts of disclosure and non-disclosure in their systematic review. Their review 
emphasized the importance of building evidence-based, developmentally and culturally 
appropriate, interventions to assist HIV-infected parents to disclose to their children, 
particularly in resource-poor settings.  
3.4 The World Health Organization HIV-disclosure Guidelines for Children  
In 2011, the World Health Organization (WHO) issued HIV-disclosure Guidelines 
recommending disclosure to children, including those below 12 years of age, of their own 
HIV status and that of their parents and caregivers (46). The purpose of the guidelines is to 
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assist health care workers to support children and their caregivers with complex disclosure 
issues. The guidelines were intended to be part of a comprehensive approach towards the 
holistic wellbeing of a developing child and as a part of the continuum of HIV care in HIV-
affected families. The guidelines were informed by evidence from a comprehensive literature 
review (72) and acknowledge that how disclosure takes place may vary from culture to 
culture and can be adapted to different geographical areas. The guidelines recommend that 
disclosure initiatives should be accompanied by efforts to increase availability and 
accessibility of HIV treatment and management of stigma associated with being infected or 
affected by HIV (72). 
Despite the WHO recommendations, both health workers and caregivers continue to express 
a lack of knowledge and skills with regards to disclosure to children (97-100). The guidelines 
recommend full disclosure to children of school age (from age 6 up to 12 years) and partial 
disclosure to younger pre-school children. The findings of the WHO review revealed that 
caregivers who disclosed had better outcomes in terms of their own ART adherence than 
those who did not disclose (64, 101, 102). In an American study where disclosure to children 
was forced due to maternal ill-health, negative outcomes following disclosure including 
changes in the child’s behaviour were reported (67). The WHO review, however, reported 
greater understanding of HIV amongst children who were disclosed to, compared to children 
who were not disclosed to (72, 103). However, it is important to note that all data were based 
on maternal reports; future studies could usefully explore children’s perspectives on this 
issue. The WHO review also acknowledged that their findings were limited by the small 
number of eligible studies.  
3.5 Maternal HIV-disclosure 
Maternal and child benefits as a result of disclosure have been reported (55, 87-89) and can 
be categorised into psychological, physical and social outcomes. Mothers’ disclosure has 
been linked to improved maternal mental health as a result of being relieved from the burden 
of keeping their HIV status a secret, and decreased depression, stress and anxiety (58, 63, 66, 
104, 105). Social and physical benefits include increased social support and improved 
physical health due to improved ART adherence (64, 106, 107). The psychological benefits 
for children include decreased depression over time as a result of custody planning (108, 
109), increased HIV knowledge and a positive association between disclosure and active 
planning for the future (83, 103, 108, 110). Higher family cohesion and improved mother-
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child relationships are some of the benefits for both mothers and children (66, 67, 83, 111) 
despite the initial negative emotional reactions of children reported in some studies (55, 67). 
An improvement in the quality of the mother-child relationship is related to psychosocial 
adjustment and higher perceived social support (105, 106). Furthermore, negotiating lifestyle 
changes that HIV treatment requires may promote family communication and cohesion (107). 
Many mothers do perceive better relations with children following disclosure, citing greater 
closeness, expressed affection, and children’s supportive behaviors (66, 107, 112).  
3.6 Motivations for disclosure and non-disclosure 
Whilst the benefits of disclosure are known, issues of stigma still prevail both globally (108, 
113, 114) and locally in African settings (53, 84, 115, 116). Disclosing to children is a 
daunting task for a number of reasons, including the perceived immaturity of children to 
handle maternal HIV-disclosure (52, 117), HIV-related stigma (96, 113, 114, 118), 
uncertainty about the child’s reaction (77), and a perception by mothers that they lack the 
skills to undertake HIV-disclosure (52, 55, 64, 77, 84, 87, 89, 116, 119). Most studies have 
found that reasons for non-disclosure to children usually fall into three main categories: 
practical (84, 113, 116), emotional (59, 65, 84, 113, 116) and HIV-related stigma (67, 96, 
118, 120). These reasons are shown in Box 1 (88). Lack of emotional maturity in children 
was cited by mothers as their reason for non-disclosure in studies in Burkina Faso (121), 
South Africa (53) and the United States (90). Similarly, reasons for disclosure to children 
were based on practicality in the American studies (66, 79, 83), including that it was better 
for the children to hear about the maternal diagnosis from the mothers themselves than from 
someone else.  
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Box 1: Reasons given by mothers for disclosure or non-disclosure of their own HIV 
status to their children 
Reasons for disclosure 
Practical  
 Wanted children to hear their HIV status from them and not from other people (65, 
66, 105) 
 Wanted to respond to their children’s questions about HIV/AIDS after hearing about 
HIV from others or observing parents taking medication (105, 122)  
 Wanted to educate their children about HIV and protect them from HIV (59, 66) 
 Concerned that their own health was deteriorating (63, 67, 123) 
 Felt children were developmentally ready for disclosure (67) 
 Wanted to make custody plans for their children (83) 
 Wished to have support from their children (81, 84) 
Moral  
 Felt that disclosure was the right thing to do (83) 
Emotional  
 Could not bear to keep a secret any longer from their children (83) 
 
Reasons for non-disclosure 
Practical  
 Did not know how to disclose (52, 64, 84, 116)  
 Lacked perception of the benefits of disclosure for children (84) 
 Concerned that children might ask how their mothers became HIV-infected (83) 
 Perceived inability of children to keep secrets (52, 53, 64, 81, 83) 
Emotional  
 Felt their children deserved a worry and carefree childhood (59, 65, 83) 
 Concerned about children’s internalizing problems (52, 53, 64, 66, 119, 122) 
 Felt children were too young (64, 66, 116, 119, 122, 124) 
HIV-related stigma 
 Wanted to protect children from stigma (67, 81, 108, 113, 116, 119, 122, 124) 
3.7 HIV-related stigma 
Stigma was used by Goffman in his seminal analysis of the term to refer to “an attribute that 
is deeply discrediting” (125). In the case of HIV-related stigma, it would be the HIV-
infection that is a discrediting attribute (126). HIV was initially associated with marginalised 
groups such as sex workers, homosexuals and injection drug users (127), but it has remained 
a stigmatising disease even in other mainstream populations (126, 128-131). It is argued that 
stigma is largely a social construct and defined contextually; what may be viewed as 
stigmatising in one context may not be viewed as such in another context (132). HIV-infected 
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children may also be victims of what Goffman referred to as courtesy stigma or stigma by 
association (125, 133), due to sharing the same residence as HIV-infected family members 
including their parents. As such, interventions to mitigate HIV-related stigma need to adopt 
family-centred approaches rather than individualised approaches (68, 69). When addressing 
HIV-related issues including stigma, some have argued that individualised approaches to HIV 
are not pragmatic because HIV is a family disease (68, 69, 134).  
3.8 Theoretical models/ frameworks of disclosure 
Over the years scholars have developed theoretical models in an attempt to inform the 
designs of disclosure studies and interventions (135). In their critical review of theoretical 
models of disclosure, Qiao and colleagues found few models or frameworks in the HIV field 
as a whole, but identified three major theoretical models of disclosure (135). The Four-Phase 
Model, the Disclosure Decision Model and, the Disclosure Process Model.  
3.8.1 The Four-Phase Model 
The Four-Phase Model is based on the work of Elizabeth Kubler-Ross (1969) who proposed a 
framework for understanding the feelings experienced by terminally ill patients (136). The 
Four-Phase Model itself was developed by Tasker (1992) in an attempt to provide guidance 
to HIV-infected parents on how to disclose their own status and that of their HIV-infected 
children to the children themselves (137). The model does not only focus on the role played 
by caregivers in executing disclosure to children, but also highlights the role of health 
professionals in guiding parents with disclosure of their own seropositive status and that of 
their children (135). Though the model has been supported by a few qualitative studies 
indicating that parents require disclosure assistance and guidance from health professionals, it 
needs to be applied with caution in collectivist cultural settings where children might have 
multiple caregivers with conflicting opinions regarding disclosure to a child, as opposed to 
individualistic cultures (135). Another critique of the Four-Phase Model is that parents may 
not want health professionals to be directly involved in their disclosure to children (59, 66).  
Tasker explains disclosure as a process with four phases: 1) secrecy phase; 2) exploratory 
phase; 3) readiness phase, and 4) disclosure phase (137). It is important to note that this 
model was developed before the introduction of ART, when HIV was still effectively a 
terminal illness (137). The Four-Phase Model should therefore be applied with caution in the 
current context where HIV is regarded as a chronic rather than a terminal illness. Since the 
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model does not identify other factors, such as full or partial disclosure, that are involved in 
the disclosure decision making process, Qiao and colleagues argue that applying it to predict 
disclosure or non-disclosure is a challenge (135). Table 3 shows a description of the Four-
Phase Model.  
Table 3: The Four-Phase Model adapted from Qiao 2012 (135) 
Behavioural patterns or needs of HIV-infected parents and health professionals 
Phases HIV-infected parent Professional 
Secrecy  Feels shock, loneliness and isolation  
 Identifies trusted adults to disclose to 
 Professionals may be the only people 
available to share feelings with  
 Respects the parents’ need for 
confidentiality 
 Creates a trusting and a safe 
environment for parents to discuss 
disclosure issues 
Exploratory  Searches for parental support groups 
to explore disclosure to children 
 Considers talking to children about 
medication and clinic visits 
 Recognises that the ultimate 
decision to disclose lies with 
parents 
 Expresses honest opinions to 
provide different perspectives.  
Readiness  Moves closer to disclosure to children 
 Makes disclosure plans and discusses 
strategies with other trusted adults 
 Collaborates with parents in 
planning disclosure 
 Mutual respect for knowledge and 
skills of both parents and 
professionals 
Disclosure  Executes a disclosure plan with or 
without presence of professionals 
 
3.8.2 The Disclosure Decision Model (DDM) 
According to Julia Omarzu who designed the Disclosure Decision Model (DDM), the 
disclosure event has four critical components (138). These critical components are the depth 
(how intimate or private is the information shared), the breadth (the number of topics covered 
during the disclosure), the duration (time spent disclosing), and the emotional content 
(emotions expressed during disclosure including love or guilt); each of which impact on how 
the disclosure target will respond to disclosure (138). The DDM is influenced by different 
theoretical perspectives listed below: 
 The Social Influence Theory as developed by Paul Lazarsfers and colleagues in the 
1940s and 1950s within the social communication theory (139, 140). The theory 
proposes that a person’s behaviour, attitudes or feelings are influenced by their 
interactions with others (139, 140). 
 The Disease Progression Theory suggests that disclosure occurs as a result of 
declining health, when an individual can no longer conceal the symptoms of a disease 
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(80). With the advancements in HIV care and treatment, the Disease Progression 
Theory is becoming less applicable as HIV-infected individuals are living longer and 
healthier lives (80).  
 The Consequence Theory suggests that the relationship between disease progression 
and disclosure is moderated by what an individual may anticipate to be the 
consequences of disclosure after weighing risks and benefits (80). As the disease 
progresses there is a need to evaluate consequences of disclosure; if benefits and 
rewards of disclosure outweigh the risks, people opt for what would offer them 
personal satisfaction (80). This theory is aligned with Thibault and Kelly’s social 
exchange theory asserting that individuals avoid costly interactions and seek to 
maximize personal gains (141).  
 
The DDM explains disclosure through decision making stages resulting in different types and 
levels of disclosure (135). During the first stage there is an assumption that there are goals to 
be realised through disclosure. At least one of these goals needs to be deemed important and 
accessible for disclosure to be considered a social strategy. In the second stage, a particular 
goal is identified and initiated, then, an individual strategizes on how to execute that goal. 
During the third and final stage, an individual evaluates relative risks and benefits of 
executing their identified goal and determines the depth, breadth and duration of disclosure 
(135). The DDM further suggests that both the discloser and the disclosure target may 
influence the disclosure process; how the disclosure target reacts to disclosure can determine 
whether disclosures to others will occur in future (135). The model acknowledges that 
disclosure is a complex phenomenon influenced by various factors including perceived 
benefits and risks, and thus emphasizes a thoughtful process of weighing those benefits and 
risks (135, 142).  
3.8.3 The Disclosure Process Model (DPM) 
The Disclosure Process Model (DPM) was first designed by Chaudoir and Fisher to provide a 
framework for studying stigmatising conditions but was later modified for HIV-disclosure 
(78). It is aimed at assisting researchers to answer two important questions; when and why 
interpersonal disclosure may be beneficial in stigmatising circumstances. It has four main 
components: 1) the antecedent goals; 2) the disclosure event; 3) mediating processes, and 4) 
outcomes and the feedback loop (143). These are discussed in detail below.  
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The DPM is based on the principle that people will disclose if they believe disclosure will 
assist them towards their intended goals, or antecedent goals (138, 143). For example, if a 
discloser perceives that they will obtain social support after disclosing, they are more likely 
to disclose (138, 143). It also proposes that people’s behaviours are regulated by two separate 
motivational systems; the approach and avoidance dimensions. Approach goals-oriented 
individuals are focussed on the prospect of a positive outcome in pursuit of their desired goal. 
They narrow the gap between themselves and their goals. Conversely, the avoidance goals-
oriented people are focussed on the possibility of a negative outcome in pursuit of their 
desired goal. They extend the gap between themselves and their goals. Chaudoir and Fisher 
argue that avoidance and approach goals are what ultimately shape how individuals perceive 
and respond to the environment (143). Those with avoidance goals are at a physical health 
risk if, for example, they cannot access and adhere to ART as a consequence of non-
disclosure (144-147).  
Disclosure impacts on every domain of a discloser’s life (78). Multiple types of mediating 
processes may influence a person’s disclosure outcome at individual, dyadic and social 
contextual levels (110, 123). At an individual level a person may benefit by improved mental 
health (65, 66). The dyadic context suggests that disclosure has implications for both the 
discloser and the disclosure target (142). As a social outcome, disclosure may create HIV 
social awareness, helping in the reduction of HIV-related stigma (148). Receiving favourable 
feedback from a disclosure target following disclosure increases the likelihood that the 
discloser will disclose to others in future; conversely, if the feedback received is negative, it 
would decrease the likelihood of disclosure being repeated in the future (143). 
There is consensus amongst the three theoretical frameworks that before embarking on 
disclosure, the discloser weighs risks and benefits (135). The need for social support seems to 
be the biggest motivator for disclosing in all three frameworks. It would benefit future 
disclosure interventions to consider how individuals make disclosure decisions and what their 
biggest motivators for disclosing are.  
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3.9 Predictors of disclosure 
3.9.1 HIV-disclosure to other adults  
Whilst there is a dearth of literature on maternal HIV-disclosure to HIV-uninfected primary 
school-aged children, numerous studies have investigated HIV-infected women’s disclosure 
to other adults including partners, family and friends (149-155).  
It is assumed that increased social support would lead to decreased stigma (2). Women 
infected with HIV in particular, disclose their status to their partners in order to practise safe 
sex as part of living positively with HIV infection (75, 156-158). Disclosure to partners poses 
its own challenges, including fear of HIV-related stigma (78, 82, 126, 152, 154, 158-165), 
blame for the HIV transmission, possible abandonment and violence from the partners (82, 
150, 155-158) but many studies report support from partners, family and friends following 
disclosure (153-155, 166-170).  
The benefits of disclosure to partners include social support, safe sex, and access and 
adherence to HIV treatment (2, 155, 157, 171). In American studies disclosure to live-in 
partner and children was associated with ART and medical appointment adherence; 
conversely, less disclosure to children was associated with poor medical appointment 
adherence (85, 172).  
Studies of disclosure to other adults have identified various predictors of HIV-disclosure: 
longer duration of HIV diagnosis; (92, 152, 155, 173), higher educational status (159, 166, 
174), older age (155, 175), being married or living together (82, 175-177), being on ART 
(178), and knowledge of partner’s status (92, 167, 176) increased likelihood of disclosure. 
 
3.9.2 Developmental stage of a child  
Early literature on children and illness has demonstrated that as children grow, so does their 
understanding of illness (105, 179-181). In their research, Christ and Christ, wrote about 
children’s understanding of a parent’s terminal illnesses such as cancer (180). They 
recommended that children be provided with age-specific information. The same 
recommendation can be applied to parental disclosure of HIV infection. The WHO Parental 
Disclosure Guidelines suggest that disclosure to children should be tailored to their cognitive-
 22 
 
developmental ability to understand the information (46). A recent Kenyan study of parental 
HIV-disclosure suggested that HIV-infected parents with both HIV-infected and HIV-
uninfected children preferred partial disclosure from the age of five years and full disclosure 
from ten years onwards (182). 
3.9.3 Maternal health status 
Mothers are advised to consider their health status before they disclose their HIV status to a 
child in order to avoid distressing the child (73). Contrasting evidence has been reported on 
maternal health status and disclosure with some mothers preferring to disclose whilst they are 
still healthy (66). Mothers with lower CD4 cell counts reported to have disclosed more 
frequently than those with higher CD4 cell counts in one study (52), while in another study 
the severity of a mother’s illness was not significantly related to disclosure (103). In a further 
study, there were no significant differences in medical variables such as CD4 cell count 
between mothers who had disclosed to their children and those who had not (106).  
Most studies have relied on maternal reports, however, in one of a few studies conducted 
with children in Kenya, children expressed a desire for parents to disclose when they are 
feeling well (183). The reasoning behind this statement was that having observed their 
mothers when they were very ill at was too traumatising for the children concerned (183). 
However, mothers expressed that there may be a case to disclose fully to children in 
exceptional cases, for example if the mother was too weak to do anything for herself so that 
children would be able to offer practical help including taking her to hospital or collecting her 
medication (183). The Kenyan study did not, however, interview parent-child dyads but 
separately interviewed parents, and both HIV-infected and uninfected children who were not 
from the same families.  
3.9.4 Access to HIV treatment and care 
In a situation where the mother has not accessed HIV treatment and care services, delaying 
disclosure to a child is recommended until the mother is able to access such services (73). It 
is beneficial for a child’s mental health to see their mother physically well and living 
positively with HIV (74, 184, 185). In a study from the US, even adults who planned to 
disclose to other adults delayed disclosure when they were ill and waited until they were on 
ART and looking well (178). Numerous studies suggest that when children are aware of their 
mothers’ HIV status and that their mothers are taking ART, they become actively involved in 
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monitoring and reminding them to take their HIV treatment (85, 101, 102, 113, 186, 187), 
thereby improving their mothers’ ART adherence.  
3.9.5 Child-friendly health facilities 
Ensuring that children have adequate social support following disclosure of maternal HIV 
status is critical (46). Increasing children’s access to health care support networks has the 
potential to improve health outcomes in families (188, 189). The challenge is that most health 
care facilities do not prioritize health promotion and are not child-friendly (190, 191). Health 
care facilities are not designed to meet the needs of children, therefore children find health 
care facilities frightening spaces (192, 193). Moreover, the medical terminology used in 
health facilities is not child-friendly (192-196). In resource-poor settings, health promotion is 
a low priority due to staff shortages (197-199) and health care facilities being over-burdened 
(35, 200). Resource-rich settings also struggle with health promotion among children in 
primary health care (190, 201). Other barriers to child-friendliness include a lack of 
infrastructure and staff fatigue (197, 202). A multi-site study in Kosovo, Uganda and Pakistan 
found that children, health care staff and parents expressed frustrations about poor health 
systems in terms of disseminating health information (190). Providing training and simple 
tools for child-friendliness and health promotion in a resource-poor, high HIV prevalence 
area, was well accepted by health care workers and HIV-infected mothers (97). 
3.9.6 Duration of maternal HIV diagnosis and disclosure patterns 
Most studies suggest an association between the duration of time since an HIV diagnosis and 
disclosure. A multinational study conducted in Tanzania, Kenya and Namibia found that 
those who had known their status for more than three years were more likely to disclose than 
those who had known it for less than a year (173). Similar findings have been observed in 
South African studies (148, 155), an Ethiopian study (92) and a Thai study (203). However, 
in a Ugandan study, 83% of the participants disclosed to someone on the day they received 
their HIV-positive results (156), while in a South African study of PMTCT attendees 72% 
disclosed their HIV status to their partners within a week of being diagnosed with HIV (75). 
The high disclosure rates in Uganda could be attributed to the participants being members of 
The AIDS Support Organization (TASO) (156). In the South African study the motivation for 
disclosure could have been the social support which the mothers received, especially with 
their infant feeding option as they were also enrolled in an infant diagnostic study (75).  
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3.9.7 Social exposure to HIV 
Due to high HIV prevalence and roll-out of treatment and care in local health services, many 
households in sub-Saharan Africa are now socially exposed to HIV. Research conducted in 
rural South Africa indicated that 40% of the population shared a household or living 
arrangements with people who were either initiated on ART or were enrolled in pre-ART 
care (204). Similar findings were observed in a study of HIV-infected pregnant women who 
were attending an antenatal clinic in an urban setting in South Africa: 36% of women 
reported knowing someone who was HIV-infected, of whom 72% were their family members 
(162). Knowing someone who is also HIV-infected increased the likelihood of disclosure in 
studies from Ethiopia and Tanzania (92, 205).  
3.9.8 Custody planning 
An association between disclosure and custody planning has been documented in the 
literature (83). In the US study, where 50% of mothers had disclosed their HIV status to their 
children, over 50% of the mothers had also made formal custody plans (110), with the 
majority nominating female relatives as guardians. In another US study, mothers who had 
disclosed wanted to open communication regarding custody of their children (186). Two Thai 
studies indicated that mothers made use of extended family networks as part of Thai culture 
when making custody plans (203, 206). Most Thai mothers made custody plans with aunts 
and uncles (54%), whilst 27% chose grandparents (203). For HIV-infected parents who were 
African immigrants in Sweden, custody planning was particularly difficult as they were 
separated from their extended families (207). There has been an increase in interventions to 
assist with making custody arrangements over recent years (73, 76, 185, 208, 209). 
3.9.9 Socio-cultural factors affecting disclosure in sub-Saharan Africa 
3.9.9.1 Intergenerational communication gap 
Discussions around HIV invariably include discussions about sex. In the African context, it is 
particularly difficult for parents to engage in discussions about sexual topics ‒ including HIV 
‒ with children, when these issues are considered taboo (84, 116, 210). For example, amongst 
Batswana people, living in Botswana, it is considered inappropriate for children to discuss 
sexual matters with their parents (116). Similar observations were made in Asia, where a 
qualitative study from Thailand revealed that parents’ HIV status and their HIV-related 
 25 
 
deaths are very sensitive topics with adults creating a “wall of silence” around children 
regarding these matters (120). An American study of Asians immigrants (East, Southeast and 
South Asian) reported similar findings that sexual behaviour, illness and death were taboo 
subjects in Asian cultures, hindering HIV discussions and disclosure processes with children 
(211). There have been interventions to narrow the intergenerational gap. One such 
intervention is the Collaborative HIV/AIDS and Adolescent Mental Health Programme 
(CHAMP), conducted in South Africa (212). This intervention was adapted from an 
American programme with the same name and sought to facilitate communication between 
pre-adolescents and their families as an HIV prevention strategy through promoting 
resiliency (212).  
3.9.1.2 Faith and religion 
People’s faith plays an integral part in their understanding of the illness and the type of 
treatment they will access. In sub-Saharan Africa, the issue of faith cannot be underestimated 
when designing interventions to assist HIV-affected families (151, 164). A multinational 
HIV-disclosure study in South Africa, Swaziland, Malawi, Lesotho and Tanzania, found that 
HIV-infected people found strength in their faith to help them disclose their status (164). In a 
Nigerian study, almost 30% of participants disclosed to their pastors which was three times 
the number that disclosed to siblings and friends (82). In a Kenyan study, pastors were at the 
top of the list that people living with HIV (PLWH) disclosed to, indicating an important role 
played by religion when dealing with life changing experiences.  
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3.10 Thesis themes 
This thesis focused on three main themes, tabled next.  
Table 4: Thesis themes 
 
Themes 
1. HIV-disclosure 
and stigma 
2. HIV-disclosure and 
family strengthening  
3. HIV-disclosure 
and access and 
adherence to HIV 
treatment care  
Key 
messages 
Stigma and lack of 
family disclosure 
may limit HIV 
prevention and 
treatment efforts. 
Family disclosure 
interventions may increase 
disclosure and family 
communication. 
Stigma impacts most 
directly at a family 
level, rather than at a 
community level, so 
interventions targeting 
communities may not 
change mothers’ 
health behaviours as 
much as home-based, 
family-centred 
disclosure change 
strategies. 
Paper I 
Maternal 
HIV-
disclosure 
literature 
Reasons for 
maternal disclosure 
and non-disclosure 
to children show 
that disclosure can 
increase family 
communication and 
reduce stigma. 
There is a relationship 
between maternal HIV-
disclosure and ART 
adherence. Disclosure of 
maternal HIV to children 
is not common, or even 
considered by mothers to 
be necessary for children’s 
well-being. Family HIV-
disclosure interventions 
increase the number of 
people to support HIV 
treatment adherence in the 
home. 
Maternal disclosure 
has health and 
relationship 
advantages for both 
the mother and the 
child. 
Paper II 
Living with 
HIV in an 
ART-era 
Implications of 
stigma on maternal 
access to HIV 
treatment and care. 
Increased access 
reduces stigma but 
stigma can still 
remain a barrier, 
especially in close 
relationships and 
families. 
Access to HIV treatment 
changes community level 
perceptions of stigma, but 
not necessarily the 
individual behaviour of 
mothers. Disclosure to 
other adults takes time, 
even to partners, but often 
happens on its own over 
time in stable 
relationships. 
Social support, 
relationships, and 
living arrangements 
are important and 
intertwined with 
disclosure. 
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Paper III 
Maternal 
HIV-
disclosure 
experience 
Consequences of 
family disclosure 
on reducing family 
stigma and 
increasing support 
for maternal HIV 
treatment. 
Capacity of children to be 
an important part of their 
mother’s ART adherence 
or adjustment to living 
with HIV. 
Mothers need support 
to develop skills to 
disclose their HIV 
status to their children 
and these skills also 
support adherence to 
their own HIV 
treatment. 
Paper IV 
Improving 
the capacity 
of families 
and clinics 
for maternal 
HIV-
disclosure 
Health service-
centred 
interventions can 
reduce clinic level 
stigma and help 
health care staff, 
including nurses, 
recognise the 
strength of mothers 
and the role that 
children can play in 
supporting 
adherence in their 
mothers. 
Family disclosure 
interventions had a 
positive impact on 
mothers’ confidence to 
take their children with 
them to their treatment 
clinic. 
Maternal-centred 
interventions can 
reduce perceived 
stigma and increase 
maternal engagement 
with health services. 
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The study was informed by a conceptual framework after a comprehensive literature review 
(88). The conceptual framework is discussed below.  
Figure 2: Conceptual framework 
 
The conceptual framework in Figure 2 above, illustrates how the presence or the absence of 
HIV treatment impacts on how HIV-infected mothers cope with their infection, including 
how family support increases disclosure, and access and adherence to HIV treatment. After 
being diagnosed with HIV, a woman may adopt either one of two coping strategies - active or 
avoidance coping (74). Active coping is an ideal strategy as it allows an HIV-infected mother 
to embrace rather than avoid her HIV status. Thus she addresses the situation positively by 
employing mechanisms to assist her, including disclosure to others for social support. 
Through maternal HIV-disclosure, communication channels between a mother and her child 
are opened, allowing for HIV education and prevention to her child and improved family 
cohesion. Those who opt for avoidance coping prefer to keep their diagnosis a secret. The 
secrecy causes mothers distress and results in poor mental health and poorer parent-child 
communication. The child is at a disadvantage as they are not provided with HIV education 
to protect themselves from HIV infection. Children are also unable to engage in custody 
planning in case of a mother’s hospitalisation or death. When treatment is not available it 
might be easier to opt for avoidance coping and have no hope for the future, but as HIV 
treatment has become more widely available and HIV-infected mothers are surviving longer 
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to care for their children, then disclosure becomes increasingly necessary for social support 
and improving access and adherence to ART.  
3.11 Conclusion 
In this literature review I have defined HIV-disclosure in general and specifically reviewed 
the global literature on parental/ maternal HIV-disclosure. The review indicated a lack of 
maternal HIV-disclosure interventions for uninfected primary school-aged children in sub-
Saharan Africa (88) (See Figure 1 in Paper 1). Although there are theoretical frameworks and 
models to assist in the understanding of HIV-disclosure, some of their components are no 
longer applicable, as HIV has evolved from being regarded as a terminal illness to being a 
chronic illness.  
However, common reasons for disclosure and non-disclosure are reported across all maternal 
HIV-disclosure studies, particularly the need for social support and the fear of HIV-related 
stigma. Maternal and child variables, including duration of HIV diagnosis, access to HIV 
treatment and care, custody planning for mothers, and developmental age and social exposure 
to HIV for children, may predict disclosure. Socio-cultural contexts including faith or religion 
and cultural practices, such as how parents discuss HIV and sex-related topics with their 
children, need to be considered when designing family-based disclosure interventions 
including maternal HIV-disclosure interventions. These factors may impact on the failure or 
success of these interventions.  
The next chapter describes the methodology, both qualitative and quantitative, used in the 
current study to explore the experiences of HIV-infected women enrolled in a maternal 
disclosure intervention. The maternal HIV-disclosure views of the health care workers where 
these women and their families receive HIV treatment, care and support were also 
investigated to understand how HIV-affected families can be further supported by health care 
facilities to manage HIV in the sub-Saharan African context.  
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4. Methodology 
This chapter first describes the Amagugu maternal HIV-disclosure intervention within which 
the current PhD is nested. Data from the Amagugu study were used to describe the 
demographic characteristics of the sample, to investigate HIV-disclosure by the enrolled 
women to other adults and children prior to the intervention, and their experiences of 
participating into a health intervention. I enrolled 20 of these women into a further sub-study 
specifically for my PhD to explore qualitatively the women’s experiences of living with HIV 
in an ART-era and their experiences of being part of a maternal HIV-disclosure intervention. 
As part of Amagugu intervention, I led a health intervention and trained health care staff on 
maternal HIV-disclosure and child-friendliness in preparation for maternal HIV-disclosure. 
This was implemented to improve mothers’ health care and custody planning and to increase 
children’s access to a health care and social support network. For the current study I used 
qualitative data from focus groups and semi-structured questionnaires. I administered 
questionnaires and conducted focus groups with 87 clinic staff from the nine clinics where 
mothers in the Amagugu study were receiving their HIV treatment and care. I will describe 
my roles in both the Amagugu study and the PhD study. Women who enrolled in the 
Amagugu study were previously part of the Vertical Transmission Study (VTS). Both the 
VTS and the Amagugu study, including the Amagugu intervention package, are explained 
below.  
4.1 The Vertical Transmission Study (VTS) 
The current study enrolled women and their primary school-aged children who had 
previously participated in the Vertical Transmission Study (VTS, 2001-2006). The VTS 
assessed HIV transmission risks and survival associated with exclusive breastfeeding and 
other types of infant feeding (38, 213). The VTS was conducted at the Africa Health 
Research Institute between 2001 and 2006 and was funded by the Wellcome Trust (Grant 
Number: 097410/Z/11/Z). In the VTS women were tested for HIV, for the first time, as part 
of a PMTCT programme which was implemented in the Umkhanyakude District from 2001 
(214). The VTS enrolled approximately 3,000 HIV-infected and HIV-uninfected women 
from eight antenatal clinics in the Hlabisa sub-district and one clinic outside Durban. Women 
were enrolled during pregnancy and subsequently followed-up with their infants for two 
years after delivery to assess vertical HIV transmission, morbidity, mortality and growth of 
infants associated with exclusive breastfeeding and other types of infant feeding (38, 215, 
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216). The morbidity and mortality of women was documented, in addition to any breast 
health problems they encountered (213, 217, 218). Women choosing to breastfeed were 
supported to exclusively breastfeed by breastfeeding counsellors who visited them at their 
homes during the first six months after delivery (213). The breastfeeding counselling visits 
were strongly associated with adherence to cumulative exclusive breastfeeding (213, 219). 
Four years after the completion of the VTS, in 2010, when the participant children were 
between 6 and 10 years of age, we tracked and sought informed consent from only the HIV-
infected mothers who had given birth to HIV-uninfected children to enrol into a new study 
called “Amagugu” - a family-centred maternal HIV-disclosure intervention (73, 76, 77) 
funded by the Canadian International Development Agency (CIDA). 
One of the challenges of identifying and locating the previous VTS participants in the study 
setting was the extreme mobility of the population (220). The majority of the mobile phone 
numbers used during the VTS were no longer working, therefore most of the re-tracing of 
potential participants was carried out by individual home visits. During a dissemination 
workshop to share the VTS results with participants in 2006, most of the mothers had 
indicated that they wished to be contacted for future studies. If we could not find one of the 
VTS mothers at her homestead during the physical tracking, we left a message to ask her to 
send a free text message to the study mobile phone if they wished to be contacted about the 
Amagugu study. This strategy was useful in re-establishing contact with some potential 
participants. 
4.2 The family-centred maternal HIV-disclosure study (Amagugu) 
The Amagugu study aimed to assist HIV-infected mothers to disclose their HIV status to their 
HIV-uninfected primary school-aged children using culturally- and age-appropriate 
disclosure materials specifically designed for the study. The VTS had been a very well 
received and highly acceptable research study that had made a positive impact in the 
community. Consequently, when the Amagugu study was presented as a ‘continuation of 
VTS’ it was easy to rebuild rapport with previous VTS participants and to ask them to 
consider enrolling in the Amagugu study.  
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My roles in the VTS, Amagugu study and current study 
I was involved in various stages of the VTS including:  
 Raising awareness about the study before it commenced, conducting talks at the 
clinics, and presenting the study at community meetings; 
 Recruitment of participants; 
 Data collection; 
 Data cleaning; 
 Data analysis that resulted in a publication (214); 
 Dissemination of VTS results. 
As a Project Coordinator for the Amagugu study, my roles in the Amagugu and current study 
included, but were not limited to the following: 
 Communicating with stakeholders about the study including local tribal authority, 
local community, the Africa Centre’s Community Engagement Unit (CEU) and the 
Community Advisory Board (CAB); 
 Development of study tools;  
 Data collection; 
 Data quality control and assurance; 
 Data analysis resulting in various publications for the Amagugu study (73, 74, 76) and 
for the PhD study (88, 97, 184), including one paper in accepted in the journal Health 
Policy and Planning on 26 April 2017 
 Dissemination of Amagugu study results. 
A consort diagram (in 4.2.1 Figure 3) illustrates how the 525 HIV-infected women who had 
an HIV-uninfected child and were still under “follow-up” at the end of the VTS in the 
Hlabisa sub-district (and not the Durban cohort) were tracked for invitation to join the 
Amagugu study. 
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4.2.1 Figure 3: Consort diagram representing women enrolled into the Amagugu study 
Total Available Pool N=525
VTS mothers (Hlabisa sub-district) known to be HIV-infected with HIV-uninfected children at end of 2 year follow up.
Traced and excluded N=150
Mother found to be dead n=73
Child found to be dead n=5
Unable to locate mother n=14
Approached to participate N=375
Not eligible to enrol N=56
Unavailable during the study period  n=25
Child has disability n=2
Mother and child living separately n=22
Found to have relocated out of study area n=58
Refused n=28Enrolled N=291
Mother denies HIV positive status n=7
Completed session 1 (291/291)
Completed session 2 (285/291)
Completed session 3 (283/291)
Completed session 4 (282/291)
Completed post intervention survey N=281 (Final data set)
Withdrawals following session 1          n=6
Had not disclosed to live in partner (1) 
Relocated out of study area (1)
Felt disclosure was too daunting (1) 
Felt too concerned about stigma to continue (1)
Employment commitments (2)
Withdrawals following session 2           n=2
Maternal ill health (1) 
Employment commitments (1)
Withdrawals following session 3          n=1
Maternal death (1) 
Withdrawals following session 4                n=1
Relocated for employment, no longer interested (1) 
Completed session 5 and 6 (281/291)
Eligible to enroll N=319
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Following tracking of the 525 HIV-infected women, 375 women were approached to 
participate in the Amagugu study. Although the homes of the other 150 women were found, 
they were excluded from invitation to participate for various reasons including maternal or 
child death, mother was living outside the study area or the mother could not be located. Of 
the 375 women that were approached, 319 were eligible for enrolment but 28 refused to 
participate, and 56 were not eligible for enrolment for various reasons including child 
disability, mother and child living separately, mother unavailable during the study period and 
mother denying her HIV infection. Of the 291 mothers that were eventually enrolled, there 
was recognition that maternal HIV-disclosure was difficult as children were perceived to be 
young and unable to maintain confidentiality. However, the women welcomed the assistance 
that they were going to be provided during the Amagugu study. Ten mothers withdrew before 
completing all the Amagugu sessions, leaving a final sample of 281 mother-child pairs 
enrolled in the Amagugu study. Following informed consent, women that had been part of the 
VTS were enrolled to the Amagugu study if: 
 They acknowledged their seropositive HIV status 
 They had a 6-10 year old HIV-uninfected child that had been part of the VTS when 
the child was between 0-2 years 
 The mother was living with the child in the study area or the mother had regular 
access to the child at least two nights per week to ensure adequate support during the 
disclosure period 
 
The Amagugu study had two main stages. Stage 1 entailed preparation for disclosure through 
provision of disclosure tools to participating mothers, and one activity-driven family session 
involving other family members. Stage 2 was a health promotion visit which comprised of 
training the mother to undertake a health promotion visit with the child to the health facility 
following disclosure as an extension of the child’s support. 4.2.2. Figure 4 illustrates these 
home-based sessions and the data collection points of the Amagugu intervention. The study 
materials are described after this.  
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4.2.2 Figure 4: The Amagugu intervention data collection points 
Stage 2 Health promotion
Stage 1 Disclosure preparation 
Pre intervention assessment
Socio-demographic and health questionnaire; GHQ-12; PSI-36; 
Parent reported CBCL
Session 1 Positive Parenting (one-on-one counselling)
Purpose: Psycho-education on disclosure, assess readiness
Tools: Intervention steps poster and calendar
Session 2 Positive families (counsellor facilitated family meeting)
Purpose: Family awareness, family communication  
Tools: Family tree with illustrated stickers
Session 3 Positive life stories (one-on-one counselling)
Purpose: Supportive counselling, emotional containment 
Tools: My life/love and HIV storytelling tools
Session 4 Positive practices (one-on-one training session)
Purpose: Training on disclosure steps, prepare for child questions
Tools: HIV body map, playing cards, disclosure hand, story book
Maternal disclosure
Mother completes  independently with the child
Semi-structured interview 
Post disclosure – experience and satifisfation
Session 5 Positive planning (one-on-one training session)
Purpose: Training on health promotion and care planning
Tools: Clinic check list, My care circle
Session 6  Positive futures (one-on-one training session)
Purpose: Training on developmental play, play for communication
Tools: “Uthando” dolls 
Health promotion clinic visit
Mother completes clinic visit with the child
Post intervention assessment 
Socio-demographic and health questionnaire; GHQ-12; PSI-36; 
Parent reported CBCL
Semi-structured interview 
Post clinic visit – experience and satisfaction
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4.2.3 The Amagugu study intervention package 
The Amagugu intervention was home-based and delivered by trained intervention 
counsellors. The counsellors did not directly intervene with the participants’ children, but 
rather provided mothers with printed materials and child-friendly activities to support age-
appropriate disclosure. The counsellors trained and supported mothers to communicate with 
their children independently and to disclose on their own, thereby transferring skills and 
empowering women. The Amagugu disclosure materials are outlined in 4.2.4 Table 5 below. 
4.2.4 Table 5: Amagugu Intervention maternal HIV-disclosure tools and materials 
Tools/ Materials Description Purpose 
Talk and Play 
Reminder 
A5 illustrated colour card Offers specific guidance on planning of disclosure 
Family Life Line A4 card artwork and stickers  
Teaches a 5-step process and what each step 
offers the child 
HIV Body Map 
A4 HIV Body Map with 
stickers 
Demonstrates a 5-step intervention and teaches 
age-appropriate activities and games  
Playing Cards 
A7 ten matching pairs playing 
card set 
Through practice ensures that a mother is skilled 
and confident and feels enabled to undertake 
disclosure using intervention tools and materials  
Safety Hand A4 card and pens for artwork 
Helps a mother to develop her own child and 
family personalised materials  
Family Treasures 
Story Book 
A5 illustrated 14 page 
English-Zulu Story Book 
Allows for role-playing practice and development 
of personal talking points  
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4.3. The current PhD study 
4.3.1 Study aim 
To explore in more depth the experiences of women involved in the Amagugu intervention. 
This includes their interaction with the clinic staff in their primary health care clinics, where 
they access HIV treatment and care during the health intervention with their children. 
4.3.2 Research questions 
1. Where have maternal HIV-disclosure studies been conducted, with whom and what 
lessons can be adapted to rural settings in sub-Saharan Africa? 
2. What are the experiences of women living with HIV in an ART-era, ten years after 
their diagnosis? 
3. What motivates HIV-infected mothers to enrol in a maternal HIV-disclosure 
intervention and what do they report post intervention? 
4. What were the experiences of women and their children of a clinic intervention to 
support maternal HIV-disclosure? How can primary health care clinics be supported 
to assist HIV-affected families to access and adhere to HIV treatment and care? 
4.3.3 Study objectives 
1. To explore HIV-infected women’s experiences of living with an HIV diagnosis in an 
ART-era using qualitative enquiry methods. 
2. To qualitatively explore HIV-infected women’s motivation for, and their experiences 
of, participating in a maternal HIV-disclosure intervention. 
3. To determine which factors within primary health care clinics facilitate or obstruct 
implementation of a family-centred HIV-disclosure intervention using mixed 
methods. 
4.3.4 The study setting 
The current study was conducted at the Africa Centre for Population Health 
(www.africacentre.ac.za), now Africa Health Research Institute, AHRI (www.ahri.org) in the 
Hlabisa sub-district of Umkhanyakude District, northern KwaZulu-Natal, South Africa. The 
setting is rural, resource-poor, and predominantly isiZulu speaking (221, 222). In 2012, the 
HIV prevalence amongst women attending antenatal clinics in KwaZulu-Natal was 37%, and 
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the local district of Umkhanyakude was among the ten health districts with the highest HIV 
prevalence in KwaZulu-Natal, estimated at 41% in 2011 and 35% in 2012 (223). Between 
2004 and 2012, health care in the study area was provided through 17 primary health care 
clinics with a comprehensive, decentralised, HIV Treatment and Care Programme through a 
partnership between the Africa Centre and the KwaZulu-Natal Department of Health, with 
support from the United States Presidents Emergency Plan for AIDS Relief (PEPFAR) (34, 
35, 224). The Department of Health has exclusively managed this programme since 2012. 
When the PMTCT programme was introduced in the local district in 2001, the Africa Centre 
worked in partnership with the provincial Department of Health to implement it, and at the 
same time the Africa Centre invited PMTCT attendees to enrol in the Vertical Transmission 
Study. How the PMTCT programme has evolved since then is illustrated in Table 2 on page 
7.  
4.3.4.1 The PMTCT of HIV Programme  
The PMTCT of HIV Programme is part of a global strategy towards an AIDS free generation 
(225, 226). In 2001, the South African government introduced a comprehensive package for a 
PMTCT Programme. This was initially introduced as a pilot programme and was later 
brought as a full-scale national programme, in response to a Constitutional Court ruling (225, 
226). In line with the International standards for a comprehensive strategy, the PMTCT 
policy recognised that in order to prevent HIV among women and children, four elements of 
PMTCT were essential (226). These included: 
 Primary prevention of HIV especially among women of childbearing age; 
 Preventing unintended pregnancies among women living with HIV; 
 Preventing HIV transmission from a woman living with HIV to her infant; and 
 Providing appropriate treatment, care and support to women living with HIV and their 
children and families  
4.3.4.2. The Africa Centre Demographic Information System (ACDIS) 
The Africa Centre was set up in 1998 when the University of KwaZulu-Natal (UKZN) and 
the South African Medical Research Council were responding to a rapidly growing HIV 
epidemic in the Hlabisa sub-district of Umkhanyakude District, in KwaZulu-Natal (222). A 
Demographic Surveillance System (DSS) was established in 2000. The DSS has collected 
demographic and socio-economic data twice yearly from eligible individuals (women aged 
 39 
 
between 15-49 years and men aged between 15-54 years) in approximately 11,000 
households within the Africa Centre’s Demographic Surveillance Area (DSA), which makes 
up about 40% of the land area and population of the Hlabisa sub-district (34, 227, 228). The 
HIV surveillance programme has been nested within the DSS since 2003 and data collected 
in the HIV surveillance can be linked anonymously to longitudinal data collected in the 
households (229). From 2007, eligibility to participate in the HIV Surveillance programme 
was extended to all residents aged 15 years and older, and since January 2012 these biennial 
visits have been extended to three times a year. The HIV burden in the DSA is immense with 
24% HIV prevalence in adults 15 years and older as reported in 2011 (171, 204, 221, 222, 
228, 230, 231). Linkage of the Amagugu data with the DSS data provides an opportunity to 
obtain additional evidence on factors such as family composition, household structure, social 
HIV exposure within households and other information that impact on the mother and child 
HIV-disclosure outcomes.  
4.3.5 Study design 
The current study used both quantitative and qualitative methods of enquiry. The sample for 
the current study comprised three groups: 1) all mothers from the Amagugu study (N=281); 
2) a sub-sample of mothers from the Amagugu study purposely selected from five of the nine 
geographic catchment areas representing both peri-urban and rural settings (N=20), and 3) 
health care staff employed in the clinics where the Amagugu study operated (N=87). 
Quantitative data were collected at different time points from the women in the Amagugu 
study including baseline, after the health intervention, and post disclosure, using semi-
structured questionnaires specifically designed for the Amagugu study. A different battery of 
semi-structured questionnaires were also administered to the clinic staff during the health 
intervention, and were used to obtain demographic characteristics prior to the health 
intervention. Qualitative data were collected through a combination of in-depth and semi-
structured interviews with the sub-sample of 20 women after the disclosure intervention, and 
nine focus groups with clinic staff which were conducted after the health intervention. Table 
6 illustrates the participants, methods of enquiry and measures used in the current study.  
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Table 6: Participants, methods of enquiry and measures for the current study 
Participants Research question 
Method of 
enquiry 
Measures 
Sub-sample of 
mothers from 
the Amagugu 
cohort: N=20 
mothers 
What are the experiences of women living 
with HIV in an ART-era, ten years after 
their diagnosis? 
Qualitative In-depth interviews 
Sub-sample of 
mothers from 
the Amagugu 
cohort: N=20 
mothers 
What motivates HIV-infected mothers to 
enrol into a maternal HIV-disclosure 
intervention and what do they report post 
intervention? 
Qualitative 
Semi-structured 
interviews 
Cohort of 
mothers from 
the Amagugu 
study: N=281 
mothers 
What were the experiences of women and 
their children of a clinic intervention to 
support maternal HIV-disclosure? 
Quantitative 
Semi-structured 
questionnaires 
Employees 
from the 9 
local primary 
health care 
clinics where 
Amagugu 
mothers 
received their 
HIV treatment 
and care: 
N=87 clinic 
staff 
How can primary health care clinics be 
supported to assist HIV-affected families to 
access and adhere to HIV treatment and 
care? 
Qualitative  Focus groups 
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The data used for analysis in this study were collected at different time points during the 
Amagugu intervention, as illustrated in Table 7.  
Table 7: Sample and data collection points for the current study 
Participants Number  Inclusion criteria Measures 
Data collection points 
and place 
HIV-infected 
women and their 
HIV-uninfected 
6-10 year old 
children from 
the Amagugu 
study  
N=281 
 Being enrolled in 
the Amagugu 
study 
 Semi-
structured 
questionnaires 
 Baseline and 
post Amagugu 
intervention at 
home before 
and after clinic 
visit following 
disclosure at 
home 
Clinic staff  N=87 
 Being over 18 
years old 
 Working at one of 
the clinics where 
Amagugu operated 
 Willingness to 
consent to enrol 
 Semi-
structured pre-
clinic and 
post-clinic 
training 
questionnaires  
 Focus groups 
 Before and 
after mothers 
undertook a 
health 
promotion 
visit with the 
child at her 
HIV treatment 
and care clinic 
A sub-sample of 
HIV-infected 
women from the 
Amagugu study  
N=20 
 Willingness to 
consent to enrol 
 In-depth and 
semi-
structured 
interviews 
 Three months 
post-
intervention at 
home 
 
4.3.6 Sample selection and measures 
The data used for the current study included data collected during the Amagugu intervention, 
data collected from health staff as part of the clinic intervention and data collected with a sub-
sample of women post Amagugu intervention. These samples and data collection tools are 
detailed in Table 8 below and explained further thereafter.  
Table 8 Data collection tools 
Amagugu study sample  Clinic intervention sample    
 Baseline Information 
Form 
 Parental Disclosure 
Interview 
 Health Update Form 
 Clinic visit Follow-up and 
Child Experience Form 
 Pre- and post- clinic 
training questionnaire 
 Focus groups  
 In-depth interviews 
 Semi-structured 
interviews 
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4.3.6.1 Amagugu study sample  
The data from the Amagugu study analysed for the PhD study included:  
4.3.6.1.1 The Baseline Information Form (N=20) 
The Baseline Information Form is a structured questionnaire that was used to collect socio-
demographics data from all the women participating in the Amagugu study. The form 
included additional data on the mother’s living arrangements and whether the mother was 
still in a relationship with the father of the child or not. I analysed the Baseline Information 
Form data of the sub-sample of 20 women. The analysis included assessment of maternal 
physical health, including whether or not the mother was on ART, her duration on ART and 
CD4 cell counts at baseline in the Amagugu study. The physical health status assisted in 
determining whether or not maternal illness was a motivation for a mother to disclose her 
status to a child. 
4.3.6.1.2 The Parental Disclosure Interview (N=20) 
The Parental Disclosure Interview (PDI) was developed by Daniel Pilowsky (1999) (232). It 
is a semi-structured questionnaire with some open-ended questions. It was specifically 
designed for HIV-infected women. The interview covers six domains and enquires about 
levels of disclosure and related information including: 
1. Personal and family information; 
2. HIV history; 
3. Disclosure to partner and other adults about HIV infection; 
4. Disclosure to children (younger than 18 years old) about HIV infection;  
5. Custody planning; 
6. Disclosure to older children (18 years old and above) about HIV infection.  
 
Women were asked to whom they had or had not disclosed their HIV status prior to the 
Amagugu intervention and their reasons for disclosing or not disclosing. This was done to 
determine whether disclosure to other adults would facilitate disclosure to children. I 
analysed the PDI data of the sub-sample of 20 of the 281 HIV-infected women enrolled in the 
Amagugu study. 
 
4.3.6.1.3 The Health Update Form (N=281) 
Post-intervention, the Health Update Form was used to collect data on maternal physical 
health status including ART information and the most recent CD4 cell count results. With 
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regards to the sub-sample of 20 women, the Health Update Form assisted in observing if 
there had been changes since the enrolment into the intervention, with regards to accessing 
HIV treatment and care services, particularly if a mother had reported not accessing such 
services at Amagugu baseline. 
4.3.6.2 Clinic intervention sample 
4.3.6.2.1 The Amagugu Study Health Promotion Clinic Visit 
Between one to two weeks after disclosure, the Amagugu counsellors trained mothers on the 
health promotion visit and provided them with the materials and activities to use with their 
children during the clinic visit. Each mother was encouraged to engage in a health promotion 
activity by taking her child for a clinic visit. I also conducted training on child-friendliness 
and maternal HIV-disclosure for the clinic staff, and provided health information posters and 
health promotional play materials. 
 
4.3.6.2.2 Clinic visit Follow-up and Child Experience Form (N=281) 
Semi-structured questionnaires were administered to the mothers on the content of the health 
promotion training and the experiences during the clinic visit. The aim of the health 
promotion clinic visit was to improve HIV-infected mothers’ health care and custody 
planning. It also aimed to increase their children’s access to a health care social support 
network, at their nearest primary health care clinic where their mothers were accessing HIV 
treatment and care. The clinic visit was also used as a health promotion exercise to orientate 
children to the clinics, and to encourage the perception that clinics are friendly, informative, 
spaces where children can come for help for illness or health advice (200, 233-235). I 
analysed data collected from (N=281) mothers and their children before and after the clinic 
visit. 
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Box 2: Amagugu materials provided for the clinic visit 
The Amagugu Name Tag: Each child was provided with a name tag to assist the child to have 
a sense of identity and pride, and serve as a visual reminder to the health care staff of their 
commitment to ensuring that children were welcomed in the clinic.  
The Clinic Checklist: The clinic checklist was designed as an “I spy” activity, to encourage 
the child to explore the clinic. It is a ‘learn by doing’ tool which helped the child become 
familiar with the clinic processes (including patient registration and medical procedures); the 
infrastructure (including the waiting area and toilet); and to meet and engage with health care 
providers (including the clerk, other patients and the HIV nurse).  
The Uthando Doll: The larger intervention included a play-for-communication component 
where children were provided with ethnically-appropriate dolls. Children were encouraged to 
take their doll to the clinic and participate in ‘pretend play’ of medical procedures such as 
checking temperatures and giving injections. Including the doll in the clinic activities 
encouraged the child to learn about medical procedures in a fun and non-threatening way.  
Clinic Visit Reminder Card: This A5 illustration card was a reminder tool for mothers, to 
help them organise, plan and execute the health care visit. The card also served as an 
advocacy tool in the clinic where the mother could use it as a reminder for busy health staff 
of the commitments to provide a child-friendly clinic visit.  
Materials provided for the clinic facilities 
Health promotion posters: An A3 poster titled “Let’s Make Clinics Child-friendly!” was 
designed. The poster provided key health promotion messages and reminders about child-
friendliness, including: children should be welcomed at clinics even when they are not ill, 
health care environments are spaces for information and advice, a health care support 
network is important for children whose parents have chronic illnesses, play is important for 
children in reducing anxieties and allowing for health promotion learning.  
A Medical Play Kit: A commercially sourced medical play kit and an Uthando doll were 
provided to each HIV nurse to engage the child in health demonstrations. The play kit 
included a stethoscope, thermometer, syringe and otoscope.  
Amagugu intervention materials: As part of the intervention mothers were provided with an 
HIV Body Map with stickers, to demonstrate to children how the HIV and other viruses 
attack the human body and how they can be managed with medication such as ARVs; health 
promotion playing cards- a set of 20 specifically designed playing cards with health 
promotion messages.  
These tools were also available in the nurses’ examination room during the child’s visit, so 
that the nurses could reinforce the messages mothers had taught their children during 
disclosure 
4.3.6.2.3 Clinic staff (N=87) 
As part of Amagugu study, an intervention to support child-friendliness at the participating 
primary health care facilities was developed and implemented. The training was first piloted 
by myself at four of the nine implementation clinics, selected to include both rural and peri-
urban settings. During piloting, dialogue and feedback were elicited from staff to finalise the 
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training programme and clinic resources for a child-friendliness component (see Box 2). The 
training was then implemented at the five remaining primary health clinics. I developed and 
gave each clinic staff member a two-page training manual that illustrated all of the steps to be 
followed when attending to the Amagugu mother-child pairs that came for a health promotion 
visit in the clinic (See Appendix B). The nine participating clinics were provided with 
materials to use during the health promotion visit.  
The clinic staff training targeted a diversity of staff including nurses, HIV counsellors and 
clerks to maximise opportunities for improving the quality of interactions with children 
during clinic visits. All clinic staff that were available in the clinics where the Amagugu 
study operated during the recruitment period were invited for participation. Only two male 
security guards in two rural clinics refused participation as they could not leave their work 
stations unattended for safety and security reasons.  
4.3.6.2.4 The Pre- and Post- clinic Training Questionnaire (N=87) 
Before requesting mothers to take their children for a clinic visit, the clinic staff were 
assessed and then trained in maternal HIV-disclosure and child-friendliness (N=87). The 
clinic staff’s knowledge and attitudes to maternal HIV-disclosure and child-friendliness were 
assessed through semi-structured questionnaires. The semi-structured questionnaires were 
used to collect socio-demographic data and also contained open ended questions on child-
friendliness and maternal HIV-disclosure. The pre-clinic training questionnaires were 
administered to the clinic staff during training on maternal HIV-disclosure and child-
friendliness training conducted for the clinic staff members in all nine facilities before 
Amagugu mothers and children undertook their clinic visit. The post-clinic training 
questionnaire was administered to the clinic staff after mothers and children had completed 
their clinic visit post disclosure. The questionnaire aimed to assess clinic staff knowledge and 
attitudes on maternal HIV-disclosure to 6-10 year olds and child-friendliness in the clinics. 
Both the pre and post clinic training questionnaires had the same set of questions. An 
example of questions in the pre-clinic training questionnaire is provided in Box 3. The full 
questionnaires are attached as Appendix C.  
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Box 3: Sample of questions in the Pre-clinic Training Questionnaire 
Child-friendliness 
Below is the Amagugu Project definition of child-friendliness. Please read before you answer 
questions that follow.  
Child-friendliness of clinics 
Clinics can be made a fun place for children as opposed to scary. Friendly and welcoming staff is 
what children need in order to feel free to approach clinics whether they are sick or are just seeking 
health information. In the clinics healthy living information can be presented in a fun way that 
children can easily understand.  
When you read the above definition, would you say this clinic is able to achieve this? 
If Yes, why and if No, why not? 
Disclosure of mother’s HIV infection to children 
Many HIV-infected mothers are giving birth to HIV-uninfected children due to access to ARVs. One of 
many challenges faced by HIV-infected mothers from this community is whether to disclose their HIV 
infection to their children? 
Do you think it is important for HIV-infected mothers to disclose their HIV status to their children? 
If yes, why, if no, why not? 
 
4.3.6.2.5 The Focus Groups  
One focus group discussion was conducted in each of the nine clinics where the Amagugu 
study operated. From nine focus groups, a total of 87 clinic staff members participated. The 
average number of participants in each clinic was 12 members. Focus groups were chosen for 
their unique capacity to capture opinions, experiences and perspectives of a group of people 
in order to gain knowledge about a particular topic while observing the interactions of 
participants (236). In order to make the environment as natural as possible and to make 
participants comfortable the focus groups were conducted in rooms in the clinics that were 
identified by either the sister-in-charge of the clinic or other personnel who were the contact 
persons for the clinics. Focus groups were deemed appropriate for the clinic staff because 
maternal HIV-disclosure and child-friendly clinics were perceived to be less sensitive topics 
for this group of participants, and they suited the time constraints and patient load in all 
participating clinics. 
Focus groups were conducted to triangulate data from the pre and post-clinic training 
questionnaires administered to the clinic staff, and the Clinic Visit Follow-Up Forms which 
captured the maternal and child experiences of the health intervention. I conducted the focus 
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groups very early in the day, immediately after morning prayers, or late in the afternoon 
when all the patients had been attended to, because it was challenging to get all staff together 
once they had started reviewing patients. These times were suggested by the clinic 
management in their respective clinics after we had held preliminary meetings with them to 
discuss the study. For example, some clinics are near schools and are frequented by learners 
after school; whilst some are busiest in the mornings as some patients come from very far and 
struggle to get transport if they do not arrive early at the clinics. All focus groups were 
conducted in isiZulu and with the participants’ permission they were audio recorded.  
The focus group discussions focused on maternal HIV-disclosure, child-friendliness and the 
clinic staff’s experiences in interacting with the Amagugu children that came for a clinic 
visit. The plan was to include as many clinic staff as possible during the administration of 
questionnaires and in the focus groups. A focus group guide was developed and used to 
facilitate the discussions (see Appendix D). Focus groups lasted approximately 60 minutes. I 
transcribed the audio-recordings verbatim, and then I translated the transcripts from isiZulu to 
English. The transcripts were then imported to ATLAS.ti for data management and coding. 
All data sources and data collection tools for the current study are shown in Table 7 on page 
41.  
Group dynamics 
I anticipated that power dynamics in terms of mixing senior and junior clinic staff members 
might be a challenge, with a possibility of junior staff members feeling intimidated to express 
their views in front of their supervisors and managers. I took extra care to emphasize upfront 
that participation was completely voluntary, and I requested all members to speak freely 
because all views were equally important. The content of the focus group discussions helped 
in facilitating the discussions because the questions in the guide were not biased towards any 
particular grouping but addressed everyone’s interaction with children that came to the clinic. 
Conducting the focus groups in isiZulu assisted in making all participants comfortable to 
express themselves openly in their own language.  
4.3.6.3 Sub-sample of women 
The 20 women from the Amagugu study 
It had been two months since the completion of the Amagugu study; I no longer had the 
‘security’ provided by fellow colleagues when they were still conducting research in the same 
 48 
 
areas. For safety and security reasons I selected only five of the nine catchment areas that 
were within the Africa Centre’s Demographic Surveillance Area because the visibility of 
other researchers in the areas provided ‘security’ for myself and the participants. Purposive 
sampling which involves choosing participants from whom the researcher can learn about the 
experience was used (237). Polinghorne refers to such a sample as ‘fertile exemplars’ of the 
experience (237). Before the in-depth interview was conducted, I explained the study 
verbally, provided written information in isiZulu and obtained written consent from the 
participants. I had anticipated that up to 20 women would be required before reaching 
saturation. As this is a PhD with publications, after completion of 15 interviews, I shared the 
transcripts with the two co-authors of the manuscripts (Tamsen Rochat and Ruth Bland), after 
which we had an analysis meeting. A preliminary round of data analysis with the co-authors 
indicated that saturation had been reached as no new themes were emerging from the data 
(238). Given resources available I conducted five more interviews, resulting in 20 interviews, 
to ensure a balance of perspectives from different geographical areas.  
The details of how the researcher attributes such as being a female and a Zulu, from the study 
area could have impacted on the current study, are noted in the Qualitative data Analysis and 
the Discussion sections. 
4.3.6.1.1. The in-depth and semi-structured interviews (N=20) 
In-depth interviews were chosen for their ability to explore issues where little is known and 
where it is important to obtain an in-depth understanding of an issue (239, 240). Interviews 
cater for a more personal, private and comfortable environment that is suitable for each 
individual participant’s needs, thus allowing greater autonomy than is easily achieved 
through other qualitative methods such as focus groups (239).  
Scientific literature, including the literature reviewed as part of the current study, indicate that 
HIV-related stigma often prevents HIV-infected women from disclosing their status to their 
children and significant others (88, 96, 108, 118, 123, 129, 130, 161, 162, 164) resulting in 
them not accessing HIV care and not adhering to ART (101, 130, 148, 187). The sample was 
selected to obtain an in-depth understanding of the experiences of women living with HIV in 
the ART-era and their experiences of participating in the Amagugu intervention. Socio-
demographic and disclosure data from the baseline survey of the Amagugu intervention were 
analysed for this sub-sample.  
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As HIV-related stigma may be associated with HIV-disclosure research, in-depth interviews 
offered a suitable tool for handling very sensitive issues including sexual relationships which 
are part of HIV research with women (239). In-depth interviews are particularly useful for 
engaging previously marginalized groups including HIV-infected mothers who are often not 
granted an opportunity to narrate their own stories (239).  
Rich information regarding the maternal experience of living with HIV in the ART-era could 
be missed if data are only captured through semi-structured questionnaires; therefore, a two- 
part qualitative interview guide was developed for in-depth, semi-structured interviews to be 
conducted with this sub-sample from the Amagugu study. 
The first part of the interview guide was an in-depth exploration of the women’s experiences 
of HIV since diagnosis in pregnancy with the study child. The second part of the guide 
addressed specific questions regarding their participation in the Amagugu intervention and 
their experiences of the disclosure materials. The semi-structured nature of the guide 
provided sufficient structure to the interview, while the open-ended nature of the questions 
enabled participants to express themselves more candidly (240). I conducted the interviews 
two months after the data collection for the Amagugu study had concluded. Each interview 
lasted approximately 60 minutes. They were all conducted in women’s homes and in the 
women’s own language, isiZulu. All twenty women were interviewed once. All participants 
granted permission for the interviews to be audio recorded and the recordings were uploaded 
as MP3 files onto a password protected computer as the Africa Centre data protection 
protocol dictated.  
I am a bilingual, with isiZulu as my first language, and was also a member of the Africa 
Centre Translation Panel. I transcribed the audio recordings verbatim and translated the 
transcripts from isiZulu to English. Where I was not sure of the most accurate translation I 
discussed the transcripts with another bilingual isiZulu first language speaker, a PhD 
candidate who was also a member of the Africa Centre Translation Panel. During the 
transcription process I also documented other expressions such as laughter, pauses, 
discomfort or hesitation in responding to some questions and tone of voice to assist in the 
interpretation of data and contextualisation of the responses. In addition, I kept a journal and 
took extensive field notes of non-verbal cues including gestures and personal reactions, and 
incorporated reflections on the interview content and information that might inform 
interpretation of results to avoid researcher bias which is the extent to which I as a researcher 
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might influence the research process (241). The in-depth interviews transcripts were imported 
to ATLAS.ti version 7 Qualitative Analysis Software (www.atlasti.com) for data 
management and coding (242, 243). Once the qualitative data were imported to ATLAS.ti it 
was easier to organise and apply codes as necessary. This part of the analysis process was 
more deductive than inductive in nature. I coded the transcripts and compared codes across 
interviews to determine dominant thematic areas. Codes were reviewed for redundancy and 
similar codes were grouped under a single higher order category called ‘family’ in ATLAS.ti. 
Higher order categories which resulted from collapsing codes with similar ideas together 
reflected the important thematic areas linked to interview guide categories. An interview 
guide is shown in Box 4. 
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Box 4: Interview Guide 
Interview guide  
Part 1: 
Reasons for enrolling in a maternal HIV-disclosure intervention  
 What made you decide to join Amagugu study? 
 
Living with HIV 
 Please tell me about how it has been living with HIV since your diagnosis. Probe o n : 
i. Who has been disclosed to? 
ii. Access to HIV treatment and care 
Part 2  
Partial or full disclosure 
 Please describe how you disclosed your status to your child? Probe on whether the words HIV were 
used 
 Reasons for full or partial disclosure 
 
Amagugu disclosure materials 
 Did you use the materials that you were provided with to disclose? 
 Please share your thoughts on the disclosure materials that you were provided with to help you during 
disclosure process 
 How did the disclosure materials inform your decision to either fully or partially disclose? 
 How did your child react after you disclosed your HIV status? 
 
Advice to other mothers 
 What do you think are the important lessons that you learned during the disclosure intervention?  
 If you were to give advice to another HIV-infected mother who has not disclosed to her child, about 
disclosure, what would your advice be 
4.4 Data management plan 
The Africa Centre has a well-established Data Centre with document management and data 
capture sections that have been in operation since 2000. For the 281 Amagugu study 
participants and the 87 clinic staff, confidentiality was maintained in line with Africa Centre 
policies. All Amagugu participants were allocated study numbers and were only identified by 
names in the tracking forms for practical reasons. The tracking of participants was conducted 
by the Amagugu study counsellors and myself. In line with Africa Centre policies, all the 
Amagugu staff including counsellors, data capturers and the administrator had signed the 
Confidentiality Oath. All Amagugu study tracking forms were returned and locked in filing 
cabinets in the Data Centre for safe keeping, including forms for those who could not be 
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located. Amagugu data collection forms were transported daily by study vehicles to the 
Africa Centre where they were stored in locked cabinets in the Data Centre. Data were 
entered into a specifically designed Amagugu Access database by designated data capturers, 
using unique study IDs to identify participating individuals.  
All qualitative data audio recordings from interviews with women and focus groups with 
clinic staff were stored on a password protected computer which was kept in the Amagugu 
study office. The consent forms were kept in a locked cabinet in the in the Data Centre.  
4.4.1 Quality control and quality assurance 
Once the data were collected, all the Amagugu study forms were submitted to the project 
administrator who checked them for completeness, consistency and accuracy. If there were 
any discrepancies the administrator returned the forms to the relevant counsellors for 
correction before submitting them into the data capturers who also checked them before 
entering them onto the Amagugu Access database.  
I transcribed the audio recordings of the interviews myself after listening to them several 
times. I checked the transcripts and compared them with my field notes for the correct 
contextualisation of qualitative data for this study. The translations of the consent forms, and 
five interview and three focus group transcripts were checked by a bilingual, isiZulu first 
language speaker who was part of the Africa Centre Translation Panel and a fellow PhD 
candidate.  
4.4.2 Debriefing sessions 
While conducting research in the participants’ homes, the counsellors and I observed that 
over and above HIV, participants and their families were also confronted by other socio-
economic challenges, as the study area has very high unemployment rates and levels of 
poverty. To relieve counsellors of the stresses of working in an HIV and poverty stricken 
community, I conducted one-hour weekly debriefing sessions with each counsellor, 
discussing each family and deciding on relevant action points to resolve specific issues. As I 
was also involved in the data collection, I also had monthly debriefing sessions with the 
Amagugu study manager, a research psychologist, to manage the emotional content of some 
data from the field and deliberate on the action points. 
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4.4.3 Reimbursement of participants 
There was no reimbursement for participating in the Amagugu study. However, due to the 
long duration of some sessions including the baseline assessment, family visit and the 
maternal disclosure training visit, participants were offered refreshments for these sessions. 
The sub-sample that participated in the interviews was also offered refreshments because the 
interviews took approximately one hour.  
4.5 Data analysis 
4.5.1 Quantitative data analysis 
All quantitative data were entered into an Access database by the study data capturers and 
then imported into STATA 11 for data management and analysis. Descriptive statistics were 
used to summarise and tabulate demographic characteristics including the mean child and 
maternal age, IQR, employment, income, education, HIV treatment status of the participants 
and child gender. Factors potentially associated with full disclosure of HIV were examined 
using univariate logistic regressions findings, and a multivariate model was investigated with 
maternal sociodemographic factors (mother education), and maternal health (mother CD4 cell 
counts and mother hospitalization).  
4.5.2 Qualitative data analysis  
From the formulation of the research questions to the interpretation of findings, thematic 
content analysis was employed for this study (244-246). This method was adapted from the 
grounded theory approach developed by Glaser and Strauss (247). The grounded theory is led 
by an inductive approach which claims that patterns, themes and categories of analysis 
emerge from the data (247). However, this study used both inductive and deductive 
approaches. The analysis process was guided by a conceptual framework that was adapted 
from the Amagugu Intervention Conceptual Framework (74), research questions, focus group 
and interview guides. Common themes and categories were extracted from the interview and 
focus group transcripts. During the analysis process I followed the 5 steps which are the basic 
elements of qualitative data analysis (245, 247-249). It is important to note that qualitative 
data analysis is a fluid and iterative process of going back and forth through these steps.  
Steps 1 and 2- Getting to know the data and the focus of the analysis 
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I made notes after each interview and focus group, documented anything that could inform 
the interpretation of results during the initial phases of analysis. I listened to the audio 
recordings, read and re-read the transcripts several times to familiarize myself with the data 
(245, 248). While listening to the audio recording and reading the transcripts, I was mindful 
of my research questions and attentive of the participants’ responses that addressed the 
research questions directly. I immersed myself in the data while identifying emergent themes.  
Step 3- Categorising data or developing a coding scheme 
I re-read the transcripts and created as many codes as possible. I excluded data that were 
unrelated to my study topic. I reviewed my code list, and removed redundant codes until I 
produced a final code list.  
 
Step 4- Coding data; identifying patterns within and between categories 
I imported nine focus group transcripts and 20 interview transcripts to ATLAS ti. for ease of 
data management and coding. I conducted separate analyses for the focus groups and 
interviews. I manually coded data from the 20 semi-structured interview transcripts and 
conducted content analysis to the participants’ responses to the specific questions from the 
interview guide. Once I completed coding, I reduced the codes by grouping together similar 
codes under higher-order categories. I collapsed codes with the same underlying idea under a 
single higher order category, called ‘family’ in ATLAS ti. The families generated from 
collapsing codes with similar ideas together formed the themes that emerged from the data. 
Step 5- Interpretation of data 
As part of the validation process, and because this is a PhD with publications, I had analysis 
meetings with my two co-authors of the manuscripts who independently read all the 
transcripts and generated their own code lists. We explored aspects of researcher bias as both 
co-authors are first language English speakers and do not share some aspects of the Zulu 
culture such as the participant’s language as I do. We deliberated on how my language and 
culture could bias my analysis process. We then discussed the three lists and reviewed codes 
to reach consensus and adjust the final list accordingly. The transcripts were read in 
accordance with the final code list to determine the degree to which the codes cover all 
aspects of the interviews and focus groups.  
 
After importing all the transcripts to Atlas ti., I coded each transcript according to the codes 
that were adopted by the three contributing authors on the final list. I then exported the coded 
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sections of the transcripts from Atas ti. to a word document with all the headings according to 
main themes and began the write up process until I had accounted for all the codes and coded 
material.  
 
Triangulation 
Triangulation refers to comparing results from different data collection methods or data 
sources (250). The results from the clinic staff data collected through the focus groups and 
the semi-structured questionnaires, and the interviews from the sub-sample of 20 women and 
semi-structured questionnaires from the 281 women were compared in terms of: 
i. the experiences of the health promotion visit  
ii. views on maternal HIV-disclosure to uninfected primary school-aged children 
iii. child-friendliness of the health facilities 
 
Additional socio-demographic data collected at Amagugu baseline on all 281 women, 
including the sub-sample of 20 women, were available, extracted (with participant consent) 
and analysed. 
4.5.2.1 Reflexivity 
A researcher may influence all the processes of the research from formulation of a research 
question, data collection, and data analysis to the interpretation of the results (241). 
Reflexivity refers to acknowledging that as a researcher you may influence all these 
processes (241). To minimise biases that may occur it is important for the researcher to be 
sensitive to their own background, race, culture, beliefs, personality and values as these may 
all impact their research positively or negatively (236). The influences that I as a researcher 
might have imposed on the research process could serve as either strengths or limitations as 
detailed in the Discussion section.  
4.6 Ethical considerations 
Ethical approval for this study was obtained from the University of KwaZulu-Natal 
Biomedical Research Ethics Committee (BREC Ref: BF 144/010) and the University of 
Witwatersrand Human Research Ethics Committee (Ref: R14/49). (See Appendix E). 
Further, the study was presented to the Africa Centre Community Advisory Board and the 
Hlabisa District Hospital Management which both granted approval. (See Appendix F). The 
consent forms for the three groups of participants are attached as Appendix G.  
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4.6.1 Minimisation of risks for study participants 
HIV stigma is a recognized and serious problem in the study area. Extra care was taken to 
minimize the risks associated with discrimination of and within, the families involved in the 
project. Since the Amagugu study was going to approach the same participants who were 
previously enrolled in the VTS, we followed the same community entry strategies that we 
had used in the VTS. The VTS had been well received in the community. Before we started 
recruitment in the participants’ homes for the Amagugu study, I requested time slots in the 
community meetings through izinduna (local tribal authority representatives) and councillors. 
In the meetings I explained that we were going to be visiting some families who had been 
visited during the VTS and would be assisting mothers with some aspects of parenting their 
children. This served as protection for the participants as both HIV-uninfected and infected 
mothers were visited in the VTS and the community would not be able to identify them as 
HIV-infected when the Amagugu home-visits were conducted. Mothers were able to keep in 
contact with their counsellors via mobile phones, provided by the project, if they needed help 
or support between sessions. Psychological support was offered, where needed, by Dr 
Rochat, one of Amagugu investigators, a clinical psychologist with expertise in family 
counselling. 
With regards to any adverse events that could emerge with mothers during qualitative 
interviews, I have several years’ experience in counselling. Furthermore, before the start of 
the Amagugu project all staff members received training around a risk response protocol that 
included how to respond to psychological and social issues such as depression and suicidal 
ideation. At the time of the study being conducted there was a well-established emergency 
referral response team within the Africa Centre. The response team included a specialist 
paediatrician (principal investigator of the Amagugu study), a clinical psychologist (co-
investigator of the Amagugu study), and social workers who were available 24 hours a day 
and were able to refer participants within the existing health facilities. This response team 
was trained and able to respond to all crisis situations including medical emergencies, 
domestic violence, sexual assault, abuse and psychological crisis. Given the close relationship 
between the Africa Centre and Hlabisa Hospital, the clinical psychologist had rights of 
admission to the hospital in cases of emergency, for example if a mother, child or family 
member were observed to be actively suicidal. The specialist paediatrician, Dr Bland, who 
was also the Amagugu study principal investigator, conducted weekly teaching ward rounds 
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in the children’s department at Hlabisa Hospital and also had rights of admission for 
emergency paediatric cases.  
We kept all participants’ information confidential and allocated study numbers instead of 
using actual names of the participants in the forms and transcripts. All participants were 
given study information sheets which were written in isiZulu and the study was explained to 
them in isiZulu. I translated the study information sheet and the informed consent forms. The 
back translation of the study information sheet and consent forms was done and verified by a 
member of the Africa Centre Translation Panel. All participants signed an isiZulu informed 
consent form before they were enrolled into the study.  
4.7 Conclusion 
In this Methodology chapter I firstly discussed the Vertical Transmiss ion Study, the study in 
which the Amagugu participants first participated. Then I briefly discussed the Amagugu 
study in which this current PhD is nested and how the three sets of participants - the 281 
women from Amagugu, the sub-sample of 20 women, and the 87 clinic staff members were 
recruited, and how both quantitative and qualitative methods were employed to answer the 
research questions. Both quantitative and qualitative analyses approaches were described. 
The next chapter will discuss the findings of the current study.  
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5. Results 
In this section I present the results from the analysis of both the quantitative and qualitative 
data collected in the current study. This includes results from the questionnaires, focus groups 
and qualitative interviews.  
The characteristics of women and children (N=281) that undertook the health promotion 
clinic visit are shown in Table 9 below. Women’s ages ranged from 23-54 years and their 
children’s ages ranged from ages 6-10 years. More than half of the women (53%) had 
completed secondary school, but only about one third were employed. There was almost an 
equal number of girl (49.8%) and boy (50.2%) children enrolled with their mothers in the 
study.  
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Table 9: Maternal and child characteristics (N=281 mothers and children) 
Maternal Characteristics N=281  
Age (years) 
Median  
Range 
 
35 
23-54 
 
 N % 
Education  
No education 
Completed some or all primary 
Completed some or all secondary 
Post school education 
Missing 
 
17 
108 
148 
5 
3 
 
6.0 
38.4 
52.7 
1.8 
1.1 
Employment 
Employed 
Unemployed 
Missing 
 
90 
188 
3 
 
32.0 
66.9 
1.1 
Regular Income 
Receives regular income 
Does not receive regular income 
 
73 
208 
 
26.0 
74.0 
Hospitalisation (<12 months) 
Yes 
No 
Missing 
 
30 
250 
1 
 
10.6 
89.0 
0.4 
CD4 Count (most recent) 
≥501 
351-500 
≤350 
Missing 
 
77 
53 
71 
80 
 
27.4 
18.9 
25.3 
28.5 
HIV treatment status 
On ART  
Not on ART 
Missing 
 
118 
155 
8 
 
42.0 
55.2 
2.8 
Child Characteristics N=281  
Age (years) 
Median 
Range 
 
7 
6-10 
 
 
 
 N % 
Gender 
Female 
Male 
 
140 
141 
 
49.8 
50.2 
Hospitalization (since birth) 
Yes 
No  
Missing 
 
43 
221 
17 
 
15.3 
78.6 
6.0 
 
The clinic staff comprised of 41 (47%) nurses, 23 (26.5%) HIV counsellors and 23 (26.5%) 
clinic clerks. Their median age was 39 years (IQR 31-49); only six were male. Sixty two 
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(71%) worked in rural clinics, while 25 (29%) worked in peri-urban clinics. During the clinic 
visit mothers rated 65% of clerks and 70% of nurses as “very friendly”.  
 
Table 10 shows the socio-demographic characteristics of the sub-sample of 20 mothers and 
their children. The median age of the women was 32 years (IQR 29-37) and the children’s 
median age was seven years (IQR 6.5-7.5). There were substantially more girl children in this 
sample (girls 13: boys 7), and the mothers had predominantly undertaken full disclosure to 
the child as part of the intervention (full 16: partial 4). Almost all women (18/20) reported 
being in stable partnerships, half were living with their partners (9/18), and disclosure to 
partners was high (13/18). Most women were unemployed (14/20) and had attended at least 
some secondary school. The majority of mothers were on ART. When comparing these 
characteristics to those of the larger sample of Amagugu mothers, there were no noticeable 
differences, apart from the over-representation of girl children, and the finding that more of 
the mothers had undertaken full disclosure (80% vs 61%).  
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Table 10: Maternal and child characteristics of the sub-sample (N=20) 
Study 
ID 
Maternal 
Age 
(Years) 
Child  
Age  
(Years) 
Child  
Sex 
Marital  
Status 
Employment 
Status 
Length of time 
on ART 
in Years 
Last CD4 
Cell 
Count 
Results 
cells/ml 
Type of 
Disclosure  
To Child 
Disclosed to 
Current 
Partner 
Lives with 
Current 
Partner 
1 26 7 F No current partner Unemployed 4 105 Partial No No 
2 32 6 M Current partner Unemployed 1 568 Full Yes No 
3 32 7 F Current partner Employed Not on ART* 379 Full No Yes 
4 44 8 M Current partner Employed 7 800 Full Yes Yes 
5 46 7 M Current partner  Unemployed 6 700 Full Yes Yes 
6 36 6 F Current partner Employed 1 297 Full Yes Yes 
7 37 7 M Current partner Unemployed 5 487 Full Yes Yes 
8 49 8 F Current partner Unemployed 6 219 Full Yes No 
9 28 6 F Current partner Unemployed 1 212 Partial Yes No 
10 39 8 F Current partner Employed 2 467 Full Yes Yes 
11 28 7 F Current partner Unemployed Not on ART 629 Full Yes No 
12 32 7 M Current partner Unemployed 2 518 Full Yes Yes 
13 37 7 M Current partner Unemployed 1 400 Partial  No No 
14 38 6 F Current partner Employed Less than 1 year 350 Full  Yes No 
15 31 8 F Current partner Unemployed Not on ART 709 Full No No 
16 36 7 F Current partner Employed Not on ART* 459 Full Yes Yes 
17 28 6 F Current partner Unemployed Less than 1 year 300 Full No No 
18 29 8 M Current partner Employed Not on ART* 370 Full No No 
19 32 7 F No current partner Unemployed Not on ART 540 Partial No No 
20 29 7 F Current partner Unemployed 3 394 Full Yes Yes 
*At the time of the study the cut-off for ART initiation was CD4+ T-cell count ≤ 350 cells/mm3 
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5.1 Themes 
The three main themes that emerged from the qualitative data analysis in current study are:  
1 HIV-related stigma 
2 HIV-disclosure and family strengthening  
3 HIV and access and adherence to HIV treatment  
5.1.1 HIV-related stigma  
5.1.1.1. Household and community level stigma 
A comprehensive review of global literature undertaken for this study indicated that the fear 
of HIV-related stigma is rife and instrumental in preventing HIV-infected individuals from 
disclosing to others (88). HIV-related stigma was found to be the most common reason for 
non-disclosure of HIV status irrespective of whether disclosure target was a partner, a family 
member or a child (53, 96, 108). 
In the qualitative study, the majority of women reported living positively with HIV and 
receiving necessary support from those that they had disclosed to prior to the Amagugu 
intervention (184).The minority of women reported not having disclosed to anyone due to the 
fear of HIV-related stigma. This finding is illustrated in the quotation below:  
“Mncfff! I have not disclosed to anyone because I know my family members. If you say 
something as problematic as this [HIV infection], the person would just dwell on that picture 
and then not regard you as their family. I don’t know under what circumstances will I ever 
tell them? For now, I’m sorry I don’t feel like telling them about my HIV infection.” 
(32 year-old mother of a 7 year-old girl) 
 
Another woman justified her reason for not disclosing to her partner as follows:  
“I have never told the man of the house. How can I even start? The problem is that he said he 
was going to go somewhere for work and he went to test at the clinic. He then showed me his 
negative results. Then I thought to myself: “How can I then show him my positive results?” I 
then just kept my mouth shut.” 
(37 year-old mother of a 7 year-old boy) 
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Two other women reported experiencing HIV-related stigma prior to the intervention.  
 
“I disclosed my HIV status to my sister-in-law; she did not know her own status then. The 
family mocked me and did not even want to use the same utensils as me. I lost weight, I wore 
size 32 but now I have regained my weight and I wear size 38. After my sister-in-law 
discovered her own positive status they stopped discriminating against me.” 
(26 year-old mother of a 7 year-old girl) 
 
“I told my boyfriend because people were talking about me and telling him that he was with 
someone has AIDS and on ARVs. I told him that’s the reason I’m using condoms with him. I 
wondered where on earth was he going to get someone without HIV if he left me?” 
(32 year-old mother of a 6 year-old boy) 
 
The study area has high social exposure to HIV with the majority of women in the qualitative 
study reporting being aware of another HIV-infected adult in their household. Some children 
were inadvertently aware of someone who was HIV-infected or was on ART either in their 
homes or in the community.  
 
“I did not tell my children about my status at the same time. I told the eldest one first, and 
then I told the middle one that was born in 2002. He seems to have an understanding because 
he even likes reading AIDS pamphlets from the clinic. He said to me: “Mom don’t stop taking 
pills.” They had a play at school about a girl who stopped taking pills and died. These days 
he is also sad because he just lost his paternal aunt through HIV during the Easter holidays. 
I told him that his aunt died because she did not want to accept her positive status.” 
(32 year-old mother of a 7 year-old boy) 
 
ARVs were openly shared in some communities and even normalised like ‘teabags’ as 
expressed by the woman in the quotation below: 
“Most of my neighbours are now open about their HIV status; we even lend one another pills 
[ARVs]. They [my neighbours] come to my house to borrow pills and say: “We have come to 
borrow our teabags.” 
(46 year-old mother of a 7 year-old boy) 
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High HIV prevalence in the study area at the time of diagnosis resulted in confusion and 
disbelief regarding sero-positive results in the women themselves and their family members: 
“The day I tested for HIV, everyone who came out of that [HIV] testing room was HIV-
infected. I thought to myself, it means we are all sick. Even those who were testing us must be 
sick. I also have a cousin who was fit and not looking sick in anyway, but one day she had a 
severe headache and went to the clinic and then discovered that she was HIV-infected. It was 
then that she started losing weight because this was eating her inside but she started 
treatment immediately because of her low CD4 cell count results. She still was not even thin. 
She looks fine; you can never tell that she is infected. I then realised that this HIV thing is 
real.” 
(29 year-old mother of an 8 year-old boy) 
 
NM: “Are you the only one who is HIV-infected in your family?” 
“My brother is also HIV-infected. He disclosed to us [the family].” 
(36 year-old mother of a 7 year-old girl) 
 
The health care staff also shared the same sentiments as the mothers regarding the high social 
exposure to HIV in the study area. They emphasized the importance of maternal HIV 
disclosure to children so that children can openly assist their mothers with the collection of 
ARVs.  
“I can see maternal HIV-disclosure is important. Children should know about our state of 
health as parents if we are infected. As we are working with pills, sometimes it is difficult for 
us [health workers]; you will find that a child comes here [to the clinic] after school and has 
been sent by their mother to fetch mother’s pills. And you would ask the child: “What pills 
have you come for?” She would say: “They are pills for TB.” When you check the mother’s 
card you realise that it is not TB pills they are fetching. Personally, it is difficult for me to 
take out that person’s file because the child has said it is TB pills to the child. I usually say: 
“Please tell mom to come to the clinic so that she can be weighed.” It is because I know these 
are not TB pills. What if the child knows of someone who is taking similar pills maybe they 
know that their friend’s mother is taking similar pills for HIV? They might get disturbed that 
way. That is why I think it is important for children to know because if you have not told 
children the truth, they can have resentment later.” 
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(39 year-old female nurse) 
5.1.1.2 Clinic level HIV-related stigma 
HIV-related stigma was also reported at a clinic level; one of the two women that had not 
disclosed to anyone prior to the Amagugu intervention, had also neglected to check her CD4 
cell count due to fear of being stigmatised when seen attending an HIV clinic. She perceived 
the physical structure of the HIV clinic to be a source of HIV-related stigma.” 
“I’m laughing at those caravans up there. It’s just that it’s frightening to walk up there [to 
the HIV clinic].  
(32 year-old mother of a 7 year-old girl) 
 
Some HIV-infected women reported experiencing discrimination by the clinic staff 
sometimes when attending to their sexual and reproductive health matters. For example, a 
woman who went to the clinic to report that her condom burst, but reported not receiving 
necessary support from the clinic staff: 
“I had this child [last born] because the condom burst. I went to the clinic but they could not 
help me, then I went to the hospital.” 
NM: “Why are you saying they did not help you?”  
“I went there and they said: “We know people like you who say condoms burst meanwhile 
they did not use them.” The following day they did not help me either. I then went to the 
hospital, and I discovered that I was pregnant. They asked me what I wanted to do and I told 
them nothing since the baby was already there. I attended all my antenatal classes there [at 
the hospital] and the child was born HIV-negative.” 
(32 year-old mother of a 7 year-old boy) 
 
5.1.2 HIV-disclosure and family strengthening 
5.1.2.1 HIV-disclosure to partners 
The qualitative study reported very high HIV-disclosure rates to other adults; the majority of 
women had disclosed their status to their partners, friends and other relatives prior to the 
Amagugu intervention. Of those who had disclosed to their partners; about half had disclosed 
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to their partner first, before disclosing to other adults. The partners had mixed reactions 
following disclosure but were overall supportive, even if they themselves were not HIV-
infected: 
NM: “Does your boyfriend know about your [HIV] status?” 
“That was the first thing I told him. He accepted it and said that HIV is a very common thing 
now, there is no need to be scared. He said what matters is how we look after ourselves, our 
lifestyle and the way we do things. He said he also checks himself every three months and he 
was still fine. He said that my [HIV] status is not a problem.” 
(37 year-old mother of a 7 year-old boy) 
 
“When I first tested I disclosed my status to my partner and he said to me: “I wonder how 
you got it.” I said: “Maybe I have had too many children. There are many ways, maybe I was 
I was helping someone. He did not fight with me. He said he was also going to go to the clinic 
to check and he did. He goes every six months. Maybe he has strong soldiers [immune 
system] because they cannot detect it.” 
NM: “What is his [HIV] status?” 
“He is [HIV] negative.” 
NM: “Did you see his results?” 
“I always go with him. His clinic card is almost full now.” 
(32 year-old mother of a 7 year-old boy) 
 
Some of the women’s partners questioned the source of HIV infection:  
“I went to check and found out that I was HIV-infected and I told him. He then asked me 
where I had gotten such news from.” 
(44 year-old mother of an 8 year-old boy) 
 
“I disclosed my [HIV] status to him. He did not want to accept and then we had our second 
child. After that I tried to break up with him. I think he already had it [HIV] by then, he was 
able to listen to me and we followed the procedures we were told at the clinic. He ended up 
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going for an HIV test. He asked where I got the virus from and I said: “My brother I don’t 
know.” 
(38 year-old mother of a 6 year-old girl) 
 
Some of the women’s partners kept their sero-positive status a secret and only revealed it 
after the woman’s own disclosure :  
“He [my fiancé] had no problem at all when I disclosed my status to him. He said: “We have 
to accept it as it is. All I can say to you is that I am sorry because this is all my fault. I fooled 
around a lot.” Oh yes he really fooled around. He said: “I know you were still young and 
innocent, I’m the one who brought this disease. I knew long time ago that things were like 
this, it’s just that I did not know how to start telling you, what would I say? Now that it has 
come out please forgive me.” I told him there is nothing I can be angry or shout about.” 
(36 year-old mother of a 6 year-old girl) 
 
“Yes I discovered that I was infected when I was pregnant with Andile*. My husband did not 
have a problem when I told him. I discovered that he was also infected; you know the males 
have that thing... they are not forthcoming with information. When I really followed-up on the 
story I found that he already knew his [HIV] status. [Laughter]. It’s just that they [men] first 
have denial if they have not seen any changes in their bodies.” 
(49 year-old mother of an 8 year-old girl) 
 
NM: “How did your husband react when you disclosed your HIV status to him?” 
“He was shocked but he said I must not say anything to anyone. He was the one to declare it 
to the family. He also tested positive and he is also on ARVs. We support each other because 
we even fetch each other’s ARVs from the clinic.” 
(39 year-old mother of an 8 year-old girl) 
 
NM: “Does your boyfriend know your [HIV] status?”  
“I disclosed my status to him but he was hiding his status from me. In fact he is the one who 
made me reach the stage of taking pills. He hid from me that he was taking ARVs. Sometimes 
we would use condoms and sometimes we would not. I ended up getting sick.” 
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NM: “How did you find out that he was taking pills?” 
“People were telling me about his [HIV] status and I did not believe them. He did not tell me. 
After a long time I started taking my ARVs. I asked him about them because he would hide 
that he was taking ARVs and he would stop taking them when he visited me until he stopped 
taking them completely. I told him that he should take them because I was also taking them. 
When I got sick I told him that maybe I was getting sick because we were not having safe sex. 
I stayed healthy for a long time after discovering my HIV status and my CD 4 cell count was 
fine when I went to check. After I got involved with him I got sick. Now he is openly taking 
ARVs.” 
(28 year-old mother of a 6 year-old girl) 
 
5.1.2.2 HIV-disclosure and improved family cohesion 
The maternal HIV-disclosure literature revealed positive outcomes for both mothers and their 
children including improved family cohesion if women disclosed (185, 187, 251). Family-
centred interventions as opposed to individualised care are perceived to be advantageous for 
HIV-infected women and their families in high HIV prevalence areas (68, 69). In this study 
women raised concerns about family-centred care such as being able to attend HIV treatment 
and care with their partners. One woman also articulated that she found that, although she had 
not yet started ART, she was already gaining a lot from her partner’s transference of 
knowledge to her after he had attended his ART classes. 
“My partner is the one who attended [ART] classes first and he is already taking treatment. I 
learn most of the things from him. Even when I get taught something, I tell him that he knows 
more than me. [Laughter]. I would say there is no problem because even the CD4 cell count I 
that I recently checked was high, it was 580. And since I first tested in 2003, I had never 
checked it before.” 
(26 year-old mother of a 6 year-old girl) 
 
All women that had disclosed to their children stated that the most beneficial aspect of 
disclosure was the social support they received from their children. While their original fears 
had been that they would be stigmatised by their children after disclosure, on the contrary, 
children were supportive. They were reported to assist their mothers with ART adherence by 
reminding them to take their HIV treatment on time:  
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“Sometimes when I am upset I go to bed early, she would come and wake me up and say: 
“It’s 8 o’clock.” I would say: “I’m sleeping”. She would insist: “Mama it’s 8 o’clock you 
have to take pills.” 
(36 year-old mother of a 6 year-old girl) 
 
NM: “How is your relationship since you have opened up about your HIV status to your 
children?”  
“What makes me happy is that they are now my alarm clock. Before I disclosed my HIV 
status, they were not my alarm clock. They were just looking at their mother taking pills and 
they could not even ask what the pills were for? Now, even when I have gone to sleep and if 
they did not see me taking pills, they would wake me up and ask: “Did you take the pills”? 
Sometimes I would say, leave me alone, I’m tired of this, just wanting them to give me 
attention. “Mom, drink your pills, you will die if you don’t.”  
(46 year-old mother of a 7 year-old boy) 
 
“The young one that I stay with, if my alarm goes off, he fetches me from wherever I am. 
Sometimes I take the pills without him noticing and I hear him asking mom, did you take pills 
and I say yes my boy, I have.” 
(37 year-old mother of a 7 year-old boy) 
 
“She is the first one to hear the sound of the alarm clock when it’s time for me to take pills.” 
(49 year-old mother of an 8 year-old girl) 
 
The health care staff concurred that disclosing to children was instrumental in supporting 
HIV-infected women to access and adhere to HIV treatment. 
 
“Maternal HIV-disclosure is important because mothers rely on their children to remind 
them to take their treatment. It is important for a child to know what they are dealing with. I 
have noticed that even at school, children are given projects about HIV and ARVs. If the 
mother does not disclose, children might see the pills being drawn on the [chalk] board at 
school and realise that these are their mother’s pills. That will not be a correct way to tell a 
child.” 
(36 year-old female HIV counsellor) 
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“Disclosure is important for them [mothers] because children help them with taking of their 
medication. The child does not forget easily.” 
(30 year-old male HIV counsellor) 
 
“Maternal disclosure is good if you can explain to the child and they understand and know 
the reason. They can also help her to take medication on time. I sometimes hear others say 
“Ey, he is the one helping me now saying, mom, it’s medication time, he says I don’t want 
you to die mom because he knows if the mother takes medication she will live longer.” 
(40 year-old female nurse) 
 
“It’s important to disclose to a child because sometimes the parent might get sick and not be 
able to do anything but if they tell their children they will remind them to take pills on time.” 
(37 year-old female counsellor) 
 
The majority of women expressed that they would advise other women in similar 
circumstances to disclose their HIV status to their children to obtain social support. The 
social support provided by children increases family cohesion and improves ART adherence. 
The same sentiments about family cohesion were echoed by the health care staff:  
 
“Yes, disclosing [an HIV status] to a child is a good idea because it strengthens the 
relationship between a mother and a child. It does not come as a surprise when a child has 
become wise on their own. She then tells the child and maybe the child has realised this long 
time ago. Maybe they were even suspecting that she is taking these pills forever and not 
finishing them. Then, it is a surprise. However, if she started bit by bit, that would strengthen 
the relationship and trust.” 
(58 year-old female nurse) 
 
“The child becomes very affectionate towards the mother if she is told the truth. Being close 
to the mother makes the child confident in whatever she is doing rather than being told by 
other people from outside. The teacher is there, but the mother is the first person and the love 
gives her strength and the child can see that mom loves me and trusts me.” 
(58 year-old female security guard) 
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5.1.3 HIV-disclosure and access and adherence to HIV treatment 
5.1.3.1 Health service-centred interventions can reduce clinic level stigma 
Though two women in a sub-sample did not access HIV treatment and care clinics, the 
majority of women in the study were openly accessing HIV treatment and care without any 
fear. Some women had even moved between clinics for convenience. The woman below 
candidly articulated how she boldly attended HIV clinics and did not care that she had 
become shapeless due to the side effects of ARVs. She expressed that the most important 
thing was being alive just like those who were managing their own chronic illnesses such as 
diabetes and high blood pressure.  
“….You see others hiding by corners [when walking to the HIV clinic], I do no such! 
Ngishaya isidanasi. [I strut my stuff]” 
NM: “What is isidanasi?” 
“It means not hiding anything. People are taking their own pills. They take pills for BP 
[blood pressure], why? They want to live. They take pills for arthritis so they can live. So, if I 
take my HIV pills, is there anything wrong with me? Must the whole world now give me a 
strange look? And must I now hide? I also want to live just like the people with BP and 
diabetes. I’m taking ARVs because I want to live. When we all die, the tomb does not say this 
one was killed by AIDS, this one was killed by BP, this one was shot, and this one was 
stabbed. We are all dead! We could go to the cemetery right now and if you could please just 
count for me the number of tombs there written: ‘This one was killed by HIV.’ [Huge 
laughter]. We all die, so if we want to live we should all want to live. When I go to the clinic I 
even strut my stuff [Ngishaya ngize ngidwale]. I don’t care that these ARVs have made me 
have thin legs. Eish, nesishwapha [and a flat bum] [Laughter].” 
(46 year-old mother of a 7 year-old boy) 
 
The women quoted below were able to openly access different HIV clinics and to do so at 
their convenience:  
 
“I started taking ARVs in 2007 at Clinic A*. Even now I collect them from there because I 
was still staying near that clinic. Then I came back. They then said it is better that I move to 
Clinic B* because it is closer to where I stay now.” 
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(37 year-old mother of a 7 year-old boy) 
 
“…. I am now taking ARVs. It does not matter, you cannot hide this thing. There is no one 
without AIDS now, I’m better because I will live and those who are hiding will die.” 
(32 year-old mother of a 6 year-old boy) 
 
5.1.3.2 Child-friendliness definition 
When asked to define a child-friendly clinic, the majority of the clinic staff made reference to 
both what they believed a child-friendly clinic should be, and what it should not be for 
children. The health staff expressed that clinics should represent a safe and a welcoming 
place for children, and should not be: a scary place for children, a place where people are 
rude to children, or a place where people discriminate against children. 
 
“I think [child-friendliness] means that if a child is below the age that they can go to the 
clinic by themselves, they should not be scared of going to the clinic when they have a 
running stomach and they are left alone at home. They should just have that confidence that 
I’m used to going to the clinic and I know that they are going to help me. They can just go 
because they know that children are welcome at the clinic, they don’t get scolded and they 
are not in that frightened state.” 
(47 year-old female nurse) 
 
“I think if we make children familiar with the clinic that can also help us if we want to give 
them injections because children are usually scared of injections. However, if you are always 
smiling they will know that they can come to the clinic. Even when the mother is getting an 
injection, they can see that it is painful but in the end they will know that it is a passing phase 
and when it is about them in the future they will know.”  
(57 year-old female nurse) 
5.1.3.3 Facilitators of child-friendliness 
In providing safe and welcoming places for children, participants noted several key activities 
as important facilitators of child-friendliness. Firstly, the emotional tone of the front line 
clinic staff, in particular, the way in which health care staff offer a warm greeting to a visiting 
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child, and make ‘small talk’ with children, were considered an important aspect of ensuring 
child-friendliness. For example, one nurse said:  
“We greet children, ask them who they are, and we introduce ourselves, and even ask them 
what they would like to study to be when they grow up? Some even say: “I would like to study 
to become a nurse.” Maybe it is because we have talked to them nicely.” 
(40 year-old female nurse) 
 
Clinic staff emphasised the importance of communication style and approach with children. 
They reported that ensuring developmentally appropriate language and ‘coming down to the 
level of a child’ were critical to helping children feel welcome and respected.  
“It’s [referring to an ideal child-friendly clinic] a clinic where children are made to be 
relaxed and feel at home. Anyone who works there can come down to the level of a child and 
talk the language that is spoken by the child so that they can understand what the child is 
saying.” 
(37 year-old male nurse) 
 
Participants highlighted the value of having child-friendly tools available that helped children 
to learn about health care in a developmentally appropriate manner:  
“Playing DVDs on the clinic TV may help. Maybe they can learn because I often hear 
children talk about things they learned from cartoons; educational stuff. I think we can also 
pick educational cartoons from Health [Department].” 
(70 year-old female nurse) 
 
5.1.3.4 Health intervention experience 
The clinic staff expressed that it was rewarding for them to interact with the children as a 
result of the Amagugu intervention. Over and above the intervention materials, the staff 
reported that they enjoyed the cleverness and the energy displayed by the Amagugu children 
in their busy and sometimes overwhelming work environment.  
 
“I was happy to see them [Amagugu children] because of their cleverness. Even the way they 
do things. You can see that if these children can continue with this thing they have started, 
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they can be able to help even a person they meet on the road. Maybe they meet a person on 
the road and notice their state of health, they can suggest that the person goes to a clinic. 
They seem knowledgeable when they carry their stuff; they look like they know everything. 
You enjoy being with them even if it is for a short period, if we can have enough time it would 
be wonderful.” 
(55 year-old female nurse) 
 
“And also this [Amagugu] programme is good because before, children knew that if they go 
to the clinic they will be given an injection. They have to be dragged in. When they arrive at 
the gate once they see a nurse they start crying. Being friendly to children is good and makes 
children get used to the clinic. Even during immunisation it is easy for children to flock to the 
clinic and know that nurses are our friends.” 
(44 year-old female general assistant) 
 
A male nurse expressed his fascinating experience of interacting with the Amagugu study 
children in the following quotation:  
“The one [child] that I saw was clever and was asking questions, she was checking the 
stethoscope out and asking whether it was for looking inside? They come with different ideas 
and expectations; like the one that came and said she was here to work. She ended up making 
orders on behalf of her mother: “Give my mother this one, check her BP, use a thermometer 
etc.” 
(34-year-old male nurse) 
 
5.1.3.5 Health intervention materials 
Following the health promotion clinic visit, maternal reports on intervention tools used by the 
clinic staff indicated that nurses referred to the child-friendly poster (233/281; 83%). Fewer 
nurses, but still the majority, were reported to have made use of the doll (204/281; 73%) and 
the medical play kit (197/281 or 70%) while just over half made use of HIV specific 
educational materials including the HIV Body Map (169/281; 60%).  
 
After the health intervention some of the staff members agreed that the Amagugu study 
materials assisted them in being child-friendly during the activities with the children during 
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the health promotion clinic visit. Despite working in an overcrowded rural clinic one nurse 
was pleased with the intervention and stated:  
 
“We orientate children using Amagugu materials and we are able to present health 
information in a fun-filled way. They start there at the front desk by the clerk and we try to 
welcome them. Sometimes the time is against us but we try. We show them whatever we can 
show them. Sometimes they just get excited and jump if they recognise Amagugu stuff because 
they can see it on the [clinic] wall.” 
(25 year-old female nurse) 
 
A role played by the intervention materials in making children less frightened of the clinics 
was expressed by another nurse: 
“......to know what is happening in the clinic is important, sometimes painful stuff like 
injections need to happen but it is important for children to get the knowledge. For instance 
because there are these play kits, we can demonstrate that your child is sick, he must get an 
injection. It’s important that the child knows that sometimes an injection is needed in order to 
get better.” 
(40 year-old female nurse) 
5.1.3.6 Barriers to child-friendliness 
The clinic staff reflected on the importance of providing mothers with education and support 
to ensure that they were able to allow the child to have a good clinic experience. Frequently 
this included encouraging mothers not to be harsh with children and advising mothers on 
sensitive care while recognising that mothers were in a stressful position often exacerbated by 
the stressors of their own, or their child's illness. For example, one nurse stated: 
"Sometimes we have a problem because the child’s mother is harsh to the child and maybe 
she is even scolding them. We end up telling them not to beat the child up in our presence. 
Sometimes we find them scolding children and we will say leave the child alone and say to 
the child come to aunty or if I want I say come to gogo [grandmother] and the child will 
come running to me.” 
(60 year-old female nurse) 
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Health care workers highlighted the importance of orientating children and adolescents 
themselves about appropriate behaviours in clinical settings. This included reducing the 
anxieties and fears that children may bring to the clinic as a result of their families and 
communities teaching children that clinics are frightening places.  
“To us child-friendliness is easy but the child comes with an attitude that you are an enemy. 
He has been told that back home. You try to reach out and the child pulls away. There was a 
child here this morning. The counsellor tried to play with him and the problem was that the 
counsellor was dressed as a nurse. The child became so quiet as if something had shocked 
him. You could see that he was quiet because he was very frightened. You wish to compliment 
them even on their clothing and say you look so handsome young man, but the child is just 
scared that you are up to something.” 
(55 year-old female nurse) 
 
However, the point of discordance which came through strongly in all focus groups related to 
the gap between knowing and believing that child-friendliness was the 'right thing to do', and 
being willing to do it, but not having the tools, capacity or human resources support to 
implement it. In the pre-child-friendliness training questionnaire some of the staff articulated 
their frustrations with the conflict they found between their willingness to be child-friendly 
and their inability to do this: 
“Yes, we try our best to be child-friendly but there are no toys or fun things that the staff can 
use to be friendly. We do not have enough time for it because this is a busy clinic and we 
have many patients with different sicknesses. We need to attend them and give quality 
treatment or counselling.” 
(36 year-old female HIV counsellor) 
 
A common theme from the focus groups indicated that participants recognised that health 
care workers’ inherent emotional capacity and willingness to be child-friendly could become 
degraded over time in contexts where health care was highly pressurised and where health 
care providers were offered little emotional support themselves. Most participants highlighted 
one or more of three key barriers to maintaining child-friendliness: lack of emotional support 
for staff members themselves; poor infrastructure and workflow; and high nursing workloads.  
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“As you can see, we are always [busy] like this. On day-to-day basis child-friendliness is 
possible but sometimes you find that we are waking up in the early hours of the morning as 
we are an early bird clinic. Let’s say there is a sick child and you have to come here and you 
have just woken up from sleep, it’s not easy then. Even if you are not frowning but ah ah you 
are not ok.” 
(38 year-old female nurse) 
 
Participants expressed that health care work was emotionally draining, and that at times they 
found it difficult to put on a ‘friendly face’ when they themselves were feeling overwhelmed 
with the difficult task of managing a variety of patients who presented with serious illnesses. 
This was particularly difficult when the child was not sick, but had just come for a health 
promotion visit. 
 
"Maybe it is [hard] because children that come for health promotion are not sick, they have 
an image they are expecting. They expect that they will find a person that will be smiling and 
then they are met with not what they expected. Maybe they find someone who does not have 
time. It’s not that you want to be like that but you have this workload."  
(40 year-old female nurse) 
 
“Sometimes it happens that the children come to the clinic and the clinic is busy in such a 
way that even if you want to give them the attention that they deserve as children, you end up 
not doing it and you cheat them. It could be due to bad timing or maybe you are running 
around, delivering babies, immunising and maybe it’s only the two of you at the time and the 
child gets cheated of the attention they deserve.” 
(34 year-old male nurse) 
 
Many participants highlighted that the physical structure of the clinic environment could be 
intimidating, even for adults, who attend clinic in a vulnerable state of illness. 
Accommodating children with an appropriate infrastructure was considered a useful way to 
create a more child-friendly atmosphere.  
Maybe the walking areas, for instance if there are steps in the clinic there should be areas 
where even the child can walk. You find that sometimes there are high steps where only 
adults can walk.” 
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(30 year-old male nurse) 
 
However, one nurse reported that even though the intervention was there, she sometimes 
forgot about it and continued to do things ‘the old way’. However, when she finally 
remembered about the intervention she tried to change her attitude and to be friendly to the 
children because she remembered the training she had received. She said:  
“I beg to differ. I don’t have the same views because we don’t have time for these children. I 
for instance, forget about them and find myself asking them “Who are you by the way?” 
Because I’m seeing someone that is disturbing me while I’m busy and then I remember and I 
try to do damage control.” 
(40 year-old female nurse) 
 
However, busy clinical settings, and in particular limited human resources, were cited as the 
most important barriers to the implementation of child-friendliness. It was also difficult for 
the clinic staff to view child-friendliness as part of their service to those attending the clinics. 
Instead they viewed child-friendliness as an extra chore that they could only fulfil when they 
were not busy.  
“The workload is not an easy thing. Sometimes the mother comes with the child and the child 
does not get attention, especially if the child is not sick. You only attend to the mother 
because you are pushing the workload and you don’t even have time to be playful with the 
kid. It’s not easy in a busy clinic. You only attend to the illness and do what you have to do.” 
(42 year-old female nurse) 
5.1.3.7 Rewards of child-friendliness 
Importantly, clinic staff recognised the reciprocal value of providing kind and sensitive care 
to children for their own sense of wellbeing and pride in their work. They reported that 
engaging more directly with children in this intervention helped them feel like they were 
good role models for children, which in turn fostered a sense of pride in health care work. In 
turn this made child-friendliness easier to maintain and contributed to the sustainability of 
child-friendliness in their clinic. This pride in health care work was most commonly 
expressed in participants’ enjoyment of children's expressed aspirations to become health 
care providers themselves as a consequence of their clinic experiences.  
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“They have these name tags and use the playing cards that you gave us [during the training] 
and a doll. We are playing with them and sometimes they end up wanting to take the clinic 
doll they are playing with to their home. They end up seeing themselves as part of health 
workers for instance if you give them a stethoscope and let them use it. They see themselves 
as doctors or see themselves as nurses.” 
(42 year-old female nurse) 
 
5.1.3.8 Recommendations for child-friendliness in clinics 
Health care workers had ideas about how to organise clinical services around child specific 
services to benefit both the child and the health care providers. This would assist the capacity 
of clinic staff to implement child-friendliness in their facilities. Allowing children and 
families to attend on specific days and encouraging group sessions with children attending 
clinic were seen as feasible solutions to work flow challenges.  
“It’s good that children have their own clinic day. On that day at least you know that if you 
see a motor-bike [toy] anywhere it’s children’s day. You also prepare yourself that today I 
am going to play. You prepare your own atmosphere from the minute you enter the clinic 
gate. It’s a bit difficult when there is a mixture; here is an old man and then suddenly you 
have to smile to a child in front of you.” 
(42 year-old female nurse) 
 
“Maybe it could be that Amagugu children don’t come individually but in groups. We can 
choose this room and have a counsellor that will just attend to them and it could be fun while 
the mothers are consulting nurses with their many files. The counsellor can just keep them 
busy; the nurse will not have to do much.” 
(29 year-old female HIV counsellor) 
 
5.2 Conclusion 
These results demonstrate how the three themes, HIV-related stigma, family strengthening 
and access and adherence to HIV treatment and care, impact on women’s disclosure of their 
status. These themes are intertwined and shape women’s management of their HIV infection 
and their relationship with their family, community and primary health care clinics.  
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This illustrates that in communities where HIV-stigma is minimal, it is easier for HIV-
infected women to disclose to their families and thus obtain social support. This social 
support strengthens family relations and is instrumental in assisting women to access and 
adhere to their HIV treatment. The important role played by primary health care clinics in 
supporting HIV-affected families, including offering child-friendly services cannot be 
underestimated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 81 
 
6. Overview of scientific papers 
6.1 Paper I 
Mkwanazi NB, Rochat TJ, Imrie J & Bland RM. Disclosure of Maternal HIV Status to 
Children: Considerations for Research and Practice in sub-Saharan Africa. Future Virology 
(2012) 7 (12) pages 1159-1182 
Research question: Where have maternal HIV-disclosure studies been conducted, with whom 
and what lessons can be adapted to rural settings in sub-Saharan Africa? 
Methods: A review of maternal HIV-disclosure literature based on 56 studies included in two 
literature reviews and a systematic review identified after searching for maternal HIV-
disclosure studies conducted between 2000 and 2010. A further two studies were identified 
after searching on Pubmed and Google Scholar for studies conducted between 2010 and 
2012.  
Findings: Improvements in HIV treatment have resulted in increasing numbers of mothers 
surviving to care for their HIV-uninfected children. One of the challenges these mothers face 
is when and how to disclose their HIV status to their children. Many benefits of maternal 
HIV-disclosure have been documented for both mothers and children of primary-school age, 
including improved mental health for the mother and increased HIV knowledge for the child. 
International research on maternal HIV-disclosure is mostly descriptive from resource-rich 
settings; few studies report on HIV-disclosure intervention or include children under the age 
of 12 years. The most cited reasons for non-disclosure to children are the perception that 
children will not be able to maintain confidentiality, and that they too young to understand 
about HIV.  
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6.2 Paper II 
Mkwanazi NB, Rochat TJ & Bland RM. Living with HIV, disclosure and partnerships a 
decade after the introduction of HIV programmes in rural South Africa. AIDS Care (2015) 
(27) Suppl 1: pages 65-72 
Research question: How have HIV-infected women experienced living with HIV in an ART-
era, ten years after their diagnosis? 
Methods: An interview guide was developed and used to conduct in-depth interviews with a 
sub-sample of 20 women that had participated in a maternal HIV-disclosure intervention. 
(Amagugu). Some additional questions in the interview guide were designed for a structured 
interview (a separate analysis for Paper III, see below).  
Findings: Women’s median age was 32 years (IQR 29-37) and their children’s median age 
was seven years (IQR 6.5-7.5). Twelve women had current partners and approximately half 
were in stable relationships with biological fathers of the study child. Approximately half 
were living with their partners and had disclosed their HIV status to partners first before 
disclosing to family and friends. Partners were reported to be supportive following disclosure. 
Most women (N=14) were on ART and social exposure to HIV was high as most women 
(N=14) were aware of another adult family member infected with HIV in their household. 
Two women had not disclosed their status to anyone due to fear of stigma. Some women 
were in sero-discordant relationships and that contributed to the complexity of disclosure. 
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6.3 Paper III 
Mkwanazi NB, Rochat TJ & Bland RM. The Amagugu intervention: A qualitative 
investigation into maternal experiences and perspectives of a maternal HIV-disclosure 
support intervention in rural South Africa (accepted in the journal Health Policy and 
Planning on 26 April 2017). 
 
Research questions: What motivates HIV-infected mothers to enrol in a maternal HIV-
disclosure intervention for primary school-aged uninfected children and what do they report 
post intervention? Why had they not disclosed to their children before the maternal HIV-
disclosure intervention and what advice can they give to other HIV-infected women? 
 
Methods: An interview guide that was developed for Paper II above also had a component for 
a structured interview which was analysed for Paper III conducted with the sub-sample of 20 
women that had participated in the Amagugu maternal HIV-disclosure intervention.  
Findings: Most women had not disclosed their status to their children prior to the intervention 
because they were concerned about their children’s developmental capacity to contain the 
information. Some expressed that their children were too young for HIV-disclosure, and 
others reported that they, themselves, were not equipped to handle questions that their 
children might ask during the disclosure process. The majority of mothers stated that they 
would advise other mothers to disclose to their children because children offered social 
support following disclosure and reminded them to take their HIV treatment.  
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6.4 Paper IV 
Mkwanazi NB, Rochat TJ, Coetzee BJ & Bland R.M. (2013) Mothers and health workers’ 
perceptions of participation in a child-friendly health initiative in rural South Africa. Health 
(2013) 5 (12) pages 2137-2145 
Research questions: What were women and their children’s experiences of a clinic 
intervention to support maternal HIV-disclosure? How can primary health care clinics be 
supported to assist HIV-affected families to access and adhere to HIV treatment and care? 
 
Methods: As part of a larger intervention (“Amagugu” Intervention), 281 mothers were 
invited to attend a primary health clinic with their primary school-aged children, and 
afterwards their views on child-friendliness of the clinic staff were documented using the 
Clinic Follow-Up and Child Experience Form (a structured questionnaire). Clinic staff 
including nurses, HIV counsellors and clinic clerks were trained on child-friendliness and 
assessed on their experiences of providing child-friendly services through focus groups post 
intervention (N=87). A sub-group of mothers (N=20) also participated in in-depth interviews 
about child-friendliness post intervention.  
Findings: Mothers rated 65% of clerks and 70% of nurses as “very friendly”. Qualitative data 
indicated that heavy clinical loads, limited human resources and inadequate infrastructure 
were perceived as barriers to child-friendliness while good clinic leadership and appropriate 
resources facilitated child-friendliness.  
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7. Discussion 
The Amagugu intervention is the first structured intervention for maternal HIV-disclosure to 
their children delivered to women in sub-Sahara Africa. It was designed for use in resource-
poor high HIV prevalence settings with a low intensity, lay counsellor- led model, aimed at 
mothers with young children (6-10 years old). The counsellors did not directly intervene with 
children, instead mothers of primary school-aged children were provided with training and 
support which empowered them to communicate with their children independently (73, 76, 
185). The Amagugu intervention proved to be acceptable and feasible and led to increased 
disclosure of mothers’ HIV status to their HIV-uninfected children, improvements in family 
health care engagements, and custody planning for the children (73, 74, 76, 185). 
The study described here adds to the disclosure literature, as experiences of women 
participating in maternal HIV-disclosure interventions have not previously been documented 
in Africa. Women’s participation experiences have however, been reported in a longitudinal 
pilot intervention from the US which was also designed to support mothers to disclose their 
status to their primary school-aged children (251). This PhD study set out to explore, in 
greater depth, the experiences of HIV-infected women who were involved in the Amagugu 
maternal HIV-disclosure intervention. The exploration included investigating women’s 
interaction with the clinic staff and their access to HIV treatment and care during the health 
intervention that they undertook with their children. The additional findings from this study 
have led to new recommendations for future interventions designed to assist maternal HIV-
disclosure. 
An encouraging finding from this work is the indication that a decade after being diagnosed 
with HIV, women in this resource-poor, rural setting are generally living positively with HIV. 
The majority were in good health and on ART with relatively high CD4 cell counts. Very low 
morbidity rates were observed among the women in the Amagugu study.  
Despite concerns raised by mothers prior to the intervention, it is very encouraging that 
mothers expressed no regrets following disclosure and no adverse reactions from children 
were reported. Mothers expressed that they would advise other mothers in similar situations 
to disclose their status to their children because disclosure increases children’s HIV 
knowledge, builds trust with their children and assists mothers with their ART adherence (66, 
67, 83, 89, 111, 251). This study has assisted in the understanding of the lives and 
experiences of HIV-infected women almost ten years on from their original HIV diagnosis. 
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We have learned how HIV-related stigma affects their lives, and how disclosure has assisted 
them to receive relevant social support, including access and adherence to HIV treatment and 
care. 
The findings from this study suggest that HIV-disclosure to adults does not necessarily 
translate into disclosure to children, and that parents require specific interventions to assist 
them with disclosure to children, and to appreciate what children can understand at different 
developmental stages. The study shows that interventions to assist parents need to be 
contextual and address the needs of parents and children. As children grow older, their 
relationships with parents evolve. Parents may require added support with intergenerational 
communication, including skills and knowledge to discuss issues such as sex with children, 
which should be considered in the design of future interventions. It would also be beneficial 
for HIV-affected families to think more about fathers and male care givers, and how they 
should be involved in processes of parental disclosure. As this study indicates, men are often 
involved in parenting of HIV-affected children, but do not always receive attention and 
support, either with parenting or participation in the HIV-disclosure interventions.  
It was encouraging that staff from the primary health care clinics welcomed the child-
friendliness and maternal HIV-disclosure training. They recognised the role that they could 
play in health promotion and increasing children’s participation opportunities in health 
facilities and that this was possible, provided they received support to address logistical 
constraints including workload, lack of infrastructure and staff shortages. The clinic staff 
found interacting with children in child-friendliness activities rewarding, suggesting that if 
such activities could be incorporated into daily clinic routines, they could boost the morale of 
the health facilities staff.  
This study demonstrates that when provided with culturally and age-appropriate disclosure 
tools, HIV-infected mothers are willing and able to disclose their status to their children. 
Although the study was conducted in a resource-poor, rural, high HIV-prevalence setting 
with high social HIV-exposure, it could be tested in other settings. Researchers can contribute 
to the literature by addressing the issue of how to conduct culturally acceptable disclosure 
research in different settings, and how to best assist and support healthcare staff and HIV-
affected parents to navigate through the process of HIV-disclosure. This is often perceived as 
being very difficult, but also to be necessary and important by mothers and health care staff. 
The important role played by families including extended families and health care facilities in 
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managing HIV in sub-Sahara African context cannot be underestimated when designing such 
interventions.  
7.1 Exploration of key findings from the PhD 
The key findings from this exploration are summarised in relation to three main areas which 
are central to this study. 
i. HIV-related stigma 
ii. HIV-disclosure and family strengthening 
iii. HIV-disclosure and access and adherence to HIV treatment 
 
7.2 HIV-related stigma 
The fear of HIV-related stigma was one of the primary reasons most women had not 
disclosed to their children prior to the Amagugu intervention (73, 76). Women in this study 
reported that they did not trust their children to be able to maintain confidentiality, and 
perceived that their children lacked the developmental capacity to cope with maternal HIV-
disclosure. Non-disclosure of maternal HIV status due to perceptions that children are too 
young has also been reported in studies in China (122), Thailand (203) and the US (64). 
Other literature suggests that a child’s young age is related to their inability to maintain 
confidentiality about their mothers’ HIV status (52, 54, 66).  
In line with the findings from China, South Africa, Kenya, and the US (53, 90, 95, 101, 183, 
187, 252), our study suggests that HIV-related stigma may impact on access to and adherence 
to HIV treatment in some cases. Two of the twenty women in the sub-sample reported having 
not accessed HIV treatment, care and support, despite knowing their HIV status for almost a 
decade. Not accessing health care due to fear of stigma is not a unique finding, and has 
previously been reported in a systematic review and meta-synthesis on the effect of the 
relationship between stigma and ART adherence (253). 
Despite the challenges of HIV-related stigma and other factors, this study has shown that 
HIV-infected mothers, and the health care staff responsible for their treatment and well-
being, view maternal HIV-disclosure as a necessary step to enable mothers to obtain adequate 
social support (97). Although HIV-related stigma has been reported in other settings (96, 126, 
128, 129, 254), with increased ART roll-out in areas of high HIV prevalence, including this 
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study area, decreased levels of HIV-related stigma are being observed (184). In this study the 
majority of women reported that they were openly accessing HIV treatment and care. This 
could be partially attributed to the high social exposure to HIV in the study area, where most 
adults and children are aware of someone who is HIV-infected, or taking ART, in their 
family or community (204). Both mothers and the clinic staff indicated that children were 
also receiving HIV education as part of Life Orientation teaching - a subject taught from 
primary school through to the school-leaving matriculation - which has increased their 
exposure to HIV and accurate information about the infection. 
7.3 HIV-disclosure and family strengthening 
Maternal HIV-disclosure benefits children by opening up communication channels for HIV 
education and prevention between mothers and their children (185). In line with findings 
from elsewhere, contained in the international literature, this study has shown that maternal 
HIV-disclosure has benefits for mothers, children and families (66, 67, 83, 89, 111, 251). It 
has also demonstrated that HIV-disclosure to children improves maternal mental health, 
promotes health care behaviours, increases HIV and health education, and strengthens parent-
child and family relationships (90, 255, 256).  
Enhancing children’s psychological well-being through maternal disclosure can prevent the 
possible negative effects of disclosure, including lack of health education, psycho-social 
problems and poor parent-child communication, all of which are reported in the literature 
(257-260). When children’s psychological well-being is enhanced, they are more likely to 
grow up to be responsible adults, better able to take responsibility for their own health, and to 
minimize risky behaviours in the future (73, 74, 76, 185, 261). This will, in turn, improve 
their life chances, making them better equipped to maximize educational and employment 
opportunities (73, 74, 76, 185, 261).  
 
This study suggests that the main reason for maternal HIV-disclosure is to obtain social 
support from their children (88, 97, 184), a finding that has been reported elsewhere in the 
literature (81-84). Mothers reported being pleasantly surprised by the amount of HIV 
knowledge their children displayed during the disclosure process, and they appreciated the 
chance of providing HIV education to their children during the intervention, a finding also 
described in studies from the US (103, 251) and in a systematic review (89). Mothers also 
appreciated the support they received from their children in reminding them to take their HIV 
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treatment, thus improving their adherence. Similar reports of closeness and supportive 
behaviour from children have been found in other studies and indicate the role of disclosure 
in family-cohesion and ART adherence (66, 107, 112). 
 
Most parental HIV-disclosure studies have been conducted with mothers, and the 
perspectives of HIV-infected fathers and the children who have been disclosed to, have been 
lacking. Only interviewing mothers leaves a gap in the research findings and takes the focus 
away from the children, who are also beneficiaries of maternal HIV-disclosure (67). One 
challenge of involving children in parental HIV-disclosure research is the risk of inadvertent 
disclosure that has been reported in other studies (107, 262). Another challenge is that 
children’s reports of their experiences of disclosure may differ from those given by their 
mothers (54, 67, 90, 113). Limitations of two studies, that interviewed children in Kenya 
(183) and China (263), included small sample sizes, and a lack of data collection from 
fathers. A further challenge in the Kenyan study, was that the interviews were not conducted 
in the participants’ home language (183). 
In this PhD study mothers were interviewed in their home language, but children were not 
interviewed due to logistical constraints and the ethical complexities of interviewing children. 
The scope of this study was therefore limited to the perspectives of mothers who had 
participated in the Amagugu HIV-disclosure intervention. Future studies could, and most 
probably should, investigate children’s perspectives, but additional caution will be required in 
designing such interventions, in order to reduce the negative consequences of an inadvertent 
disclosure. The inclusion of males in disclosure interventions would also be beneficial, so 
that the child’s support network is further extended through the disclosure process.  
Despite women in this study reporting high levels of disclosure to other adults, HIV-infected 
women and health care staff from primary health care clinics noted that assistance is required 
with maternal HIV-disclosure to primary school-aged children. Addressing the socio-cultural 
context including HIV-related stigma, social exposure to HIV and the child’s developmental 
capacity (101, 114, 183, 187, 263, 264) are required to encourage and support maternal HIV-
disclosure. Normalisation of ARVs in the study area - to the extent of them being likened to 
everyday substances that are openly shared like teabags was - an interesting and encouraging 
finding that showed a high degree of de-stigmatisation of HIV in some parts of the study 
communities.  
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7.4 HIV-disclosure and access and adherence to HIV treatment  
The WHO’s Parental Disclosure Guidelines recommend HIV-disclosure as part of the 
continuum of care for HIV-affected families (46). This, and other studies, have demonstrated 
that HIV-disclosure leads to increased social support (103, 114), better ART and clinic 
appointment adherence (89, 101, 113, 187), and improved family cohesion (66, 67, 83, 111, 
251). The wide roll-out of HIV treatment and care programmes provides an enabling 
environment for maternal disclosure because HIV-infected parents survive much longer and 
are able to care for their children to adulthood, as compared to the pre-ART-era where many 
children were orphaned (88).  
Most women in this study were in stable partnerships and were still in a relationship with the 
father of the study child from the Vertical Transmission Study. Reports on disclosure to 
partners are documented in other studies (92, 93, 173, 205, 265). That most women disclosed 
to their partners first, before disclosing to anyone else (184), suggests that stability of 
partnerships is an important factor to be considered when designing HIV-disclosure 
interventions.  
One critique of the existing theoretical models and frameworks that could guide future 
parental HIV-disclosure interventions is that most of them were developed prior to the 
availability of ART, when HIV was regarded as a fatal, rather than a chronic, illness (78, 
135). As a result, the models tend to focus on disclosure as a process between two 
individuals, and did not necessarily take into consideration the complexities of the family 
context in which the two individuals, for an example a child and a parent, exist (90). For this 
reason, it is also argued that the theoretical models used for parental HIV-disclosure 
interventions should be applied with caution in collectivist cultural settings, including those 
commonly found in Asia and Africa (78, 135). In such settings children may have multiple 
caregivers who hold contrasting views regarding parental HIV-disclosure, and thus, the 
theoretical models need to make provision for these cultural differences (78, 135) and not 
adopt a ‘fits one, fits all’ model. Providing family-centred HIV care to infected women and 
their families may be more beneficial than individual-centred care in areas of high HIV 
prevalence (68, 69, 266).  
It is encouraging that in recent years there has been an emerging literature addressing parental 
HIV-disclosure to children in low and middle income countries such as Kenya (183), South 
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Africa (73, 74, 76) and China (95, 252, 263, 267). The health intervention which was part of 
the Amagugu study and the current study, also demonstrated that in areas of high HIV 
prevalence, providing the primary health care clinics with child-friendliness and health 
promotion activities was acceptable to both mothers and health care staff (97). Heavy clinical 
loads, limited human resources, and inadequate infrastructure were perceived as barriers to 
child-friendliness, while good clinic leadership and appropriate resources facilitated child-
friendliness.  
 
7.5 Strengths and limitations of the current study 
7.5.1 Strengths 
This study contributes to the global scientific literature on maternal HIV-disclosure (88) and 
the lives of African, rural women who have been living with HIV in an ART-era for almost a 
decade (184). It describes their living arrangements, disclosure patterns, and partnerships. 
The study also contributes to the literature on the perspectives of health staff, and their 
involvement in supporting HIV-affected families in resource-poor settings with high HIV 
prevalence (97). Finally, it also explores in depth, the mothers’ experiences of participating in 
an HIV-disclosure intervention, including reports of their own children’s reactions to 
disclosure. 
All the interviews and the focus group discussions were conducted in isiZulu, the 
participants’ and the interviewer’s home language. I viewed being Zulu and from the local 
area as an advantage and not a disadvantage throughout the research process. I did not need a 
translator and I felt I had control driving the interviews and the focus groups and probing 
appropriately according to my research questions. I was comfortable with the language and 
most participants appeared to be at ease when they expressed themselves in their home 
language. However, with some participants, in both interviews and focus groups, there was 
an assumption that: “as a Zulu, you should know these things” especially when I probed on 
some issues that were related to the Zulu culture, such as being involved in a polygamous 
marriage. On a few occasions, I had to “defend” myself and declare my ignorance and state 
that I was unaware of some of the Zulu cultural practices that I was “assumed” to share or 
have experienced. These included rituals that are only performed by some families that I was 
not exposed to in my household. My ignorance of some aspects of the Zulu culture enabled 
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me to have no assumptions, and to probe and be open to new information and to interrogate 
those narratives further in detail, when listening to the audio-recordings.  
During the home visits I would make sure that I dressed appropriately; I wore skirts or 
dresses instead of pants and politely declined a chair but instead sat down on a reed mat with 
the participant so that we could be on the same level. Being an approachable person by 
nature, helped to neutralize the influence I might have had over the participants as I am from 
a prominent local Mkhwanazi royal family. In this context it was even more important to 
emphasize that participation in this research was completely voluntary. At all times I strove 
to make participants feel as comfortable as possible, because I was conscious of how my 
family name could impact on my research. I believe conducting the interviews in the comfort 
of participants’ homes made them more relaxed, and with all 20 participants I was able to 
negotiate private space with minimum interruptions, which assisted with ensuring the quality 
of the audio-recordings.  
Since I have not given birth to, or raised, a child, I could ask questions relating to disclosure 
of an HIV status to a child with few preconceived ideas, which I believe contributed to the 
richness of the data collected. At times the naiveté I displayed in matters relating to bearing 
and raising children seemed to empower women to display their skills and knowledge, as 
they had something which I, ‘an educated researcher’, did not have. I assumed that this 
‘upper hand’ and my lack of experience mitigated any tacit power relation imbalance that 
might have existed between me, a researcher, and them, as participants.  
 
7.5.2 Limitations 
Ideally it would have been more beneficial to have had bilingual members in the research 
team to assist with the verification of transcript translations. My co-investigators and the co-
authors on the study publications could not speak or read isiZulu, and therefore, they could 
not listen to the audio-recordings or verify the interview and focus group transcript 
translations. For that part of the process I had to rely on a bilingual, first-language isiZulu-
speaking colleague, who was not part of the research team, to verify a few translations of 
both interviews and the focus group discussions.  
The staff rotation at the clinics made it challenging to assess whether there were significant 
changes in the knowledge and attitudes before, and after, the training in child-friendliness and 
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maternal HIV-disclosure had taken place. In most cases, when I returned to administer 
questionnaires after the clinic training (the post-clinic training questionnaires), I found that 
there were clinic staff members present who had not been part of the original training. 
However, the focus groups provided an opportunity for everyone to express their views on 
the child-friendliness and maternal HIV-disclosure materials and training. The majority of 
clinic staff who participated in the focus groups had, in one way or another come across, or 
interacted with, Amagugu study mother-child pairs, who had come to the clinics for health 
promotion visits and could share their experiences.  
Although the women in this study were from a high HIV prevalence area, they were different 
to other HIV-infected women from the general population, in that they had been exposed to 
two home-based interventions previously, the Vertical Transmission Study and the Amagugu 
Study. It is possible therefore, that they were more receptive to research involving their 
children and were more used to adhering to research procedures than other women, and hence 
the high rates of maternal HIV-disclosure reported. It would be interesting to examine results 
from future studies using the same intervention materials, but enrolling HIV-infected women 
with uninfected children from the general population, not previously involved in research.  
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8. Conclusion, implications and future research 
8.1 Summary 
In this Discussion section, I have highlighted how this PhD study contributes to the literature 
of HIV-infected women who have been living with HIV and have been part of a maternal 
HIV-disclosure intervention, and the role health care workers have in supporting HIV-
affected families in areas of high HIV prevalence. I have also discussed the research findings 
in relation to the three main themes of the study and how they are similar or different to what 
is already known from the international scientific literature. I have demonstrated how my 
background and the way I conducted and presented myself as a researcher could have 
impacted on the research process, and the steps I took to minimise researcher biases from 
data collection to data analysis.  
8.2 Implications for future interventions and research 
The Amagugu intervention shows promise as a method of assisting HIV-infected mothers to 
disclose their HIV status to their primary school-aged children, using a counsellor-led, home-
based, model. The work of this PhD further explored the experiences of the women who took 
part in this intervention, and my findings lead to the following recommendations for future 
interventions and research: 
1. The important role played by families including extended families, and primary health 
care clinics, should be considered when designing HIV-disclosure interventions for 
sub-Saharan Africa. 
2. Specific interventions are needed to assist with HIV-disclosure to children. It should 
not be assumed that adult disclosure will automatically lead to disclosure to children. 
3. It would benefit HIV-affected families if future research involves fathers because they 
are also caregivers. 
4. That most women disclosed to their partners first, before disclosing to anyone else, 
suggests that stability of partnerships is an important factor to be considered when 
designing HIV-disclosure interventions. 
5. That the mothers expressed no regrets in actively engaging their children about their 
HIV, and that their experience was reported to be highly satisfying regardless of their 
circumstances, are findings that could be used to promote maternal HIV-disclosure 
interventions more widely. 
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6. Provided there are culturally and age-appropriate intervention tools, HIV-disclosure 
can be a basis for health and sex education with children, which most parents struggle 
with in sub-Saharan Africa. 
7. When conducted in an age-appropriate manner, maternal HIV-disclosure 
interventions may lead to children assisting mothers with their treatment adherence. 
8. Providing child-friendly services at health facilities not only helps to establish a 
productive and trusting health care relationship, but has the potential to improve the 
experience of health visits for children and their parents and be rewarding for health 
staff. 
9. The barriers to child-friendliness articulated by the clinic staff could be a starting 
point for recognising what needs to be done to incorporate child-friendliness and 
health promotion activities into a model of family-centred care. 
10. Persisting incidents of HIV-related stigma indicate efforts to mitigate stigma need to 
be continued and strengthened at all levels, including in households, the communities 
and health facilities. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 96 
 
9. References 
1. Casale M, Wild L. The relationship between social support and the health of HIV-positive 
caregivers of children: A review of the empirical literature. Vulnerable Children and Youth Studies. 
2012;7(3):260-82. 
2. Gaede B, Majeke S, Modeste RRM, Naidoo JR, Titus MJ, Uys LR. Social support and health  
behaviour in women living with HIV in KwaZulu-Natal. SAHARA-J: Journal of Social Aspects of 
HIV/AIDS. 2006;3(1):362-8. 
3. Kalichman SC, DiMarco M, Austin J, Luke W, DiFonzo K. Stress, Social Support, and HIV -
Status Disclosure to Family and Friends Among HIV-Positive Men and Women. Journal of Behavioral 
Medicine. 2003;26(4):315-32. 
4. Maman S, van Rooyen H, Groves AK. HIV status disclosure to families for social support in 
South Africa (NIMH Project Accept/HPTN 043). AIDS care. 2014;26(2):226-32. 
5. Siegal FP, Lopez C, Hammer GS, Brown AE, Kornfeld SJ, Gold J, et al. Severe acquired 
immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex 
lesions. New England Journal of Medicine. 1981;305(24):1439-44. 
6. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis 
carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a 
new acquired cellular immunodeficiency. New England Journal of Medicine. 1981;305(24):1425-31. 
7. Curran J. Epidemiologic Aspects of the Current Outbreak of Kaposis Sarcoma and 
Opportunistic Infections. New England Journal of Medicine. 1982;306(4):248-52. 
8. Davis KC, Horsburgh CR, Hasiba U, Schocket AL, Kirkpatrick CH. Acquired immunodeficiency 
syndrome in a patient with hemophilia. Annals of internal medicine. 1983;98(3):284-6. 
9. Curran JW, Lawrence DN, Jaffe H, Kaplan JE, Zyla LD, Chamberland M, et al. Acquired 
immunodeficiency syndrome (AIDS) associated with transfusions. New England journal of medicine. 
1984;310(2):69-75. 
10. Clumek N, Mascart-Lemone F, De Maubeuge J, Brenez D, Marcelis L. Acquired immune 
deficiency syndrome in black Africans. Lancet. 1983;1(8325):642. 
11. Oleske J, Minnefor A, Cooper R, Thomas K, dela Cruz A, Ahdieh H, et al . Immune deficiency 
syndrome in children. Jama. 1983;249(17):2345-9. 
12. Essex M, Essex M. AIDS in Africa: Springer Science & Business Media; 2002.  
13. Karim QA, Karim SSA. The evolving HIV epidemic in South Africa. International Journal of 
Epidemiology. 2002;31(1):37-40. 
14. Department of Health. Department of Health National Survey Pregnant Women 2001 
Eleventh Attending Antenatal Clinics of Public Health Services. 2001. 
15. National Department of Health. National HIV and Syphillis Ante-natal Sero-prevalence survey 
in South Africa 2008. South African Department of Health, Pretoria. 2008. 
16. Barron P, Pillay Y, Doherty T, Sherman G, Jackson D, Bhardwaj S, et al. Eliminating mother-to-
child HIV transmission in South Africa. Bulletin of the World Health Organization. 2013;91(1):70-4. 
17. HIV/AIDS JUNPo. UNAIDS Report on the Global AIDS Epidemic. UNAIDS; 2012. Google 
Scholar. 2012. 
18. Williams B, Gouws E, Wilkinson D, Karim SA. Estimating HIV incidence rates from age 
prevalence data in epidemic situations. Statistics in medicine. 2001;20(13):2003-16. 
19. UNAIDS. Global Report 2012: UNAIDS Report on the Global AIDS Epidemic: 
ebookpartnership. com; 2013. 
20. Dunkle KL, Jewkes RK, Brown HC, Gray GE, McIntryre JA, Harlow SD. Gender-based violence, 
relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa. 
The lancet. 2004;363(9419):1415-21. 
21. Moodley P, Parboosing R, Moodley D. Reduction in perinatal HIV infections in KwaZulu-
Natal, South Africa, in the era of more effective prevention of mother to child transmission 
 97 
 
interventions (2004–2012). JAIDS Journal of Acquired Immune Deficiency Syndromes. 
2013;63(3):410-5. 
22. World Health Organization. Guidelines on HIV and infant feeding: principles and 
recommendations for infant feeding in the context of HIV and a summary of evidence: World Health 
Organization; 2010. 
23. World Health Organization. Breastfeeding and replacement feeding practices in the context 
of mother-to-child transmission of HIV: an assessment tool for research. WHO/RHR/01.12 
(WHO/CAH/01.21) ed. Geneva: World Health Organization; 2001. 
24. Pillay Y, White C, McCormick N. How times have changed-HIV and AIDS in South Africa in 
2011. SAMJ: South African Medical Journal. 2012;102(2):77-8. 
25. National Department of Health. National Action Framework for PMTCT. No child born with 
HIV by 2015 and improving the health and wellbeing of mothers, babies and partners in South Africa, 
2012-2016. 2014. 2011. 
26. Goga A, Dinh T, Jackson D, Dlamini N, Mosala T, Lombard T, editors. Impact of the national 
prevention of mother-to-child transmission of HIV (PMTCT) program on perinatal mother-to-child 
transmission of HIV (MTCT) measured at six weeks postpartum, South Africa (SA). XIX  International 
AIDS Conference; 2012 22–27 July; Washington, United States; 2012. 
27. Goga AE, Dinh T-H, Jackson DJ, Lombard C, Delaney KP, Puren A, et al. First population-level 
effectiveness evaluation of a national programme to prevent HIV transmission from mother to child, 
South Africa. Journal of epidemiology and community health. 2014:jech-2014-204535. 
28. Department of Health. National consolidated guidelines for the prevention of mother-to-
child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. 
Department of Health, Republic of South Africa Pretoria; 2014. 
29. Nattrass N. Mortal combat: AIDS denialism and the struggle for antiretrovirals in South 
Africa: University of KwaZulu-Natal Press; 2007. 
30. Kalichman S. Denying AIDS: Conspiracy theories, pseudoscience, and human tragedy: 
Springer Science & Business Media; 2009. 
31. Squire C. HIV in South Africa: talking about the big thing. London: Routledge; 2007.  
32. Mbali M. The Treatment Action Campaign and the history of rights-based, patient-driven 
HIV/AIDS activism in South Africa. Leiden: Koninklike Brill NV; 2005. p. 213-44. 
33. Bland RM, Ndirangu J. Maximising opportunities for increased antiretroviral treatment in 
children in an existing HIV programme in rural  South Africa. benefits. 2013;13:15. 
34. Houlihan CF, Bland RM, Mutevedzi PC, Lessells RJ, Ndirangu J, Thulare H, et al. Cohort 
Profile: Hlabisa HIV Treatment and Care Programme. Int J Epidemiol. 2010:dyp402.  
35. Janssen N, Ndirangu J, Newell M-L, Bland RM. Successful paediatric HIV treatment in rural 
primary care in Africa. Archives of disease in childhood. 2010;95(6):414-21. 
36. Filteau S. The HIV-exposed, uninfected African child. Tropical Medicine & International 
Health. 2009;14(3):276-87. 
37. McNally LM, Hadingham J, Archary D, Moodley R, Coovadia HM. HIV-exposed but uninfected 
children: Why are they vulnerable? Vulnerable Children and Youth Studies. 2006;1(2):139-48. 
38. Coovadia HM, Rollins NC, Bland RM, Little K, Coutsoudis A, Bennish ML, et al. Mother-to-
child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an 
intervention cohort study. Lancet. 2007;369(9567):1107-16. 
39. Suthar AB, Granich R, Merminc J, Van Riea A. Systematic reviews. Bull World Health Organ. 
2012;90:128-38C. 
40. Stinson K, Jennings K, Myer L. Integration of antiretroviral therapy services into antenatal 
care increases treatment initiation during pregnancy: a cohort study. PLoS One. 2013;8(5):e63328.  
41. Mnyani CN, Marinda E, Struthers H, Gulley M, Machepa R, McIntyre J. Timing of antenatal 
care and ART initiation in HIV-infected pregnant women before and after introduction of NIMART. 
Southern African Journal of HIV Medicine. 2014;15(2):55-6. 
42. UNAIDS. Progress Report on the Global Plans. Geneva; 2014. 
 98 
 
43. UNICEF. Children and AIDS: Fifth Stocktaking Report: Joint United Nations Programme on 
HIV/AIDS; 2010. 
44. UNICEF. Towards an AIDS-free generation: children and AIDS: sixth stocktaking report, 
20132013. 
45. Taha TE, Graham SM, Kumwenda NI, Broadhead RL, Hoover DR, Markakis D, et al. Morbidity 
among human immunodeficiency virus-1-infected and-uninfected African children. Pediatrics. 
2000;106(6):e77-e. 
46. World Health Organization. Guideline on HIV disclosure counselling for children up to 12 
years of age. Geneva, WHO. 2011. 
47. AIDS CoP. Disclosure of Illness Status to Children and Adolescents With HIV Infection. 
Pediatrics. 1999;103(1):164-6. 
48. Coetzee B, Kagee A, Bland R. Barriers and facilitators to paediatric adherence to 
antiretroviral therapy in rural South Africa: a multi-stakeholder perspective. AIDS care. 
2015;27(3):315-21. 
49. Waugh S. Parental views on disclosure of diagnosis to their HIV-positive children. AIDS Care. 
2003;15(2):169-76. 
50. Vreeman R, Wiehe S, Ayaya S, Musick B, Nyandiko W. Association of antiretroviral and clinic 
adherence with orphan status among HIV-infected children in Western Kenya. J Acquir Immune Defic 
Syndr. 2008;49(2):163 - 70. 
51. Brown BJ, Oladokun RE, Osinusi K, Ochigbo S, Adewole IF, Kanki P. Disclosure of HIV status to 
infected children in a Nigerian HIV Care Programme. AIDS Care. 2011;23(9):1053-8. 
52. Corona R, Beckett MK, Cowgill BO, Elliott MN, Murphy DA, Zhou AJ, et al. Do Children Know 
Their Parent's HIV Status? Parental Reports of Child Awareness in a Nationally Representative 
Sample. Ambulatory Pediatrics. 2006;6(3):138-44. 
53. Palin F, Armistead L, Clayton A, Ketchen B, Lindner G, Kokot-Louw P, et al. Disclosure of 
Maternal HIV-Infection in South Africa: Description and Relationship to Child Functioning. AIDS and 
Behavior. 2009;13(6):1241-52. 
54. Bauman LJC, S. Silver, E.J. Hudis, J. & Draimin, B. Behavioural Problems in School -Aged 
Children of Mothers with HIV/AIDS. Clinical Child Psychology and Psychiatry. 2002;7( 39):39-54. 
55. Murphy DA. HIV-positive Mothers' Disclosure of Their Serostatus to Their Young Children: A 
Review. Clinical Child Psychology and Psychiatry. 2008;13(1):105-22. 
56. Hosegood V, Preston-Whyte E, Busza J, Moitse S, Timaeus IM. Revealing the full extent of 
households’ experiences of HIV and AIDS in rural South Africa. Social Science &amp; Medicine. 
2007;65(6):1249-59. 
57. Sherr L, Croome N, Castaneda KP, Bradshaw K. A Systematic Review of Psychological 
Functioning of Children Exposed to HIV: Using Evidence to Plan for Tomorrow’s HIV Needs. AIDS and 
Behavior. 2014:1-16. 
58. Armistead L, Klein K, Forehand R, Wierson M. Disclosure of parental HIV infection to children 
in the families of men with hemophilia: Description, outcomes, and the role of family processes. 
Journal of Family Psychology. 1997;11(1):49-61. 
59. Dematteo D, Harrison C, Arneson C, Goldie RS, Lefebvre A, Read SE, et al. Disclosing 
HIV/AIDS to children: The paths families take to truthtelling. Psychology, Health & Medicine. 
2002;7(3):339-56. 
60. Sherr L. Fathers and HIV: considerations for families. Journal of the International AIDS 
Society. 2010;13(Suppl 2):S4. 
61. Pequegnat W, Bauman LJ, Bray JH, DiClemente R, DiIorio C, Hoppe SK, et al. Measurement of 
the role of families in prevention and adaptation to HIV/AIDS. AIDS and Behavior. 2001;5(1):1-19. 
62. Pequegnat W, Family TNCo, HIV/AIDS Research. Research Issues with Children Infected and 
Affected with HIV and their Families. Clinical Child Psychology and Psychiatry. 2002;7(1):7-15. 
63. Armistead L, Tannenbaum L, Forehand R, Morse E, Morse P. Disclosing HIV Status: Are 
Mothers Telling Their Children? Journal of Pediatric Psychology. 2001;26(1):11-20. 
 99 
 
64. Murphy DA, Steers WN, Dello Stritto ME. Maternal disclosure of mothers' HIV serostatus to 
their young children. J Fam Psychol. 2001;15(3):441-50. 
65. Delaney RO, Serovich JM, Lim J-Y. Psychological Differences Between HIV-Positive Mothers 
Who Disclose to All, Some, or None of Their Biological Children. Journal of Marital and Family 
Therapy. 2009;35(2):175-80. 
66. Schrimshaw EW, Siegel K. Hiv-Infected Mothers' Disclosure to their Uninfected Children: 
Rates, Reasons, and Reactions. Journal of Social and Personal Relationships. 2002;19(1):19-43. 
67. Vallerand AH, Hough E, Pittiglio L, Marvicsin D. The Process of Disclosing HIV Serostatus 
Between HIV-Positive Mothers and their HIV-Negative Children. AIDS Patient Care and STDs. 
2005;19(2):100-9. 
68. Betancourt T, Abrams E, McBain R, Fawzi M. Family-centred approaches to the prevention of 
mother to child transmission of HIV. Journal of the International AIDS Society. 2010;13(Suppl 2):S2.  
69. Richter L. An introduction to family-centred services for children affected by HIV and AIDS. 
Journal of the International AIDS Society. 2010;13(0):1-6. 
70. Hosegood V, Madhavan. Data availability on men's involvement in families in sub-Saharan 
Africa to inform family-centred programmes for children affected by HIV and AIDS. J Int AIDS Soc. 
2010;13(Suppl 2):S5. 
71. DeGennaro V, Zeitz P. Embracing a family-centred response to the HIV/AIDS epidemic for the 
elimination of pediatric AIDS. Glob Public Health. 2009;4:386 - 401. 
72. Krauss BJ, Letteney S, De Baets AJ, Baggaley R, Okero FA. Caregiver's HIV disclosure to 
children 12 years and under: A review and analysis of the evidence. AIDS Care. 2013;25(4):415-29. 
73. Rochat TJ, Arteche AX, Stein A, Mkwanazi N, Bland RM. Maternal HIV disclosure to young 
HIV-uninfected children: an evaluation of a family-centred intervention in South Africa. AIDS. 
2014;28:S331-S41. 
74. Rochat TJ, Mitchell J, Stein A, Mkwanazi NB, Bland RM. The Amagugu Intervention: A 
Conceptual Framework for Increasing HIV Disclosure and Parent-Led Communication about Health 
among HIV-Infected Parents with HIV-Uninfected Primary School-Aged Children. Frontiers in Public 
Health. 2016;4(183). 
75. Varga CA, Sherman GG, Jones SA. HIV-disclosure in the context of vertical transmission: HIV-
positive mothers in Johannesburg, South Africa. AIDS Care. 2006;18(8):952-60. 
76. Rochat T, Mkwanazi N, Bland R. Maternal HIV disclosure to HIV-uninfected children in rural 
South Africa: a pilot study of a family-based intervention. BMC Public Health. 2013;13(1):147. 
77. Rochat TJ, Arteche AX, Stein A, Mitchell J, Bland RM. Maternal and child psychological 
outcomes of HIV disclosure to young children in rural South Africa: the Amagugu intervention. AIDS. 
2015;29:S67-S79. 
78. Chaudoir SR, Fisher JD, Simoni JM. Understanding HIV disclosure: a review and application of 
the Disclosure Processes Model. Soc Sci Med. 2011;72(10):1618-29. 
79. Wiener L, Mellins CA, Marhefka S, Battles HB. Disclosure of an HIV diagnosis to children: 
history, current research, and future directions. J Dev Behav Pediatr. 2007;28(2):155-66. 
80. Serovich JM. A test of two HIV disclosure theories. AIDS Educ Prev. 2001;13(4):355-64. 
81. Thomas B, Nyamathi A, Swaminathan S. Impact of HIV/AIDS on Mothers in Southern India: A 
Qualitative Study. AIDS and Behavior. 2009;13(5):989-96. 
82. Akani CI, Erhabor O. Rate, pattern and barriers of HIV serostatus disclosure in a resource-
limited setting in the Niger delta of Nigeria. Tropical doctor. 2006;36(2):87-9. 
83. Pilowsky D, Sohler N, Susser E. Reasons given for disclosure of maternal HIV status to 
children. Journal of Urban Health. 2000;77(4):723-34. 
84. Rwemisisi J, Wolff B, Coutinho A, Grosskurth H, Whitworth J. ‘What if they ask how I got it?’ 
Dilemmas of disclosing parental HIV status and testing children for HIV in Uganda. Health Policy and 
Planning. 2008;23(1):36-42. 
 100 
 
85. Mellins CA, Havens JF, McCaskill EO, Leu CS, Brudney K, Chesney MA. Mental health, 
substance use and disclosure are significantly associated with the medical treatment adherence of 
HIV-infected mothers. Psychology, Health & Medicine. 2002;7(4):451-60. 
86. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing 
HIV infection. Geneva: World Health Organization. 2013. 
87. Hawk ST. Disclosures of maternal HIV infection to seronegative children: A literature review. 
Journal of Social and Personal Relationships. 2007;24(5):657-73. 
88. Mkwanazi NB, Rochat TJ, Imrie J, Bland RM. Disclosure of maternal HIV status to children: 
considerations for research and practice in sub-Saharan Africa. Future Virology. 2012;7(12):1159-82. 
89. Qiao S, Li X, Stanton B. Disclosure of Parental HIV Infection to Children: A Systematic Review 
of Global Literature. AIDS and Behavior. 2011:1-21. 
90. Kennedy D, Cowgill B, Bogart L, Corona R, Ryan G, Murphy D, et al. Parents’ Disclosure of 
Their HIV Infection to Their Children in the Context of the Family. AIDS and Behavior. 
2010;14(5):1095-105. 
91. Kirshenbaum SB, Nevid JS. The Specificity of Maternal Disclosure of HIV/AIDS in Relation to 
Children's Adjustment. AIDS Education and Prevention. 2002;14(1):1-16. 
92. Alemayehu M, Aregay A, Kalayu A, Yebyo H. HIV disclosure to sexual partner and associated 
factors among women attending ART clinic at Mekelle hospital, Northern Ethiopia. BMC public 
health. 2014;14(1):746. 
93. Mayfield Arnold E, Rice E, Flannery D, Rotheram-Borus MJ. HIV disclosure among adults 
living with HIV. AIDS Care. 2008;20(1):80-92. 
94. Serovich JM, Craft SM, Yoon H-J. Women's HIV Disclosure to Immediate Family. AIDS Patient 
Care and STDs. 2007;21(12):970-80. 
95. Li X, Qiao S, de Wit J, Sherr L. What's in the telling? Understanding social, psychological and 
clinical aspects of HIV disclosure. AIDS care. 2015;27(sup1):1-5. 
96. Qiao S, Li X, Zhou Y, Shen Z, Tang Z, Stanton B. The role of enacted stigma in parental HIV 
disclosure among HIV-infected parents in China. AIDS care. 2015;27(sup1):28-35. 
97. Mkwanazi N, Rochat T, Coetzee B, Bland R. Mothers’ and health workers’ perceptions of 
participation in a child-friendly health initiative in rural South Africa. 2013. 
98. Simoni JM, Yang JP, Shiu C-S, Chen W-t, Udell W, Bao M, et al. Nurse-delivered counselling 
intervention for parental HIV disclosure: Results from a pilot randomized controlled trial in China. 
AIDS. 2015;29:S99-S107. 
99. Nie J-B, Walker ST, Qiao S, Li X, Tucker JD. Truth-telling to the patient, family, and the sexual 
partner: a rights approach to the role of healthcare providers in adult HIV disclosure in China. AIDS 
care. 2015;27(sup1):83-9. 
100. Bott S, Obermeyer CM. The social and gender context of HIV disclosure in sub-Saharan 
Africa: A review of policies and practices. SAHARA-J: Journal of Social Aspects of HIV/AIDS. 
2013;10(sup1):S5-S16. 
101. Madiba S, Matlala C. Disclosure of Parental HIV Positive Status: What, Why, When, and How 
Parents Tell Their Children in the Era of HAART in South Africa. World. 2012;2:194-202. 
102. Winstead BA, Derlega VJ, Barbee AP, Sachdev M, Antle B, Greene K. Close Relationships As 
Sources Of Strength Or Obstacles For Mothers Coping With HIV. Journal of Loss and Trauma. 
2002;7(3):157-84. 
103. Shaffer A, Jones DJ, Kotchick BA, Forehand R. Telling the Children: Disclosure of Maternal 
HIV Infection and Its Effects on Child Psychosocial Adjustment. Journal of Child and Family Studies. 
2001;10(3):301-13. 
104. Brackis-Cott E, Mellins CA, Dolezal C, Spiegel D. The Mental Health Risk of Mothers and 
Children: The Role of Maternal HIV Infection. The Journal of Early Adolescence. 2007;27(1):67-89. 
105. Wiener LS, Battles HB, Heilman NE. Factors associated with parents' decision to disclose 
their HIV diagnosis to their children. Child Welfare. 1998;77(2):115-35. 
 101 
 
106. Letteney S. Mothers Disclosure of Maternal HIV Status to Children. Journal of HIV/AIDS & 
Social Services. 2006;5(1):67-84. 
107. Tompkins TL, Henker B, Whalen CK, Axelrod J, Comer LK. Motherhood in the context of HIV 
infection: Reading between the numbers. Cultural Diversity and Ethnic Minority Psychology. 
1999;5(3):197-208. 
108. Letteney S, LaPorte HH. Deconstructing stigma: perceptions of HIV-seropositive mothers and 
their disclosure to children. Soc Work Health Care. 2004;38(3):105-23. 
109. Murphy DA, Marelich WD, Hoffman D. A Longitudinal Study of the Impact on Young Children 
of Maternal HIV Serostatus Disclosure. Clinical Child Psychology and Psychiatry. 2002;7(1):55-70. 
110. Simoni JM, Davis ML, Drossman JA, Weinberg BA. Mothers with HIV/AIDS and their children: 
disclosure and guardianship issues. Women Health. 2000;31(1):39-54. 
111. Murphy DA, Marelich WD, Amaro H. Maternal HIV/AIDS and adolescent depression: A 
covariance structure analysis of the ‘Parents and Children Coping Together’ (PACT) Model. 
Vulnerable Children and Youth Studies. 2009;4(1):67-82. 
112. Brackis-Cott E, Mellins CA, Block M. Current Life Concerns of Early Adolescents and Their 
Mothers. The Journal of Early Adolescence. 2003;23(1):51-77. 
113. Murphy D, Roberts K, Hoffman D. Young Children's Reactions to Mothers’ Disclosure of 
Maternal HIV+ Serostatus. Journal of Child and Family Studies. 2006;15(1):38-55. 
114. Zhou Y, Zhang L, Li X, Kaljee L. Do Chinese parents with HIV tell their children the truth? A 
qualitative preliminary study of parental HIV disclosure in China. Child Care Health Dev. 
2012;8(10):1365-2214. 
115. De Baets A, Sifovo S, Parsons R, Pazvakavambwa I. HIV disclosure and discussions about grief 
with Shona children: a comparison between health care workers and community members in 
Eastern Zimbabwe. Soc Sci Med. 2008;66(2):479 - 91. 
116. Nam SL, Fielding K, Avalos A, Gaolathe T, Dickinson D, Geissler PW. Discussing matters of 
sexual health with children: what issues relating to disclosure of parental HIV status reveal. AIDS 
Care. 2009;21(3):389-95. 
117. Kennedy I. Getting it right for children and young people: overcoming cultural barriers in the 
NHS so as to meet their needs. 2010. 
118. Ostrom RA, Serovich JM, Lim JY, Mason TL. The role of stigma in reasons for HIV disclosure 
and non-disclosure to children. AIDS Care. 2006;18(1):60-5. 
119. Nöstlinger C, Jonckheer T, de Belder E, van Wijngaerden E, Wylock C, Pelgrom J, et al. 
Families affected by HIV: Parents’ and children's characteristics and disclosure to the children. AIDS 
Care. 2004;16(5):641-8. 
120. Ishikawa N, Pridmore P, Carr-Hill R, Chaimuangdee K. Breaking down the wall of silence 
around children affected by AIDS in Thailand to support their psychosocial health. AIDS Care. 
2010;22(3):308-13. 
121. Tiendrebeogo G, Hejoaka F, Belem EM, Compaore PL, Wolmarans L, Soubeiga A, et al. 
Parental HIV disclosure in Burkina Faso: experiences and challenges in the era of HAART. Sahara j. 
2013;10 Suppl 1:S46-59. 
122. Xu T, Yan Z, Rou K, Wang C, Ye R, Duan S, et al. Disclosure of parental HIV/AIDS to children in 
rural China. Vulnerable Children and Youth Studies. 2007;2(2):100-5. 
123. Lee MB, Rotheram-Borus MJ. Parents' disclosure of HIV to their children. AIDS. 
2002;16(16):2201-7. 
124. Tompkins T. Disclosure of Maternal HIV Status to Children: To Tell or Not To Tell … That is 
the Question. Journal of Child and Family Studies. 2007;16(6):773-88. 
125. Goffman E. Stigma Englewood Cliffs. NJ: Spectrum. 1963. 
126. Brown L, Macintyre K, Trujillo L. Interventions to Reduce HIV/AIDS Stigma: What Have We 
Learned? AIDS Education and Prevention. 2003;15(1):49-69. 
127. Lekas H-M, Siegel K, Leider J. Felt and enacted stigma among HIV/HCV-coinfected adults the 
impact of stigma layering. Qualitative health research. 2011;21(9):1205-19. 
 102 
 
128. Clark HJ, Lindner G, Armistead L, Austin B-J. Stigma, disclosure, and psychological functioning 
among HIV-infected and non-infected African-American women. Women & health. 2004;38(4):57-
71. 
129. Emlet CA. A comparison of HIV stigma and disclosure patterns between older and younger 
adults living with HIV/AIDS. AIDS Patient Care & STDs. 2006;20(5):350-8. 
130. Mahajan AP, Sayles JN, Patel VA, Remien RH, Sawires SR, Ortiz DJ, et al. Stigma in the 
HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. Aids. 
2008;22(2):S67-79. 
131. Maman S, Abler L, Parker L, Lane T, Chirowodza A, Ntogwisangu J, et al. A comparison of HIV 
stigma and discrimination in five international sites: the influence of care and treatment resources in 
high prevalence settings. Social science & medicine. 2009;68(12):2271-8. 
132. Heatherton TF. The social psychology of stigma: Guilford Press; 2003. 
133. Mason S, Sultzman V, Berger B. “Like being in a cage”: stigma as experienced by adolescents 
whose mothers are living with HIV. Vulnerable Children and Youth Studies. 2014;9(4):323-31. 
134. Rotheram-Borus M, Swendeman D, Lee S-J, Li L, Amani B, Nartey M. Interventions for 
families affected by HIV. Translational Behavioral Medicine. 2011;1(2):313-26. 
135. Qiao S, Li X, Stanton B. Theoretical models of parental HIV disclosure: A critical review. AIDS 
Care. 2012;6:6. 
136. Kubler-Ross EOD, Death O. Dying. New York, NY, Scribner. 1969. 
137. Tasker M. How can I tell you. Secrecy and Disclosure with Children When a Family Member 
Has AIDS Bethesda of Maryland: Association for the Care of Children's Health. 1992.  
138. Omarzu J. A disclosure decision model: Determining how and when individuals will self -
disclose. Personality and Social Psychology Review. 2000;4(2):174-85. 
139. Katz E, Lazarsfeld PF. Personal Influence, The part played by people in the flow of mass 
communications: Transaction Publishers; 1966. 
140. Lazarsfeld PF, Rosenberg M. The Language of Social Research; a Reader in the Methodology 
of Social Research. Journal of Philosophy. 1956;53(7):248-55. 
141. Thibaut JW, Kelley HH. The social psychology of groups. 1959. 
142. Black BP, Miles MS. Calculating the Risks and Benefits of Disclosure in African American 
Women Who Have HIV. Journal of Obstetric, Gynecologic, & Neonatal Nursing. 2002;31(6):688-97. 
143. Chaudoir SR, Fisher JD. The disclosure processes model: understanding disclosure decision 
making and postdisclosure outcomes among people living with a concealable stigmatized identity. 
Psychological bulletin. 2010;136(2):236. 
144. Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, Mermin J, et al. Disclosure 
of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS 
and Behavior. 2006;10(1):85-93. 
145. Simoni JM, Amico KR, Pearson CR, Malow R. Strategies for promoting adherence to 
antiretroviral therapy: a review of the literature. Curr Infect Dis Rep. 2008;10(6):515-21. 
146. Murphy DA, Greenwell L, Hoffman D. Factors associated with antiretroviral adherence 
among HIV-infected women with children. Women Health. 2002;36(1):97-111. 
147. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to 
Antiretroviral Therapy in Sub-Saharan Africa and North America. JAMA: The Journal of the American 
Medical Association. 2006;296(6):679-90. 
148. Mkwanazi NB, Rochat TJ, Bland RM. Living with HIV, disclosure patterns and partnerships a 
decade after the introduction of HIV programmes in rural South Africa. AIDS Care. 2015;27 Suppl 
1:65-72. 
149. Chandra PS, Deepthivarma S, Manjula V. Disclosure of HIV infection in South India: patterns, 
reasons and reactions. AIDS Care. 2003;15(2):207-15. 
150. Groves AK, Maman S, Moodley D. HIV+ women's narratives of non-disclosure: Resisting the 
label of immorality. Global Public Health. 2012;7(8):799-811. 
 103 
 
151. Kimberly JA, Serovich JM, Greene K. Disclosure of HIV-positive status: Five women's stories. 
Family Relations. 1995:316-22. 
152. Petrak JA, Doyle AM, Smith A, Skinner C, Hedge B. Factors associated with self‐disclosure of 
HIV serostatus to significant others. British Journal of Health Psychology. 2001;6(1):69-79. 
153. Skogmar S, Shakely D, Lans M, Danell J, Andersson R, Tshandu N, et al. Effect of antiretroviral 
treatment and counselling on disclosure of HIV-serostatus in Johannesburg, South Africa. AIDS Care. 
2006;18(7):725-30. 
154. Sowell RL, Seals BF, Phillips KD, Julious C. Disclosure of HIV infection: how do women decide 
to tell? Health education research. 2003;18(1):32-44. 
155. Wong LH, Van Rooyen H, Modiba P, Richter L, Gray G, McIntyre JA, et al. Test and tell: 
correlates and consequences of testing and disclosure of HIV status in South Africa (HPTN 043 
Project Accept). Journal of acquired immune deficiency syndromes (1999). 2009;50(2):215. 
156. King R, Katuntu D, Lifshay J, Packel L, Batamwita R, Nakayiwa S, et al. Processes and 
outcomes of HIV serostatus disclosure to sexual partners among people living with HIV in Uganda. 
AIDS and Behavior. 2008;12(2):232-43. 
157. Sagay AS, Musa J, Ekwempu C, Imade GE, Babalola A, Daniyan G, et al. Partner disclosure of 
HIV status among HIV positive mothers in Northern Nigeria. 2010. 
158. Visser MJ, Neufeld S, De Villiers A, Makin JD, Forsyth BW. To tell or not to tell: South African 
women's disclosure of HIV status during pregnancy. AIDS Care. 2008;20(9):1138-45. 
159. Hardon A, Gomez GB, Vernooij E, Desclaux A, Wanyenze RK, Ky-Zerbo O, et al. Do support 
groups members disclose less to their partners? the dynamics of HIV di sclosure in four African 
countries. BMC Public Health. 2013;13(1):589. 
160. Linda P. To tell or not to tell: Negotiating disclosure for people living with HIV on 
antiretroviral treatment in a South African setting. SAHARA-J: Journal of Social Aspects of HIV/AIDS. 
2013;10(sup1):S17-S27. 
161. Tsai AC, Bangsberg DR, Katz IT, Haberer JE, Conrad Muzoora MBChB M, Elias Kumbakumba 
MBChB M, et al. Internalized stigma, social distance, and disclosure of HIV seropositivity in rural 
Uganda. Annals of Behavioral Medicine. 2013:1-10. 
162. Makin JD, Forsyth BW, Visser MJ, Sikkema KJ, Neufeld S, Jeffery B. Factors affecting 
disclosure in South African HIV-positive pregnant women. AIDS patient care and STDs. 
2008;22(11):907-16. 
163. Smith R, Rossetto K, Peterson BL. A meta-analysis of disclosure of one's HIV-positive status, 
stigma and social support. AIDS Care. 2008;20(10):1266-75. 
164. Greeff M, Phetlhu R, Makoae LN, Dlamini PS, Holzemer WL, Naidoo JR, et al. Disclosure of 
HIV Status: Experiences and Perceptions of Persons Living With HIV/AIDS and Nurses Involved in 
Their Care in Africa. Qualitative Health Research. 2008;18(3):311-24. 
165. Simbayi LC, Kalichman S, Strebel A, Cloete A, Henda N, Mqeketo A. Internalized stigma, 
discrimination, and depression among men and women living with HIV/AIDS in Cape Town, South 
Africa. Soc Sci Med. 2007;64(9):1823-31. 
166. Bouillon K, Lert F, Sitta R, Schmaus A, Spire B, Dray-Spira R. Factors correlated with 
disclosure of HIV infection in the French Antilles and French Guiana: results from the ANRS-EN13-
VESPA-DFA Study. AIDS (London, England). 2007;21:S89. 
167. Deribe K, Woldemichael K, Wondafrash M, Haile A, Amberbir A. Disclosure experience and 
associated factors among HIV positive men and women clinical service users in southwest Ethiopia. 
BMC Public Health. 2008;8(1):81. 
168. Fekete E, Antoni M, Durán R, Stoelb B, Kumar M, Schneiderman N. Disclosing HIV Serostatus 
to Family Members: Effects on Psychological and Physiological Health in Minority Women Living with 
HIV. International Journal of Behavioral Medicine. 2009;16(4):367-76. 
169. Keogh P, Allen S, Almedal C, Temahagili B. The social impact of HIV infection on women in 
Kigali, Rwanda: A prospective study. Social Science &amp; Medicine. 1994;38(8):1047-53. 
 104 
 
170. Maman S, Mbwambo JK, Hogan NM, Weiss E, Kilonzo GP, Sweat MD. High rates and positive 
outcomes of HIV-serostatus disclosure to sexual partners: reasons for cautious optimism from a 
voluntary counseling and testing clinic in Dar es Salaam, Tanzania. AIDS and Behavior. 2003;7(4):373-
82. 
171. McGrath N, Lessells R, Newell M. Time to eligibility for antiretroviral therapy in adults with 
CD4+ count> 500 cells/µl in rural KwaZulu-Natal, South Africa. 2013. 
172. Mellins CA, Kang E, Leu CS, Havens JF, Chesney MA. Longitudinal study of mental health and 
psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS 
patient care and STDs. 2003;17(8):407-16. 
173. Bachanas P, Medley A, Pals S, Kidder D, Antelman G, Benech I, et al. Disclosure, knowledge 
of partner status, and condom use among HIV-positive patients attending clinical care in Tanzania, 
Kenya, and Namibia. AIDS patient care and STDs. 2013;27(7):425-35. 
174. Wouters E, van Loon F, van Rensburg D, Meulemans H. Community support and disclosure 
of HIV serostatus to family members by public-sector antiretroviral treatment patients in the Free 
State Province of South Africa. AIDS Patient Care STDS. 2009;23(5):357-64. 
175. Loubiere S, Peretti-Watel P, Boyer S, Blanche J, Abega S-C, Spire B. HIV disclosure and unsafe 
sex among HIV-infected women in Cameroon: results from the ANRS-EVAL study. Social Science & 
Medicine. 2009;69(6):885-91. 
176. Amoran O. Predictors of disclosure of sero-status to sexual partners among people living 
with HIV/AIDS in Ogun State, Nigeria. Nigerian journal of clinical practice. 2013;15(4):385-90. 
177. Brou H, Djohan G, Becquet R, Allou G, Ekouevi DK, Viho I, et al. When do HIV -infected 
women disclose their HIV status to their male partner and why? A study in a PMTCT programme, 
Abidjan. PLoS medicine. 2007;4(12):e342. 
178. Klitzman R, Kirshenbaum S, Dodge B, Remien R, Ehrhardt A, Johnson M, et al. Intricacies and 
inter-relationships between HIV disclosure and HAART: a qualitative study. AIDS Care. 
2004;16(5):628-40. 
179. Bibace R, Walsh ME. Development of Children's Concepts of Illness. Pediatrics. 
1980;66(6):912-7. 
180. Christ GH, Christ AE. Current Approaches to Helping Children Cope with a Parent's Terminal 
Illness. CA: A Cancer Journal for Clinicians. 2006;56(4):197-212. 
181. Lesch A, Swartz L, Kagee A, Moodley K, Kafaar Z, Myer L, et al. Paediatric HIV/AIDS 
disclosure: towards a developmental and process-oriented approach. AIDS Care. 2007;19(6):811-6. 
182. Gachanja G, Burkholder GJ, Ferraro A. HIV-positive parents, HIV-positive children, and HIV-
negative children’s perspectives on disclosure of a parent’s and child’s illness in Kenya. PeerJ. 
2014;2:e486. 
183. Gachanja G, Burkholder GJ. A model for HIV disclosure of a parent’s and/or a child’s illness. 
PeerJ. 2016;4:e1662. 
184. Mkwanazi NB, Rochat TJ, Bland RM. Living with HIV, disclosure patterns and partnerships a 
decade after the introduction of HIV programmes in rural South Africa. AIDS care. 2015;27(sup1):65-
72. 
185. Rochat T, Arteche AX, Stein A, Mitchell  J, Bland R. Maternal and child psychological 
outcomes of HIV disclosure to young children in rural South Africa: The Amagugu intervention. AIDS. 
2015;29:567-79. 
186. Ingram D, Hutchinson SA. Double Binds and the Reproductive and Mothering Experiences of 
HIV-Positive Women. Qualitative Health Research. 2000;10(1):117-32. 
187. Visser M, Finestone M, Sikkema K, Boeving-Allen A, Ferreira R, Eloff I, et al. Development 
and piloting of a mother and child intervention to promote resilience in young children of HI V-
infected mothers in South Africa. Evaluation and program planning. 2012;35(4):491-500. 
188. Pritchett R, Fitzpatrick B, Watson N, Cotmore R, Wilson P, Bryce G, et al. A Feasibility 
Randomised Controlled Trial of the New Orleans Intervention for Infant Me ntal Health: A Study 
Protocol. The Scientific World Journal. 2013;2013. 
 105 
 
189. Rochat TJ, Mitchell C. Young Children and HIV in Sub-Saharan Africa: Implications for Practice 
and Intervention. In: Fitzgerald HE, Puura K, Tomlinson M, Campbell P, editors. Inte rnational 
Perspective on Children and Mental Health. Volum 2 Prevention and Treatment2011. p. 45-74. 
190. Clarke A, Nicholson MS. The Child Friendly Healthcare Initiative--an update. Paediatr Nurs. 
2007;19(8):36-7. 
191. Emeghebo L. The image of nursing as perceived by nurses. Nurse Education Today. 
2012;32(6):e49-e53. 
192. Kikuta A, Gardezi F, Dubey V, Taddio A. Practices and perceptions regarding pain and pain 
management during routine childhood immunizations: Findings from a focus-group study with 
nurses working at Toronto Public Health, Ontario. Can J Infect Dis Med Microbiol. 2011;22(2):43-8. 
193. Norton‐Westwood D. The health‐care environment through the eyes of a child—Does it 
soothe or provoke anxiety? International Journal of Nursing Practice. 2012;18(1):7-11. 
194. Cox ED, Smith MA, Brown RL. Evaluating deliberation in pediatric primary care. Pediatrics. 
2007;120(1):e68-e77. 
195. Coyne I. Consultation with children in hospital: children, parents’ and nurses’ perspectives. 
Journal of clinical nursing. 2006;15(1):61-71. 
196. Coyne I, Kirwan L. Ascertaining children’s wishes and feelings about hospital life. Journal of 
Child Health Care. 2012;16(3):293-304. 
197. Jewkes R, Abrahams N, Mvo Z. Why do nurses abuse patients? Reflections from South 
African obstetric services. Social Science & Medicine. 1998;47(11):1781-95. 
198. Richter LM, Rochat TJ, Hsiao C, Zuma TH. Evaluation of a Brief Intervention to Improve the 
Nursing Care of Young Children in a High HIV and AIDS Setting. Nurs Res Pract. 2012;647182(10):15. 
199. Rujumba J, Mbasaalaki-Mwaka CL, Ndeezi G. Challenges faced by health workers in providing 
counselling services to HIV-positive children in Uganda: a descriptive study. J Int AIDS Soc. 2010;13:9.  
200. Govender L, Rochat T, Richter L, Rollins N. Pediatric Nursing in the Context of the HIV/AIDS 
Epidemic in Resource-poor Settings-Balancing the" Art and the Science". Holistic Nursing Practice. 
2006;20(5):247-54. 
201. Whiting LS. Health promotion: the views of children's nurses. Paediatric nursing. 
2001;13(3):27-31. 
202. Nabirye RC, Brown KC, Pryor ER, Maples EH. Occupational stress, job satisfaction and job 
performance among hospital nurses in Kampala, Uganda. J Nurs Manag. 2011;19(6):760-8. 
203. Dane B. The voices of Thai women living with HIV/AIDS. International Social Work. 
2002;45(2):185-204. 
204. Bor J, Bärnighausen T, Newell C, Tanser F, Newell M-L. Social exposure to an antiretroviral 
treatment programme in rural KwaZulu-Natal. Tropical Medicine & International Health. 
2011;16(8):988-94. 
205. Antelman G, Fawzi MCS, Kaaya S, Mbwambo J, Msamanga GI, Hunter DJ, et al. Predictors of 
HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es 
Salaam, Tanzania. Aids. 2001;15(14):1865-74. 
206. Skunodom N, Linkins RW, Culnane ME, Prymanee J, Kannasoot C, Suwannapha W, et al. 
Factors associated with non-disclosure of HIV infection status of new mothers in Bangkok. 2006. 
207. Åsander A-S, Björkman A, Belfrage E, Faxelid E. HIV-Infected African Parents Living in 
Stockholm, Sweden: Disclosure and Planning for Their Children's Future. Health & Social Work. 
2009;34(2):107-15. 
208. Mason S. Custody Planning with Families Affected by HIV. Health and Social Work. 
2007;32(2):143-6. 
209. Rotheram-Borus MJ, Lee MB, Gwadz M, Draimin B. An intervention for parents with AIDS 
and their adolescent children. Am J Public Health. 2001;91(8):1294-302. 
210. Singhal A, Howard WS. The children of Africa confront AIDS : from vulnerability to possibility. 
Athens: Ohio University Press; 2003. 
 106 
 
211. Yoshioka MR, Schustack A. Disclosure of HIV status: cultural issues of Asian patients. AIDS 
Patient Care and STDs. 2001;15(2):77-82. 
212. Bhana A, Petersen I, Mason A, Mahintsho Z, Bell C, McKay M. Children and youth at risk: 
adaptation and pilot study of the CHAMP (Amaqhawe) programme in South Africa. African Journal of 
AIDS Research. 2004;3(1):33-41. 
213. Bland R, Coovadia H, Coutsoudis A, Rollins N, Newell M. Cohort Profile: Mamanengane or 
the Africa Centre Vertical Transmission Study. International Journal of Epidemiology. 
2010;39(2):351-60. 
214. Mkwanazi NB, Patel D, Newell M-L, Rollins NC, Coutsoudis A, Coovadia HM, et al. Rapid 
Testing May Not Improve Uptake of HIV Testing and Same Day Results in a Rural South African 
Community: A Cohort Study of 12,000 Women. PLoS ONE. 2008;3(10):e3501. 
215. Rollins NC, Ndirangu J, Bland RM, Coutsoudis A, Coovadia HM, Newell M-L. Exclusive 
breastfeeding, diarrhoeal morbidity and all-cause mortality in infants of HIV-infected and HIV 
uninfected mothers: an intervention cohort study in KwaZulu Natal, South Africa. PloS one. 
2013;8(12):e81307. 
216. Patel D, Bland R, Coovadia H, Rollins N, Coutsoudis A, Newell M-L. Breastfeeding, HIV status 
and weights in South African children: a comparison of HIV-exposed and unexposed children. AIDS. 
2010;24(3):437-45. 
217. Bland R, Becquet R, Rollins N, Coutsoudis A, Coovadia H, Newell M-L. Breast health problems 
are rare in both HIV-infected and HIV-uninfected women who receive counseling and support for 
breast-feeding in South Africa. Clinical Infectious Diseases. 2007;45(11):1502-10. 
218. Coutsoudis A, England K, Rollins N, Coovadia H, Newell M-L, Bland R. Women's morbidity 
and mortality in the first 2 years after delivery according to HIV status. AIDS. 2010;24(18):2859-66. 
219. Bland RM, Little KE, Coovadia HM, Coutsoudis A, Rollins NC, Newell M-L. Intervention to 
promote exclusive breast-feeding for the first 6 months of life in a high HIV prevalence area. Aids. 
2008;22(7):883-91. 
220. Hosegood V, Benzler J, Solarsh G. Population mobility and household dynamics in rural South 
Africa: implications for demographic and health research. Southern African Journal of Demography. 
2005;10(1&2):43-67. 
221. Bärnighausen T, Tanser F, Malaza A, Herbst K, Newell ML. HIV status and parti cipation in HIV 
surveillance in the era of antiretroviral treatment: a study of linked population‐based and clinical 
data in rural South Africa. Tropical Medicine & International Health. 2012;17(8):e103-e10. 
222. Tanser F, Hosegood V, Bärnighausen T, Herbst K, Nyirenda M, Muhwava W, et al. Cohort 
Profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. 
International Journal of Epidemiology. 2008;37(5):956-62. 
223. Department of Health. The 2012 National Antenatal Sentinel HIV & Herpes Simplex Type -2 
Prevalence Survey in South Africa. 2012. 
224. Hontelez J, de Vlas S, Baltussen R, Newell M, Bakker R, Tanser F, et al. The impact of 
antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa. AIDS. 
2012;26(Suppl 1):S19 - S30. 
225. World Health Organization. New data on the Prevention of Mother-to-Child transmission of 
HIV and their policy implications: Conclusions and Recommendations: WHO Technical consultation 
on behalf of the UNFP. 2001. 2001. 
226. KwaZulu-Natal Provincial Department of Health. Protocol for the Phased Implementation of 
a Comprehensive Package of Care for the PMTCT of HIV in KwaZulu-Natal. 2003. 
227. Welz T HV, Shabbar J,  et al. Continued very high prevalence of HIV infection in rural 
KwaZulu-Natal, South Africa: a population-based longitudinal study. AIDS. 2007;21:1467-72. 
228. Tanser F, Bärnighausen T, Grapsa E, Zaidi J, Newell M-L. High coverage of ART associated 
with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 
2013;339(6122):966-71. 
 107 
 
229. Reynolds L, Cousins T, Newell M-L, Imrie J. The social dynamics of consent and refusal in HIV 
surveillance in rural South Africa. Social Science & Medicine. 2013;77(11):8e125.  
230. Bärnighausen T, Tanser F, Newell M-L. Lack of a Decline in HIV Incidence in a Rural 
Community with High HIV Prevalence in South Africa, 2003–2007. AIDS Research and Human 
Retroviruses. 2009;25(4):405-9. 
231. Zaidi J, Grapsa K, Tanser M, Newell M, Barnighausen T. USA: Washington DC; 2012. 22 - 7 p. 
232. Pilowsky DJ, Sohler N, Susser E. The parent disclosure interview. AIDS Care. 1999;11(4):447-
52. 
233. Bishop KG. From their perspectives: Children and young people's experience of a paediatric 
hospital environment and its relationship to their feeling of well-being. 2008. 
234. Coyne I, O’Neill C, Murphy M, Costello T, O’Shea R. What does family‐centred care mean to 
nurses and how do they think it could be enhanced in practice. Journal of Advanced Nursing. 
2011;67(12):2561-73. 
235. Moore L, Kirk S. A literature review of children’s and young people’s participation in 
decisions relating to health care. Journal of clinical nursing. 2010;19(15‐16):2215-25. 
236. Flick U. An introduction to qualitative research: Sage; 2009. 
237. Polkinghorne DE. Language and meaning: Data collection in qualitative research. Journal of 
counseling psychology. 2005;52(2):137. 
238. Hennink MM, Kaiser BN, Marconi VC. Code Saturation Versus Meaning Saturation How Many 
Interviews Are Enough? Qualitative Health Research. 2016:1049732316665344. 
239. Boyce C, Neale P. Conducting in-depth interviews: A guide for designing and conducting in-
depth interviews for evaluation input: Pathfinder International Watertown, MA; 2006.  
240. Quinn PM. Qualitative research and evaluation methods. California EU: Sage Publications 
Inc. 2002. 
241. Mays N, Pope C. Qualitative research in health care: Assessing quality in qualitative research. 
BMJ: British Medical Journal. 2000;320(7226):50. 
242. Friese S. Qualitative data analysis with ATLAS. ti: SAGE Publications Limited; 2012. 
243. Muhr T, Friese S. User's Manualfor ATLAS. ti 5.0. Berlin: Scientific Software Development; 
2004. 
244. Babbie ER, Huitt RE. Practising Social Research: Wadsworth; 1979. 
245. Burnard P. A method of analysing interview transcripts in qualitative research. Nurse 
Education Today. 1991;11(6):461-6. 
246. Field P-A, Morse JM. Nursing research: The application of qualitative approaches: Chapman 
and Hall; 1985. 
247. Glaser B. Strauss (1967): The Discovery of Grounded Theory: Strategies for Qualitative 
Research. London: Wiedenfeld and Nicholson.81. 
248. Patton MQ, Cochran M. A guide to using qualitative research methodology. Retrieved with 
permission by Nouria Brikci-Research Officer, MSF UK (February 2007) http://evaluation msf 
at/fileadmin/evaluation/files/documents/resources_MSF/MSF_Qualitative_ Methods pdf. 2002.  
249. Renner M, Taylor-Powell E. Analyzing qualitative data. Programme Development & 
Evaluation, University of Wisconsin-Extension Cooperative Extension. 2003. 
250. Mays N, Pope C. Assessing quality in qualitative research. British medical journal. 
2000;320(7226):50. 
251. Murphy DA, Armistead L, Marelich WD, Payne DL, Herbeck DM. Pilot Trial of a Disclosure 
Intervention for HIV+ Mothers: The TRACK Program. Journal of Consulting and Clinical Psychology. 
2011;79(2):203-14. 
252. Qiao S, Li X, Zhou Y, Shen Z, Tang Z, Stanton B. Factors influencing the decision-making of 
parental HIV disclosure: a socio-ecological approach. AIDS (London, England). 2015;29(0 1):S25. 
253. Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, et al. Impact of HIV -related 
stigma on treatment adherence: systematic review and meta-synthesis. Journal of the International 
AIDS Society. 2013;16(3Suppl 2). 
 108 
 
254. Murphy DA, Roberts KJ, Hoffman D. Stigma and Ostracism Associated with HIV/AIDS: 
Children Carrying the Secret of Their Mothers' HIV+ Serostatus. Journal of Child and Family Studies. 
2002;11(2):191-202. 
255. Letteney S. Disrupted Caregiving and Maternal HIV Disease: A Proposed Model for 
Evaluating HIV-Affected Children's Psychosocial Adjustment. Social Work in Health Care. 
2010;49(8):753-63. 
256. Murphy DA, Marelich WD, Armistead L, Herbeck DM, Payne DL. Anxiety/stress among 
mothers living with HIV: effects on parenting skills and child outcomes. AIDS Care. 2010;22(12):1449-
58. 
257. Allen AB, Finestone M, Eloff I, Sipsma H, Makin J, Triplett K, et al. The role of parenting in 
affecting the behavior and adaptive functioning of young children of HIV -infected mothers in South 
Africa. AIDS and behavior. 2014;18(3):605-16. 
258. Betancourt TS, Ng LC, Kirk CM, Munyanah M, Mushashi C, Ingabire C, et al. Family-based 
prevention of mental health problems in children affected by HIV and AIDS: an open trial. A IDS. 
2014;28:S359-S68. 
259. Bhana A, Bachoo S. The determinants of family resilience among families in low-and middle-
income contexts: a systematic literature review. South african journal of psychology. 2011;41(2):131-
9. 
260. Chi P, Li X. Impact of parental HIV/AIDS on children’s psychological well-being: a systematic 
review of global literature. AIDS and Behavior. 2013;17(7):2554-74. 
261. Tompkins TL. Disclosure of maternal HIV status to children: To tell or not to tell… that is the 
question. Journal of Child and Family Studies. 2007;16(6):773-88. 
262. Zhao J, Li X, Qiao S, Zhao G, Zhang L, Stanton B. Parental HIV disclosure: from perspectives of 
children affected by HIV in Henan, China. AIDS care. 2015;27(4):416-23. 
263. Li H, Li X, Tso LS, Qiao S, Holroyd E, Zhou Y, et al. HIV-negative children’s experiences and 
opinions towards parental HIV disclosure: a qualitative study in China. Vulnerable Children and 
Youth Studies. 2016:1-7. 
264. Edwards LV, Irving SM, Amutah NN, Sydnor KD. Am I My Mother’s Keeper? Children as 
Unexpected Sources of Social Support Among African American Women Living With HIV -AIDS. 
Journal of Black Studies. 2012;43(5):571-95. 
265. Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV 
serostatus disclosure among women in developing countries: implications for prevention of mother-
to-child transmission programmes. Bull World Health Organ. 2004;82:299 - 307. 
266. Kairania R, Gray RH, Kiwanuka N, Makumbi F, Sewankambo NK, Serwadda D, et al. Disclosure 
of HIV results among discordant couples in Rakai, Uganda: a facilitated couple counselling approach. 
AIDS care. 2010;22(9):1041-51. 
267. Li L, Ji G, Liang LJ, Ding Y, Tian J, Xiao Y. A multilevel intervention for HIV-affected families in 
China: Together for Empowerment Activities (TEA). Social Science & Medicine. 2011;73(8):1214-21. 
 109 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 110 
 
10. List of Appendices 
Appendix A: Scientific papers (Papers I-IV) 
Appendix B: Training manual for clinic staff  
Appendix C: Data collection forms (Baseline Information Form, Parental Disclosure 
Interview, Clinic Visit Follow-up and Child Experience Form, Pre-Clinic Training 
Questionnaire and Health Update Form) 
Appendix D: Focus Group Guide 
Appendix E: Ethical clearances (the University of KwaZulu-Natal BREC and the University 
of Witwatersrand HREC) 
Appendix F: Approval letters (the Africa Centre Community Advisory Board and the Hlabisa 
Hospital Management) 
Appendix G: Consent forms (Amagugu mothers, sub-sample of 20 mothers and clinic staff)  
115910.2217/FVL.12.109 © 2012 Africa Centre/UKZN ISSN 1746-0794Future Virol. (2012) 7(12), 1159–1182
Fu
tu
re
 V
iro
lo
g
y
part of
Sub-Saharan Africa is disproportionately 
affected by HIV. The region is home to 10% of 
the world’s population, but includes two-thirds 
of all people with HIV, and an estimated 40% 
of all HIV-infected women [1]. Improvements in 
HIV-treatment and prevention have resulted in 
substantial decreases in mother-to-child trans-
mission of HIV in sub-Saharan Africa [1], and 
a higher proportion of parents surviving to care 
for their HIV-uninfected children [2–5]. This has 
resulted in large numbers of HIV-uninfected 
children living with at least one HIV-infected 
parent [2,5–7].
Children exposed to HIV in utero and raised 
by HIV-infected mothers face a number of 
potential adverse consequences of HIV exposure 
including delays in cognitive and motor develop-
ment [5,8]. Furthermore, they reach school-going 
age (6–10 years), and the journey into adoles-
cence facing possible vulnerabilities associated 
with the HIV-positive status of their parents 
[2,5,9,10]. The early years of school are a crucial 
time in a child’s development, when their life 
and educational chances, and their moral and 
social development, are highly dependent on 
consistent and attentive care and a sense of hope 
for the future [11,12]. The quality of that care 
may be affected by a number of factors associ-
ated with their parents’ status, including possible 
maternal ill health, maternal hospitalization and, 
in some cases, death [2,5,13,14]. These are often 
compounded by stigma and discrimination, and 
a lack of adequate familial and social support [15].
One particular challenge faced by HIV-infected 
mothers is when and how to disclose their HIV 
status to their children [14,16–21]. There is limited 
research relating to maternal HIV disclosure 
globally [20,22,23], and particularly in the African 
context. Furthermore, only a few studies from the 
USA [9,16,22,24–34] and one from Thailand have 
included mothers with primary school-aged chil-
dren [35]. This article offers a critical overview 
of existing research, and conceptualizes models 
for disclosure interventions for younger children 
living in high HIV prevalence regions. 
Overview of current literature
Two literature reviews [14,36] and a recent sys-
tematic review [22] have examined the issue of 
maternal HIV disclosure, finding 56 published 
studies. We further searched the online database 
Pubmed and Google Scholar for studies pub-
lished in English from 2010 onwards, with the 
following search terms ‘maternal HIV disclosure 
and HIV-uninfected children’. Two further stud-
ies were identified, giving a total of 58 studies, 
which are described in Tables 1 & 2 for adolescent 
research and in Tables 3 & 4 for pre-adolescence 
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at
in
g
 in
 m
o
re
 s
ev
er
e 
su
b
st
an
ce
 a
b
u
se
 t
ha
n 
ad
o
le
sc
en
ts
 w
h
o
 h
ad
 n
o
t 
b
ee
n
 d
is
cl
o
se
d
 t
o.
 T
h
e 
m
aj
o
ri
ty
 o
f 
p
ar
en
ts
, 
8
0
%
, 
d
is
cu
ss
ed
 
cu
st
o
d
y 
p
la
n
s 
w
it
h
 m
em
b
er
s 
o
f 
th
ei
r 
so
ci
al
 n
et
w
o
rk
s;
 h
o
w
ev
er
, 
o
n
ly
 3
0
%
 in
it
ia
te
d
 le
g
al
 
cu
st
o
d
y 
p
la
n
s 
fo
r 
th
ei
r 
ch
ild
re
n
[4
7]
M
ur
ph
y 
et
 a
l. 
(1
9
9
9
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
4
0 
m
ot
he
rs
(c
hi
ld
re
n’
s 
ag
es
 
no
t 
sp
ec
ifi
ed
)
U
SA
: H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
w
it
h 
b
ot
h 
H
IV
-i
nf
ec
te
d 
an
d 
un
in
fe
ct
ed
 c
hi
ld
re
n 
w
er
e 
re
cr
ui
te
d 
fr
om
 a
n 
H
IV
 c
lin
ic
Th
e 
st
u
d
y 
in
ve
st
ig
at
ed
 p
at
te
rn
s 
o
f 
d
is
cl
o
su
re
 a
n
d
 p
sy
ch
o
lo
g
ic
al
 a
d
ju
st
m
en
t 
am
o
n
g 
H
IV
-i
nf
ec
te
d
 m
o
th
er
s.
 T
h
e 
d
is
cl
o
su
re
 in
te
rv
ie
w
 a
sk
ed
 t
o
 w
h
o
m
 p
ar
ti
ci
p
an
ts
 h
ad
 d
is
cl
o
se
d 
th
ei
r 
o
w
n
 o
r 
th
ei
r 
in
fe
ct
ed
 c
h
ild
’s
 H
IV
 s
ta
tu
s 
to
. 
A
ll 
m
o
th
er
s 
d
is
cl
o
se
d
 t
h
ei
r 
st
at
u
s 
to
 
so
m
eo
n
e,
 b
u
t 
o
n
ly
 3
9
%
 d
is
cl
o
se
d
 t
o
 c
h
ild
re
n.
 A
ll 
m
o
th
er
s 
w
it
h
 a
n
 H
IV
-i
nf
ec
te
d
 c
h
ild
 
d
is
cl
o
se
d
 t
h
e 
ch
ild
’s
 s
ta
tu
s 
to
 s
o
m
eo
n
e.
 S
o
m
e 
w
o
m
en
 a
d
ju
st
ed
 t
h
ei
r 
liv
es
 p
o
si
ti
ve
ly
 
fo
llo
w
in
g
 a
n
 H
IV
 d
ia
g
n
o
si
s.
 H
al
f 
o
f 
m
o
th
er
s 
d
is
cl
o
se
d
 a
 c
h
ild
’s
 d
ia
g
n
o
si
s 
to
 a
 c
h
ild
 
[1
20
]
Si
m
on
i e
t 
al
. 
(2
0
0
0
)
C
ro
ss
-
se
ct
io
na
l;
qu
an
ti
ta
ti
ve
18
8 
m
ot
he
rs
 a
nd
 
26
7 
ch
ild
re
n
(1
–1
9 
ye
ar
s)
U
SA
: H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
re
cr
ui
te
d 
fr
om
 o
ut
pa
ti
en
t 
cl
in
ic
s 
in
 N
ew
 Y
or
k 
C
it
y
O
nl
y 
m
ot
h
er
s 
w
er
e 
as
se
ss
ed
. 
D
is
cl
o
su
re
 r
at
e 
w
as
 5
3
%
. 
M
ot
h
er
s 
m
ad
e 
d
is
cl
o
su
re
 d
ec
is
io
ns
 
o
n 
a 
ch
ild
-b
y-
ch
ild
 b
as
is
. 
C
hi
ld
’s
 a
g
e 
in
flu
en
ce
d 
d
is
cl
o
su
re
; 
ch
ild
re
n 
th
at
 w
er
e 
d
is
cl
o
se
d 
to
 
w
er
e 
o
ld
er
 c
o
m
p
ar
ed
 w
it
h 
th
o
se
 w
h
o 
w
er
e 
n
ot
 d
is
cl
o
se
d 
to
. 
Th
e 
ch
ild
’s
 a
g
e 
in
flu
en
ce
d 
w
h
et
h
er
 t
h
e 
m
ot
h
er
 f
ul
ly
 d
is
cl
o
se
d 
th
at
 s
h
e 
ha
d 
H
IV
 o
r 
p
ar
ti
al
ly
 d
is
cl
o
se
d 
th
at
 s
h
e 
ha
d 
an
 
ill
n
es
s.
 A
 t
ot
al
 o
f 
57
%
 o
f 
m
ot
h
er
s 
ha
d 
m
ad
e 
fo
rm
al
 p
la
ns
 f
o
r 
th
e 
ch
ild
re
n’
s 
fu
tu
re
 c
ar
e
[5
0]
Pi
lo
w
sk
y 
et
 a
l. 
(2
0
0
0
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
29
 m
ot
he
rs
(c
hi
ld
re
n 
ag
ed
 
4
–1
7 
ye
ar
s)
U
SA
: w
om
en
 li
vi
ng
 in
 t
w
o 
co
m
m
un
it
y 
re
si
d
en
ce
s 
fo
r 
ad
ul
ts
 li
vi
ng
 w
it
h 
A
ID
S 
re
cr
ui
te
d
D
is
cl
o
su
re
 w
as
 a
ss
es
se
d
 w
it
h
 a
 M
at
er
na
l D
is
cl
o
su
re
 In
te
rv
ie
w
 d
ev
el
o
p
ed
 b
y 
th
e 
fi
rs
t 
au
th
o
r.
 C
h
ild
re
n
 w
er
e 
n
o
t 
as
se
ss
ed
. 
A
 t
o
ta
l o
f 
17
 m
o
th
er
s 
d
is
cl
o
se
d
 t
h
ei
r 
st
at
u
s,
 1
2
 o
f 
w
h
o
m
 s
ta
te
d
 t
ha
t 
d
is
cl
o
su
re
 w
as
 ‘
th
e 
ri
g
ht
 t
h
in
g
 t
o
 d
o’
. 
Th
e 
ci
te
d
 r
ea
so
n
s 
g
iv
en
 b
y 
th
e 
12
 m
o
th
er
s 
w
h
o
 d
id
 n
o
t 
d
is
cl
o
se
 w
as
 t
ha
t 
th
e 
ch
ild
 w
as
 t
o
o
 y
o
u
n
g
 t
o
 u
n
d
er
st
an
d
 a
n
d
 t
ha
t 
th
ey
 w
er
e 
co
n
ce
rn
ed
 a
b
o
u
t 
d
is
cu
ss
in
g
 d
ea
th
 w
it
h
 t
h
ei
r 
ch
ild
re
n
[4
6]
Ro
th
er
am
-
B
or
us
 (2
0
01
)
Lo
ng
itu
di
na
l;
qu
an
ti
ta
ti
ve
3
07
 m
ot
he
rs
 a
nd
 
41
2 
ch
ild
re
n 
(1
1–
18
 y
ea
rs
)
U
SA
: H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
w
it
h 
th
ei
r 
H
IV
-u
ni
nf
ec
te
d 
ad
o
le
sc
en
ts
 w
er
e 
re
cr
ui
te
d 
fr
om
 t
he
 N
ew
 Y
or
k 
C
it
y 
D
iv
is
io
n 
of
 A
ID
S
M
o
th
er
–c
h
ild
 p
ai
rs
 w
er
e 
as
si
g
n
ed
 in
to
 e
it
h
er
 a
n
 in
te
rv
en
ti
o
n
 o
r 
co
nt
ro
l g
ro
u
p.
 T
h
e 
p
u
rp
o
se
 o
f 
th
e 
in
te
rv
en
ti
o
n
 w
as
 t
o
 h
el
p
 p
ar
en
ts
 a
n
d
 t
h
ei
r 
ad
o
le
sc
en
ts
 c
o
p
e 
w
it
h
 il
ln
es
s-
re
la
te
d
 t
as
ks
. 
Pa
re
nt
s’
 d
ep
re
ss
io
n
 s
co
re
s 
an
d
 m
u
lt
ip
le
 p
ro
b
le
m
 b
eh
av
io
rs
 f
ro
m
 3
 t
o 
15
 m
o
nt
h
s 
d
ec
re
as
ed
 a
m
o
n
g
 t
h
e 
in
te
rv
en
ti
o
n
 g
ro
u
p.
 7
1%
 o
f 
m
o
th
er
s 
in
 b
o
th
 g
ro
u
p
s 
ha
d 
d
is
cl
o
se
d
 t
h
ei
r 
st
at
u
s 
to
 a
t 
le
as
t 
o
n
e 
ad
o
le
sc
en
t 
an
d
 6
6
%
 h
ad
 d
is
cl
o
se
d
 t
o
 a
ll 
ad
o
le
sc
en
ts
 
in
 t
h
e 
fa
m
ily
. 
A
t 
2
 y
ea
rs
 a
d
o
le
sc
en
ts
 in
 t
h
e 
in
te
rv
en
ti
o
n
 g
ro
u
p
 r
ep
o
rt
ed
 f
o
u
r-
ti
m
es
 f
ew
er
 
p
ro
b
le
m
 b
eh
av
io
rs
 a
n
d
 2
.4
-t
im
es
 f
ew
er
 c
o
n
d
u
ct
 p
ro
b
le
m
s 
th
an
 t
h
e 
co
nt
ro
l g
ro
u
p
[1
21
]
A
RT
: A
nt
ir
et
ro
vi
ra
l t
he
ra
py
. 
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Ta
b
le
 1
. S
tu
d
ie
s 
re
la
ti
n
g
 t
o
 a
d
o
le
sc
en
ts
 in
 t
h
e 
U
SA
, C
an
ad
a 
an
d
 E
u
ro
p
e 
(c
o
n
t.
).
A
u
th
o
r 
(y
ea
r)
St
u
d
y 
d
es
ig
n
 
Sa
m
p
le
Lo
ca
ti
o
n
 a
n
d
 p
ar
ti
ci
p
an
t 
re
cr
u
it
m
en
t
Fi
n
d
in
g
s
R
ef
.
K
ir
sh
en
ba
um
 
an
d 
N
ev
id
 
(2
0
02
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
5
8 
m
ot
he
rs
 a
nd
5
8 
ch
ild
re
n 
(4
–1
8 
ye
ar
s)
U
SA
: H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
an
d 
th
ei
r 
H
IV
-u
ni
nf
ec
te
d 
ch
ild
re
n 
re
cr
ui
te
d 
fr
om
 
H
IV
/A
ID
S 
se
rv
ic
e 
ce
nt
er
s 
in
 
th
e 
N
ew
 Y
or
k 
m
et
ro
p
o
lit
an
 
ar
ea
D
is
cl
o
su
re
 r
at
e 
w
as
 5
7%
. 
In
 7
5%
 o
f 
th
e 
ca
se
s 
th
e 
ch
ild
re
n
 w
er
e 
d
is
cl
o
se
d
 t
o
 b
y 
th
e 
m
o
th
er
 a
n
d
 6
6
%
 w
er
e 
n
o
t 
as
ke
d
 t
o
 k
ee
p
 d
is
cl
o
su
re
 a
 s
ec
re
t.
 C
h
ild
re
n
 t
h
at
 w
er
e 
as
ke
d
 t
o 
ke
ep
 d
is
cl
o
su
re
 s
ec
re
t 
d
is
p
la
ye
d
 m
o
re
 b
eh
av
io
ra
l p
ro
b
le
m
 s
co
re
s 
w
h
en
 a
ss
es
se
d
 u
si
n
g
 t
h
e 
C
h
ild
 B
eh
av
io
r 
C
h
ec
kl
is
t 
th
an
 t
h
o
se
 w
h
o
 w
er
e 
n
o
t 
as
ke
d
 t
o
 m
ai
nt
ai
n
 t
h
e 
se
cr
et
[4
0]
Le
e 
an
d 
Ro
th
er
am
-
B
or
us
 (2
0
02
)
Lo
ng
itu
di
na
l;
qu
an
ti
ta
ti
ve
3
01
 p
ar
en
ts
 a
nd
 
39
5 
ad
o
le
sc
en
ts
(1
1–
18
 y
ea
rs
)
U
SA
: H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
an
d 
fa
th
er
s 
w
it
h 
H
IV
-u
ni
nf
ec
te
d 
ad
o
le
sc
en
ts
 
re
cr
ui
te
d 
fr
om
 t
he
 N
ew
 Y
or
k 
C
it
y 
D
iv
is
io
n 
of
 A
ID
S
Pa
rt
ic
ip
an
ts
 w
er
e 
fo
llo
w
ed
 u
p
 f
o
r 
5
 y
ea
rs
. 
Pa
re
nt
s 
w
er
e 
m
o
re
 li
ke
ly
 t
o
 d
is
cl
o
se
 t
o
 o
ld
er
 
(7
5%
) 
th
an
 y
o
u
n
g
er
 (
4
0
%
) 
ch
ild
re
n
. 
M
o
th
er
s 
w
er
e 
m
o
re
 li
ke
ly
 t
o
 d
is
cl
o
se
 t
h
an
 f
at
h
er
s,
 
an
d
 w
er
e 
m
o
re
 li
ke
ly
 t
o
 d
o
 s
o
 a
t 
a 
yo
u
n
g
er
 a
g
e.
 M
o
re
 m
o
th
er
s 
co
m
p
ar
ed
 w
it
h
 f
at
h
er
s 
d
is
cl
o
se
d
 t
o
 d
au
g
ht
er
s 
th
an
 s
o
n
s.
 C
h
ild
re
n’
s 
se
x 
d
id
 n
o
t 
in
fl
u
en
ce
 d
is
cl
o
su
re
 a
m
o
n
g 
fa
th
er
s.
 D
is
cl
o
su
re
 w
as
 a
ss
o
ci
at
ed
 w
it
h
 m
o
re
 p
ro
b
le
m
 b
eh
av
io
rs
 a
n
d
 n
eg
at
iv
e 
fa
m
ily
 li
fe
 
ev
en
ts
 a
m
o
n
g
 a
d
o
le
sc
en
ts
. 
Pa
re
nt
s 
w
h
o
 h
ad
 d
is
cl
o
se
d
 h
ad
 a
 h
ig
h
er
 n
u
m
b
er
 o
f 
st
re
ss
fu
l 
lif
e 
an
d
 f
am
ily
 li
fe
 e
ve
nt
s.
 D
is
cl
o
su
re
 w
as
 h
ig
h
er
 a
m
o
n
g
 p
ar
en
ts
 w
it
h
 a
 p
o
o
r 
h
ea
lt
h
 s
ta
tu
s.
 
Pa
re
nt
s 
w
it
h
 la
rg
er
 s
o
ci
al
 n
et
w
o
rk
s 
w
er
e 
m
o
re
 li
ke
ly
 t
o
 d
is
cl
o
se
 t
o
 c
h
ild
re
n
. 
A
t 
re
cr
u
it
m
en
t,
 a
d
o
le
sc
en
ts
 t
h
at
 w
er
e 
d
is
cl
o
se
d
 t
o
 r
ep
o
rt
ed
 s
ig
n
ifi
ca
nt
ly
 h
ig
h
er
 p
ro
b
le
m
 
b
eh
av
io
rs
; 
h
o
w
ev
er
, 
p
ro
b
le
m
 b
eh
av
io
rs
 d
ec
re
as
ed
 o
ve
r 
ti
m
e 
an
d
 in
cr
ea
se
d
 a
m
o
n
g 
ad
o
le
sc
en
ts
 w
h
o
 w
er
e 
n
o
t 
d
is
cl
o
se
d
 t
o
[4
1]
Le
e 
et
 a
l. 
(2
0
02
)
C
ro
ss
-
se
ct
io
na
l;
qu
an
ti
ta
ti
ve
12
1 
m
ot
he
rs
 a
nd
 
12
1 
ch
ild
re
n 
(1
1–
18
 y
ea
rs
)
U
SA
: H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
an
d 
un
in
fe
ct
ed
 a
d
o
le
sc
en
t 
da
ug
ht
er
s 
w
er
e 
re
cr
ui
te
d 
fr
om
 t
he
 D
iv
is
io
n 
of
 A
ID
S 
Se
rv
ic
es
 in
 N
ew
 Y
or
k
B
o
th
 m
o
th
er
s 
an
d
 d
au
g
ht
er
s 
w
er
e 
as
se
ss
ed
. 
A
t 
th
e 
ti
m
e 
o
f 
re
cr
u
it
m
en
t 
75
%
 o
f 
m
o
th
er
s 
h
ad
 a
lr
ea
d
y 
d
is
cl
o
se
d
 t
o
 t
h
ei
r 
d
au
g
ht
er
s.
 T
h
er
e 
w
er
e 
n
o
 d
if
fe
re
n
ce
s 
b
et
w
ee
n
 m
o
th
er
s’
 
an
d
 d
au
g
ht
er
s’
 r
ep
o
rt
s 
o
f 
at
te
m
p
te
d
 s
u
ic
id
e 
d
u
ri
n
g
 t
h
ei
r 
lif
et
im
e 
(2
1–
25
%
).
 D
ec
is
io
n
 t
o 
d
is
cl
o
se
 w
as
 n
o
t 
as
so
ci
at
ed
 w
it
h
 m
o
th
er
s’
 s
ta
g
e 
o
f 
d
is
ea
se
. 
Po
o
r 
sc
h
o
o
l r
ep
o
rt
s 
w
er
e 
as
so
ci
at
ed
 w
it
h
 m
o
th
er
s’
 e
m
o
ti
o
n
al
 d
is
tr
es
s.
 M
o
re
 m
o
th
er
s 
th
an
 d
au
g
ht
er
s 
re
p
o
rt
ed
 
h
is
to
ry
 o
f 
se
xu
al
 a
b
u
se
 d
u
ri
n
g
 t
h
ei
r 
lif
et
im
e 
(3
7
 v
s 
10
%
)
[1
22
]
M
el
lin
s 
(2
0
02
)
Lo
ng
itu
di
na
l;
qu
an
ti
ta
ti
ve
12
8 
m
ot
he
rs
(c
hi
ld
re
n 
ag
ed
 
<1
8 
ye
ar
s)
U
SA
: H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
w
er
e 
re
cr
ui
te
d 
fr
om
 a
n 
in
fe
ct
io
us
 d
is
ea
se
 c
lin
ic
C
h
ild
re
n
 w
er
e 
n
o
t 
as
se
ss
ed
. 
B
as
el
in
e 
d
at
a 
fr
o
m
 a
 lo
n
g
it
u
d
in
al
 s
tu
d
y 
in
ve
st
ig
at
in
g
 f
ac
to
rs
 
th
at
 a
ff
ec
t 
A
R
T 
an
d
 m
ed
ic
al
 a
p
p
o
in
tm
en
t 
ad
h
er
en
ce
 in
 H
IV
-i
n
fe
ct
ed
 m
o
th
er
s 
ar
e 
re
p
o
rt
ed
 
h
er
e.
 D
is
cl
o
su
re
 w
as
 a
ss
es
se
d
 w
it
h
 a
 d
is
cl
o
su
re
 q
u
es
ti
o
n
n
ai
re
 d
ev
el
o
p
ed
 b
y 
th
e 
st
u
d
y 
in
ve
st
ig
at
o
rs
. 
Th
e 
m
aj
o
ri
ty
 o
f 
m
o
th
er
s 
(9
5%
) 
h
ad
 d
is
cl
o
se
d
 t
o
 t
h
ei
r 
ad
u
lt
 f
am
ily
 m
em
b
er
s,
 
w
h
ile
 in
 4
8
%
 o
f 
th
e 
fa
m
ili
es
 n
o
n
e 
o
f 
th
e 
ch
ild
re
n
 w
er
e 
d
is
cl
o
se
d
 t
o.
 M
o
th
er
s 
h
ad
 
d
is
cl
o
se
d
 t
o
 a
ll 
o
f 
th
ei
r 
ch
ild
re
n
 in
 9
%
 o
f 
th
e 
fa
m
ili
es
. 
O
f 
th
e 
69
%
 o
f 
m
o
th
er
s 
w
h
o
 w
er
e 
o
n
 A
R
T,
 2
0
%
 r
ep
o
rt
ed
 m
is
si
n
g
 m
ed
ic
at
io
n
 in
 t
h
e 
p
as
t 
2
 d
ay
s 
an
d
 4
3
%
 o
f 
th
e 
sa
m
p
le
 
re
p
o
rt
ed
 m
is
si
n
g
 m
ed
ic
al
 a
p
p
o
in
tm
en
ts
 in
 t
h
e 
p
as
t 
ye
ar
. 
A
R
T 
an
d
 m
ed
ic
al
 a
p
p
o
in
tm
en
t 
ad
h
er
en
ce
 w
as
 a
ss
o
ci
at
ed
 w
it
h
 d
is
cl
o
su
re
 t
o
 a
 li
ve
-i
n
 p
ar
tn
er
 a
n
d
 c
h
ild
re
n
; 
m
o
re
 
ad
h
er
en
ce
 w
as
 r
ep
o
rt
ed
 b
y 
th
o
se
 w
h
o
 h
ad
 d
is
cl
o
se
d
 t
o
 p
ar
tn
er
s 
an
d
 c
h
ild
re
n
 t
h
ey
 w
er
e 
liv
in
g
 w
it
h
[1
23
]
M
el
lin
s 
et
 a
l. 
(2
0
03
)
Lo
ng
itu
di
na
l;
qu
an
ti
ta
ti
ve
12
8 
m
ot
he
rs
(c
hi
ld
re
n 
ag
ed
 
<1
8 
ye
ar
s)
U
SA
: p
ar
ti
ci
pa
nt
s 
re
cr
ui
te
d 
fr
om
 t
he
 s
am
e 
co
ho
rt
 a
s 
ab
ov
e 
st
ud
y 
[1
23
]
C
h
ild
re
n
 w
er
e 
n
o
t 
as
se
ss
ed
. 
D
at
a 
fr
o
m
 a
 6
-m
o
nt
h
 f
o
llo
w
-u
p
 a
re
 r
ep
o
rt
ed
 h
er
e.
 M
o
re
 
m
o
th
er
s 
re
p
o
rt
ed
 m
is
si
n
g
 m
ed
ic
al
 a
p
p
o
in
tm
en
ts
 in
 t
h
e 
6
-m
o
nt
h
 f
o
llo
w
-u
p
 c
o
m
p
ar
ed
 
w
it
h
 b
as
el
in
e 
(4
3
 v
s 
5
4
%
).
 P
o
o
r 
m
ed
ic
al
 a
p
p
o
in
tm
en
t 
ad
h
er
en
ce
 w
as
 a
ss
o
ci
at
ed
 w
it
h
 le
ss
 
d
is
cl
o
su
re
 t
o
 c
h
ild
re
n
. 
Pr
es
en
ce
 o
f 
a 
p
sy
ch
ia
tr
ic
 d
is
o
rd
er
 a
n
d
 h
ig
h
er
 le
ve
ls
 o
f 
st
re
ss
fu
l l
if
e 
ev
en
ts
 w
er
e 
as
so
ci
at
ed
 w
it
h
 p
o
o
r 
m
ed
ic
al
 a
p
p
o
in
tm
en
ts
 in
 6
-m
o
nt
h
 f
o
llo
w
-u
p
[1
24
]
A
RT
: A
nt
ir
et
ro
vi
ra
l t
he
ra
py
. 
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Ta
b
le
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. S
tu
d
ie
s 
re
la
ti
n
g
 t
o
 a
d
o
le
sc
en
ts
 in
 t
h
e 
U
SA
, C
an
ad
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an
d
 E
u
ro
p
e 
(c
o
n
t.
).
A
u
th
o
r 
(y
ea
r)
St
u
d
y 
d
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ig
n
 
Sa
m
p
le
Lo
ca
ti
o
n
 a
n
d
 p
ar
ti
ci
p
an
t 
re
cr
u
it
m
en
t
Fi
n
d
in
g
s
R
ef
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Le
tt
en
ey
 a
nd
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Po
rt
e 
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0
0
4
)
C
ro
ss
-
se
ct
io
na
l;
qu
an
ti
ta
ti
ve
8
8 
m
ot
he
rs
 
(c
hi
ld
re
n 
ag
ed
 
5
–1
8 
ye
ar
s)
U
SA
: H
IV
-in
fe
ct
ed
 m
ot
he
rs
 
re
cr
ui
te
d 
fr
om
 a
n 
ou
tp
at
ie
nt
 
m
ed
ic
al
 c
lin
ic
 in
 N
ew
 
Yo
rk
 C
it
y
C
hi
ld
re
n 
w
er
e 
no
t 
as
se
ss
ed
. D
is
cl
os
ur
e 
ra
te
 w
as
 6
7%
. D
is
cl
os
ur
e 
be
ha
vi
or
 w
as
 m
ea
su
re
d 
by
 
th
e 
D
is
cl
os
ur
e 
In
ve
nt
or
y 
(a
 1
4
-it
em
 in
st
ru
m
en
t)
 d
ev
el
op
ed
 b
y 
th
e 
in
ve
st
ig
at
or
. A
pa
rt
 f
ro
m
 a
ge
 
an
d 
ed
uc
at
io
n 
th
os
e 
w
ho
 d
is
cl
os
ed
 a
nd
 t
ho
se
 w
ho
 d
id
 n
ot
 w
er
e 
si
m
ila
r 
in
 m
os
t 
so
ci
od
em
og
ra
ph
ic
 c
ha
ra
ct
er
is
tic
s.
 N
on
di
sc
lo
se
rs
 c
ite
d 
fe
ar
 o
f 
st
ig
m
a 
as
 t
he
 m
ai
n 
re
as
on
 f
or
 
no
t 
di
sc
lo
si
ng
[4
2]
M
ur
ph
y 
et
 a
l. 
(2
0
0
6
)
C
ro
ss
-
se
ct
io
na
l;
qu
an
ti
ta
ti
ve
11
8 
m
ot
he
rs
 a
nd
 
11
8 
ch
ild
re
n 
(1
0
–1
7 
ye
ar
s)
U
SA
: H
IV
-in
fe
ct
ed
 m
ot
he
rs
 
an
d 
H
IV
-u
ni
nf
ec
te
d 
ad
ol
es
ce
nt
s 
re
cr
ui
te
d 
fr
om
 a
 
co
ho
rt
 in
 t
he
 P
A
C
T 
st
ud
y
A
 t
ot
al
 o
f 
51
%
 o
f 
ad
ol
es
ce
nt
s 
ha
d 
no
 im
m
ed
ia
te
 r
ea
ct
io
n 
to
 d
is
cl
os
ur
e;
 4
9
%
 e
xp
re
ss
ed
 a
n 
em
ot
io
na
l r
ea
ct
io
n.
 A
do
le
sc
en
ts
 w
ho
 w
er
e 
di
sc
lo
se
d 
to
 h
ad
 lo
w
er
 d
ep
re
ss
io
n 
sc
or
es
. A
 t
ot
al
 
of
 4
9
%
 c
hi
ld
re
n 
re
po
rt
ed
 w
or
ry
in
g 
m
or
e 
si
nc
e 
th
ey
 h
av
e 
be
en
 d
is
cl
os
ed
 t
o.
 T
he
re
 w
er
e 
di
sc
re
pa
nc
ie
s 
be
tw
ee
n 
m
ot
he
r 
an
d 
ch
ild
 r
ep
or
ts
. F
ea
r 
of
 s
tig
m
a 
w
as
 t
he
 m
os
t 
ci
te
d 
re
as
on
 f
or
 
no
nd
is
cl
os
ur
e
[2
5]
C
or
on
a 
et
 a
l. 
(2
0
0
6
)
C
ro
ss
-
se
ct
io
na
l;
qu
an
ti
ta
ti
ve
27
4 
pa
re
nt
s 
an
d 
45
3 
ch
ild
re
n 
(5
–1
7 
ye
ar
s)
U
SA
: H
IV
-in
fe
ct
ed
 m
ot
he
rs
 
an
d 
fa
th
er
s 
re
ce
iv
in
g 
H
IV
 c
ar
e 
an
d 
H
IV
-u
ni
nf
ec
te
d 
ch
ild
re
n 
w
er
e 
re
cr
ui
te
d
Th
is
 s
tu
dy
 a
na
ly
ze
d 
da
ta
 f
ro
m
 t
he
 H
IV
 c
os
t 
an
d 
se
rv
ic
es
 u
til
iz
at
io
n 
st
ud
y 
w
hi
ch
 u
se
d 
m
ul
ti-
st
ag
e 
sa
m
pl
in
g 
to
 s
el
ec
t 
a 
ra
nd
om
 s
am
pl
e 
of
 H
IV
-in
fe
ct
ed
 a
du
lt
s 
[1
25
].
 D
is
cl
os
ur
e 
ra
te
 w
as
 
4
4%
. R
ea
so
ns
 f
or
 n
on
di
sc
lo
su
re
 in
cl
ud
ed
; w
or
ry
 a
bo
ut
 e
m
ot
io
na
l c
on
se
qu
en
ce
s 
of
 d
is
cl
os
ur
e 
(6
7%
),
 c
hi
ld
re
n 
w
ou
ld
 t
el
l o
th
er
 p
eo
pl
e 
(3
6%
) a
nd
 la
ck
 o
f 
sk
ill
s 
an
d 
kn
ow
le
dg
e 
on
 h
ow
 t
o 
di
sc
lo
se
 (2
8
%
)
[6
5]
Le
tt
en
ey
 
(2
0
0
6
)
C
ro
ss
-
se
ct
io
na
l;
qu
an
ti
ta
ti
ve
8
8 
m
ot
he
rs
 
(c
hi
ld
re
n 
ag
ed
 
5
–1
8 
ye
ar
s)
U
SA
: H
IV
-in
fe
ct
ed
 m
ot
he
rs
 
w
er
e 
re
cr
ui
te
d 
fr
om
 a
n 
ou
tp
at
ie
nt
 H
IV
 c
lin
ic
C
hi
ld
re
n 
w
er
e 
no
t 
as
se
ss
ed
. M
ot
he
rs
 w
ho
 h
ad
 d
is
cl
os
ed
 t
he
ir 
H
IV
-s
ta
tu
s 
to
 t
he
ir 
ch
ild
re
n 
w
er
e 
co
m
pa
re
d 
w
ith
 t
ho
se
 w
ho
 h
ad
 n
ot
 d
is
cl
os
ed
. D
is
cl
os
ur
e 
ra
te
 t
o 
ch
ild
re
n 
w
as
 6
6%
. O
f 
th
os
e 
w
ho
 d
id
 n
ot
 d
is
cl
os
e,
 1
9
%
 h
ad
 n
o 
in
te
nt
io
n 
of
 d
is
cl
os
in
g 
in
 t
he
 f
ut
ur
e.
 T
ho
se
 w
ho
 d
is
cl
os
ed
 
w
er
e 
le
ss
 li
ke
ly
 t
o 
pe
rc
ei
ve
 H
IV
 d
ia
gn
os
is
 t
o 
be
 s
tig
m
at
iz
in
g 
th
an
 t
ho
se
 w
ho
 d
id
 n
ot
 d
is
cl
os
e.
 
Th
er
e 
w
er
e 
no
 d
if
fe
re
nc
es
 in
 p
sy
ch
ol
og
ic
al
 a
nd
 p
hy
si
ca
l l
ev
el
s 
of
 s
tr
es
s 
be
tw
ee
n 
th
e 
tw
o 
gr
ou
ps
 o
f 
m
ot
he
rs
. T
ho
se
 w
ho
 d
is
cl
os
ed
 r
ep
or
te
d 
hi
gh
 le
ve
ls
 o
f 
so
ci
al
 s
up
po
rt
[1
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m
pk
in
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)
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-
se
ct
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na
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it
at
iv
e
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he
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ar
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U
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: H
IV
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fe
ct
ed
 m
ot
he
rs
 
an
d 
H
IV
-u
ni
nf
ec
te
d 
ch
ild
re
n 
w
ho
 h
ad
 b
ee
n 
pa
rt
 o
f 
a 
lo
ng
itu
di
na
l s
tu
dy
 
in
ve
st
ig
at
in
g 
ps
yc
ho
so
ci
al
 
ad
ju
st
m
en
t,
 r
is
k 
be
ha
vi
or
 a
nd
 
so
ci
al
 c
on
te
xt
s 
(t
he
 U
C
LA
-
D
re
w
 W
om
en
 P
ro
je
ct
, i
n 
Lo
s 
A
ng
el
es
)
D
is
cl
os
ur
e 
ra
te
 w
as
 6
1%
. C
hi
ld
re
n 
w
ho
 h
ad
 b
ee
n 
as
ke
d 
to
 k
ee
p 
di
sc
lo
su
re
 s
ec
re
t 
sc
or
ed
 
hi
gh
er
 o
n 
th
e 
te
ac
he
r 
re
po
rt
 f
or
m
 w
hi
ch
 a
ss
es
se
d 
be
ha
vi
or
al
 p
ro
bl
em
s 
an
d 
m
ot
he
rs
 r
ep
or
te
d 
hi
gh
er
 e
xt
er
na
liz
in
g 
pr
ob
le
m
s 
in
 t
he
 c
hi
ld
 b
eh
av
io
r 
ch
ec
kl
is
t
[1
26
]
Br
ac
ki
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C
ot
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)
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ng
itu
di
na
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qu
an
ti
ta
ti
ve
22
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m
ot
he
rs
 a
nd
22
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ild
re
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(1
0
–1
4 
ye
ar
s)
U
SA
: H
IV
-i
nf
ec
te
d 
an
d 
un
in
fe
ct
ed
 m
ot
he
rs
 o
f 
un
in
fe
ct
ed
 e
ar
ly
 a
d
o
le
sc
en
ts
 
re
cr
ui
te
d 
fr
om
 H
IV
 c
lin
ic
s 
an
d 
no
n
-H
IV
 c
lin
ic
s
Ba
se
lin
e 
da
ta
 f
or
 t
he
 s
tu
d
y 
w
hi
ch
 in
ve
st
ig
at
ed
 r
is
k 
an
d 
re
si
lie
nc
e 
in
 y
ou
th
 w
it
h 
H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 w
er
e 
us
ed
. H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 d
is
pl
ay
ed
 m
or
e 
d
ep
re
ss
iv
e 
sy
m
pt
om
s 
th
an
 
un
in
fe
ct
ed
 m
ot
he
rs
 w
he
n 
as
se
ss
ed
 w
it
h 
th
e 
B
ec
k 
D
ep
re
ss
io
n 
In
ve
nt
or
y.
 N
o 
si
gn
ifi
ca
nt
 
di
ff
er
en
ce
s 
w
er
e 
o
bs
er
ve
d 
in
 d
ep
re
ss
iv
e 
sy
m
pt
om
s 
of
 c
hi
ld
re
n 
of
 H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 a
nd
 
un
in
fe
ct
ed
 m
ot
he
rs
. T
he
re
 w
er
e 
no
 d
if
fe
re
nc
es
 in
 a
n
xi
et
y 
sc
or
es
 b
et
w
ee
n 
ch
ild
re
n 
w
ho
 w
er
e 
di
sc
lo
se
d 
to
 a
nd
 t
ho
se
 w
ho
 w
er
e 
no
t 
di
sc
lo
se
d 
to
, a
nd
 n
o 
di
ff
er
en
ce
s 
w
er
e 
o
bs
er
ve
d 
in
 
an
xi
et
y 
sc
or
es
 b
et
w
ee
n 
ch
ild
re
n 
of
 H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 a
nd
 u
ni
nf
ec
te
d 
m
ot
he
rs
. C
hi
ld
re
n 
w
ho
 w
er
e 
di
sc
lo
se
d 
to
 w
er
e 
le
ss
 d
ep
re
ss
ed
 t
ha
n 
th
o
se
 w
ho
 w
er
e 
no
t 
di
sc
lo
se
d 
to
 w
he
n 
as
se
ss
ed
 u
si
ng
 t
he
 C
hi
ld
 D
ep
re
ss
io
n 
In
ve
nt
or
y
[1
27
]
A
RT
: A
nt
ir
et
ro
vi
ra
l t
he
ra
py
. 
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Ta
b
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. S
tu
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ie
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re
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o
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 in
 t
h
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U
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, C
an
ad
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d
 E
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o
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an
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C
ro
ss
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m
ot
he
rs
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ild
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n 
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ye
ar
s)
U
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d 
m
ot
h
er
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an
d 
H
IV
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d 
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re
n 
re
cr
ui
te
d 
th
ro
u
gh
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ID
S 
se
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ic
e 
o
rg
an
iz
at
io
ns
D
is
cl
o
su
re
 r
at
e 
w
as
 6
1%
. 
Th
e 
ci
te
d
 r
ea
so
n
s 
fo
r 
d
is
cl
o
su
re
 in
cl
u
d
ed
: 
w
an
ti
n
g
 c
h
ild
re
n
 t
o 
h
ea
r 
th
e 
d
ia
g
n
o
si
s 
fr
o
m
 m
o
th
er
s 
an
d
 t
ha
t 
ch
ild
re
n
 h
ad
 a
 r
ig
ht
 t
o
 k
n
o
w
. 
R
ea
so
n
s 
fo
r 
n
o
n
d
is
cl
o
su
re
 in
cl
u
d
ed
: 
b
el
ie
vi
n
g
 c
h
ild
re
n
 d
es
er
ve
d
 a
 c
ar
ef
re
e 
ch
ild
h
o
o
d
 a
n
d
 n
o
t 
w
an
ti
n
g 
to
 w
o
rr
y 
ch
ild
re
n.
 M
o
th
er
s 
w
an
te
d
 t
o
 t
ak
e 
a 
le
ad
in
g
 r
o
le
 in
 d
is
cl
o
si
n
g
 d
ep
en
d
in
g
 o
n
 t
h
e 
ch
ild
re
n’
s 
ab
ili
ty
 t
o
 h
an
d
le
 in
fo
rm
at
io
n,
 p
ro
vi
d
ed
 t
h
e 
p
ro
ce
ss
 w
as
 n
o
t 
ha
rm
fu
l t
o
 c
h
ild
re
n.
 
A
 t
o
ta
l o
f 
9
0
%
 o
f 
m
o
th
er
s 
d
id
 n
o
t 
re
g
re
t 
d
is
cl
o
si
n
g
 t
o
 c
h
ild
re
n
[6
3]
M
el
lin
s 
et
 a
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0
0
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)
C
ro
ss
-
se
ct
io
na
l;
qu
an
ti
ta
ti
ve
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0 
m
ot
he
rs
 a
nd
22
0 
ch
ild
re
n 
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4 
ye
ar
s)
U
SA
: H
IV
-i
nf
ec
te
d 
an
d 
H
IV
-u
ni
nf
ec
te
d 
m
ot
h
er
s 
an
d 
H
IV
-u
ni
nf
ec
te
d 
ad
o
le
sc
en
ts
 
re
cr
ui
te
d 
fr
o
m
 H
IV
 c
lin
ic
s,
 
co
m
m
un
it
y-
b
as
ed
 
o
rg
an
iz
at
io
ns
 a
nd
 o
th
er
 c
ar
e 
p
ro
vi
d
er
s
D
at
a 
o
n
 t
h
e 
d
is
cl
o
su
re
 p
ro
ce
ss
 w
er
e 
n
o
t 
co
lle
ct
ed
, 
b
u
t 
m
o
th
er
s 
w
er
e 
as
ke
d
 if
 c
h
ild
re
n 
w
er
e 
aw
ar
e 
o
f 
th
ei
r 
m
o
th
er
s’
 s
ta
tu
s.
 A
d
o
le
sc
en
ts
’ 
kn
o
w
le
d
g
e 
o
f 
th
ei
r 
m
o
th
er
s’
 H
IV
 
in
fe
ct
io
n
 a
n
d
 o
ve
ra
ll 
h
ea
lt
h
 w
as
 a
ss
o
ci
at
ed
 w
it
h
 w
o
rs
e 
ad
o
le
sc
en
t 
m
en
ta
l h
ea
lt
h 
o
u
tc
o
m
es
, 
in
cl
u
d
in
g
 h
ig
h
er
 c
h
ild
 d
ep
re
ss
io
n
 s
co
re
s 
in
 t
h
e 
C
h
ild
 D
ep
re
ss
io
n
 In
ve
nt
o
ry
[4
3]
D
em
at
te
o 
et
 a
l. 
(2
0
02
)
C
ro
ss
-
se
ct
io
na
l;
qu
an
ti
ta
ti
ve
51
 a
du
lt
s 
an
d 
5
4 
ch
ild
re
n
(5
–1
9 
ye
ar
s)
C
an
ad
a:
 H
IV
-a
ff
ec
te
d 
fa
m
ili
es
 f
ro
m
 p
ed
ia
tr
ic
 
h
o
sp
it
al
s 
an
d 
A
ID
S 
se
rv
ic
e 
o
rg
an
iz
at
io
ns
 w
er
e 
re
cr
ui
te
d
M
o
st
 c
h
ild
re
n,
 6
7%
, 
kn
ew
 a
b
o
u
t 
th
ei
r 
p
ar
en
ts
 H
IV
 in
fe
ct
io
n,
 3
5%
 k
n
ew
 a
b
o
u
t 
th
ei
r 
o
w
n 
in
fe
ct
io
n
 a
n
d
 9
%
 w
er
e 
to
ld
 a
b
o
u
t 
th
ei
r 
si
b
lin
g
s’
 o
r 
o
th
er
 f
am
ily
 m
em
b
er
s’
 H
IV
 in
fe
ct
io
n.
 
C
o
m
p
ar
ed
 w
it
h
 b
o
ys
, 
m
o
re
 g
ir
ls
 w
er
e 
d
is
cl
o
se
d
 t
o
 (
59
 v
s 
3
9
%
).
 A
sk
ed
 a
b
o
u
t 
p
re
p
ar
at
io
n
s 
fo
r 
d
is
cl
o
su
re
: 
78
%
 o
f 
ca
re
g
iv
er
s 
re
p
o
rt
ed
 t
ha
t 
th
ey
 t
al
ke
d
 w
it
h
 s
o
m
eo
n
e 
th
ey
 t
ru
st
ed
, 
71
%
 w
ai
te
d
 f
o
r 
im
p
ro
ve
d
 h
ea
lt
h,
 5
0
%
 p
ra
ye
d
 a
n
d
 4
9
%
 t
al
ke
d
 w
it
h
 p
ro
fe
ss
io
na
ls
[5
4]
Th
or
n
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et
 a
l. 
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)
C
ro
ss
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se
ct
io
na
l;
qu
an
ti
ta
ti
ve
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1 
pa
re
nt
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5
0 
ca
re
gi
ve
rs
 a
nd
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6 
ch
ild
re
n 
(≤
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 y
ea
rs
)
G
er
m
an
y,
 It
al
y,
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N
et
h
er
la
nd
s,
 P
o
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u
ga
l, 
Sp
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n,
 S
w
it
ze
rl
an
d 
an
d 
th
e 
U
K
: d
at
a 
re
p
o
rt
ed
 in
 t
hi
s 
st
u
d
y 
w
er
e 
co
lle
ct
ed
 f
ro
m
 
p
ar
ti
ci
p
an
ts
 a
s 
p
ar
t 
of
 a
 
la
rg
er
 s
ur
ve
y 
co
nd
u
ct
ed
 in
 
te
n 
p
ed
ia
tr
ic
 H
IV
 c
en
te
rs
 
lo
ca
te
d 
in
 s
ev
en
 E
ur
o
p
ea
n 
co
un
tr
ie
s
Th
e 
m
aj
o
ri
ty
, 
8
9
%
, 
o
f 
p
ar
en
ts
 w
er
e 
o
ri
g
in
al
ly
 f
ro
m
 A
fr
ic
a 
an
d
 h
ad
 im
m
ig
ra
te
d
 t
o
 E
u
ro
p
e 
m
ai
n
ly
 a
s 
re
fu
g
ee
s 
o
r 
as
yl
u
m
 s
ee
ke
rs
. 
B
o
th
 H
IV
-i
nf
ec
te
d
 (
92
%
) 
an
d
 H
IV
-u
n
in
fe
ct
ed
 
p
ar
en
ts
 o
r 
ca
re
g
iv
er
s 
o
f 
H
IV
-a
ff
ec
te
d
 c
h
ild
re
n
 w
er
e 
re
cr
u
it
ed
. 
A
 t
o
ta
l o
f 
62
%
 o
f 
ch
ild
re
n 
w
er
e 
H
IV
-i
nf
ec
te
d,
 a
n
d
 5
5%
 o
f 
ch
ild
re
n
 w
er
e 
ag
ed
 ≤
6
 y
ea
rs
. 
D
is
cl
o
su
re
 r
at
e 
w
as
 1
1%
. 
Pa
re
nt
s 
w
h
o
 d
is
cl
o
se
d
 h
ad
 o
n
 a
ve
ra
g
e 
kn
o
w
n
 t
h
ei
r 
d
ia
g
n
o
si
s 
fo
r 
lo
n
g
er
 t
ha
n
 t
h
o
se
 w
h
o 
d
id
 n
o
t 
d
is
cl
o
se
. 
M
o
st
 c
h
ild
re
n
 w
er
e 
d
is
cl
o
se
d
 t
o
 b
y 
th
e 
ag
e 
o
f 
10
 y
ea
rs
. 
A
 t
o
ta
l o
f 
5
0
%
 o
f 
H
IV
-i
nf
ec
te
d
 p
ar
en
ts
 h
ad
 m
ad
e 
lo
n
g
-t
er
m
 p
la
n
s 
fo
r 
th
ei
r 
ch
ild
re
n’
s 
fu
tu
re
 s
o
ci
al
 c
ar
e.
 
D
is
cl
o
su
re
 w
as
 n
o
t 
as
so
ci
at
ed
 w
it
h
 g
en
d
er
, 
m
ar
it
al
 s
ta
tu
s 
o
r 
co
nt
in
en
t 
o
f 
o
ri
g
in
, 
o
r 
w
it
h 
th
e 
ch
ild
’s
 o
w
n
 in
fe
ct
io
n
 s
ta
tu
s.
 F
ew
 (1
5%
) 
in
fe
ct
ed
 p
ar
en
ts
 w
an
te
d
 s
u
p
p
o
rt
 f
ro
m
 a
 
p
ro
fe
ss
io
na
l t
o
 h
el
p
 w
it
h
 d
is
cl
o
su
re
 t
o
 c
h
ild
re
n
[5
6]
N
ö
st
lin
g
er
 
et
 a
l. 
(2
0
0
4
)
C
ro
ss
-
se
ct
io
na
l;
qu
an
ti
ta
ti
ve
16
8 
pa
re
nt
s 
an
d 
27
9 
ch
ild
re
n 
(≤
17
 y
ea
rs
)
B
el
gi
um
: c
ar
eg
iv
er
s 
liv
in
g 
w
it
h 
H
IV
 a
nd
 t
h
ei
r 
H
IV
-
in
fe
ct
ed
 a
nd
 H
IV
-u
ni
nf
ec
te
d 
ch
ild
re
n,
 a
nd
 p
eo
p
le
 li
vi
ng
 
w
it
h 
H
IV
 w
it
h
o
u
t 
ch
ild
re
n 
re
cr
ui
te
d 
fr
o
m
 t
hr
ee
 F
le
m
is
h 
A
ID
S 
re
fe
re
n
ce
 c
en
te
rs
Th
e 
m
aj
o
ri
ty
 o
f 
ch
ild
re
n
 w
er
e 
p
re
-a
d
o
le
sc
en
ts
 a
n
d
 a
d
o
le
sc
en
ts
 (
m
ed
ia
n
 a
g
e 
11
 y
ea
rs
).
 
Th
e 
m
aj
o
ri
ty
 o
f 
p
ar
ti
ci
p
an
ts
 w
er
e 
p
re
d
o
m
in
an
tl
y 
o
f 
B
el
g
ia
n
 o
ri
g
in
. 
D
is
cl
o
su
re
 r
at
e 
w
as
 
10
%
. 
M
o
re
 w
o
m
en
 (
5
8
%
) 
w
er
e 
ca
re
g
iv
er
s.
 M
o
st
 p
ar
ti
ci
p
an
ts
 (
8
2%
) 
to
o
k 
A
R
T 
at
 t
h
e 
ti
m
e 
o
f 
d
at
a 
as
se
ss
m
en
t.
 T
h
er
e 
w
er
e 
n
o
 d
if
fe
re
n
ce
s 
in
 m
ed
ic
al
 p
ar
am
et
er
s 
su
ch
 a
s 
C
D
4
, 
vi
ra
l 
lo
ad
 a
n
d
 m
ed
ia
n
 t
im
e 
si
n
ce
 H
IV
 d
ia
g
n
o
si
s 
b
et
w
ee
n
 c
ar
eg
iv
er
s 
liv
in
g
 w
it
h
 H
IV
 a
n
d
 p
eo
p
le
 
liv
in
g
 w
it
h
 H
IV
 w
it
h
o
u
t 
ch
ild
re
n.
 D
is
cl
o
su
re
 in
fo
rm
at
io
n
 is
 o
n
ly
 r
ep
o
rt
ed
 o
n
 c
ar
eg
iv
er
s 
liv
in
g
 w
it
h
 H
IV
[3
7]
A
RT
: A
nt
ir
et
ro
vi
ra
l t
he
ra
py
. 
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Ta
b
le
 1
. S
tu
d
ie
s 
re
la
ti
n
g
 t
o
 a
d
o
le
sc
en
ts
 in
 t
h
e 
U
SA
, C
an
ad
a 
an
d
 E
u
ro
p
e 
(c
o
n
t.
).
A
u
th
o
r 
(y
ea
r)
St
u
d
y 
d
es
ig
n
 
Sa
m
p
le
Lo
ca
ti
o
n
 a
n
d
 p
ar
ti
ci
p
an
t 
re
cr
u
it
m
en
t
Fi
n
d
in
g
s
R
ef
.
N
ö
st
lin
g
er
 
et
 a
l. 
(2
0
0
6
)
C
ro
ss
-
se
ct
io
na
l;
qu
an
ti
ta
ti
ve
71
8 
pa
re
nt
s 
an
d 
11
3
6 
ch
ild
re
n 
(≤
18
 y
ea
rs
)
Te
n 
w
es
te
rn
 E
ur
o
p
ea
n 
co
un
tr
ie
s:
 d
at
a 
w
er
e 
co
lle
ct
ed
 f
ro
m
 p
ar
ti
ci
pa
nt
s 
of
 
EU
RO
SU
PP
O
RT
 IV
, a
 n
et
w
or
k 
of
 1
5 
H
IV
-t
re
at
m
en
t 
ce
nt
er
s 
an
d 
re
se
ar
ch
 o
rg
an
iz
at
io
ns
 
lo
ca
te
d 
in
 t
en
 w
es
te
rn
 
Eu
ro
p
ea
n 
co
un
tr
ie
s
C
ar
eg
iv
er
s 
w
er
e 
H
IV
-i
n
fe
ct
ed
 a
n
d
 t
h
e 
m
aj
o
ri
ty
 o
f 
ch
ild
re
n
 (
8
3.
5%
) 
w
er
e 
H
IV
-u
n
in
fe
ct
ed
, 
o
n
ly
 (
8
.5
%
) 
w
er
e 
H
IV
-i
n
fe
ct
ed
 a
n
d
 8
%
 h
ad
 a
n
 u
n
kn
o
w
n
 H
IV
-s
ta
tu
s.
 A
 t
o
ta
l o
f 
55
%
 o
f 
H
IV
-i
n
fe
ct
ed
 c
h
ild
re
n
 w
er
e 
aw
ar
e 
o
f 
th
ei
r 
o
w
n
 s
ta
tu
s,
 w
h
ile
 2
1%
 w
er
e 
aw
ar
e 
o
f 
m
at
er
n
al
 
H
IV
 s
ta
tu
s.
 A
 t
o
ta
l o
f 
74
%
 o
f 
ca
re
g
iv
er
s 
w
er
e 
o
n
 A
R
T.
 V
ar
io
u
s 
re
ac
ti
o
n
s 
to
 d
is
cl
o
su
re
 w
er
e 
re
p
o
rt
ed
 b
y 
p
ar
en
ts
: 
a 
to
ta
l o
f 
6
4
%
 r
ep
o
rt
ed
 t
h
ey
 f
el
t 
th
e 
ch
ild
 w
as
 c
o
p
in
g
 b
et
te
r,
 1
0
%
 
fe
lt
 t
h
e 
ch
ild
 w
as
 c
o
p
in
g
 w
o
rs
e 
an
d
 t
h
e 
re
m
ai
n
in
g
 2
6
%
 n
o
ti
ce
d
 n
o
 c
h
an
g
e 
in
 c
h
ild
re
n 
fo
llo
w
in
g
 d
is
cl
o
su
re
 w
h
en
 a
ss
es
se
d
 u
si
n
g
 a
n
 a
d
ap
te
d
 v
er
si
o
n
 o
f 
th
e 
ch
ild
 b
eh
av
io
r 
ch
ec
kl
is
t 
an
d
 in
d
ir
ec
tl
y 
th
ro
u
g
h
 p
ar
en
ts
’ 
re
p
o
rt
s
[5
5]
N
ie
bu
hr
 e
t 
al
. 
(1
9
9
4
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
5
4 
pa
re
nt
s 
an
d 
th
ei
r 
ch
ild
re
n
/a
du
lt 
ch
ild
re
n 
(4
–4
8 
ye
ar
s)
U
SA
: H
IV
-i
nf
ec
te
d 
pa
re
nt
s 
w
er
e 
re
cr
ui
te
d 
fr
om
 a
n 
H
IV
 
cl
in
ic
C
h
ild
re
n
 w
er
e 
n
o
t 
as
se
ss
ed
, 
b
u
t 
p
ar
ti
ci
p
an
ts
 r
ep
o
rt
ed
 fi
ve
 o
f 
th
ei
r 
ch
ild
re
n
 (
al
l <
5
 y
ea
rs
 o
f 
ag
e)
 t
o
 a
ls
o
 b
e 
in
fe
ct
ed
. 
Fr
o
m
 2
42
 p
ar
en
ts
 w
it
h
 1
3
8
 c
h
ild
re
n,
 a
 s
u
b
se
t 
o
f 
5
4
 p
ar
en
ts
 w
it
h 
ch
ild
re
n
 >
4
 y
ea
rs
 o
f 
ag
e 
w
er
e 
an
al
yz
ed
 f
o
r 
th
is
 s
tu
d
y.
 A
 t
o
ta
l o
f 
55
.7
%
 o
f 
ch
ild
re
n
 w
er
e 
d
is
cl
o
se
d
 t
o.
 W
h
en
 s
p
ec
ifi
ca
lly
 a
sk
ed
, 
al
m
o
st
 h
al
f 
o
f 
th
e 
p
ar
en
ts
 (
4
8
%
) 
re
p
o
rt
ed
 t
h
at
 t
h
ey
 
d
id
 n
o
t 
n
ee
d
 h
el
p
 in
 d
ea
lin
g
 w
it
h
 c
h
ild
re
n
 w
it
h
 H
IV
-r
el
at
ed
 is
su
es
. 
A
 t
o
ta
l o
f 
53
.5
%
 o
f 
p
ar
en
ts
 r
ep
o
rt
ed
 t
h
at
 t
h
ei
r 
ch
ild
re
n
 w
o
u
ld
 b
e 
d
is
cr
im
in
at
ed
 a
g
ai
n
st
 b
ec
au
se
 o
f 
p
ar
en
ts
’ 
H
IV
 d
ia
g
n
o
si
s.
 A
 t
o
ta
l o
f 
47
%
 o
f 
p
ar
en
ts
 w
er
e 
w
o
rr
ie
d
 a
b
o
u
t 
w
h
o
 w
o
u
ld
 t
ak
e 
ca
re
 o
f 
th
ei
r 
ch
ild
re
n
 if
 t
h
ey
 d
ie
d
[1
28
]
Fo
rs
yt
h 
et
 a
l. 
(1
9
9
6
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
26
 m
ot
he
rs
 a
nd
 
26
 c
hi
ld
re
n 
(6
–1
6 
ye
ar
s)
U
SA
: H
IV
-u
ni
nf
ec
te
d 
ch
ild
re
n 
fr
om
 H
IV
-a
ff
ec
te
d 
fa
m
ili
es
 
an
d 
un
af
fe
ct
ed
 f
am
ili
es
 
(c
on
tr
o
ls
) w
er
e 
re
cr
ui
te
d 
fr
om
 a
n 
H
IV
 c
lin
ic
 a
nd
 a
 
pr
im
ar
y 
he
al
th
ca
re
 c
lin
ic
B
o
th
 m
o
th
er
s 
an
d
 c
h
ild
re
n
 w
er
e 
as
se
ss
ed
. 
Th
e 
st
u
d
y 
in
ve
st
ig
at
ed
 m
en
ta
l h
ea
lt
h
 p
ro
b
le
m
s 
o
f 
ch
ild
re
n
 o
f 
H
IV
-i
n
fe
ct
ed
 m
o
th
er
s.
 T
h
e 
su
b
je
ct
s 
w
er
e 
in
te
rv
ie
w
ed
 in
 t
h
ei
r 
h
o
m
e,
 w
h
ile
 
th
e 
co
nt
ro
ls
 w
er
e 
in
te
rv
ie
w
ed
 in
 t
h
e 
cl
in
ic
. 
Th
er
e 
w
as
 a
n
 a
g
re
em
en
t 
b
et
w
ee
n
 m
o
th
er
s’
 
an
d
 c
h
ild
re
n
 r
ep
o
rt
s;
 c
h
ild
re
n
 o
f 
in
fe
ct
ed
 m
o
th
er
s 
re
p
o
rt
ed
 t
h
em
se
lv
es
 t
o
 b
e 
m
o
re
 
d
ep
re
ss
ed
 a
n
d
 t
h
ei
r 
m
o
th
er
s 
re
p
o
rt
ed
 c
h
ild
re
n
 t
o
 b
e 
m
o
re
 w
it
h
d
ra
w
n
 t
h
an
 c
h
ild
re
n
 o
f 
u
n
in
fe
ct
ed
 m
o
th
er
s
[1
29
]
W
ie
n
er
 e
t 
al
. 
(1
9
9
8
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
17
 p
ar
en
ts
 a
nd
 
17
 c
hi
ld
re
n 
(5
–1
8 
ye
ar
s)
U
SA
: H
IV
-i
nf
ec
te
d 
ch
ild
re
n 
at
te
nd
in
g 
th
e 
p
ed
ia
tr
ic
 
br
an
ch
 o
f 
th
e 
N
at
io
na
l 
C
an
ce
r 
In
st
itu
te
, B
et
he
sd
a,
 
an
d 
th
ei
r 
pa
re
nt
s 
w
er
e 
re
cr
ui
te
d
Se
ve
n
 o
f 
17
 p
ar
en
ts
 d
is
cl
o
se
d
 t
h
ei
r 
o
w
n
 s
ta
tu
s 
an
d
 c
h
ild
re
n’
s 
st
at
u
s 
to
 c
h
ild
re
n
. 
M
at
er
n
al
 
d
is
cl
o
su
re
 o
ft
en
 le
d
 t
o
 d
is
cl
o
su
re
 o
f 
ch
ild
’s
 o
w
n
 d
ia
g
n
o
si
s.
 R
ea
so
n
s 
fo
r 
d
is
cl
o
su
re
 
in
cl
u
d
ed
: 
n
o
t 
w
an
ti
n
g
 c
h
ild
re
n
 t
o
 h
ea
r 
fr
o
m
 o
th
er
 p
eo
p
le
, 
p
re
p
ar
in
g
 c
h
ild
re
n
 f
o
r 
m
at
er
n
al
 
d
ea
th
 a
n
d
 a
d
d
re
ss
in
g
 c
h
ild
re
n’
s 
q
u
es
ti
o
n
s 
ab
o
u
t 
H
IV
. 
R
ea
so
n
s 
fo
r 
n
o
n
d
is
cl
o
su
re
 in
cl
u
d
ed
: 
co
n
ce
rn
s 
th
at
 c
h
ild
re
n
 w
o
u
ld
 b
e 
n
eg
at
iv
el
y 
af
fe
ct
ed
 p
sy
ch
o
lo
g
ic
al
ly
 a
n
d
 w
er
e 
n
o
t 
d
ev
el
o
p
m
en
ta
lly
 r
ea
d
y 
to
 u
n
d
er
st
an
d
 a
b
o
u
t 
H
IV
[5
3]
To
m
pk
in
s 
et
 a
l. 
(1
9
9
9
)
Lo
ng
itu
di
na
l;
qu
al
it
at
iv
e
91
 m
ot
he
rs
 
(c
hi
ld
re
n 
ag
ed
 
<1
8 
ye
ar
s)
U
SA
: H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
w
er
e 
re
cr
ui
te
d 
fr
om
 a
 
lo
ng
itu
di
na
l s
tu
d
y 
on
 f
am
ily
 
st
ru
ct
ur
e 
an
d 
pa
re
nt
in
g 
ch
al
le
ng
es
C
h
ild
re
n
 w
er
e 
n
o
t 
as
se
ss
ed
. 
A
 t
o
ta
l o
f 
9
%
 o
f 
th
e 
ch
ild
re
n
 w
er
e 
al
so
 H
IV
-i
n
fe
ct
ed
 a
n
d 
75
%
 o
f 
m
o
th
er
s 
h
ad
 d
is
cl
o
se
d
 t
o
 t
h
ei
r 
so
ci
al
 n
et
w
o
rk
s.
 A
p
p
ro
xi
m
at
el
y 
h
al
f 
o
f 
th
e 
H
IV
-i
n
fe
ct
ed
 c
h
ild
re
n
 k
n
ew
 t
h
ei
r 
an
d
 t
h
ei
r 
m
o
th
er
s’
 s
ta
tu
s.
 M
o
st
 m
o
th
er
s 
h
ad
 d
is
cl
o
se
d
 t
o 
th
ei
r 
ch
ild
re
n,
 b
u
t 
th
er
e 
w
er
e 
a 
fe
w
 in
ad
ve
rt
en
t 
d
is
cl
o
su
re
s,
 in
 s
o
m
e 
ca
se
s 
o
th
er
 p
eo
p
le
 
h
ad
 d
is
cl
o
se
d
 w
it
h
o
u
t 
th
e 
m
o
th
er
’s
 p
er
m
is
si
o
n
. 
A
 t
h
ir
d
 o
f 
ch
ild
re
n
 r
ea
ct
ed
 t
o
 d
is
cl
o
su
re
 
b
y 
sh
o
w
in
g
 c
o
n
ce
rn
, 
10
%
 w
er
e 
ac
ce
p
ti
n
g
 a
n
d
 m
o
re
 t
h
an
 1
0
%
 d
is
ta
n
ce
d
 t
h
em
se
lv
es
 a
n
d 
re
fu
se
d
 t
o
 t
al
k 
ab
o
u
t 
th
e 
d
is
cl
o
su
re
. 
Se
ve
ra
l h
ad
 b
eh
av
io
ra
l p
ro
b
le
m
s,
 a
n
d
 w
er
e 
w
o
rr
ie
d 
an
d
 s
ad
. 
M
o
re
 t
h
an
 h
al
f 
o
f 
th
e 
ch
ild
re
n
 d
id
 n
o
t 
as
k 
an
y 
q
u
es
ti
o
n
s 
d
u
ri
n
g
 d
is
cl
o
su
re
. 
Th
o
se
 
w
h
o
 a
sk
ed
 q
u
es
ti
o
n
s 
co
m
m
o
n
ly
 a
sk
ed
 a
b
o
u
t 
m
o
d
es
 o
f 
tr
an
sm
is
si
o
n
 a
n
d
 a
b
o
u
t 
th
e 
m
o
th
er
s’
 h
ea
lt
h,
 s
u
ch
 a
s 
if
 s
h
e 
w
as
 t
ak
in
g
 h
er
 m
ed
ic
at
io
n
 a
n
d
 k
ee
p
in
g
 d
o
ct
o
r’
s 
ap
p
o
in
tm
en
ts
. 
M
o
st
 m
o
th
er
s 
re
p
o
rt
ed
 a
n
 in
cr
ea
se
 in
 c
lo
se
n
es
s 
w
it
h
 c
h
ild
re
n
 a
ft
er
 
d
is
cl
o
su
re
[2
1]
A
RT
: A
nt
ir
et
ro
vi
ra
l t
he
ra
py
. 
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Ta
b
le
 1
. S
tu
d
ie
s 
re
la
ti
n
g
 t
o
 a
d
o
le
sc
en
ts
 in
 t
h
e 
U
SA
, C
an
ad
a 
an
d
 E
u
ro
p
e 
(c
o
n
t.
).
A
u
th
o
r 
(y
ea
r)
St
u
d
y 
d
es
ig
n
 
Sa
m
p
le
Lo
ca
ti
o
n
 a
n
d
 p
ar
ti
ci
p
an
t 
re
cr
u
it
m
en
t
Fi
n
d
in
g
s
R
ef
.
In
gr
am
 a
nd
 
H
ut
ch
in
so
n 
(2
0
0
0
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
20
 m
ot
he
rs
(c
hi
ld
re
n’
s 
ag
es
 
no
t 
sp
ec
ifi
ed
)
U
SA
: H
IV
-i
nf
ec
te
d 
w
om
en
 
re
cr
ui
te
d 
fr
om
 H
IV
 
or
ga
ni
za
ti
on
s 
an
d 
H
IV
 c
lin
ic
s
O
nl
y 
m
ot
he
rs
 w
er
e 
in
te
rv
ie
w
ed
. T
he
 s
tu
d
y 
d
es
cr
ib
ed
 t
he
 r
ep
ro
du
ct
iv
e 
an
d 
m
ot
he
rin
g 
ex
p
er
ie
nc
es
 o
f 
H
IV
-p
o
si
ti
ve
 m
ot
he
rs
. M
an
y 
m
ot
he
rs
 p
er
ce
iv
ed
 h
ea
lt
hc
ar
e 
w
or
ke
rs
 t
o 
ha
ve
 
n
eg
at
iv
e 
at
ti
tu
d
es
 t
ow
ar
ds
 H
IV
-i
nf
ec
te
d 
m
ot
he
rs
’ r
ep
ro
du
ct
io
n
; t
he
y 
re
p
or
te
d 
re
ce
iv
in
g 
lit
tl
e 
su
p
p
or
t 
re
ga
rd
in
g 
th
ei
r 
re
pr
o
du
ct
iv
e 
ch
o
ic
es
. S
ti
gm
a 
w
as
 o
n
e 
of
 t
he
 m
aj
or
 t
he
m
es
 f
or
 
m
ot
he
rs
; t
he
y 
di
d 
no
t 
w
an
t 
to
 b
e 
se
en
 in
 H
IV
 c
lin
ic
s.
 M
o
st
 m
ot
he
rs
 r
ep
or
te
d 
th
at
 m
ot
he
rin
g 
is
 h
ar
d 
w
or
k 
ev
en
 f
or
 H
IV
-u
ni
nf
ec
te
d 
ch
ild
re
n.
 S
om
e 
m
ot
he
rs
 c
ar
ed
 f
or
 H
IV
-n
eg
at
iv
e 
ch
ild
re
n 
w
ho
 h
ad
 o
th
er
 m
ed
ic
al
 c
on
di
ti
on
s 
in
cl
ud
in
g 
ep
ile
pt
ic
 s
ei
zu
re
s,
 s
ev
er
e 
as
th
m
a 
an
d 
m
en
ta
l i
lln
es
s.
 M
o
st
 m
ot
he
rs
 r
ep
or
te
d 
th
e 
un
co
nd
it
io
na
l l
ov
e 
th
ey
 r
ec
ei
ve
d 
fr
om
 a
nd
 g
av
e 
to
 t
he
ir 
ch
ild
re
n.
 O
n
e 
of
 t
he
 r
ec
ur
rin
g 
th
em
es
 w
as
 t
he
 s
tr
ug
gl
e 
ab
ou
t 
w
he
th
er
 t
o 
di
sc
lo
se
 t
o 
th
e 
ch
ild
re
n 
ab
ou
t 
th
ei
r 
H
IV
 s
ta
tu
s.
 H
ow
ev
er
, s
om
e 
m
ot
he
rs
 r
ep
or
te
d 
fe
el
in
g 
gu
ilt
y 
ab
ou
t 
br
in
gi
ng
 H
IV
 in
to
 t
he
ir 
ch
ild
re
n’
s 
liv
es
. A
p
pr
ox
im
at
el
y 
ha
lf 
of
 t
he
 m
ot
he
rs
 d
is
cl
o
se
d 
th
ei
r 
st
at
us
. C
hi
ld
re
n 
th
at
 w
er
e 
di
sc
lo
se
d 
to
 w
er
e 
of
te
n 
pr
ot
ec
ti
ve
 o
f 
th
ei
r 
m
ot
he
rs
’ p
hy
si
ca
l a
nd
 
em
ot
io
na
l h
ea
lt
h,
 m
on
ito
rin
g 
th
ei
r 
m
ot
he
rs
’ H
IV
 m
ed
ic
at
io
n,
 d
ef
en
di
ng
 t
he
m
 a
ga
in
st
 
H
IV
-r
el
at
ed
 s
ti
gm
a 
an
d 
ta
ki
ng
 o
n 
m
or
e 
re
sp
on
si
bi
lit
ie
s 
at
 h
om
e.
 M
ot
he
rs
 w
ho
 d
is
cl
o
se
d 
w
an
te
d 
to
 o
p
en
 c
om
m
un
ic
at
io
n 
re
ga
rd
in
g 
fu
tu
re
 c
us
to
d
y 
of
 c
hi
ld
re
n.
 T
ho
se
 w
ho
 d
id
 n
ot
 
di
sc
lo
se
 c
ite
d 
th
at
 t
he
y 
w
er
e 
w
or
ri
ed
 t
ha
t 
ch
ild
re
n 
w
er
e 
to
o 
yo
un
g 
an
d 
w
er
e 
co
nc
er
n
ed
 
ab
ou
t 
th
e 
n
eg
at
iv
e 
em
ot
io
na
l i
m
pa
ct
 o
f 
di
sc
lo
su
re
[6
6]
W
in
st
ea
d 
an
d 
D
er
le
ga
(2
0
02
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
25
 m
ot
he
rs
(c
hi
ld
re
n
/a
du
lt 
ch
ild
re
n 
ag
ed
 
1–
31
 y
ea
rs
)
U
SA
: H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
w
er
e 
re
cr
ui
te
d 
fr
om
 H
IV
 
se
rv
ic
e 
or
ga
ni
za
ti
on
s 
w
it
h 
H
IV
-i
nf
ec
te
d 
an
d 
un
in
fe
ct
ed
 
ch
ild
re
n
C
hi
ld
re
n 
w
er
e 
no
t 
as
se
ss
ed
. T
he
 s
tu
d
y 
in
ve
st
ig
at
ed
 t
he
 im
pa
ct
 o
f 
H
IV
 d
is
ea
se
 o
n 
th
e 
in
te
rp
er
so
na
l r
el
at
io
ns
hi
ps
 a
nd
 s
o
ci
al
 s
up
p
or
t 
ex
p
er
ie
nc
es
 o
f 
m
ot
he
rs
 li
vi
ng
 w
it
h 
H
IV
. M
o
st
 
m
ot
he
rs
 s
tr
ug
gl
ed
 w
it
h 
w
ho
m
 t
o 
di
sc
lo
se
 t
o 
am
on
g 
th
ei
r 
so
ci
al
 n
et
w
or
ks
, b
ec
au
se
 o
f 
th
e 
fe
ar
 o
f 
st
ig
m
a.
 R
ea
so
ns
 c
ite
d 
fo
r 
di
sc
lo
su
re
 t
o 
ot
he
rs
 in
cl
ud
ed
 t
he
 n
ee
d 
fo
r 
so
ci
al
 s
up
p
or
t,
 
w
an
tin
g 
to
 e
du
ca
te
 o
th
er
s,
 d
o
in
g 
th
e 
ri
gh
t 
th
in
g 
an
d 
re
lie
vi
ng
 t
he
m
se
lv
es
 f
ro
m
 t
he
 b
ur
d
en
 
of
 k
ee
pi
ng
 t
he
 s
ec
re
t.
 F
ea
r 
of
 s
ti
gm
a 
w
as
 t
he
 m
o
st
 c
ite
d 
re
as
on
 f
or
 n
on
di
sc
lo
su
re
. M
o
st
 
w
om
en
 h
ad
 d
is
cl
o
se
d 
th
ei
r 
ch
ild
re
n’
s 
H
IV
 d
ia
gn
o
si
s 
to
 t
he
 c
hi
ld
re
n.
 M
o
st
 u
ni
nf
ec
te
d 
ch
ild
re
n 
th
at
 w
er
e 
di
sc
lo
se
d 
to
 w
er
e 
re
p
or
te
d 
to
 b
e 
ac
ce
pt
in
g,
 lo
vi
ng
 a
nd
 p
ro
te
ct
iv
e 
af
te
r 
di
sc
lo
su
re
. 
M
o
st
 c
hi
ld
re
n 
re
m
in
d
ed
 m
ot
he
rs
 t
o 
ta
ke
 t
he
ir 
m
ed
ic
at
io
n.
 S
om
e 
ch
ild
re
n 
as
ke
d 
fo
r 
m
or
e 
in
fo
rm
at
io
n 
ab
ou
t 
H
IV
/A
ID
S.
 F
ew
 c
hi
ld
re
n 
w
er
e 
p
er
ce
iv
ed
 t
o 
b
e 
an
gr
y 
af
te
r 
di
sc
lo
su
re
. T
he
 
m
aj
or
it
y 
of
 m
ot
he
rs
 h
ad
 m
ad
e 
cu
st
o
d
y 
pl
an
s 
fo
r 
th
ei
r 
ch
ild
re
n.
 M
o
st
 m
ot
he
rs
 o
f 
pr
e-
ad
o
le
sc
en
ts
 a
nd
 a
d
o
le
sc
en
ts
 h
ad
 e
xp
lic
it
ly
 t
al
ke
d 
ab
ou
t 
sa
fe
 s
ex
 w
it
h 
th
ei
r 
ch
ild
re
n
[1
30
]
Sc
hr
im
sh
aw
 
an
d 
Si
eg
el
 
(2
0
02
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
45
 m
ot
he
rs
 
(c
hi
ld
re
n 
ag
ed
 
≤2
5 
ye
ar
s)
U
SA
: S
ub
sa
m
pl
e 
of
 
H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 w
er
e 
re
cr
ui
te
d 
fr
om
 a
 la
rg
er
 
sa
m
pl
e 
of
 w
om
en
 w
ho
 
pa
rt
ic
ip
at
ed
 in
 a
 s
tu
d
y 
of
 
ps
yc
ho
so
ci
al
 a
da
pt
at
io
n 
to
 
liv
in
g 
w
it
h 
H
IV
/A
ID
S
C
hi
ld
re
n 
w
er
e 
no
t 
as
se
ss
ed
. D
is
cl
o
su
re
 r
at
es
 w
er
e 
6
6%
. M
ai
n 
re
as
on
s 
fo
r 
w
an
tin
g 
to
 
di
sc
lo
se
 t
o 
ch
ild
re
n 
in
cl
ud
ed
: e
du
ca
tin
g 
ch
ild
re
n 
ab
ou
t 
H
IV
, w
an
tin
g 
to
 b
e 
ho
n
es
t 
w
it
h 
ch
ild
re
n,
 w
an
tin
g 
to
 b
e 
th
e 
on
es
 d
is
cl
o
si
ng
 t
o 
ch
ild
re
n 
an
d 
w
an
tin
g 
to
 d
is
cl
o
se
 b
ef
or
e 
m
ot
he
rs
 b
ec
am
e 
ill
 w
it
h 
H
IV
[4
9]
A
RT
: A
nt
ir
et
ro
vi
ra
l t
he
ra
py
. 
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Ta
b
le
 1
. S
tu
d
ie
s 
re
la
ti
n
g
 t
o
 a
d
o
le
sc
en
ts
 in
 t
h
e 
U
SA
, C
an
ad
a 
an
d
 E
u
ro
p
e 
(c
o
n
t.
).
A
u
th
o
r 
(y
ea
r)
St
u
d
y 
d
es
ig
n
 
Sa
m
p
le
Lo
ca
ti
o
n
 a
n
d
 p
ar
ti
ci
p
an
t 
re
cr
u
it
m
en
t
Fi
n
d
in
g
s
R
ef
.
Bl
ac
k 
an
d 
M
ile
s 
(2
0
02
)
Lo
ng
itu
di
na
l;
qu
al
it
at
iv
e
4
8 
m
ot
he
rs
(c
hi
ld
re
n’
s 
ag
es
 
no
t 
sp
ec
ifi
ed
)
U
SA
: H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
w
er
e 
re
cr
ui
te
d 
fr
om
 
in
fe
ct
io
us
 d
is
ea
se
 c
lin
ic
s.
 
D
at
a 
fr
om
 a
 la
rg
er
 
ra
nd
om
iz
ed
 c
lin
ic
al
 
in
te
rv
en
ti
on
 s
tu
d
y 
w
it
h 
H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
w
er
e 
us
ed
O
nl
y 
m
ot
he
rs
 w
er
e 
as
se
ss
ed
. F
ea
r 
of
 b
ei
ng
 s
tig
m
at
iz
ed
 o
nc
e 
th
ei
r 
st
at
us
 w
as
 k
no
w
n 
to
 o
th
er
s 
w
as
 a
 m
aj
or
 t
he
m
e;
 m
ot
he
rs
 t
he
re
fo
re
 w
ei
gh
ed
 r
is
ks
 a
nd
 b
en
efi
ts
 o
f 
di
sc
lo
su
re
 t
o 
ot
he
rs
. 
Th
re
e 
ge
ne
ra
l p
at
te
rn
s 
of
 d
is
cl
os
ur
e 
am
on
g 
w
om
en
 w
er
e 
ob
se
rv
ed
; s
ec
re
tiv
e 
(k
ee
pi
ng
 a
 s
ec
re
t 
to
 a
ll 
bu
t 
fe
w
 t
ru
st
ed
 in
di
vi
du
al
s)
, f
ul
l (
di
sc
lo
se
d 
to
 a
ll 
re
le
va
nt
 a
du
lt 
re
la
tio
ns
hi
ps
) a
nd
 s
el
ec
tiv
e 
di
sc
lo
se
rs
 (d
is
cl
os
ur
e 
to
 s
el
ec
tiv
e 
in
di
vi
du
al
s 
in
 t
he
 f
am
ily
 b
ut
 n
ot
 o
ut
si
de
). 
W
ei
gh
in
g 
ris
ks
 a
nd
 
be
ne
fit
s 
w
as
 a
n 
on
go
in
g 
pr
oc
es
s 
bu
t 
w
as
 d
is
ru
pt
ed
 a
t 
tim
es
 w
he
n 
fa
m
ily
 m
em
be
rs
 o
r 
he
al
th
ca
re
 p
ro
fe
ss
io
na
l b
et
ra
ye
d 
m
ot
he
rs
’ c
on
fid
en
ce
. M
os
t 
ch
ild
re
n 
w
er
e 
no
t 
di
sc
lo
se
d 
to
 
be
ca
us
e 
m
ot
he
rs
 f
el
t 
th
ey
 w
er
e 
to
o 
yo
un
g 
an
d 
m
ig
ht
 d
is
cl
os
e 
to
 o
th
er
s.
 M
an
y 
w
om
en
 
pl
an
ne
d 
to
 d
is
cl
os
e 
to
 c
hi
ld
re
n 
w
he
n 
th
ey
 w
er
e 
ol
de
r 
bu
t 
no
 s
pe
ci
fic
 a
ge
 w
as
 m
en
tio
ne
d
[1
31
]
Br
ac
ki
s-
C
ot
t 
et
 a
l. 
(2
0
03
)
Lo
ng
itu
di
na
l;
qu
al
it
at
iv
e
3
0 
m
ot
he
rs
 a
nd
28
 a
d
o
le
sc
en
ts
(1
0
–1
5 
ye
ar
s)
 
U
SA
: H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
an
d 
th
ei
r 
un
in
fe
ct
ed
 c
hi
ld
re
n 
w
er
e 
re
cr
ui
te
d 
fr
om
 H
IV
 
cl
in
ic
s 
an
d 
co
m
m
un
it
y-
ba
se
d 
or
ga
ni
za
ti
on
s.
 T
he
 
pa
rt
ic
ip
an
ts
 w
er
e 
pa
rt
 o
f 
a 
la
rg
er
 s
tu
d
y 
in
ve
st
ig
at
in
g 
se
xu
al
 b
eh
av
io
rs
 a
nd
 d
ru
g 
b
eh
av
io
rs
 o
f 
H
IV
-a
ff
ec
te
d 
ad
o
le
sc
en
ts
Th
e 
fo
cu
s 
gr
ou
ps
 e
xp
lo
re
d 
co
nc
er
ns
 a
nd
 p
ri
or
it
ie
s 
of
 H
IV
-a
ff
ec
te
d 
fa
m
ili
es
. T
he
 m
ai
n 
co
nc
er
ns
 f
or
 a
d
o
le
sc
en
ts
 w
er
e 
se
xu
al
 b
eh
av
io
rs
, s
af
et
y,
 v
io
le
nc
e 
an
d 
dr
ug
s.
 A
d
o
le
sc
en
ts
 
re
p
or
te
d 
th
ey
 w
er
e 
al
so
 c
on
ce
rn
ed
 a
b
ou
t 
p
o
si
ti
ve
 li
fe
 c
ho
ic
es
 s
uc
h 
as
 g
et
tin
g 
g
o
o
d 
gr
ad
es
. 
So
m
e 
ad
o
le
sc
en
ts
 r
ep
or
te
d 
th
at
 t
he
ir 
m
ot
he
rs
’ H
IV
 h
ad
 b
ro
ug
ht
 t
he
m
 c
lo
se
r 
w
it
h 
th
em
. 
So
m
e 
ad
o
le
sc
en
ts
 a
dm
it
te
d 
th
at
 a
t 
tim
es
 t
he
y 
w
er
e 
sc
ar
ed
, s
ad
, a
ng
ry
 a
nd
 c
on
ce
rn
ed
 a
b
ou
t 
th
ei
r 
m
ot
he
rs
’ h
ea
lt
h 
an
d 
ho
p
ed
 f
or
 a
 c
ur
e 
fo
r 
H
IV
. M
ot
he
rs
 r
ep
or
te
d 
th
e 
sa
m
e 
m
ai
n 
co
nc
er
ns
 f
or
 a
d
o
le
sc
en
ts
 s
uc
h 
as
 s
ex
ua
l b
eh
av
io
rs
, s
af
et
y,
 v
io
le
nc
e 
an
d 
dr
ug
s.
 M
ot
he
rs
 w
er
e 
w
or
ri
ed
 a
b
ou
t 
br
in
gi
ng
 u
p 
ch
ild
re
n 
of
 t
hi
s 
ag
e 
gr
ou
p.
 H
IV
-r
el
at
ed
 s
ti
gm
a,
 d
is
cl
o
su
re
, 
b
ec
om
in
g 
ill
 a
nd
 h
av
in
g 
ad
o
le
sc
en
ts
 t
ak
in
g 
ad
ul
t 
ro
le
s 
w
er
e 
ot
he
r 
co
nc
er
ns
 e
xp
re
ss
ed
 b
y 
m
ot
he
rs
[7
3]
V
al
le
ra
nd
 
et
 a
l. 
(2
0
05
)
Lo
ng
itu
di
na
l;
qu
al
it
at
iv
e
35
 m
ot
he
rs
 a
nd
 
19
 c
hi
ld
re
n 
(1
0
–1
8 
ye
ar
s)
U
SA
: H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
an
d 
H
IV
-u
ni
nf
ec
te
d 
ad
o
le
sc
en
ts
 w
er
e 
re
cr
ui
te
d 
fr
om
 a
 lo
ng
itu
di
na
l s
tu
d
y 
of
 
p
er
so
ns
 li
vi
ng
 w
it
h 
H
IV
Re
as
on
s 
fo
r 
di
sc
lo
su
re
 in
cl
ud
ed
: p
ro
te
ct
in
g 
ad
o
le
sc
en
ts
 f
ro
m
 H
IV
, f
ee
lin
g 
ad
o
le
sc
en
ts
 w
er
e 
d
ev
el
o
pm
en
ta
lly
 r
ea
d
y 
an
d 
fe
ar
 o
f 
fo
rc
ed
 d
is
cl
o
su
re
 if
 h
ea
lt
h 
st
at
us
 d
et
er
io
ra
te
d.
 R
ea
so
ns
 f
or
 
no
nd
is
cl
o
su
re
 in
cl
ud
ed
: t
he
 c
hi
ld
 w
ou
ld
 n
ot
 u
nd
er
st
an
d 
b
ec
au
se
 o
f 
th
ei
r 
d
ev
el
o
pm
en
ta
l 
st
at
us
 a
nd
 f
ea
r 
of
 s
ti
gm
a.
 M
ot
he
rs
 a
nd
 a
d
o
le
sc
en
ts
 r
ep
or
te
d 
di
ff
er
en
t 
p
er
sp
ec
ti
ve
s 
of
 t
he
 
di
sc
lo
su
re
 e
ve
nt
. M
o
st
 m
ot
he
rs
’ r
ep
or
ts
 w
er
e 
p
o
si
ti
ve
, w
hi
le
 m
o
st
 a
d
o
le
sc
en
ts
 (1
8 
ou
t 
of
 1
9
) 
re
p
or
te
d 
n
eg
at
iv
e 
p
er
sp
ec
ti
ve
s 
of
 t
he
 d
is
cl
o
su
re
 e
ve
nt
[5
2]
W
o
o
dr
in
g 
et
 a
l. 
(2
0
05
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
N
in
e 
ad
o
le
sc
en
ts
 
(1
1–
17
 y
ea
rs
)
U
SA
: H
IV
-u
ni
nf
ec
te
d 
ad
o
le
sc
en
ts
 w
ho
 w
er
e 
aw
ar
e 
of
 t
he
ir 
pa
re
nt
s’
 H
IV
 
di
ag
no
si
s 
w
er
e 
re
cr
ui
te
d 
fr
om
 a
 m
en
to
rin
g 
pr
o
gr
am
 
an
d 
su
p
p
or
t 
gr
ou
p 
fo
r 
ad
o
le
sc
en
ts
 a
ff
ec
te
d 
w
it
h 
H
IV
/A
ID
S
M
o
st
 a
d
o
le
sc
en
ts
 n
ee
d
ed
 t
he
ir 
fr
ie
nd
s’
 s
up
p
or
t 
b
ec
au
se
 o
f 
th
ei
r 
pa
re
nt
s’
 H
IV
 in
fe
ct
io
n,
 b
ut
 
fe
ar
ed
 f
ri
en
ds
 m
ig
ht
 h
av
e 
n
eg
at
iv
e 
re
ac
ti
on
s.
 T
ra
ns
it
io
n 
to
 h
ig
h 
sc
ho
o
l m
ad
e 
ad
o
le
sc
en
ts
 
re
al
iz
e 
th
e 
im
pa
ct
 p
ar
en
ts
’ d
ia
gn
o
si
s 
ha
d 
on
 t
he
m
. M
an
y 
ad
o
le
sc
en
ts
 r
ep
or
te
d 
th
ey
 s
ta
rt
ed
 
sk
ip
pi
ng
 s
ch
o
o
l a
ft
er
 d
is
cl
o
su
re
 b
ec
au
se
 t
he
y 
fe
lt 
d
em
ot
iv
at
ed
 b
y 
lif
e 
ev
en
ts
. S
om
e 
ad
o
le
sc
en
ts
 e
nd
ea
vo
re
d 
to
 a
ch
ie
ve
 g
o
o
d 
gr
ad
es
 a
t 
sc
ho
o
l s
o 
as
 n
ot
 t
o 
st
re
ss
 p
ar
en
ts
 a
nd
 
lo
w
er
 p
ar
en
ts
’ i
m
m
un
e 
sy
st
em
. M
o
st
 a
d
o
le
sc
en
ts
 a
p
pr
ec
ia
te
d 
sh
ar
in
g 
w
it
h 
ot
he
rs
 w
it
h 
si
m
ila
r 
ci
rc
um
st
an
ce
s 
in
 s
up
p
or
t 
gr
ou
ps
[1
3]
A
RT
: A
nt
ir
et
ro
vi
ra
l t
he
ra
py
. 
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Ta
b
le
 1
. S
tu
d
ie
s 
re
la
ti
n
g
 t
o
 a
d
o
le
sc
en
ts
 in
 t
h
e 
U
SA
, C
an
ad
a 
an
d
 E
u
ro
p
e 
(c
o
n
t.
).
A
u
th
o
r 
(y
ea
r)
St
u
d
y 
d
es
ig
n
 
Sa
m
p
le
Lo
ca
ti
o
n
 a
n
d
 p
ar
ti
ci
p
an
t 
re
cr
u
it
m
en
t
Fi
n
d
in
g
s
R
ef
.
K
en
n
ed
y 
et
 a
l. 
(2
01
0
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
33
 p
ar
en
ts
,
15
 c
ar
eg
iv
er
s 
an
d 
4
6 
ch
ild
re
n
/a
du
lt
s
(≥
18
 y
ea
rs
)
U
SA
: H
IV
-i
nf
ec
te
d 
pa
re
nt
s 
w
er
e 
re
cr
ui
te
d 
fr
om
 t
he
 H
IV
 
co
st
 a
nd
 s
er
vi
ce
s 
ut
ili
za
ti
on
 
st
ud
y 
[1
25
] a
b
ou
t 
th
ei
r 
m
em
or
y 
of
 d
is
cl
o
su
re
O
nl
y 
ch
ild
re
n 
w
it
h 
pr
io
r 
kn
ow
le
d
g
e 
of
 m
at
er
na
l H
IV
 s
ta
tu
s 
w
er
e 
in
cl
ud
ed
. A
ll 
pa
re
nt
s 
ha
d 
di
sc
lo
se
d 
to
 o
n
e 
or
 m
or
e 
ch
ild
re
n.
 M
o
st
 c
om
m
on
 r
ea
so
n 
fo
r 
w
ai
tin
g 
w
as
 c
hi
ld
re
n’
s 
p
er
ce
iv
ed
 la
ck
 o
f 
m
at
ur
it
y.
 F
am
ili
es
 r
ep
or
te
d 
th
at
 s
om
et
im
es
 c
hi
ld
re
n 
ga
ve
 im
m
ed
ia
te
 
em
ot
io
na
l s
up
p
or
t 
by
 d
is
pl
ay
in
g 
af
fe
ct
io
n.
 In
cr
ea
se
d 
fa
m
ili
al
 c
lo
se
n
es
s 
w
as
 r
ep
or
te
d 
ov
er
 
tim
e 
as
 a
 r
es
ul
t 
of
 d
is
cl
o
su
re
[7
2]
D
em
at
te
o 
et
 a
l. 
(2
0
02
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
51
 a
du
lt
s 
an
d 
5
4 
ad
o
le
sc
en
ts
 
(5
–1
9 
ye
ar
s)
C
an
ad
a:
 s
am
e 
co
ho
rt
 a
s 
D
em
at
te
o 
(o
n
e 
of
 t
he
 
qu
an
ti
ta
ti
ve
 s
tu
di
es
 a
b
ov
e 
[5
4]
) b
ut
 u
se
d 
qu
al
it
at
iv
e 
m
et
ho
ds
. H
IV
-i
nf
ec
te
d 
an
d 
H
IV
-u
ni
nf
ec
te
d 
ad
ul
ts
 f
ro
m
 
H
IV
-a
ff
ec
te
d 
fa
m
ili
es
 a
nd
 
H
IV
-i
nf
ec
te
d 
an
d 
H
IV
-
un
in
fe
ct
ed
 c
hi
ld
re
n 
w
er
e 
in
te
rv
ie
w
ed
 r
et
ro
sp
ec
ti
ve
ly
 
(f
ro
m
 1
9
95
 t
o 
19
9
8
),
 
re
cr
ui
te
d 
fr
om
 t
he
 p
ed
ia
tr
ic
 
H
IV
 p
ro
gr
am
 a
t 
th
e 
H
o
sp
it
al
 
fo
r 
Si
ck
 C
hi
ld
re
n 
in
 T
or
on
to
 
an
d 
A
ID
S 
se
rv
ic
e 
or
ga
ni
za
ti
on
s
M
in
im
um
 a
g
e 
fo
r 
ch
ild
re
n 
w
as
 5
 y
ea
rs
, n
o 
m
ax
im
um
 a
g
e 
w
as
 s
et
. D
is
cl
o
su
re
 in
vo
lv
ed
 t
el
lin
g 
th
e 
ch
ild
 a
b
ou
t 
th
ei
r 
ow
n,
 p
ar
en
ts
’ o
r 
fa
m
ily
 m
em
b
er
s’
 H
IV
 in
fe
ct
io
n.
 B
ec
au
se
 p
ar
ti
ci
pa
nt
s 
w
er
e 
in
te
rv
ie
w
ed
 r
et
ro
sp
ec
ti
ve
ly
, m
o
st
 c
hi
ld
re
n 
w
ho
 h
ad
 b
ee
n 
di
sc
lo
se
d 
to
 a
t 
a 
yo
un
g
er
 a
g
e 
(b
ef
or
e 
ag
e 
11
 y
ea
rs
) f
el
t 
th
e 
ri
gh
t 
ag
e 
fo
r 
di
sc
lo
su
re
 s
ho
ul
d 
b
e 
11
 y
ea
rs
. M
or
e 
gi
rls
 t
ha
n 
b
oy
s 
w
er
e 
di
sc
lo
se
d 
to
 p
ri
or
 t
o 
ag
e 
11
 y
ea
rs
. A
 t
ot
al
 o
f 
8
6%
 o
f 
ch
ild
re
n 
sa
id
 t
he
y 
w
er
e 
di
sc
lo
se
d 
to
 a
t 
th
e 
ri
gh
t 
tim
e 
or
 a
g
e 
an
d 
91
%
 s
ai
d 
th
ey
 w
er
e 
di
sc
lo
se
d 
to
 in
 a
 g
o
o
d 
w
ay
. 
Tr
us
t 
w
as
 a
 m
aj
or
 t
he
m
e 
up
on
 w
hi
ch
 d
is
cl
o
su
re
 d
ec
is
io
ns
 r
es
te
d 
fo
r 
b
ot
h 
pa
re
nt
s 
an
d 
ch
ild
re
n
[5
4]
N
ö
st
lin
g
er
 
et
 a
l. 
(2
0
0
4
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
13
 c
ar
eg
iv
er
s 
an
d 
27
 c
hi
ld
re
n
(c
hi
ld
re
n 
ag
ed
 
≤1
7 
ye
ar
s)
B
el
gi
um
: c
ar
eg
iv
er
s 
liv
in
g 
w
it
h 
H
IV
 r
ec
ru
ite
d 
fr
om
 
Fl
em
is
h 
A
ID
S 
re
fe
re
nc
e 
ce
nt
er
s
C
hi
ld
re
n 
w
er
e 
no
t 
as
se
ss
ed
. E
ve
ry
 c
on
se
cu
ti
ve
 p
at
ie
nt
 w
as
 o
ff
er
ed
 a
 s
ur
ve
y 
an
d,
 in
 a
d
di
ti
on
 
a 
sm
al
l-
sc
al
e 
qu
al
it
at
iv
e 
st
ud
y 
w
as
 c
on
du
ct
ed
 a
m
on
g 
13
 A
fr
ic
an
 c
ar
eg
iv
er
s 
of
 2
7 
ch
ild
re
n,
 
di
sc
lo
su
re
 r
at
e 
w
as
 1
0
%
. H
ow
ev
er
, t
ho
se
 w
ho
 d
id
 n
ot
 d
is
cl
o
se
 e
xp
re
ss
ed
 t
ha
t 
th
ey
 w
er
e 
no
t 
co
nv
in
ce
d 
th
ey
 h
ad
 t
ak
en
 t
he
 r
ig
ht
 d
ec
is
io
n.
 R
ea
so
ns
 f
or
 n
ot
 d
is
cl
o
si
ng
 in
cl
ud
ed
: d
is
cl
o
su
re
 
w
ou
ld
 b
e 
to
o 
em
ot
io
na
lly
 d
is
tu
rb
in
g 
fo
r 
th
e 
ch
ild
, t
he
 c
hi
ld
 w
as
 t
o
o 
yo
un
g,
 s
ti
gm
a-
re
la
te
d 
n
eg
at
iv
e 
co
ns
eq
u
en
ce
s,
 p
er
ce
iv
ed
 in
ca
pa
bi
lit
y 
to
 d
is
cl
o
se
 a
nd
 n
o 
p
er
ce
iv
ed
 b
en
efi
ts
 o
f 
di
sc
lo
su
re
 f
or
 t
he
 c
hi
ld
[3
7]
Å
sa
nd
er
 
et
 a
l. 
(2
0
0
9
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
47
 p
ar
en
ts
 a
nd
87
 c
hi
ld
re
n 
(≤
18
 y
ea
rs
)
Sw
ed
en
: a
 s
ub
se
t 
of
 7
73
 
H
IV
-i
nf
ec
te
d 
im
m
ig
ra
nt
s 
of
 
A
fr
ic
an
 o
ri
gi
n 
liv
in
g 
in
 
Sw
ed
en
 a
nd
 r
ec
ei
vi
ng
 
he
al
th
ca
re
 a
t 
tw
o 
d
ep
ar
tm
en
ts
 o
f 
in
fe
ct
io
us
 
di
se
as
es
 w
er
e 
re
cr
ui
te
d
Pa
re
nt
s 
an
d 
ch
ild
re
n 
in
te
rv
ie
w
ed
. D
is
cl
o
su
re
 w
as
 r
at
e 
w
as
 1
2%
. M
ed
ia
n 
ag
e 
fo
r 
di
sc
lo
su
re
 
w
as
 1
1 
ye
ar
s.
 O
nl
y 
m
ot
he
rs
 d
is
cl
o
se
d 
to
 t
he
ir 
ch
ild
re
n,
 n
o 
fa
th
er
s 
di
sc
lo
se
d.
 F
iv
e 
ou
t 
of
 
87
 c
hi
ld
re
n 
w
er
e 
H
IV
-i
nf
ec
te
d 
an
d 
no
n
e 
kn
ew
 a
b
ou
t 
th
ei
r 
ow
n 
in
fe
ct
io
n.
 T
he
 m
aj
or
it
y 
of
 
pa
rt
ic
ip
an
ts
, 3
0 
ou
t 
of
 4
7,
 h
ad
 a
 c
us
to
d
y 
pl
an
 f
or
 t
he
ir 
ch
ild
re
n 
in
 c
as
e 
th
ey
 w
er
e 
or
ph
an
ed
 
in
 S
w
ed
en
[3
8]
A
RT
: A
nt
ir
et
ro
vi
ra
l t
he
ra
py
. 
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Ta
b
le
 2
. S
tu
d
ie
s 
re
la
ti
n
g
 t
o
 a
d
o
le
sc
en
ts
 in
 A
si
a 
an
d
 A
fr
ic
a.
A
u
th
o
r 
(y
ea
r)
St
u
d
y 
d
es
ig
n
 
Sa
m
p
le
Lo
ca
ti
o
n
 a
n
d
 p
ar
ti
ci
p
an
t 
re
cr
u
it
m
en
t
Fi
n
d
in
g
s
R
ef
.
D
an
e 
(2
0
02
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
26
 w
om
en
 
(c
hi
ld
re
n 
ag
ed
 
3
–1
9 
ye
ar
s)
Th
ai
la
nd
: H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
re
cr
ui
te
d 
fr
om
 a
 h
om
e 
ca
re
 
pr
o
gr
am
 w
he
n 
th
ey
 c
am
e 
fo
r 
th
ei
r 
cl
in
ic
 c
he
ck
-u
ps
O
nl
y 
m
ot
he
rs
 w
er
e 
in
te
rv
ie
w
ed
. E
le
ve
n 
ou
t 
of
 2
6 
m
ot
he
rs
 d
is
cl
o
se
d 
to
 t
he
ir 
ch
ild
re
n.
 T
he
 
m
aj
or
it
y 
of
 m
ot
he
rs
 r
eq
u
es
te
d 
th
at
 c
hi
ld
re
n 
ke
ep
 d
is
cl
o
su
re
 a
 s
ec
re
t 
in
 o
rd
er
 t
o 
pr
ot
ec
t 
th
em
 f
ro
m
 s
ti
gm
a 
at
 s
ch
o
o
l. 
A
ll 
m
ot
he
rs
 w
er
e 
w
id
ow
ed
 d
u
e 
to
 A
ID
S 
an
d 
al
l r
ep
or
te
d 
th
at
 t
he
ir 
hu
sb
an
ds
 w
er
e 
in
fe
ct
ed
 t
hr
ou
gh
 p
ro
st
itu
te
s.
 T
w
en
ty
 fi
ve
 o
ut
 o
f 
26
 m
ot
he
rs
 
di
sc
lo
se
d 
to
 o
th
er
 m
em
b
er
s 
of
 t
he
ir 
fa
m
ili
es
[3
9]
X
u 
et
 a
l. 
(2
0
07
) 
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
16
 c
ar
eg
iv
er
s,
 fi
ve
 
ke
y 
in
fo
rm
an
ts
 
an
d 
16
 c
hi
ld
re
n 
(8
–1
7 
ye
ar
s)
C
hi
na
: H
IV
-n
eg
at
iv
e 
ch
ild
re
n 
af
fe
ct
ed
 b
y 
H
IV
, t
he
ir 
ca
re
gi
ve
rs
 a
nd
 k
ey
 in
fo
rm
an
ts
 
w
er
e 
re
cr
ui
te
d 
th
ro
ug
h 
lo
ca
l 
he
al
th
 s
er
vi
ce
 p
ro
vi
d
er
s 
w
or
ki
ng
 w
it
h 
H
IV
-i
nf
ec
te
d 
p
eo
pl
e 
in
 t
he
 c
om
m
un
it
y
Th
e 
m
aj
or
it
y 
of
 c
hi
ld
re
n 
w
er
e 
or
ph
an
s 
(1
1 
ou
t 
of
 1
6
).
 O
nl
y 
th
re
e 
ou
t 
of
 1
6 
ch
ild
re
n 
kn
ew
 
th
ei
r 
pa
re
nt
s’
 H
IV
 d
ia
gn
o
si
s.
 M
o
st
 c
hi
ld
re
n 
w
er
e 
ca
re
d 
fo
r 
by
 t
he
ir 
gr
an
dm
ot
he
rs
. T
w
o 
m
ai
n 
re
as
on
s 
fo
r 
di
sc
lo
su
re
 w
er
e:
 c
hi
ld
re
n 
he
ar
d 
ot
he
r 
p
eo
pl
e 
ta
lk
in
g 
ab
ou
t 
H
IV
 a
nd
 
as
ke
d 
ab
ou
t 
m
ed
ic
at
io
n 
ta
ke
n 
by
 c
ar
eg
iv
er
s.
 R
ea
so
ns
 f
or
 n
on
di
sc
lo
su
re
 in
cl
ud
ed
: c
hi
ld
re
n 
w
er
e 
to
o 
yo
un
g 
to
 u
nd
er
st
an
d,
 c
ar
eg
iv
er
s 
di
d 
no
t 
kn
ow
 h
ow
 t
o 
an
sw
er
 q
u
es
ti
on
s 
ab
ou
t 
H
IV
, a
nd
 c
hi
ld
re
n 
m
ig
ht
 t
el
l o
th
er
 p
eo
pl
e 
ab
ou
t 
ca
re
gi
ve
rs
’ s
ta
tu
s 
an
d 
th
e 
fa
m
ily
 w
ou
ld
 
b
e 
st
ig
m
at
iz
ed
[5
9]
Th
om
as
 e
t 
al
. 
(2
0
0
9
) 
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
6
0 
m
ot
he
rs
 
(o
ve
r 
4
0
%
 o
f 
ch
ild
re
n 
ag
ed
 ≥
10
 y
ea
rs
)
In
di
a:
 H
IV
-i
nf
ec
te
d 
m
ot
he
rs
 
w
er
e 
re
cr
ui
te
d 
fr
om
 t
w
o 
m
at
er
ni
ty
 h
o
sp
it
al
s,
 s
ex
ua
lly
 
tr
an
sm
it
te
d 
in
fe
ct
io
n 
cl
in
ic
s 
an
d 
an
 H
IV
-t
re
at
m
en
t 
cl
in
ic
 in
 
a 
g
ov
er
nm
en
t 
ho
sp
it
al
C
hi
ld
re
n 
w
er
e 
no
t 
as
se
ss
ed
. M
aj
or
it
y 
of
 m
ot
he
rs
 a
gr
ee
d 
th
at
 d
is
cl
o
su
re
 w
as
 a
 v
er
y 
se
ns
it
iv
e 
is
su
e 
an
d 
w
er
e 
m
o
st
ly
 c
on
ce
rn
ed
 a
b
ou
t 
st
ig
m
a.
 S
om
e 
st
at
ed
 t
ha
t 
it 
w
as
 b
es
t 
no
t 
to
 d
is
cl
o
se
 t
o 
ch
ild
re
n 
un
til
 t
he
y 
w
er
e 
o
ld
er
; a
n 
ag
e 
of
 1
5 
ye
ar
s 
w
as
 p
er
ce
iv
ed
 t
o 
b
e 
ap
pr
o
pr
ia
te
 f
or
 d
is
cl
o
su
re
. T
he
 m
aj
or
it
y 
re
p
or
te
d 
st
ig
m
at
iz
at
io
n 
by
 d
o
ct
or
s 
an
d 
ot
he
r 
he
al
th
ca
re
 w
or
ke
rs
 in
 a
cc
es
si
ng
 h
ea
lt
hc
ar
e
[5
7]
Zh
ou
 e
t 
al
. 
(2
01
2)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
39
 p
ar
en
ts
 a
nd
 
93
 c
hi
ld
re
n
/a
du
lt
s
(8
–2
1 
ye
ar
s)
C
hi
na
: H
IV
-i
nf
ec
te
d 
pa
re
nt
s 
w
it
h 
un
in
fe
ct
ed
 c
hi
ld
re
n 
w
er
e 
re
cr
ui
te
d 
fr
om
 v
o
lu
nt
ar
y 
co
un
se
lin
g 
an
d 
te
st
in
g 
cl
in
ic
s
Tw
en
ty
 t
w
o 
ou
t 
of
 9
3 
ch
ild
re
n 
w
er
e 
di
sc
lo
se
d 
to
. A
 t
ot
al
 o
f 
67
%
 o
f 
pa
rt
ic
ip
an
ts
 w
er
e 
m
al
e 
an
d 
th
e 
m
aj
or
it
y 
of
 d
is
cl
o
se
rs
 w
er
e 
m
en
. A
p
pr
ox
im
at
el
y 
27
%
 o
f 
fa
th
er
s 
an
d 
15
%
 o
f 
m
ot
he
rs
 h
ad
 d
is
cl
o
se
d 
to
 o
n
e 
or
 m
or
e 
ch
ild
re
n.
 H
al
f 
of
 d
is
cl
o
se
rs
 w
er
e 
on
 A
RT
. R
ea
so
ns
 
fo
r 
no
nd
is
cl
o
su
re
 in
cl
ud
ed
: c
hi
ld
re
n 
ar
e 
to
o 
yo
un
g 
to
 u
nd
er
st
an
d,
 f
ea
r 
of
 s
ti
gm
at
iz
at
io
n,
 
co
nc
er
ns
 a
b
ou
t 
ch
ild
re
n’
s 
st
ud
y 
an
d 
co
nc
er
ns
 a
b
ou
t 
in
cr
ea
se
d 
ps
yc
ho
lo
gi
ca
l b
ur
d
en
 t
o 
ch
ild
re
n
[6
0]
D
e 
Ba
et
s 
et
 a
l. 
(2
0
0
8
)
C
ro
ss
-
se
ct
io
na
l;
qu
al
it
at
iv
e
61
 p
rim
ar
y 
he
al
th
ca
re
 
w
or
ke
rs
 a
nd
 
13
1 
co
m
m
un
it
y 
m
em
b
er
s
Zi
m
ba
bw
e:
 p
ar
ti
ci
pa
nt
s 
w
er
e 
re
cr
ui
te
d 
fr
om
 p
rim
ar
y 
he
al
th
ca
re
 c
en
te
rs
 a
nd
 a
 
co
m
m
un
it
y 
in
 r
ur
al
 Z
im
ba
bw
e
C
hi
ld
re
n 
w
er
e 
no
t 
as
se
ss
ed
. P
ar
tia
l d
is
cl
o
su
re
 (
di
sc
lo
si
ng
 a
n 
ill
n
es
s 
bu
t 
no
t 
sp
ec
ifi
ca
lly
 
H
IV
) w
as
 p
re
fe
rr
ed
 f
or
 1
0 
ye
ar
 o
ld
s,
 a
nd
 f
ul
l d
is
cl
o
su
re
 (
di
sc
lo
si
ng
 t
ha
t 
th
e 
m
ot
he
r 
ha
s 
H
IV
) w
as
 p
re
fe
rr
ed
 f
or
 a
d
o
le
sc
en
ts
. M
or
e 
th
an
 6
3
%
 o
f 
th
e 
pa
rt
ic
ip
an
ts
 w
ou
ld
 w
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research. Given the maturity and demograph-
ics of the HIV epidemic in the USA, most 
of the research to date on maternal disclo-
sure has been undertaken among low-income 
African–American families [36]. Several more 
recent studies have emerged from Europe, 
important given the high levels of African 
immigration to this region (see for example [38]) 
[37–39]. Of the 58 studies, 43 (75%) have been 
conducted in the USA [18,21,25–32,40–53], one in 
Canada [54], four in Europe [37,38,55,56], six in Asia 
[35,39,57–60] and only four in sub-Saharan Africa 
(Figure 1) [20,23,61,62]. 
Although the largest population of HIV-
infected parents live in Africa, very little 
research has examined maternal HIV disclo-
sure in this region [22] and, to date, there are no 
reported intervention studies [14]. Similarly, the 
international research on maternal HIV disclo-
sure is mostly descriptive, is almost exclusively 
conducted in resource-rich settings, with few 
studies reporting on interventions, and hardly 
any targeting children under the age of 12 years 
[14]. Only 13 studies were reported with primary 
school-aged children [9,16,25–35]; seven of these 
are by the same author [25–31], and six [25,27–31] 
use the same cohort in the USA. The pilot inter-
vention trial (the TRACK program; Teaching, 
Raising And Communicating with Kids pro-
gram [26]), designed to prepare HIV-infected 
mothers for disclosure to their children aged 
6–12 years, showed that mothers in the inter-
vention group were six-times more likely to dis-
close their HIV status to their HIV-uninfected 
primary school-aged children than those in the 
control group over a 9-month follow-up period 
(33 vs 7.3%) [26].
Published studies show that HIV disclosure 
rates to children vary across studies from as low as 
11% [37,38,56,59] to as high as 84% [41–43,49,63], with 
most studies reporting rates between 30–45% 
[32,47,53,54,62,64,65]. In one of the few studies with 
nationally representative samples of HIV-infected 
adults in the USA, Corona et al. reported disclo-
sure to be 44%, with 90% of the children that 
were disclosed to, also being informed that HIV 
or AIDS might lead to their parents’ death [65]. 
Research suggests that mothers are willing to dis-
close once children reach primary school-going 
age [36], but do not feel equipped to do so for a 
variety of reasons, including feeling unsure of the 
appropriate age to undertake disclosure, not feel-
ing confident about how to answer HIV-related 
questions their children might ask, and not hav-
ing age-appropriate tools to help them during the 
disclosure process [20,23,30,37,46,57,59,62,65,66]. T
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 r
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9
%
)
[3
1]
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 c
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 c
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 c
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 d
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. C
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 m
ot
he
rs
 w
ith
 h
ig
he
r 
ps
yc
hi
at
ric
 s
ym
pt
om
 in
de
x 
va
lu
es
 h
ad
 
hi
gh
er
 c
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 c
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b
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 b
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er
e 
on
 a
nt
ire
tr
ov
ira
l t
he
ra
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at
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er
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 d
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ch
ild
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 d
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 d
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 d
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 c
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 o
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 d
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at
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 o
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si
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ea
rly
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en
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ye
ar
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w
ar
ds
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 D
is
cl
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ur
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w
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 a
ss
o
ci
at
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he
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de
pr
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si
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ea
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 d
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 c
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 C
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l p
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tio
n 
de
si
gn
ed
 t
o 
as
si
st
 m
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 m
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ild
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n 
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 c
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 d
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th
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ld
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 d
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N
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e 
of
 t
he
 c
hi
ld
re
n 
w
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 w
er
e 
di
sc
lo
se
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to
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er
e 
re
po
rt
ed
 t
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ha
ve
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ee
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ps
et
) c
ry
in
g 
or
 
an
gr
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te
r 
di
sc
lo
su
re
. O
ve
ra
ll,
 t
he
 in
te
rv
en
tio
n 
gr
ou
p 
sh
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 in
cr
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m
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un
ic
at
io
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ot
he
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 c
hi
ld
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th
 f
ol
lo
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p
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 T
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te
rv
en
tio
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tiv
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ot
h 
m
ot
he
rs
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nd
 c
hi
ld
re
n 
su
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im
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ov
ed
 f
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he
si
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. H
ap
pi
ne
ss
 a
nd
 g
re
at
er
 f
re
ed
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 f
ro
m
 a
nx
ie
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 w
as
 n
ot
ed
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 t
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 in
te
rv
en
tio
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gr
ou
p 
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in
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th
e 
Pi
er
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ar
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nx
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ne
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ca
le
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 d
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 c
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 c
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b
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 t
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fe
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 c
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 c
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 c
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 c
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d
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at
ed
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pa
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m
at
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l H
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to
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ng
 c
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ld
re
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g
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ye
ar
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ho
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H
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ct
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ie
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 c
hi
ld
re
n 
di
d 
no
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 d
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xi
m
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 c
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w
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er
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 d
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r 
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er
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l d
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tig
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re
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b
ec
am
e 
pr
ot
ec
tiv
e 
of
 t
he
ir 
m
ot
he
rs
, e
sp
ec
ia
lly
 t
he
ir 
ph
ys
ic
al
 h
ea
lth
, r
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 m
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 c
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[2
5] The decision to disclose or not is most com-
monly linked to the age and gender of the child, 
and the stage of disease or illness of the mother 
[16,36,41,52]. While few mothers disclose their 
HIV status to a child before the age of 7 years, 
many are forced to do so during HIV-related 
illnesses or hospitalization, which has been 
shown to impact negatively on a child’s emo-
tional and behavioral outcomes [14,41,43,47,52,65]. 
Mothers who deferred disclosure until adoles-
cence reported more behavioral and emotional 
difficulties in their children than those who 
disclosed pre-adolescence [41,43,47,52,65].
One of the limitations in the disclosure lit-
erature is the lack of studies that address pater-
nal disclosure of HIV status to children; only 
18 of the 58 studies reviewed (31%) included 
fathers as participants [56]. A study conducted 
with parents in the USA found that mothers 
were more likely to disclose their status, and to 
disclose earlier, compared with fathers [41]. In a 
qualitative study, fathers did not want to disclose 
their status to children because of concerns that 
they would not understand about HIV, while the 
mothers who delayed disclosure did so because 
they wanted their children to enjoy a normal 
childhood [54]. Compared with fathers, mothers 
were more likely to use written materials such as 
books and pamphlets when they were preparing 
for disclosure [54].
A further limitation of the maternal dis-
closure literature, and a consequence of most 
papers emanating from the USA, is a lack of 
exploration of differences in sociocultural fac-
tors across regions. In the sub-Saharan con-
text, sociocultural factors that might influence 
maternal disclosure include the presence of HIV-
related stigma [20,23,61,62,67] and social exposure 
to HIV, with more children being exposed to 
HIV at younger ages and often witnessing sev-
eral family members living with HIV [68]. In 
studies conducted in Africa, some mothers have 
expressed discomfort in talking to their children 
about sexuality, as such issues are considered 
taboo [23,68,69]. The same discomfort extends to 
talking to children about illness and death [68,69].
However, it is reasonable to hypothesize that 
maternal HIV disclosure interventions in Africa 
could benefit families in similar ways to the 
developed world. These benefits could include 
increased family cohesion [21,31], improved antiret-
roviral therapy (ART) adherence by HIV-infected 
mothers [21,42], consideration about custody plan-
ning for children [42], improved maternal mental 
health [22] and increased social support for the 
mother and child following disclosure [18,31]. 
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It is possible that issues such as gender inequal-
ity, discrimination and stigma, and the complex 
nature of HIV epidemiology (with the epidemic 
being generalized rather than concentrated in 
specific risk groups) may limit the applicability 
of western models in Africa [70]. We therefore 
recommend further research in high HIV preva-
lence regions and suggest that a balance needs 
to be sought between what is culturally appro-
priate and what has been shown to work in the 
developed world. 
Lessons learnt from maternal 
disclosure studies
Reasons for maternal disclosure
Studies report a variety of reasons given by 
mothers desiring to disclose their HIV status to 
their children [16,20,39,42,49,53]. These are remark-
ably similar across all studies, regardless of geo-
graphical situation. The most often cited reason 
for wanting to disclose was practical, including 
not wishing the child to discover the mother’s 
status from someone else. The most common 
reasons for nondisclosure were more emotional, 
such as perceiving that the child was too young 
to understand about HIV or illness, and con-
cerns that the child would be distressed or tell 
someone else (box 1). Interestingly, in a recent 
study from China examining secondary disclo-
sure of maternal HIV status by children, a high 
proportion of children did not want to disclose 
maternal HIV status to others [71]. 
Benefits of disclosure for mothers 
& their children
Numerous studies have suggested that maternal 
HIV disclosure has benefits for mothers in terms 
of mental health, healthcare behaviors includ-
ing adherence to HIV medication, family rela-
tionships and support [16,26,41,42,47,49,52,53,65,72]. 
Ensuring timely, age-appropriate disclosure of 
maternal status to HIV-uninfected children 
has also been shown to increase the quality 
of custody and emergency care planning for 
children living in HIV-affected families [38]. 
Similarly, several studies have shown improve-
ments in children’s emotional and social func-
tioning, with children reporting feeling better 
prepared for the future, more involved in family 
decision-making, closer to their mothers and 
less afraid following maternal HIV-disclosure 
[14,21,28,31,42,49,73]. While children’s first reaction 
to disclosure might include worry, shock, anger 
or sadness, there is consensus in the literature 
that younger children, in particular, exhibit no 
significant long-term adjustment problems as a T
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research in southern Africa [75]. More recently, 
recognizing the scale and impact of the HIV 
epidemic in resource-limited settings, the WHO 
released a systematic review and guidelines on 
HIV disclosure for children up to 12 years of 
age, recommending that they should be told 
about their own or their parents’ HIV status 
at primary school age [76]. These documents 
also highlight the importance of understand-
ing a child’s developmental stage in considering 
HIV disclosure, and the limited availability of 
research on interventions for HIV-uninfected 
children living with HIV-infected parents [76].
The few published intervention studies, 
including the work of Murphy et al. [26], have 
tended to rely on adult models for understand-
ing HIV-disclosure, including the integrative 
disclosure theory [77] and the HIV disclosure 
process model [78,79]. These adult models focus 
on factors that influence decisions to disclose, 
result of HIV disclosure [16,21,24,64]. Maternal 
HIV may become normalized in children’s 
lives, especially if the mother’s health remains 
good. The literature suggests that few mothers 
regret disclosing, and that disclosure improves 
the quality of the mother–child relationship 
and increases the mother’s social support 
network (box 2) [30].
Theoretical approach to maternal 
HIV disclosure for children
Research examining child development and HIV 
disclosure has focused on the disclosure of HIV 
to HIV-infected children. In 1999, the American 
Academy of Pediatrics first published guidelines 
on HIV disclosure, emphasizing that disclosure 
should be viewed as an ongoing process involv-
ing parents, children and healthcare providers, 
and not as a one-off event [74]. The importance of 
this approach to disclosure is also supported by 
Thorne et al. (2000)
Nostlinger et al. (2004)
Nostlinger et al. (2006)
Asander et al. (2009)
Letteney et al. (2004)
Letteney (2006)
Mellins (2002)
Mellins (2003)
Mellins (2008)
Lee et al. (2002)
Lee et al. (2002)
Rotheram-Borus (2001)
Pilowsky et al. (2000)
Winstead et al. (2001)
Delaney et al. (2008)
Brackis-Cott et al. (2003)
Brackis-Cott et al. (2007)
Tompkins (2007)
Corona et al. (2006)
Murphy et al. (2006)
Dematteo et al. (2002)
Xu et al. (2007)
Xu et al. (2010)
Zhou et al. (2012)
Thomas et al. (2009)
Ishikawa et al. (2010)
Dane (2002)
Rwemisi et al. (2008)
De Baets et al. (2008)
Nam et al. (2009)
Palin et al. (2009)
Tompkins et al. (1999)
Ingram et al. (2000)
Forsythe et al. (1996)
Wiener et al. (1998)
Scrimshaw et al. (2002)
Black et al. (2002)
Kirshenbaum et al. (2002)
Vallerand et al. (2005)
Woodring et al. (2005)
Kennedy et al. (2010)
Niebuhr et al. (1994)
Armistead et al. (1997)
Rotheram-Borus et al. (1997)
Murphy et al. (1999)
Simoni et al. (2000)
Maternal HIV disclosure studies with adolescents (black text)
Maternal HIV disclosure studies with primary school-aged children (blue text)
Canada
USA
India
Thailand
China
Uganda
Belgium
Zimbabwe
Botswana
South Africa
Armistead et al. (1999)
Armistead et al. (1999)
Armistead et al. (2001)
Shaffer et al. (2001)
Murphy et al. (2001)
Murphy et al. (2002)
Murphy et al. (2002)
Murphy et al. (2003)
Murphy et al. (2006)
Murphy et al. (2009)
Murphy et al. (2011)
Bauman et al. (2002)
North America
South America
Europe
Africa
Asia
Australia
Figure 1. A global overview of maternal HIV disclosure studies.
www.futuremedicine.com 1175future science group
Disclosure of maternal HIV status to children Special Report
and do not address the complexities of disclo-
sure involving children, for example maternal 
and child characteristics [14], the family environ-
ment and culture [80], and stigma [81]. A further 
critique of using adult models of disclosure for 
parent–child interventions is the narrow focus 
that disclosure is a process between two indi-
viduals (i.e., in this case a parent and a child), an 
assumption which ignores the complexity of the 
family environment in which the parent–child 
dyad is embedded [72]. 
In the childhood chronic disease literature 
Bibace and Walsh developed one of the first 
models to inform our understanding of a child’s 
developmental capacity to understand their own, 
or their parents’ illnesses [82]. According to this 
model, children aged 7–10 years are considered 
to fall into a stage known as the ‘concrete–logi-
cal stage’, where distinctions of self and other, 
and the assigning and understanding of inter-
nal and external causes of disease become more 
developed. As a result children begin to under-
stand something that is known as the ‘concept 
of contamination’; that many diseases are caused 
by factors whose origin is external to the body 
(e.g., bacteria and viruses), but that illness itself is 
internalized within the human body. The Bibace 
and Walsh model has evolved and developed and 
has been applied and validated for many illnesses 
[82]. However, in general, research in the area 
of childhood understandings of disease is cri-
tiqued for its methodological weaknesses, small 
sample sizes, observer bias and poor attention to 
reliability and validity [83]. 
More recent literature specific to managing 
parental terminal illness has further informed 
what we understand about a child’s developmen-
tal capacity to understand parental illnesses such 
as cancer and HIV [84]. Findings show that pro-
viding age-appropriate information at the time 
of illness disclosure is key to ameliorating the 
impact of later parental loss, and has a positive 
impact on a child’s well being. Children aged 
between 6 and 8 years, when confronted with 
parental terminal illness, may have difficulty 
containing emotions, are likely to blame them-
selves when bad things happen and can easily 
misunderstand the cause and effect of events. If 
a child misinterprets the reason for parental ill 
health, this can be difficult to correct later [84].
Key points that can be drawn from a develop-
mentally sensitive approach to discussing 
terminal illness include: 
n	Provide the child with well-timed illness-related 
information [23,46,85];
n	Repeat the information, in addition to 
carefully explaining what the child will observe 
and what the child should expect [36,84];
n	Offer frequent reassurance to the child that 
they will be looked after, even in 
difficult circumstances [11,12,86];
n	Allow and encourage the child to initiate con-
versations about the illness and to ask 
questions [14,16];
n	Reassure the child that being upset is a normal 
and accepted response [14,36].
Both this broader literature, and the litera-
ture on the process of disclosure of maternal 
HIV to children suggests that the quality of the 
disclosure event, especially how it is planned 
and executed, can influence the child’s abil-
ity to cope with the information in the future 
[14]. The existing HIV intervention literature 
offers few examples of interventions that are 
developmentally framed, offer age specific infor-
mation on HIV, and that have been tested in 
high-HIV-prevalence settings such as southern 
Africa. 
Future perspective
The literature presented in this article introduces 
a number of challenges for the design and scale-
up of maternal disclosure interventions in high 
HIV prevalence settings where they are most 
needed. Evidence suggests that HIV-infected 
men and women with access to HIV treatment 
express desires and plans to have further children 
despite their status, and thus the challenges of 
maternal HIV disclosure will continue for at 
least another decade [87–89]. A key issue for dis-
closure research in sub-Saharan Africa is how 
maternal HIV disclosure should be undertaken, 
how best to help HIV-infected mothers, and 
how to support healthcare staff in high-HIV-
prevalence, low-resource areas to facilitate this 
process that we already know is fraught with its 
own challenges. 
Following a systematic review and meta-
analysis [90], there is growing support in preven-
tion and implementation science for a shift in 
focus to positive prevention. This concept tar-
gets HIV-infected individuals, with the expec-
tation of a broader impact among the multiple 
HIV-uninfected individuals in relationships 
with them. While most positive prevention has 
focused on serodiscordant couples, maternal 
HIV disclosure interventions scaled through 
HIV treatment programs may offer one such 
opportunity to maximize and strengthen the 
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capacity of HIV-infected mothers to continue 
to prevent infection in their HIV-uninfected 
children long after successful completion of 
prevention of mother-to-child transmission. 
Conceptualizing this in the sub-Saharan con-
text introduces several feasibility challenges. 
Feasibility challenges for the sub-Saharan con-
text include where the intervention is to be 
conducted (family setting or health facility), 
who the unit of the intervention is (individual 
or family), what human resources are avail-
able to conduct the intervention (healthcare 
staff or community health workers) and how 
the interventions can be scaled up. These are 
discussed below.
The family as a context for interventions
The review by Kennedy et al. illustrates the 
point that many HIV-infected individuals have 
limited contact with healthcare settings, and 
given resource limitations it is reasonable that 
contacts in clinical settings should focus on the 
initiation and management of HIV treatment 
[90]. Leverage of the home and family context 
may thus be an important intervention design 
element. There is growing acknowledgement 
of the key role played by families in man-
aging the burden of HIV care in southern 
Africa [20,23,61,62,91,92]. While there is increas-
ing acknowledgement of the central, sup-
portive and educational role that parents play 
for their children, and of the importance of 
family-centered services in the context of HIV, 
interventions that render services to children 
in the family context in high HIV prevalence 
areas have been slow to emerge [93]. Instead, 
HIV interventions frequently emphasize set-
tings outside the family, such as healthcare 
facilities where professional assistance can be 
sought, possibly with the implicit message that 
these external efforts are needed to compensate 
for the failure or limitations of parents [94]. 
Children stand to benefit from models that 
strengthen and engage families and focus on 
building parents’ capacity to provide psycho-
logical and social care for their children within 
the family. 
The concept of families in Africa is complex 
and more broadly defined than the traditional 
nuclear family, and frequently includes the 
extended family [92]. Research undertaken in 
southern Africa indicates that most children 
live in the same households as, and are raised 
by, their biological mothers [95]. However, due 
to migrant labor many African communities 
are mobile, resulting in children being absorbed 
into extended families, and being raised by other 
caregivers including fathers, grandmothers and 
aunts [92]. Qualitative research in South Africa 
has highlighted the interconnectedness of house-
holds, suggesting that ‘households are not iso-
lated from events occurring in their immediate 
social networks as well as elsewhere in the com-
munity’ [92]. These extensive social networks 
have historically provided support such as fos-
tering and adoption to children in times of crisis 
[68]. Intervention research around HIV disclo-
sure needs to consider not just the mother, but 
all the possible primary caregivers of the child. 
Research on health behavior change in chronic 
illness suggests that the characteristics of fam-
ily relationships that are important to facilitate 
effective and consistent management of chronic 
disease include the fact that family relationships 
persist over time, are emotionally intense and 
involve high levels of intimacy in day-to-day life 
[96]. Family-centered HIV disclosure support 
approaches are thus likely to be effective because 
it is in the context of family life that we expect 
health-related behavior changes to occur [97]. 
Box 1. Reasons given by mothers for disclosure and nondisclosure of 
their HIV status.
Reasons for disclosure
	n Practical reasons:
– Wanted children to hear their HIV status from them and not from other 
people [49,53,63]
– Wanted to respond to their children’s questions about HIV/AIDS after hearing 
about HIV from others or observing their parents taking medication [53,59] 
– Wanted to educate their children about HIV and protect them from HIV [49,54]
– Concerned that their own health was deteriorating [16,41,52]
– Felt children were developmentally ready for disclosure [52]
– Wanted to make arrangements for their children’s future [46]
– Sought support from their children [20,57]
	n Moral reasons:
– Felt that disclosure was the right thing to do [46]
	n Emotional reasons:
– Did not want to keep their HIV status a secret from their children any 
longer [46]
Reasons for nondisclosure
	n Practical reasons:
– Did not know how to disclose [20,23,31,65] 
– Lacked perception of benefits of disclosure for children [19,20,37]
– Concerned that children might ask how their mothers got infected [46]
– Perceived inability of children to keep secrets [31,46,57,62,65]
	n Emotional reasons:
– Felt their children deserved a worry- and care-free childhood [46,54,63]
– Concerned about children internalizing problems [31,37,49,59,62,65]
– Felt children were too young [23,31,37,49,59,60,126]
	n Stigma-related reasons:
– Wanted to protect children from stigma [23,25,35,37,42,52,57,59,60,126]
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Intervention studies that involve other fam-
ily members are more common in childhood 
than in adult diseases [96], including research 
on childhood diabetes [98–100], asthma [101,102], 
cystic fibrosis [103] and cancer [104]. These inter-
ventions included giving information on disease 
management and psycho-education to child and 
adult, strategies to improve the quality of family 
relationships and functioning, or provision of 
direct family therapy. 
Supporting maternal skills & care-giving 
capacity
While there is a clear need for further research 
demonstrating models for effective maternal 
HIV disclosure, and an increasing focus on the 
family as the unit of intervention, there is less 
consensus on the methods of intervention. One 
of the reasons cited by mothers for not under-
taking disclosure with their children is being 
unsure how to initiate the discussion and how to 
proceed thereafter, in particular how to impart 
difficult information about potentially seri-
ous illness and how to address questions that 
may include issues relating to death or sexual 
relationships [20,23,46,59,65]. 
Examples of structured interventions that 
focus on passing on skills and competencies to 
parents are available in the literature outside 
of HIV. One example is breastfeeding sup-
port where simply providing information about 
the benefits of breastfeeding alone does not 
necessarily lead to increased rates of exclusive 
breastfeeding [105]. However, several interven-
tions, led by breastfeeding counselors and 
based on training from the WHO breastfeed-
ing counseling course [106], supported mothers 
with practical and problem-solving skills, and 
demonstrated substantial increases in exclusive 
breastfeeding rates [107–109]. What can be learned 
from the breastfeeding example is the impor-
tance of standardized intervention approaches 
and developing generalized training models 
based on a train-the-trainer approach, minimum 
standards of competence in both the trainers and 
participants, and the development of counseling 
skills in those being trained.
A recent review examined core concepts and 
key practices that resulted in successful inter-
ventions with families affected by HIV in the 
USA, Thailand and South Africa [110]. Several 
lessons can be drawn from this review that are 
of relevance to skills building for maternal HIV 
disclosure. These include positive framing of the 
desired behavior change using a strengths-based 
approach focused on family wellness as opposed 
to HIV illness management; addressing barri-
ers to change; and providing information in a 
manner that makes it practical and applicable to 
real life. The interventions themselves included 
demonstration tools, games and activities, as 
opposed to simply giving information; building 
of cognitive and behavioral skills using tech-
niques that increased relaxation and self aware-
ness; and skill building in evaluating options 
and the consequences of decisions. 
Box 2. Benefits of maternal disclosure of HIV status to children.
Benefits to the mother
	n Psychological benefits: 
– Relieved the burden of secrecy and resulted in supportive responses from others [49]
– Improved mothers’ mental health by decreasing stress related to keeping HIV status a secret [133]
– Improved maternal mental health and healthcare behaviors [42]
– Increased social support resulting in decreased depression, stress and anxiety [16,47,53,63] 
	n Social and physical health benefits:
– Mothers reported higher levels of social support [18,31]
– Improved physical health due to behavioral changes following antiretroviral therapy initiation 
and family support [21]
Benefits to the child
	n Psychological benefits:
– Improved custody planning with indirect benefits for children in the longer term [42]
– Decreased depression in children over time following disclosure [28]
	n Social benefits:
– Increase in HIV/AIDS knowledge following disclosure [32]
– Positive association between disclosure and plans for children’s future [42,46,50]
Benefits to both mothers and children
– Higher family cohesion, with more affection between mothers and children [27,52]
– Improved mother–child relationship [45,46,49]
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While this review clearly illustrates the 
important impact of such intensive interven-
tions, applying these to scale remains a challenge 
given the human resource limitations in health 
systems in the most affected regions [110].
Lay counseling models for interventions
Any conceptualization of psycho-social inter-
ventions at the primary healthcare level is 
restricted by critical shortages of adequately 
trained healthcare professionals and the absence 
of disclosure counseling or intervention guide-
lines. Task shifting of primary care and pre-
vention functions to community healthcare 
workers or lay counselors is showing promise 
in improving health outcomes at reasonable 
cost, including examples of cognitive behav-
ioral interventions for postnatal depression and 
complex treatment regimes such as ART. In 
resource-limited settings, lay HIV counselors 
are responsible for psycho-social education 
within HIV-treatment programs, including 
HIV counseling and testing, health promo-
tion, training to initiate ART and monitoring 
of treatment adherence [111,112]. Mental health 
research has illustrated the capacity of commu-
nity healthcare workers to deliver psycho-social 
interventions [113], including interpersonal 
group therapies [114] and cognitive behavioral 
therapies [115], and other treatments for depres-
sion [116]. Given adequate training and support, 
community healthcare workers would be well 
positioned to provide disclosure support at a 
family level. Ensuring that interventions are 
appropriate for community healthcare workers 
to deliver is in line with current priorities in 
task shifting of healthcare to lay professionals 
where possible and feasible [112,117].
Given this potential, it is important that inter-
vention design focuses carefully on the structure, 
support and training required to make such lay 
counselor-driven interventions not only feasible, 
but of high impact.
Scalable models for HIV–disclosure
Lastly, given that most research to date in 
the field of maternal HIV disclosure has been 
undertaken on a small scale and has tended 
to use intensive resources, there is a need for 
larger demonstration projects designed to 
assess the feasibility and acceptability of such 
lay counselor-driven interventions delivered 
at scale in resource-limited, epidemic settings 
[118]. Such projects need to address human and 
other resource capacity challenges, and test 
the acceptability of maternal HIV disclosure 
interventions in traditional African cultures. 
There is increasing concern in the field of 
HIV about the practical application of inter-
ventions at scale, with examples from preven-
tion of mother-to-child transmission programs 
illustrating the loss of intervention effect when 
small-scale effective interventions are delivered 
at population level [119]. Research that not only 
establishes effective intervention models but 
also clearly describes the key mechanisms by 
which it achieves its effect will be important 
in the future. 
Executive summary
The problem
	n Sub-Saharan Africa is disproportionately affected by HIV; up to 40% of pregnant women are HIV-infected, but most of their children 
will be HIV-uninfected owing to the availability of effective prevention of mother-to-child transmission regimens.
	n Improvements in HIV-treatment have also resulted in increasing numbers of mothers surviving to care for their HIV-uninfected children.
	n One challenge faced by HIV-infected mothers is when and how to disclose their HIV status to their children.
Overview of current literature
	n International research on maternal HIV disclosure is mostly descriptive from developed world settings; few studies report on HIV 
disclosure interventions or include children under the age of 12 years.
	n There are many documented benefits of maternal HIV disclosure both for the mother and a child of primary school age.
	n Disclosure should be an ongoing process and take into account a child’s stage of development and ability to understand illness.
Future perspective
	n When considering models of HIV disclosure interventions for sub-Saharan Africa the following should be considered:
– The key role played by the family and the potential benefits of interventions that strengthen and engage with families;
– Empowering mothers with skills and competencies is likely to be more effective than simply providing relevant information;
– The documented ability of lay counselors to deliver health interventions, potentially relieving already overburdened medical staff at 
health facilities;
– The need for larger demonstration projects designed to assess the feasibility and acceptability of HIV-disclosure interventions 
delivered at scale in resource-limited settings with high-HIV prevalence.
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Prevention of mother-to-child Transmission and HIV Treatment programmes were scaled-up in resource-constrained settings
over a decade ago, but there is still much to be understood about women’s experiences of living with HIV and their HIV
disclosure patterns. This qualitative study explored women’s experiences of living with HIV, 6–10 years after being
diagnosed during pregnancy. The area has high HIV prevalence, and an established HIV treatment programme. Participants
were enrolled in a larger intervention, “Amagugu”, that supported women (n = 281) to disclose their HIV status to their
children. Post-intervention we conducted individual in-depth interviews with 20 randomly selected women, stratified by
clinic catchment area, from the total sample. Interviews were entered into ATLAS.ti computer software for coding. Most
women were living with their current sexual partner and half were still in a relationship with the child’s biological father.
Household exposure to HIV was high with the majority of women knowing at least one other HIV-infected adult in their
household. Eighteen women had disclosed their HIV status to another person; nine had disclosed to their current partner
first. Two main themes were identified in the analyses: living with HIV and the normalisation of HIV treatment at a family
level; and the complexity of love relationships, in particular in long-term partnerships. A decade on, most women were
living positively with HIV, accessing care, and reported experiencing little stigma. However, as HIV became normalised new
challenges arose including concerns about access to quality care, and the need for family-centred care. Women’s sexual
choices and relationships were intertwined with feelings of love, loyalty and trust and the important supportive role played
by partners and families was acknowledged, however, some aspects of living with HIV presented challenges including
continuing to practise safe sex several years after HIV diagnosis.
Keywords: maternal HIV disclosure; partnerships; HIV treatment; stigma; family
Introduction
Successful prevention of mother-to-child-transmission
(PMTCT) and HIV treatment programmes have reduced
mortality and resulted in HIV-positive women living
longer to care for their children who are mostly HIV-
uninfected (WHO, 2013). Keeping women alive is bene-
ficial for children, and associated with decreased child
mortality in highly prevalent HIV settings (Ndirangu,
Newell, Tanser, Herbst, & Bland, 2010; Ndirangu, Newell,
Thorne, & Bland, 2012).
Much is known about the clinical health of HIV-
infected women in resource-constrained settings (Coutsou-
dis et al., 2010; Miiro et al., 2009), however, less is known
about their experiences of living with HIV several years
after their diagnosis, and to whom they have disclosed.
Emerging literature on HIV disclosure describes both
positive and negative outcomes following disclosure;
increased social support has been reported (Bouillon et al.,
2007; Groves, Maman, & Moodley, 2012; Maman et al.,
2003) violence and abandonment have also been docu-
mented (Linda, 2013; Medley, Garcia-Moreno, McGill, &
Maman, 2004). There is a dearth of evidence from
longitudinal research in African settings to inform adher-
ence support programmes (Bärnighausen, Tanser, Dabis, &
Newell, 2012; Dewing et al., 2012; Santer, Ring, Yardley,
Geraghty, & Wyke, 2014) and limited data on client
perspectives of antiretroviral treatment (ART) services
(Orner et al., 2008).
This qualitative study explores the experiences of 20
HIV-infected women, who learnt their HIV diagnosis
during pregnancy as participants in the Vertical Transmis-
sion Study (VTS; 2001–2006), rural South Africa (Bland,
Coovadia, Coutsoudis, Rollins, & Newell, 2010; Coovadia
et al., 2007; Mkwanazi et al., 2008). It explores their
experiences of living with HIV and taking ART, their
partnerships and issues of access and equity to treatment.
Methods
The setting
This study was conducted in northern KwaZulu-Natal, at
the Africa Centre for Health and Population Studies
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(www.africacentre.com). The setting is rural, resource-
limited and predominantly Zulu speaking (Bärnighausen,
Tanser, Malaza, Herbst, & Newell, 2012; Tanser
et al., 2008).
In 2001 the Department of Health, in partnership
with the Africa Centre, launched a PMTCT programme
and, in keeping with policy at the time, single-dose
Nevirapine was offered to HIV-infected women during
labour, and their infants post-partum. Since then PMTCT
regimens have changed, and now all HIV-infected
pregnant women, not already on treatment, receive
ART at their first antenatal visit (WHO, 2013). Since
2004 an HIV Programme has provided free HIV
treatment and care in a devolved programme at primary
health care clinics in the area (Bland & Ndirangu, 2013;
Houlihan et al., 2010; Janssen, Ndirangu, Newell, &
Bland, 2010). Initially, the eligibility criteria for ART
was a CD4 cell count of ≤200 cells/ml, but since 2014
has been extended to include all those with a CD4 cell
count of ≤500 cells/ml (WHO, 2013).
Measures
This qualitative study was undertaken with a sub-sample
of women who had participated in two intervention
studies, one to support exclusive breastfeeding to reduce
vertical transmission of HIV (“VTS”; Bland et al., 2010)
and the other to support maternal HIV disclosure
(“Amagugu”; Rochat, Arteche, Stein, Mkwanazi, &
Bland, 2014). The aim of this qualitative research was to
better understand women’s experiences of living with HIV
over a long period of time, and to explore their
experiences of participating in the VTS and Amagugu
interventions. A two-part interview guide was developed:
Part One was open-ended and explored women’s experi-
ences of being HIV-infected since their diagnosis in the
VTS and is the subject of this manuscript. Part Two
focused on their experiences of participating in the
Amagugu intervention, the subject of a separate analysis.
The interview started with an open-ended narrative and
then included topic area probes. The open-ended question
was: “Tell me about your life since we last saw you in the
VTS”. Through these interviews we sought to address less
understood psychosocial topics about women of child-
bearing age, highlighted in the literature, including HIV
testing during pregnancy, safe sex negotiations and
experiences of living with HIV (McGrath, Richter, &
Newell, 2013; Rochat et al., 2006; Varga, Sherman, &
Jones, 2006). The probes explored the following:
(1) Women’s experiences of access to HIV care and
treatment.
(2) Women’s experiences of their sexual partner-
ships since the VTS.
Sample
HIV-infected women included in these analyses were a
sub-sample of participants enrolled in the Amagugu
study, who had received support to disclose their HIV
status to their 6- to 10-year-old child (Rochat, Mkwa-
nazi, & Bland, 2013; Rochat et al., 2014). Women had
first been tested for HIV in the local PMTCT programme
and had known their HIV status for at least six years
(Mkwanazi et al., 2008). The Amagugu disclosure
intervention targeted the VTS index child specifically,
but mothers were encouraged to disclose their status to
their other children post-intervention. Resources and
time available determined the initial sample size and
we purposefully selected 20 participants from five of the
nine clinic areas in which the Amagugu study operated,
representing urban and rural settings. After completion
of the 20 interviews a preliminary round of data analysis
was undertaken and it was concluded that saturation had
been reached.
Data collection
Socio-demographic and disclosure data were collected
during a baseline survey in the Amagugu intervention.
Two months after completing the intervention one of the
researchers (NM) contacted the sample of women by
telephone, explained the qualitative study and requested
an appointment to conduct individual in-depth interview;
all 20 women agreed to participate and provided written,
informed, consent.
Data preparation and analysis
The in-depth interviews lasted approximately 60 minutes
at the women’s homes were tape recorded, transcribed
verbatim and translated from isiZulu to English by NM.
All interviews were read several times for familiarity
with the data and the transcripts were entered into
ATLAS.ti computer software for coding of common
themes (Friese, 2012). NM analysed the interviews by
category to determine common elements, patterns and
themes within each participant’s interview. These were
coded and compared across interviews to determine
dominant thematic areas within the content areas. To
ensure researcher reflexivity, NM, who is herself a Zulu
woman, kept detailed daily notes of personal reactions
to, and reflections on, interview content, which might
inform interpretation bias. Transcripts were then inde-
pendently reviewed by the second author (TJ) after
which all three authors reviewed the results to reach
consensus on the most salient themes, their organisation
and to explore aspects of researcher reflexivity.
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Results
The characteristics of participating women are shown in
Table 1. Their median age was 32 years (IQR 29–37);
their children’s median age was seven years (IQR 6.5–
7.5). Of the five women reported as married, two were
legally married and three were engaged; of those
reported as unmarried (n = 14), 12 had current partners
and approximately half were living with their current
partner. HIV exposure in the households was high with
most women (n = 14) reporting that another adult family
member was HIV-infected. The majority of women were
on ART (n = 14), with a median CD4 cell count of 430
(IQR 310–554) cells/ml; one woman eligible for treat-
ment had not accessed ART.
Table 2 presents people to whom the women had
disclosed their HIV status. More than half had disclosed
to their current partners (n = 13), half of whom were also
HIV-infected. Two women had not disclosed to anyone
due to fear of HIV-related stigma.
In total, the 20 women had 56 biological children,
aged 2–18 years, of whom 43 were reported to have been
tested for HIV and were HIV negative. One mother
reported that she had disclosed her HIV status to her 12-
year-old, HIV negative, child, a sibling of the study
child, prior to the intervention. Post-intervention, all
mothers had disclosed to their study children – 10 fully
(i.e., explained they had HIV) and 10 partially (i.e.,
explained they had a “virus” of whom six mothers
subsequently fully disclosed).
In data analysis two main themes emerged:
(1) Living with HIV and normalising ART.
(2) Love, partnerships and sex.
Theme 1: Living with HIV and normalizing ART
At the time of diagnosis, HIV testing had recently been
introduced into the study area, and HIV prevalence
amongst pregnant women was high (approximately
40%). This led to suspicion or disbelief about a positive
HIV test, for the women and some of their families:
You know when you are at the clinic and you are
checking and you ask one another: “How come we all
are found to be infected?” They must be playing with us.
You don’t pay attention to anything. When you suffer
from things such as headaches then you start paying
attention. (29-year-old)
However, given the increased access to ART in the years
following the VTS, the majority of women shared
experiences of living positively with HIV. Availability
of ART was considered a privilege previously denied to
many, and this changed how women perceived HIV:
At home we were eight, now only four are left. My sister
left a 9 month old child who is now 16 years old. So,
Table 1. Characteristics of the 20 women that were interviewed.
Study
Number
Maternal
age
(years)
Child
age
(years)
Child
sex
Marital
status
PMTCT
Site
Currently
employed
Bore child
after
index child
Last CD4 cell
count result
cells/ml
Currently
on ART
1 26 7 F Single Peri-urban No Yes 105 Yes
2 32 6 M Single Peri-urban No Yes 568 Yes
3 32 7 F Single Rural Yes Yes 379 Noa
4 44 8 M Single Peri-urban Yes No 800 Yes
5 46 7 M Married Peri-urban No No 700 Yes
6 36 6 F Married Peri-urban Yes No 297 Yes
7 37 7 M Single Rural No No 487 Yes
8 49 8 F Widowed Rural No No 219 Yes
9 28 6 F Single Rural No No 212 Yes
10 39 8 F Married Rural Yes No 467 Yes
11 28 7 F Single Rural No Yes 629 No
12 32 7 M Married Rural No Yes 518 Yes
13 37 7 M Single Rural No Yes 400 Yes
14 38 6 F Married Rural Yes Yes 350 Yes
15 31 8 F Single Rural No Yes 709 No
16 36 7 F Single Rural Yes Yes 459 No
17 28 6 F Single Rural No Yes 300 Yes
18 29 8 M Single Rural Yes Yes 320 No*
19 32 7 F Single Rural No No 540 No
20 29 7 F Single Rural No Yes 394 Yes
aAt the time of the interview ART eligibility criteria was ≤350 cells/ml.
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Table 2. HIV disclosure of participating women.
Study
number
In a relationship
with the child’s
father
Lives with
current
partner
Partner
HIV
positive
Aware of other adult
family members
with HIV
Disclosed to
current
partner
Disclosed
to parent
Disclosed
to sibling
Disclosed
to friend
Disclosed to
other
relative
Disclosed to
religious
person
Whom
disclosed
to first
1 No No No Yes No No No No Yes No Partner
2 No No No Yes Yes Yes Yes Yes Yes Yes Parent
3 No Yes Yes Yes No No No No No No No
disclosure
4 Yes Yes Yes Yes Yes No No No Yes No Partner
5 Yes Yes No No Yes Yes Yes Yes Yes Yes Parent
6 Yes Yes Yes Yes Yes Yes No Yes No No Partner
7 No Yes No Yes Yes No Yes Yes Yes No Sibling
8 Yes No Yes Yes Yes No Yes No Yes Yes Partner
9 No No Yes Yes Yes No Yes Yes No No Sibling
10 Yes Yes Yes Yes Yes No Yes Yes Yes No Friend
11 No No No No Yes No Yes Yes No No Friend
12 Yes Yes No Yes Yes No Yes Yes Yes No Partner
13 Yes No No Yes No No No No No No No
disclosure
14 Yes No No No Yes No No Yes No No Partner
15 Yes No No No No No No No No No Partner
16 Yes Yes Yes Yes Yes No No No No No Partner
17 No No No Yes No Yes No No No No Parent
18 No No No Yes No No No Yes Yes Yes Other
relative
19 No No No No No No No No Yes No Other
relative
20 No Yes Yes No Yes Yes Yes Yes Yes No Partner
Total 10 9 8 14 13 5 9 11 11 4
68
N
.B
.
M
kw
anazi
et
al.
AIDS Care
when we take pills [ART] now, we are taking them for
the reason that we had siblings who died without getting
help. Children were left without parents. I have survived,
and now free pills are available. (46-year-old)
Most women were taking ART, regularly attending ART
clinics and knew other HIV-infected people, which
helped to reduce stigma:
Sometimes you see others hiding by the corners when
they attend HIV clinics, I do no such [thing]! People are
taking their own pills for BP [blood pressure problems],
arthritis, why? They want to live. I’m taking ARVs
[antiretroviral drugs] because I want to live. If we all die,
the tomb does not say this one was killed by AIDS, this
one was killed by BP. We are all dead! When I go to the
clinic I even strut my stuff. I don’t care that ARVs have
made me have thin legs and flat buttocks, eish!
[Laughter]. (46-year-old)
There was a sense of HIV causing a chronic, rather than
fatal, illness and pride rather than shame in going to HIV
clinics:
Most of my neighbours are open now; we even lend
each other pills. They come and say we have come to
borrow our “teabag”. I was counting that I have been
taking ARVs for 10 years. We are going to push my
husband in a wheel barrow [when he gets sick] because
he does not want to test. (46-year-old)
As women settled into longer term HIV care they
became increasingly concerned about the quality of
health services and understanding more about their
illness. Women described becoming selective about
ART clinics based either on the quality of care received,
or on being able to attend the same clinic as a partner:
I also want to change from Clinic A to Clinic B, they are
not safe there. They sometimes give you pills that are
not enough. They are careless. I go to Clinic B because
my partner also took his ARVs there and sometimes we
can walk to town together. (26-year old)
Some women expressed confusion over the clinical
course of HIV infection, and were perplexed about the
relationship between CD4 counts and their physical
health:
I just started ARVs six months ago. When I checked I
discovered that my CD4 count was 112. I was beyond
shocked, I can’t explain it. I was dead walking. I felt
fine. I realised that is why people just drop dead. (37-
year-old)
Theme 2: Love, partnerships and sex
All women agreed that partnerships were complex and
discordant HIV results presented particular difficulties:
He showed me his negative results. I thought how can
I show him my positive result? I told my sister my fear
was if I say I’m positive he will say I am the one who
brought the virus. We discussed with my sister that we
have to plan how we are going to tell him because he has
to be protected and we should not practise unsafe sex.
(37-year-old)
When I disclosed, he did not want to accept it. He did
not fight me though; I think it is because he knows of his
ways. We continued getting other children. I also do not
want to lie; when I discovered my HIV status, it was not
such an issue. (29-year-old)
Women reported that some partners were accepting of
their HIV status, and supportive, despite discordant
results:
I am a kind of a person that discloses everything. I always
have my ARVs with me, openly. I’m visiting here but
I have them openly with my cosmetics. When I disclosed
to my partner he said: “I wonder how you got it”. I said
maybe I have had too many children, maybe I was
helping someone. He did not fight with me. He said he
was also going to go to the clinic to test and he did. He
goes every six months and is negative. Maybe he has
strong soldiers [CD4 cells] because they cannot detect it
[HIV]. I tell him he will end up starting treatment or
he will just fall and die but we are using condoms.
(32-year-old)
Some partners provided finances for women’s children,
although they were not the biological fathers. While this
made the partner more attractive, it also complicated
disclosure due to women’s fears of abandonment:
… on Thursday he said let’s go and see “o-small” [the
small ones, my children not his] and we first went to the
shop. I thought we were just buying snacks but he said:
“Don’t they eat? Take rice”. And we packed the trolley
and took the stuff to them. So, when you have such
people you don’t want to spoil things and you think this
is my last chance if I do not use it I will not find
someone like him. (32-year-old)
Despite knowing about safe sex, women articulated that
they were not consistent with condom use, talking about
their own weaknesses, rather than male coercion which
is often reported in the literature:
Sometimes there are things that make you weak and
your resistance crumbles. Sometimes it happens that
someone judges you and they think this one is fine she
has nothing. That mistake happens sometimes, I don’t
want to lie but it’s not an everyday mistake, I try to
avoid it. I try to be strict. (29-year-old)
Discussion
This qualitative study adds to the literature about the
lives of rural, African, women living with HIV, including
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their disclosure patterns (Stevens & Galvao, 2007; Varga
et al., 2006). We found high levels of stability in
partnerships with half the women still in a relationship
with the biological father of the child, only two of whom
had not disclosed to them. Approximately half the
women had disclosed to their partners first and their
broader family network subsequently, suggesting that
stability of partnerships (reflected by duration and co-
residency) is an important facilitator of partner disclos-
ure, as documented in the literature (Alemayehu, Aregay,
Kalayu, & Yebyo, 2014; Antelman et al., 2001; Bacha-
nas et al., 2013; Mayfield Arnold, Rice, Flannery, &
Rotheram-Borus, 2008; Medley et al., 2004). Our
finding that partners were generally described as being
supportive is similar to findings from other parts of
Africa and Asia (Deribe, Woldemichael, Wondafrash,
Haile, & Amberbir, 2008; Medley et al., 2004; Skuno-
dom et al., 2006). Importantly, for many women HIV
disclosure did not necessarily facilitate low risk beha-
viours, raising questions about the support couples might
need beyond the disclosure itself. The 2012 WHO
Couple Counselling Guidelines highlights that couple
counselling has not received programmatic attention
especially in situations of HIV sero-discordance (WHO,
2012), and studies have shown that couple counselling
support has an important role in facilitating long-term
ART adherence (Anglemyer, Horvath, & Rutherford,
2013; Brown et al., 2011).
High HIV prevalence rates in the study area, and the
political climate during women’s diagnosis at pregnancy,
led to suspicion about the existence of HIV, but women
reported gradual acceptance of HIV as a chronic illness.
In the early years of the epidemic there was significant
focus on stigma and its impact on testing, however, this
research suggests that, with increased access to treat-
ment, stigma is reduced (Maman et al., 2009), and most
women were living positively with HIV and taking ART
without fear. However, as they stabilised on ART their
needs changed and they expressed new concerns includ-
ing quality of health care and counselling support. With
large numbers of people attending HIV clinics, counsel-
lors are often trained to give generic information to
everyone to maximise efficiency, and seldom have time
to address individual concerns or for health promotion.
Counselling training curricula need to evolve to include
issues such discordant results in relationships (Dworkin
& Ehrhardt, 2007), the challenges of living with a
chronic disease and ART adherence (Rochat, Bland,
Coovadia, Stein, & Newell, 2011). Offering family-
centred, rather than individual, care may hold particular
advantages for women and their families in high
prevalence settings (Betancourt, Abrams, McBain, &
Fawzi, 2010; Kairania et al., 2010; Richter, 2010).
To date literature on gender and HIV has often
portrayed men as determinants of women’s HIV risk
(Dunkle et al., 2004; Greig, Peacock, Jewkes, &
Msimang, 2008), and while this is mostly correct, the
contribution of this research is important as it presents a
more assertive, women’s voice, with women gaining
autonomy over their health through access to care, and
the ability to make decisions about their sexual health.
The vast majority of research supporting a particularly
gendered perspective on risk is cross-sectional rather
than longitudinal, and may, by its design, preclude a
clear understanding of how women’s power and inde-
pendence in relationships may change over time in stable
partnerships. This research highlights that sexual health
resides within love relationships which are complex, and
it is this complexity that informs the decisions women
make in relation to HIV care.
Conclusion
The wide-scale roll-out of HIV prevention and treatment
programmes have brought about considerable changes
for women who are now surviving to parent children in a
society that has less HIV-related stigma. However, the
transition to longer term care raises new challenges,
including securing quality family-centred care and deal-
ing with disclosure in new sexual partnerships. The
narratives of this group of women contribute to under-
standing the challenges of African HIV-positive women
of childbearing age in the ART era.
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Abstract (300 words) 
The World Health Organization recommends disclosure of parental HIV to children aged 6-12 years. 
The maternal HIV-disclosure intervention (Amagugu), a lay counsellor-led, home-based 
intervention with six sessions, was implemented. The intervention included provision of 
disclosure tools, training and support for mothers, a family session and health promotion 
clinic visit for mothers and children. Amagugu demonstrated success as a maternal disclosure 
support programme but less is known about the experiences of participants. A sub-sample of HIV-
infected mothers (n=20) with primary school-aged HIV-uninfected children, from Amagugu, was 
purposely selected. Using semi-structured interviews and interview-guide, we explored maternal 
perceptions of disclosure prior to participation and experiences of participating in Amagugu. Audio-
recorded interviews conducted in participants’ homes, in isiZulu, were transcribed, and content 
analysis was undertaken. The most common reasons for prior non-disclosure were concerns about 
children’s developmental capacity to understand HIV, fear of HIV-related stigma towards mothers 
and their families, and lack of skills to undertake disclosure. Intervention materials, rapport with 
counsellors, and flexibility of the proposed disclosure process motivated mothers to participate. While 
expressing satisfaction with the intervention, some mothers remained concerned about their children’s 
understanding of HIV and ability to maintain confidentiality. Mothers also requested support in 
discussing sex-related topics with their children. Despite prior high rates of disclosure to other adults, 
mothers had little awareness about the importance of disclosure to children and lacked skills to 
undertake this. The intervention approach, rapport with counsellors, and practicality of the materials, 
helped overcome child disclosure barriers. Mothers reported their children as very supportive 
following disclosure and stated they would advise other women to disclose to children for practical 
support around HIV treatment adherence. This qualitative evaluation suggests that mothers with 
primary school-aged children may require structured support when disclosing to children, which 
could be achieved through supportive home-based counselling and user-friendly materials. 
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Introduction 
Advances in HIV treatment and prevention have resulted in fewer HIV-infected children born to HIV-
infected mothers (Burton, Giddy et al. 2015). HIV-exposed but uninfected children are a growing 
population with estimates suggesting that between 30-50 % of HIV-uninfected children in Sub-
Saharan Africa currently live with HIV-infected parents, most frequently their mothers (Short and 
Goldberg 2015). A growing body of literature on the impact of parental HIV on children has 
illustrated that these children are at risk of poor health and educational outcomes (Chi and Li 2013, 
Cluver, Boyes et al. 2013, Goldberg 2014, Jao, Hazra et al. 2016) and that their parents need support 
with the complexities of parenting with HIV (Rochat, Bland et al. 2011, Mkwanazi, Rochat et al. 
2012, Lachman, Cluver et al. 2014, Sherr, Cluver et al. 2014). An important issue facing all HIV-
infected parents is how and when to disclose their HIV status to their children and families.  
In 2011, based on growing evidence on the benefits of disclosure to children (Krauss, Letteney et al. 
2013), the World Health Organization (WHO) recommended that parents disclose their own HIV 
status to their children, between 6 and 12 years of age (World Health Organization 2011). Benefits of 
disclosure include improved family cohesion and mother-child relationships (Pilowsky, Sohler 
et al. 2000, Schrimshaw and Siegel 2002, Vallerand, Hough et al. 2005, Murphy, Marelich et 
al. 2009), improved maternal mental health, (Armistead, Klein et al. 1997, Wiener, Battles et 
al. 1998, Armistead, Tannenbaum et al. 2001, Schrimshaw and Siegel 2002, Brackis-Cott, 
Mellins et al. 2007), increased social support and improved maternal physical health due to 
improved ART adherence (Tompkins, Henker et al. 1999, Murphy, Steers et al. 2001, 
Letteney 2006). However, despite these reported benefits, disclosure rates are low (Qiao, Li 
et al. 2011, Mkwanazi, Rochat et al. 2012, Krauss, Letteney et al. 2013) and very little research 
on parental support to undertake disclosure has been conducted in low and middle income countries 
(Li, de Wit et al. 2015). A systematic review (Simoni, Yang et al. 2015) found only 13 disclosure 
intervention studies, 12 of which focused on adult disclosure while only one, the Amagugu 
intervention reported on here, focused on parental disclosure to children (Rochat, Arteche et al. 2014, 
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Rochat, Arteche et al. 2015) Amagugu is a low intensity intervention designed to be delivered by lay 
counsellors in a task shifting approach. It was developed through careful formative work (Rochat, 
Mkwanazi et al. 2013), and the conceptual framework (Rochat, Mitchell et al. 2016) and evaluation 
which found Amagugu to be acceptable and effective at increasing parental disclosure are described 
in detail elsewhere (Rochat, Mkwanazi et al. 2013, Rochat, Arteche et al. 2014, Rochat, Arteche et al. 
2015). The intervention led to high maternal disclosure rates (61% full disclosure with the mother 
using the words ‘HIV’, and 39% partial disclosure with the mother using the word ‘virus’). An 
uncontrolled evaluation study found that Amagugu led to substantial decreases in maternal and child 
psychological morbidity, and parenting stress, and helped mothers to communicate with their children 
about the nature of HIV, its treatment and the possibility of illness and death (Rochat, Arteche et al. 
2014, Rochat, Arteche et al. 2015). Children’s understanding of HIV and death remains an under-
researched area in epidemic regions (Rochat, Mitchell et al. 2017). Amagugu was an evaluation study 
with no control group; a randomised controlled trial of the intervention has recently been completed 
(NCT01922882).  
 
While Amagugu has been extensively reported on, less is known about the perspectives and 
experiences of the mothers participating in the intervention. Understanding maternal perspectives on 
participation is important because there is a growing recognition that participant engagement and 
involvement in intervention development and evaluation can improve outcomes (Armstrong, Herbert 
et al. 2013). It is argued that the successes of interventions at scale are strongly associated with the 
extent to which participants report feeling engaged in the intervention and consider it responsive to a 
clearly identifiable, relevant need. Qualitative research on participant perspectives can help 
researchers understand - at least indirectly- whether the intervention facilitated behaviour change in 
the manner conceptualised, and what facilitated or impeded its success. There is a dearth of literature 
on participant perspectives in health and social intervention research (Armstrong, Herbert et al. 2013, 
Brett, Staniszewska et al. 2014). The primary aim of this qualitative study was an in-depth exploration 
of HIV-infected mothers’ experiences of the Amagugu intervention.  
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Methods 
Setting 
This research took place at the Africa Centre for Population Health (Africa Centre), now Africa 
Health Research Institute (AHRI) (www.ahri.org). The research community is predominantly rural, 
isiZulu-speaking and impoverished, with one peri-urban area (Tanser, Hosegood et al. 2008). HIV 
prevalence amongst women attending antenatal clinics was estimated at 35% in 2012 (Department of 
Health 2012). Prevention of Mother-to-Child Transmission services were implemented in the sub-
district in 2001, and an HIV treatment and care programme providing antiretroviral therapy (ART) 
through public health facilities, was introduced in 2004 (Houlihan, Bland et al. 2010).  
 
Sample 
In this qualitative study (Mkwanazi, Rochat et al. 2015), we purposely recruited a sub-sample of 
twenty HIV-infected women, who were part of the larger Amagugu intervention evaluation (2010-
2012) of 281 HIV-infected women and their HIV-uninfected 6-10 year old children (Rochat, Arteche 
et al. 2014). To be eligible to participate in this qualitative study the women had to have been tested 
for HIV during pregnancy (Mkwanazi, Patel et al. 2008) as part of the Vertical Transmission Study 
(VTS) (Bland, Coovadia et al. 2010) and to have participated in Amagugu.  
 
Sample size and selection 
The sample size was determined by the time and resources available, and the expectation of reaching 
saturation with an estimated sample of 20-30 mothers (Mason 2010). Geographical area served as the 
main selection criteria to ensure participation of mothers across a variety of settings within the 
research population. The 20 women were purposely selected from nine geographic areas representing 
both peri-urban and rural settings. While mothers were purposely selected to represent all geographic 
areas, within each geographic area the mothers selected for the qualitative interview were randomly 
selected from the pool of mothers available. The researcher, using a list of participant identifiers 
(IDs), selected each tenth participating ID - by area – using a round robin technique until 20 
participants had been selected across all areas. After completion of the 20 interviews a preliminary 
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round of data analysis was undertaken, and the authors concluded that saturation had been reached, 
and no further mothers were recruited. 
 
The Amagugu Intervention 
The intervention included six home-based counselling sessions, led by a lay-counsellor. The 
counsellor provided the mother with specifically designed age-appropriate materials and tools to use 
during disclosure with the child. The counsellor did not intervene directly with the child; instead they 
provided training and support to the mother who then disclosed to her child independently. The 
sessions and the conceptual framework by which each session contributes towards disclosure are 
summarised in Figure 1, and a detailed description of the intervention is available in open access 
elsewhere (Rochat, Mitchell et al. 2016). By completion of the Amagugu intervention 170 (61%) 
women had fully disclosed their HIV status to their children using the words ‘HIV’ and 110 (39%) 
had partially disclosed their HIV status using the words ‘virus’ or ‘illness’(Rochat, Arteche et al. 
2014, Rochat, Arteche et al. 2015).  
 
Data collection 
The first author, a PhD candidate who is isiZulu speaking and from the local area, contacted each 
participating mother by phone and scheduled an appointment for a home visit to explain the study and 
invite participation. At this home visit the researcher obtained written consent, and immediately 
completed the semi-structured interview. The semi-structured interview guide addressed specific 
questions regarding women’s participation in the Amagugu intervention and their experiences 
of using the disclosure materials. All 20 women who were contacted and approached agreed to 
participate, and granted permission for the interviews to be audio-recorded. Interviews took place in 
the women’s homes, two months after completion of the Amagugu study, and each woman was 
interviewed once for approximately one hour. The first author also took extensive notes of non-verbal 
cues, and observed the home surroundings during the interviews, to inform the interpretation of the 
results. 
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Data triangulation 
Additional data were available and extracted (with participant consent) for each woman participating 
in the qualitative study from the main Amagugu database, including socio-demographic data collected 
at baseline in the Amagugu study. Data collected post-disclosure on what the women enjoyed most 
about the intervention were extracted from a post-disclosure interview which was part of the 
Amagugu study. Using the semi-structured interview guide, content areas, including motivations for 
participating in the intervention, whether mothers perceived the intervention to be valuable and 
relevant, their views on the intervention package, and children’s reactions following disclosure, were 
explored.  
 
Ethical considerations 
The study was approved by the relevant institutions. 
 
Data analysis 
The first author (NM) transcribed the audio-recordings verbatim and translated them from isiZulu to 
English. To familiarise herself with the data NM listened to the audio-recordings, read and re-read the 
transcripts several times (Burnard 1991), and developed a code list derived from the literature. After a 
thorough review of all data, the two co-authors independently generated their own code lists. 
Preliminary findings were presented and discussed amongst the three authors in an analysis meeting. 
The three code lists were discussed, reviewed to reach consensus and the final list was 
adjusted accordingly to reflect the thematic areas identified.  
Each mother’s data were organised to reflect her specific content areas based on responses to 
questions in the interview guide. NM then studied the content of the transcripts looking for patterns 
within data chunks across all women linked to each of the specific questions in the interview guide 
and the thematic areas raised by the mothers in response to these questions. The coding approach was 
deductive, based on the interview questions in the guide which were developed to cover common 
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areas in the patient engagement literature. In reviewing the data the researchers made an exhaustive 
code list of all the participants’ responses. This list was then summarised into a code book which was 
used to code all the transcripts and make comparisons across the participants to determine which 
experiences were common for most of all participants. A further data analysis meeting was convened 
and consensus reached on the main research findings. 
 
Results 
Table 1 shows socio-demographic information of mothers and their children. The median age of the 
women was 32 years (IQR 29-37) and of the children seven years (IQR 6.5-7.5). There were 
substantially more girl children in the sample (girls 13: boys 7), and mothers had predominantly 
undertaken full disclosure to the child as part of the intervention (full 16: partial 4). Almost all women 
(18/20) reported being in stable partnerships, half were living with their partners (9/18), and 
disclosure to partners was high (13/18). Most women were unemployed (14/20) and had attended at 
least some secondary school. The majority of mothers were on ART. When comparing these 
characteristics to those of the larger sample of Amagugu mothers, apart from the over-representation 
of girl children and mothers who had undertaken full disclosure, we did not find noticeable 
differences between characteristics of this sub-sample and the larger Amagugu study group.  
 
Following coding and counting, three categories of content areas were identified: 
1. Barriers to disclosure prior to intervention  
2. Facilitation of behavioural change towards disclosure  
3. Satisfaction with the intervention package and unmet intervention needs 
We present data for each of these categories, below.  
Category 1: Barriers to disclosure prior to intervention  
We summarised the codes reflecting what the mother reported had prevented them from disclosing 
prior to the intervention (disclosure barriers) along with the codes for aspects of the intervention 
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(facilitators) which the mothers reported motivated and facilitated their change towards child 
disclosure as part of the intervention. 
Child’s developmental capacity: n=11  
The most common barrier that prevented disclosure prior to the intervention was related to children’s 
developmental capacity, in particular their ability to contain information disclosed to them.  
‘There was that question in the beginning, that how can you tell such a young child about that? I told their 
father about Amagugu and he said, how can you tell a child that? But I said let’s do it!’ (44 year-old mother of 
an 8 year-old boy) 
 
‘I had told myself that I would disclose to my children when they were older and when I was sick. I have two 
children including a boy who is 15 years old and a 7-year old girl. I thought she was too young and even the 
boy I thought I was going to hurt him.’ (29 year-old mother of a 7 year-old girl) 
 
HIV-related stigma n=6 
More than a quarter of mothers cited fear of HIV-related stigma, which included worrying that the 
child may disclose to others, view the mother differently, or would be stigmatised themselves, as a 
reason they had not disclosed to their children prior to the intervention.  
 
‘I could not bring myself to tell her because I feared that she would go around telling other people.’ (49 year-
old mother of an 8 year-old girl) 
 
‘When the counsellor came and told me about telling my child about my HIV status I told her that I cannot tell 
my child about HIV because she is talkative.’ (26 year-old mother of a 7 year-old girl)  
 
Protective of child (n=2)  
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A minority of women perceived their children to be too sensitive to handle their mothers’ HIV 
information and therefore wished to protect them emotionally. 
‘As I said it was not easy because I knew it was going to sadden him…I don’t think I was going to tell them. Oh! 
I was going to say I will wait until they were older, but then again, it was going to be more difficult when they 
were older.’ (46 year-old mother of a 7 year-old boy) 
 
Mother’s capacity (n=1) 
One woman reported that she did not feel confident about her capacity to answer questions the child 
might raise during disclosure. 
‘With Amagugu they really helped us because how could you disclose to your child? Where can you even start?’ 
(31 year-old mother of an 8 year-old girl) 
 
Category 2: Facilitators of behavioural change towards disclosure  
Most women were motivated to move towards behavioural change around disclosure based mostly on 
the intervention approach and intervention content, materials and tools (n=11/20 or 55%). Some were 
motivated by the supportive relationship developed with the counsellor (n=5/20 or 25%); while others 
(n=4/20 or 20%) were motivated more by pragmatism, as the intervention was considered both 
important and timely, and allowed flexibility in the level of disclosure that could be undertaken.  
 
Each of these motivations is presented in greater detail below.  
 
Behavioural change motivated by the intervention approach, content, materials and tools (n=11) 
For over half of the mothers (11/20) the intervention approach and content was the primary 
motivating factor in facilitating behavioural change towards disclosure. Mothers reported that the 
intervention approach made the task feel more manageable, and the simplicity and user- friendliness 
of the materials made them feel empowered to undertake disclosure.  
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‘The way the intervention was presented had a big impact because we first learnt and then educated  our 
children. The materials made it easy.’ (31 year-old mother of an 8 year-old girl) 
 
Mothers reported that the intervention approach also increased their confidence in their abilities to 
communicate more generally.  
‘…What I was taught at the Amagugu gave me strength. I even got tricks on how to start with things such as 
playing; you know just from playing, something profound comes out….. This is where this thing [Amagugu] 
helps because you don’t just shout: “My child I am sick!” No, you start slowly, and tell them step by step.’ (39 
year-old mother of an 8 year-old girl) 
 
The mothers’ favourable perspectives on the intervention content were reinforced by their children’s 
positive responses to the intervention. This served to solidify that disclosure was a positive step, 
resulting in healthy parent-child interaction and communication with the child. That the intervention 
approach aimed to deal with HIV disclosure at a time when the parent was healthy and illness-free, in 
order to reassure the child, was important for mothers and children alike. 
 
‘There were pictures and when he saw pictures he got excited. He even had questions. What he enjoyed the most 
was that I am healthy; when he comes from school I am here, I have cooked, and he eats and goes out to play.’ 
(44 year-old mother of an 8 year-old boy) 
 
Behavioural change motivated by the supportive relationship with the counsellor (n=5) 
A second, but less common reason for being motivated to change disclosure behaviour was linked to 
the quality of the counsellor relationship, conferring trust and confidence, which was reported by 25% 
of mothers. These made reference to counsellor attributes which inspired a sense of trust and 
confidence in the intervention process. The counsellor was thus experienced as a supportive expert 
advisor and teacher who inspired mothers to undertake disclosure with children.  
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‘I learnt a lot from [the counsellor]… the way he communicated was so kind. He has love for the children and 
makes you feel welcome. He also taught me that you cannot underestimate children , because they know a lot.’ 
(32 year-old mother of a 7 year-old girl) 
 
Behaviour change motivated by the practicality and flexibility of the intervention approach (n=4) 
For a slightly smaller proportion of mothers (4/20) the pragmatic nature of the intervention, and the 
fact that it responded to what the mother considered to be a valid need (which she had been feeling 
concerned about) was what motivated the mother to make behavioural change towards disclosure, 
rather than the counsellor relationship or the intervention approach per se. 
 
‘Being sick without your children’s knowledge, when this disease is so common, is not good. I would advise the 
person to sit down with children and explain the situation so that children will know. (37 year-old mother of a 7 
year-old boy) 
 
The flexibility to adjust the intervention to the level of disclosure she preferred, and being able to start 
with partial disclosure and move towards full disclosure over time was an important attraction in 
moving forward with the intervention. It allowed the mother to feel she could take steps to protect her 
child (for example through education about universal protections) without having to enter into full 
disclosure, for which she did not necessarily feel ready. Interestingly for both of these mothers, their 
experience of undertaking partial disclosure led them to understand that their child was already 
receiving education about HIV in other settings, such as at school.  
 
‘I didn’t tell her directly that I have HIV because I thought she was still young. I was not specific. I taught her 
about the virus but I found out that she already knew a lot.’ (32 year-old mother of a 7 year-old girl)  
 
‘I told her that I am educating her about diseases. It is important that she does not use my toothbrush and my 
facecloth and to use gloves if there is blood. She told me that at school they also teach them about HIV. I did not 
tell her a lot of things because she is 7 years old, she is young.’ (26 year-old mother of a 7 year-old girl) 
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Category 3: Satisfaction with the intervention package and unmet intervention needs 
As illustrated in Table 2, mothers reported a variety of positive experiences in relation to the 
intervention approach and materials package, and highlighted various aspects of the intervention that 
yielded satisfaction. These were coded under four categories:  
Communication (n=6) These mothers stated that the increased communication and having tools to use 
to increase communication about health messages and family life with the child were the most 
satisfying parts of undertaking the intervention.  
Child capacity (n= 5) The opportunity to see the child’s capacity to understand health and to 
understand the mother’s HIV infection was the most satisfying part of undertaking the intervention 
with the child.  
HIV Education (n= 5) Access to, and use of, education tools about HIV as a disease (most especially 
the HIV body map) were the most satisfying part of undertaking the intervention with the child.  
Play and Health Promotion (n=4) Mothers reported that the play tools, including the activities and 
games, were the most satisfying part of undertaking the intervention. 
Beyond these aspects of the intervention and the specific intervention content, for a few women who 
had been ill since the intervention, the most satisfying aspect of the intervention was linked to the 
discovery, post-disclosure, of the child’s capacity to understand HIV, to provide support, and assist 
them in managing their illness and adherence to medication.  
‘I had boils on my breasts and I would be so hot that I would not know what to do. By 8pm I would be so 
drowsy, he would ask me: “How many pills do you take?” If I happen to fall asleep at 8pm I would feel water 
spilling on me as he tried to give me pills [ARVs] in my sleep.’ (32 year-old mother of a 7 year-old boy) 
 
‘She asks me all the time if I have taken my pills, even when they get finished she would tell me that your pills 
are running out. She is very supportive.’ (39 year-old mother of an 8 year-old girl) 
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All women, even those who were not ill, stated that the most beneficial aspect of disclosure was the 
support they received from their children after disclosure. While their original fears had been that they 
would be stigmatised by their children, on the contrary, most children were supportive. Mothers 
reported that their children assisted them with HIV medication adherence by reminding them to take 
their pills on time: 
‘Sometimes when I am upset I go to bed early, she would come, wake me up and say: “Mama it’s 8 o’clock you 
have to take pills.” (36 year-old mother of a 6 year-old girl) 
 
‘What makes me happy is that my children are now my alarm clock. Before, they were just looking at me taking 
pills and they could not even ask what the pills were for. Now, even when I have gone to sleep and if they did not 
see me taking pills, they would wake me up and ask ’: “Did you take the pills”? (46 year-old mother of a 7 year-
old boy) 
 
One aspect which mothers raised as a challenge that was not addressed by the intervention was the 
general taboo in Zulu culture around intergenerational communication about sex. Mothers expressed a 
desire for specific guidance (and tools similar to the HIV education tools which could provide 
assistance) with intergenerational communication around sexual behaviour and life as children 
become older. Mothers highlighted this as a significant need as they expected that, in due course, the 
discussions about the mother’s HIV might shift to exploring the mode of infection with HIV and that 
this provided an opportunity for parent-led sex education.  
 
‘You know that it is hard to talk about sex with children being a Zulu. As Zulus we regard that as being 
disrespectful….what is still difficult is an appropriate way of telling them. Yes there are other ways [of 
contracting HIV] but it is difficult to tell your child about sex.’ (46 year-old mother of a 7 year-old boy) 
 
‘I wish there could be something motivating children and educating them about how to conduct themselves and 
be careful about [dangers] in life.’ (39 year-old mother of an 8 year-old girl) 
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Absence of questions and lack of negative reactions by children following disclosure were perceived 
by mothers to mean that children did not understand disclosure: 
“I am saying maybe she forgot because things were just normal after I told her, nothing changed.” (32 year-old 
mother of a 7 year-old girl) 
 
Despite all mothers having disclosed to their children, a few questioned the effectiveness of the 
‘Safety Hand’ in ensuring that children maintained confidentiality. 
 
‘You cannot trust that they will keep quiet.’ 
NM: ‘Did you not use the Safety Hand? ’ 
‘I did but I think he will tell other people.’ (37 year-old mother of a 7 year-old boy) 
 
Discussion 
We find that our qualitative sample reflects closely the characteristics of the larger group of mothers 
who participated in Amagugu, except that in this sample we report an over-representation of girl 
children, and that more mothers had undertaken full as opposed to partial disclosure. There is some 
evidence in the literature (Qiao, Li et al. 2011) that mothers tend to disclose to girl children prior to 
disclosing to boy children, linked to expectations that the girl child will assist with caregiving during 
periods of illness. While the larger Amagugu study did not find these gender effects (Rochat, Arteche 
et al. 2014), it is important to consider that the views expressed in this research reflect those of 
mothers with a girl, rather than boy child. While this limits generalizability, the literature (Cluver, 
Boyes et al. 2013) suggests that girl children exposed to, or affected by, HIV are particularly 
vulnerable, thus these results make an important contribution to understanding how to approach 
support for that population.  
 
Children’s supportive behaviours, including expressed affection following disclosure that are reported 
in this study, have also been described in the disclosure literature (Tompkins, Henker et al. 1999, 
Schrimshaw and Siegel 2002, Brackis-Cott, Mellins et al. 2003). A significant role played by children 
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in assisting their mothers with adherence to clinic appointments and HIV treatment is beneficial for 
HIV-affected families and needs to be supported.  
 
Mothers in this study cited similar barriers to child disclosure as those highlighted in the literature. 
Specifically mothers were concerned about the children’s developmental capacity to understand HIV 
(Kennedy, Cowgill et al. 2010, Madiba and Matlala 2012, Gachanja, Burkholder et al. 2014, Li, Li et 
al. 2016), the potential negative psychological impact of disclosure on a child (Murphy, Roberts et al. 
2006, Murphy, Marelich et al. 2013, Qiao, Li et al. 2015), the potential effects of stigma particularly 
given the perceived inability of a child to contain information and not disclose to other people 
(Tiendrebeogo, Hejoaka et al. 2013, Jao, Hazra et al. 2016), and a lack of skills and confidence to 
undertake disclosure (Qiao, Li et al. 2011). We show that for the overwhelming majority of mothers, 
the Amagugu intervention has a powerful mobilizing effect, minimising these barriers and shifting 
mothers to change their disclosure behaviour.  
 
In the larger Amagugu study we reported high rates of current partnerships and disclosure to current 
partners. We demonstrated that full disclosure to a current partner prior to the intervention was 
associated with full disclosure to children in the intervention (Rochat, Arteche et al. 2014). In this 
sample we see similarly high rates of partnerships, disclosure to partners, and full disclosure to 
children. Importantly, we demonstrate here that at baseline, despite these relatively high rates of 
disclosure to significant adults in the mother’s life, mothers had not undertaken disclosure to their 
children. This finding suggests that if rates of disclosure to children are to be increased, additional 
interventions focused specifically on supporting disclosure to children are required to overcome 
barriers to child disclosure (Dass-Brailsford, Eckman et al. 2014, Edwards, Donovan-Kicken et al. 
2014, Gachanja, Burkholder et al. 2014). Interventions which focus on adult disclosure alone are not 
likely to increase disclosure to children (Kennedy, Fonner et al. 2015, Li, de Wit et al. 2015).  
 
We found that the supportive counsellor relationship played an important role in the mother’s ability 
to engage with, and achieve, intervention success. The quality of the participant-counsellor 
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relationship has been shown to influence outcomes in other research on home visiting programmes in 
southern Africa (Thurman, Kidman et al. 2014) and this may be particularly true in communities 
where stigma remains high and where mothers feel isolated. Other studies report HIV-related stigma 
as the most common reason for non-disclosure (Letteney and LaPorte 2004, Palin, Armistead 
et al. 2009, Qiao, Li et al. 2015). However, research conducted in this study area illustrates that 
access to HIV treatment and care has significantly reduced HIV-related stigma and women feel 
supported by their partners and families (Evangeli, Newell et al. 2014, Mkwanazi, Rochat et al. 2015). 
 
Our results show that specific facilitators play an important role in shifting a mother’s behaviour 
towards disclosure. Most importantly, mothers reported that the intervention approach, content, 
materials and tools, were the strongest facilitators in behaviour change toward disclosure. We have 
reported previously (Rochat, Mkwanazi et al. 2013) that mothers and counsellors in the pilot study 
highlighted the importance of the branding and presentation of the materials as central to their 
engagement with, what would otherwise be considered, a daunting task. Here we again demonstrate 
that the design of Amagugu as a user- friendly, interactive, participatory, activity-driven process, 
which provides age-appropriate games and activities, and makes learning about HIV a fun and 
engaging activity, contributes to successful engagement with disclosure (Rochat, Mitchell et al. 2016).  
 
That the intervention content, approach and materials matter is an important finding, particularly in 
resource-constrained settings where the design of intervention packages may be primarily driven by 
the need to keep costs to a minimum. However, it is plausible that the additional investment in 
materials which are colourful, engaging, practical and user-friendly, may make an important 
contribution to participant engagement with the intervention, and the resulting behavioural change. In 
the longer term, this may result in the intervention package becoming more cost effective, particularly 
since without this active engagement of the target population of parents, most community-based 
interventions aimed to enhance parenting would be ineffective (Staudt 2007).  
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There is substantial support in the literature on the importance of fostering participant engagement as 
a means to enhancing prevention and intervention outcomes (Snell-Johns, Mendez et al. 2004). There 
is also substantial evidence to suggest that increased engagement is related to improvements in 
prevention and intervention outcomes in research (Brown, Goslin et al. 2012). An important aspect of 
the Amagugu intervention, which is linked to the design of the intervention, is the flexibility with 
which mothers were allowed to adjust the intervention to meet their specific needs. Accommodating 
such variations, or allowing participant autonomy, may appear counter-intuitive to keeping 
intervention design simple and low cost, but we illustrate here that this removes barriers to 
behavioural change for participating mothers. This may serve to increase the applicability of the 
intervention to a wider audience of mothers with differing needs, capacities and circumstances. 
Further research is required to establish the cost-benefit ratios of providing a bespoke designed 
intervention package such as Amagugu, in a low-resource setting.  
 
Despite mostly positive results in terms of participant engagement in Amagugu, and the additional 
benefits of ongoing treatment support to mothers within the family, some new challenges were raised 
by participating mothers that were not addressed through the intervention content and approach. There 
were concerns that the ‘Safety Hand’, a tool provided by the intervention to assist mothers to 
negotiate confidentiality of their HIV status with their children, was not trusted by some mothers to be 
effective in achieving that purpose. Absence of questions and lack of negative reactions by children 
following disclosure made some mothers doubt whether their children had fully understood the 
implications of their HIV status. Mothers also highlighted that, as children become older, the 
relationship between a parent and a child demands additional knowledge in dealing with issues such 
as sex education (Bhana, Petersen et al. 2004, Visser, Finestone et al. 2012). Women expressed a 
desire for Amagugu to be augmented with materials on sex education, including teenage pregnancy, 
and they requested something to motivate and educate their children about how they should conduct 
themselves in social situations. An age-appropriate illustrated ‘Where do babies come from?’ sex 
education storybook has been developed by the authors, and was tested as part of the randomised 
controlled trial of the intervention recently completed and currently being analysed.  
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Limitations  
This study did not aim to address community stigma, however, future studies could assess the impact 
of maternal HIV disclosure on stigma outside the family setting. Women in this study had been 
exposed to two home-based interventions previously, the VTS and the Amagugu Study. 
Therefore, it is possible that they were more receptive to research involving their children and 
were more used to adhering to research procedures than other women, hence the high rates of 
maternal HIV-disclosure reported. It would be interesting to examine results from future 
studies using the same intervention materials, but enrolling HIV-infected women from the 
general population, who had not previously been involved in research. It is also possible that 
social desirability bias resulted in fewer mothers complaining about the intervention despite 
the researcher’s assurance that this would be acceptable. In the context of poverty, 
participants with very little access to services and support may not feel comfortable to give 
negative feedback about a programme designed to support them. Due to logistical constraints 
and ethical complexities, children were not interviewed directly. Future studies could, and 
most probably should, investigate children’s perspectives on maternal HIV disclosure. 
 
Conclusion 
It should not be assumed that adult disclosure will automatically lead to disclosure to children. 
Specific interventions are needed to support and encourage disclosure to children. The design and the 
practical content of the intervention, and investments in the branding and quality of materials, are the 
most important factors which elicit participant engagement. To a lesser extent the quality of the 
counselling support relationship also matters for mothers who have concerns about stigma. Providing 
mothers with the opportunity to engage their children in active participation about their HIV is highly 
satisfying to mothers, regardless of their circumstances. 
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Figure 1: Outline of the home-based sessions in the Amagugu Intervention with expected behaviour change paths (Rochat, Mitchell et al. 
2016) 
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Figure 2: Interview Guide 
1. What were your initial thoughts when you were first informed about the maternal HIV disclosure intervention? 
2. What made you decide to take part in the HIV disclosure intervention? 
3. Please take me through your Amagugu experience; what do you think worked for you and what do you think did not work for you? 
4. Did you choose to fully disclose or partially disclose your status as part of the intervention? 
5. Please share your thoughts on the disclosure materials that you were provided with to help you during disclosure process 
6. What do you think are the important lessons that you learned during the disclosure intervention? 
7. If giving advice to another HIV-infected mother who has not disclosed to her child, about disclosure, what would your advice be? 
 
  
29 
 
Table 1: Characteristics of mothers and their children (N=20) 
Study 
ID 
Maternal 
Age 
(Years) 
Child  
Age  
(Years) 
Child  
Sex 
Marital 
Status 
Employment 
Status 
Length of time 
on ART 
in Years 
Last CD4 
Cell 
Count 
Results 
cells/ml 
Type of 
Disclosure  
To Child 
Disclosed to 
Current 
Partner 
Lives with 
Current 
Partner 
1 26 7 F No current partner Unemployed 4 105 Partial No No 
2 32 6 M Current partner Unemployed 1 568 Full Yes No 
3 32 7 F Current partner Employed Not on ART* 379 Full No Yes 
4 44 8 M Current partner Employed 7 800 Full Yes Yes 
5 46 7 M Current partner  Unemployed 6 700 Full Yes Yes 
6 36 6 F Current partner Employed 1 297 Full Yes Yes 
7 37 7 M Current partner Unemployed 5 487 Full Yes Yes 
8 49 8 F Current partner Unemployed 6 219 Full Yes No 
9 28 6 F Current partner Unemployed 1 212 Partial Yes No 
10 39 8 F Current partner Employed 2 467 Full Yes Yes 
11 28 7 F Current partner Unemployed Not on ART 629 Full Yes No 
12 32 7 M Current partner Unemployed 2 518 Full Yes Yes 
13 37 7 M Current partner Unemployed 1 400 Partial  No No 
14 38 6 F Current partner Employed Less than 1 year 350 Full  Yes No 
15 31 8 F Current partner Unemployed Not on ART 709 Full No No 
16 36 7 F Current partner Employed Not on ART* 459 Full Yes Yes 
17 28 6 F Current partner Unemployed Less than 1 year 300 Full No No 
18 29 8 M Current partner Employed Not on ART* 370 Full No No 
19 32 7 F No current partner Unemployed Not on ART 540 Partial No No 
20 29 7 F Current partner Unemployed 3 394 Full Yes Yes 
*At the time of the study the cut-off for ART initiation was CD4+ T-cell count ≤ 350 cells/mm3 
 
30 
 
Table 2: Aspects of the intervention reported as key to maternal satisfaction 
Maternal satisfaction 
aspect 
Quotations from mothers in support of maternal satisfaction  
Communication (n=6) 
"I enjoyed that our talk brought back hope of life to me as we were 
talking.” 
"I enjoyed telling my child about my status and Family Life Line." 
"I enjoyed opening up to my child about the pills I take every day." 
"I enjoyed the Playing Cards and their messages the most." 
"I enjoyed our Family Life Line." 
"I enjoyed the Family Life Line the most because (before this) the 
child did not know about her father." 
HIV education (n=5) 
"I enjoyed the HIV Body Map the most." 
"I enjoyed explaining the HIV Body Map the most." 
"I enjoyed the Body Map because it helped to clarify my illness." 
"I enjoyed the HIV Body Map the most." 
"I enjoyed the HIV Body Map the most." 
Child’s developmental 
capacities (n=5) 
"I enjoyed that my child answered all the questions well when I 
confirmed that he understood.” 
"I enjoyed that my child showed more HIV knowledge." 
"I enjoyed that my child easily understood what we were talking about 
the most." 
"I enjoyed that my child easily understood what we were talking about 
the most." 
"I enjoyed that my child understood what we were discussing and had 
sympathy for me." 
Play and health promotion 
(n=4) 
"I enjoyed the Playing Cards and the Story Book the most." 
"I enjoyed the Playing Cards the most because my child understood 
the messages." 
"I enjoyed the Playing Cards the most." 
"I enjoyed the Playing Cards the most." 
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ABSTRACT 
Background: Primary health care clinics pro- 
mote health in addition to treating illness, but 
are often perceived as unfriendly and frightening 
places for children. This research aimed to im- 
prove child-friendliness in primary health care 
settings in a rural, high HIV prevalence area in 
South Africa. Methods: As part of a larger inter- 
vention (“Amagugu” Intervention) health staff in 
nine primary health care clinics were trained in a 
child-friendliness approach. 281 enrolled moth- 
ers were invited to attend clinic with their pri- 
mary school-aged children and assessed child- 
friendliness via structured questionnaires admi- 
nistered by independent assessors; a sub-group 
also participated in in-depth interviews. Post in- 
tervention, focus groups were conducted with 
87 primary health staff to determine their ex- 
periences of providing child-friendly services. 
Results: Mothers rated 65% of clerks and 70% of 
nurses as “very friendly”. Qualitative data show- 
ed that heavy clinical loads, limited human re-
sources and inadequate infrastructure were per- 
ceived as barriers to child-friendliness, while 
good clinic leadership and appropriate resour- 
ces facilitated child-friendliness. Post interven-
tion most health workers reported that child-fri- 
endly health promotion activities were rewarding. 
Conclusions: Providing child-friendliness train- 
ing and support to primary health care facilities 
in low-resource settings is feasible, acceptable 
and yielded encouraging results. 
Keywords: Primary Health Care; Child-Friendliness; 
Health Promotion; HIV; South Africa 
1. INTRODUCTION 
In South Africa HIV care is commonly delivered in 
primary health care clinics (PHCs) where health workers 
are instrumental in supporting good adherence to anti-
retroviral treatment (ART) [1]. In the family context 
HIV-uninfected children often play an important role in 
supporting their HIV-infected parents, including helping 
them to adhere to their medication [2-5]. Therefore, in-
creasing children’s access to health care support net-
works has the potential to improve health outcomes in 
families.  
However, PHCs are often not perceived as child- 
friendly spaces [6,7]. Barriers reported to lower child- 
friendliness includes inappropriate physical structures 
and job dissatisfaction or fatigue amongst health workers 
[8,9]. Facilitators include staff training on child-friend- 
liness and engaging children with toys and activities 
[10,11]. In resource-poor settings PHCs are often over- 
burdened, so health promotion is a low priority [12-14]. 
A multi-site study in Uganda, Kosovo and Pakistan 
found that children, parents and health workers shared 
frustrations with rigid health care structures and poor 
systems for disseminating health information [6]. Even 
in resource-rich settings health workers acknowledge the 
challenges of promoting health amongst children in pri-
mary health care [6,15]. 
Despite being home to most of the world’s families 
living with HIV, literature addressing the health care 
support needed by HIV-affected families in South and 
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southern Africa is minimal [3,12,16-18]. Most has fo-
cused on the utilization of health services by sick people 
[13,14,17,19,20] and suggests that children are often 
marginalised as they find health care facilities frighten-
ing [21,22] and do not understand the terminology being 
used [23,24].  
A family-centred HIV disclosure intervention, the 
“Amagugu intervention” [25], was developed and tested 
in rural South Africa to support HIV-infected mothers to 
disclose their HIV status to their 6 - 10-year-old, HIV- 
uninfected, children. The intervention was tested with 
281 families and found to increase maternal HIV disclo-
sure [25]. After disclosure the mother was encouraged to 
engage in a health promotion activity by taking her child 
with her to a clinic visit. The mothers were educated on 
the importance of early health promotion for children 
and provided with health education tools for use at the 
clinic visit. In addition, an intervention to support child- 
friendliness at the nine participating health facilities was 
developed and implemented. This research used qualita-
tive and quantitative methodology to explore health 
workers’ perceptions of delivering child-friendly services 
and presents maternal data to support improvements in 
child-friendliness as a result of this intervention.  
2. METHODS 
The research setting: This study was undertaken at 
the Africa Centre for Health and Population Studies 
(www.africacentre.com) in northern KwaZulu-Natal, 
South Africa, in a predominantly rural area with a high 
HIV prevalence [1,26]. Health care, including HIV care, 
is delivered through 17 PHCs and one district hospital 
with a comprehensive, decentralised, HIV Treatment and 
Care Programme [13,27,28].  
Research design: This research used both quantitative 
rating data from structured questionnaires administered 
to mothers, and qualitative data from focus groups with 
health workers and in-depth interviews with a sub-group 
of mothers. Mixed methodology was chosen because of 
its value in understanding health behaviours and percep-
tions in under-researched issues and populations [29,30].  
Health care initiative: A health facility intervention 
was developed specifically for this research, using par-
ticipatory qualitative techniques to increase its relevance 
and acceptability for health staff. Thereafter, the training 
was piloted at four of the nine implementation clinics, 
selected to include both rural and peri-urban settings. 
During piloting, dialogue and feedback were elicited 
from staff at participating clinics to finalise the training 
programme and clinic resources for a child-friendliness 
component (see Box 1). The training was then imple-
mented at the five remaining PHCs. The health worker 
training targeted a diversity of staff including nurses, 
HIV counsellors and clerks to maximise opportunities for  
Box 1. Health care educational materials provided as part of the 
Amagugu intervention. 
Materials provided for the children as part of the “Amagugu” 
intervention 
The Amagugu Name Tag: Each child was provided with a name 
tag to assist the child to have a sense of identity and pride, and 
serve as a visual reminder to health staff of their commitment to 
ensuring that children were welcomed in the clinic.  
The Clinic Checklist: The clinic checklist was designed as an “I 
spy” activity, to encourage the child to explore the clinic. It is a 
“learn by doing” tool which helped the child become familiar with 
the clinic processes (including patient registration and medical 
procedures); the infrastructure (including the waiting area and 
toilet); and to meet and engage with health care providers (in- 
cluding the clerk, other patients and the HIV nurse).  
The Uthando Doll: The larger intervention included a play-for- 
communication component where children were provided with 
ethnically-appropriate dolls. Children were encouraged to take 
their doll to the clinic and participate in “pretend play” of medical 
procedures such as checking temperatures and giving injections. 
Including the doll in the clinic activities encouraged the child to 
learn about medical procedures in a fun and non-threatening way. 
Clinic Visit Reminder Card: This A5 illustrated card was a re- 
minder tool for mothers, to help them organise, plan and execute 
the health care visit. The card also served as an advocacy tool in 
the clinic where the mother could use it as a reminder for busy 
health staff of the commitments to provide a child-friendly clinic 
visit.  
Materials provided for the clinic facilities 
Health promotion posters: An A3 poster was designed, titled “Let’s 
Make Clinics Child-friendly!”. The poster provided key health 
promotion messages and reminders about child-friendliness, inclu- 
ding: children should be welcome at clinics even when they are 
not ill, health care environments are spaces for information and 
advice, a health care support network is important for children 
whose parents have chronic illnesses, play is important for 
children to reduce anxieties and allow health promotion learn-  
ing.  
A Medical Play Kit: A commercially sourced medical play kit and 
an Uthando doll were provided to each HIV nurse to engage the 
child in health demonstrations. The play kit included a stetho- 
scope, thermometer, syringe and otoscope.  
Amagugu intervention materials: As part of the intervention mo- 
thers were provided with an HIV Body Map with stickers, and 
health promotion playing cards. These tools were also available in 
the nurses’ examination room during the child’s visit, so that the 
nurses could reinforce the messages mothers had taught their 
children during disclosure. 
 
 
improving the quality of interactions with children dur-
ing clinic visits.  
Data collection tools: Three data collection tools were 
utilized in this research: 1) Interviews with mothers (N = 
281): These structured interviews followed the health 
promotion clinic visit and collected maternal ratings of 
child-friendliness; 2) In-depth interviews with a sub-set 
of mothers (N = 20): A group of mothers were inter-
viewed at their homes two weeks after the Amagugu 
intervention, to explore their experiences of participating; 
3) Health care worker focus groups (N = 87): Focus 
groups were conducted with health staff at all nine par-
ticipating clinics, three months after the intervention. 
Focus group methodology was used to explore percep-
tions, opinions and attitudes towards child-friendliness. 
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Prior to the research we identified five key issues from 
the literature [10-12,19-21,31-33] which were important 
for the development and uptake of this kind of interven-
tion: 1) willingness to engage in child-friendliness; 2) 
activities to support child-friendliness; 3) barriers and 4) 
facilitators of child-friendliness; and 5) contributors to 
sustainability. These formed the basis of the focus group 
guide and were also used as guiding categories in focus 
group analyses.  
Data analysis: Quantitative data analysis: Mothers’ 
data from the post clinic interviews were entered into an 
Access database and imported into STATA 11 for analy-
sis. Descriptive statistics were used to quantify and de-
scribe the demographic characteristics of the participants 
including mothers and health workers. Qualitative data 
analysis: Focus groups and in-depth interviews were 
transcribed verbatim, translated from IsiZulu to English, 
imported into ATLAS. ti version 7 for analysis [34,35], 
and organised using the themes explored in the focus 
group and interview guides. Categories were reviewed 
for redundancy and similar codes and categories grouped 
under a single higher order category. Higher order cate-
gories which resulted from collapsing codes with similar 
ideas together reflected the important thematic areas 
linked to the focus group and interview guide categories. 
Ethics permissions: Approval was granted by the 
University of KwaZulu-Natal Biomedical Research Eth-
ics and the University of Witwatersrand Human Re-
search Ethics Committees.  
3. RESULTS 
Sample: All 281 HIV-positive mothers enrolled in 
Amagugu completed the health promotion training; their 
socio-demographic and health characteristics are shown 
in Table 1.  
Maternal intervention impact: Mothers’ experiences 
of the clinic visit, including ratings of child-friendliness 
of health workers are shown in Table 2. Almost all the 
mothers took their child to the clinic, with a third report-
ing waiting less than 5 minutes to see the nurse. Approxi- 
mately two-thirds of the mothers rated the clerks and 
nurses as “very friendly”, and most reported that the nurses 
had used the medical play kits and the childfriendliness 
posters, although only a third used the HIV Body Map.  
Characteristics of health workers participating in 
focus groups N = 87: Forty-one (47%) participants were 
nurses, 23 (26.5%) HIV counsellors and 23 (26.5%) 
clinic clerks. The median age of participants was 39 
years (IQR 31 - 49); six were male. Sixty two (71%) 
participants were from rural, 17 (20%) from peri-urban 
and 8 (9%) from urban clinics.  
Themes from the focus groups of health workers and 
in-depth interviews of mothers:  
Table 1. Maternal and child characteristics. 
Maternal characteristics   
Age (years)   
Median 35  
Range 23 - 54  
 N % 
Education   
No education 17 6.0 
Completed some or all primary 108 38.4 
Completed some or all secondary 148 52.7 
Post school education 5 1.8 
Missing 3 1.1 
Employment   
Employed 90 32.0 
Unemployed 188 66.9 
Missing 3 1.1 
Regular income   
Receives regular income 73 26.0 
Does not receive regular income 208 74.0 
Hospitalisation (<12 months)   
Yes 30 10.6 
No 250 89.0 
Missing 1 0.4 
CD4 count (most recent)   
≥501 77 27.4 
351 - 500 53 18.9 
≤350 71 25.3 
Missing 80 28.5 
HIV treatment status   
On ART (1) 118 42.0 
Not on ART (2) 155 55.2 
Missing 8 2.8 
Child characteristics   
Age (years)   
Median 7 7 
Range 5 - 10 5 - 10 
 N % 
Gender   
Female 140 49.8 
Male 141 50.2 
Hospitalization (since birth)   
Yes 43 15.3 
No 221 78.6 
Missing 17 6.0 
Copyright © 2013 SciRes.                                                                    OPEN ACCESS 
N. Mkwanazi et al. / Health 5 (2013) 2137-2145 2140 
Table 2. Maternal experiences of child-friendliness at the 
health promotion clinic visit. 
Mother reported data from clinic visit N = 281 
Did you take your child for a clinic visit?  
Yes 277 (98.58%)
No 4 (1.42%) 
Did your child wear his/her name tag?  
Yes 276 (98.22%)
No 5 (1.78%) 
Did your child meet the clerk  
and complete the register?  
Yes  263 (93.59%)
No  17 (6.05%) 
Missing 1 (0.36%) 
How would you rate child-friendliness 
of the clerk that you met?  
Very friendly 184 (65.48%)
Neutral 73 (25.98%) 
Unfriendly 5 (1.78%) 
Don’t know (did not meet one) 18 (6.41%) 
Missing  1 (0.36%) 
Did your child complete his/her clinic checklist?  
Yes 271 (96.44%)
No 8 (2.85%) 
Missing 2 (0.71%) 
Did you see the Amagugu child-friendliness 
poster at the clinic?  
Yes 259 (92.17%)
No 21 (7.47%) 
Missing 1 (0.36%) 
How long did you wait to see the nurse 
for the health care visit?  
<5 min 90 (32.03 %)
5 - 20 min 82 (29.18%) 
20 - 60 min 79 (28.11) 
>60 min 25 (8.90 %) 
Missing 5 (1.78%) 
How would you rate friendliness of the nurse?  
Very friendly 196 (69.75%)
Neutral 62 (22.06%) 
Unfriendly 3 (1.07%) 
Don’t know (did not see the nurse) 18 (6.41%) 
Continued 
Missing 2 (0.71%) 
Did the nurse use any of the following 
Amagugu educational tools?  
HIV Body map education tool 112 (39.86%)
Medical play kit 197 (70.11%)
Child-friendliness posters 233 (82.92%)
 
1) Willingness to participate in, and acceptability of, 
child-friendly initiatives and health promotion for chil-
dren 
The importance of children’s rights to friendly and 
accessible health facilities, emphasised in the training, 
resonated with most participants. In focus groups, dis-
cussion centred on beliefs about what a child-friendly 
clinic should or should not be. Participants felt that clin-
ics should represent safe and welcoming places where 
children were not discriminated against. One 47-year- 
old female nurse stated: “I think it (child-friendliness) 
means that if the child is below the age that they can go 
to the clinic by themselves, they should not be scared of 
going to the clinic when left alone at home and they have 
a running stomach. They should just have that confi-
dence that I’m used to going to the clinic and I know that 
they are going to help me. They can just go because they 
know that children are welcome at the clinic, they don’t 
get scolded and they are not in that frightened state.” 
Mothers agreed that the health promotion visit en-
couraged their children to visit the PHCs. A 49-year-old 
mother of an 8-year-old boy said: “From there (after 
disclosing) I started talking to him about positive living, 
and we continued educating each other about sickness 
and pills and I made him have an interest in going to the 
clinic and enjoy it. He used to be that person that fears 
going to the clinic; he feared that they will give him an 
injection. He ended up liking the clinic and being inter-
ested in going there and wants us to go there all the 
time.” 
A 36-year-old mother of an 8-year-old girl echoed the 
same sentiments: “Through participating in the Ama-
gugu intervention I got encouraged to go to the clinic 
because we sometimes forget. The child also enjoyed 
visiting the clinic”.  
2) Activities that support child-friendly initiatives 
Table 3 summarises the activities thought to support 
child-friendliness in the focus groups. 
3) Barriers to child-friendliness 
Busy clinical settings and inadequate human resources 
were cited as the most important barriers to child-friend- 
liness. A 38-year-old male nurse stated: “Sometimes it 
happens that the children come to the clinic and the 
clinic is busy in such a way that even if you want to give   
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Table 3. Activities supporting child-friendliness identified in focus groups. 
Activities which health workers believe support child-friendliness 
Actions required by health workers Statements made by health worker 
Orientate and welcome children 
 Come down to the level of the child 
and use developmentally appropriate 
language  
“Anyone who works there can come down to the level of the child and talk the language that is 
spoken by the child so that they can understand what the child is saying.” 
“This should be a place where children feel relaxed and at home.”  
Provide information and support 
 Offer reassurance to reduce fears and 
anxieties of clinics 
“It is easy for us, but for the children it is harder. They arrive with an attitude that you are the enemy. 
They have been told that back home. You try to reach out and the child pulls away. There was a child 
here this morning. The counsellor tried to play but the problem was that she was dressed as a nurse, 
the child became so quiet as if something had shocked him. You could see that he was quiet because 
he was very frightened.” 
“You wish to compliment them even on their clothing and say ‘you look so handsome young man’ but 
the child is just so scared that you are up to something.” 
Set boundaries for children 
 Set boundaries and explain acceptable 
behaviour in the clinic 
“It’s a problem when these school children visit the clinic. They can misbehave, make noise, ring 
their phones, play with wheelchairs and other stuff that helps patients. Then you have to show that 
no, what they are doing is wrong. Not because you don’t want them to come to the clinic but you 
explain that wheelchairs are not for playing but they are for very sick patients-maybe one day you 
will also be very sick and use a wheelchair or your parent.” 
Providing parental guidance 
 Demonstrate sensitive care to parents 
“Sometimes we have a problem because the child’s mother is harsh to the child in front of us and 
maybe even scolding them. We end up telling them not to do that.”  
 
them the attention they deserve as children you end up 
not doing it. You cheat them because of the bad timing. 
Maybe you are running around, delivering babies, im-
munising and maybe it’s only the two of you at the time 
and the child gets cheated of the attention they deserve.” 
A 42-year-old female nurse stated: “The workload is 
not an easy thing. Sometimes the mother comes with the 
child and the child does not get attention. Especially if 
the child is not sick, you only attend to the mother be-
cause you are pushing work and you don’t even have 
time to be playful with the child. It’s not easy in a busy 
clinic. You only attend to the illness and do what you are 
doing.” 
Some health workers supported the child-friendliness 
intervention but complained about the mothers and did 
not appear to appreciate the “service role” of the clinics 
that remain open until 16:30 hours. A 43-year-old female 
nurse complained about the mothers: “Maybe you can 
rectify with them (mothers) that they cannot come when-
ever because some mothers arrive at 4 pm and you have 
already locked the room and they say [Imitating the 
mother] “This is the only time I could come, I was told to 
come whenever”... then it will be like we have an attitude 
towards them whereas we know we have to attend to 
them.” 
A point of discord that featured strongly in the focus 
groups related to the gap between being willing to prac-
tise child-friendliness and not having the tools or human 
resources to do this. A 36-year-old female counsellor 
stated: “Yes, we try our best (to be child-friendly) but 
there are no toys or fun things that the staff can use. We 
do not have enough time for it because this is a busy 
clinic and we have many patients with different sick-
nesses.” 
The lack of child-friendly spaces was frequently raised, 
as one 30-year-old female HIV counsellor stated: “Be-
cause there is no place where the children can play as 
children, so sometimes it can appear as if they are not 
taken good care of, but it (child-friendliness) is doable.” 
Participants also highlighted that health care work was 
emotionally draining, and at times they felt overwhelmed 
with critically ill patients. For example, a 40-year-old 
female nurse stated: “Maybe it is [hard] because children 
that come for health promotion are not sick. They have 
an image they are expecting—they expect that they will 
find a person that will be smiling and then they are met 
with not what they expected... It’s not that you want to be 
like that but you have this load.” 
4) Facilitators of child-friendliness 
Participants discussed ways to be child-friendly in the 
face of staff shortages. One idea was to share tasks 
among health workers. A 39-year-old female HIV coun-
sellor’s idea was: “... we can choose this Room 2 and 
have a counsellor that will just attend to them (children) 
and it could be fun whilst the mothers are consulting 
nurses with their many files. The counsellor can just keep 
them busy.” 
Participants agreed that the Amagugu materials as-
sisted them despite working in an overcrowded, rural, 
clinic. A 25-year-old female nurse was pleased with the 
intervention and stated: “We orientate children using 
Amagugu materials and we are able to present health in- 
formation in a fun-filled way. They start there at the front 
desk by the clerk and we try to welcome them. Sometimes 
the time is against us but we try. Sometimes they just get 
excited and jump if they recognise Amagugu stuff”. 
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For many participants, the ability to be child-friendly 
was connected to the leadership of the clinic, and how 
emotionally supportive they were to the health staff. In 
one clinic the sister-in-charge was regarded by the clinic 
staff to be “loving and caring”; participants from this 
clinic reported that it was easy to follow her lead. A 44- 
year-old female general assistant made the following 
statement: “We are grateful for Clinic X because the 
mother [referring to the sister-in-charge] that is manag-
ing, the supervisor, is loving. Even when she is busy she 
can allocate someone else to take children around. This 
is a friendly clinic to anyone, not just children.” 
5) Sustainability of child-friendly initiatives and re-
wards for participating health staff  
Participants highlighted, and recognised, the value of 
providing kind and sensitive care to children for their 
own sense of wellbeing and pride in their work. This 
made child-friendliness easier to maintain and sustain. 
This was most commonly expressed in participants’ en-
joyment of children’s expressed aspirations to become 
health care providers themselves. A 42-year-old female 
nurse gave the following example: “We greet them (chil-
dren), we welcome them very nicely and ask them who 
they are, and introduce ourselves and even ask them 
‘what would you like to study to be (when you grow up)’? 
Some even say, ‘I would like to study to be a nurse’. 
Maybe it is because we have talked to them nicely”. 
A 55-year-old nurse stated: “I was happy to see them 
(the Amagugu children) because of their cleverness. 
Even the way they do things. You can see that if these 
children can continue with this thing they have started, 
they can be able to help even the person they meet on the 
street. ... You enjoy being with them even if it is for a 
short period. If we can have enough time it would be 
wonderful”. 
Participants felt that the activities in the intervention 
package encouraged a positive interaction between them 
and the children. A 42-year-old female nurse explained 
how they participated in the intervention: “They have 
these name tags and use the playing cards that you gave 
us and the doll. They end up seeing themselves as health 
workers. For instance if you give them a stethoscope and 
let them use it. They see themselves as doctors or see 
themselves as nurses”.  
A 40-year-old female nurse was impressed by some of 
the Amagugu children that came for the health promo-
tion visit: “What I can say is there are those that are 
quiet and those that are open..... we had twins, one twin 
was quiet and the other one was energetic and talking 
about HIV and saying what she learnt at Amagugu, 
showing how the HIV enters the body”.  
A 34-year-old male nurse expressed his exciting ex-
perience of interacting with the study children: “The one 
(child) that I saw was clever and was asking questions, 
she was checking out the stethoscope and asking ‘is this 
for seeing inside’? She even wanted to leave with the doll 
and was putting it in her bag. They come with different 
ideas and expectations. Like the one that came and said 
‘I am here to work’. That child ended up ordering for her 
mother: ‘Give my mother this one, check her BP, use the 
thermometer’. When that Amagugu child came and said I 
am here to work, I got interested and thought ‘that is an 
idea’ and wanted to see and I said ‘let’s work’. It be-
comes fun”. 
Participants talked of the challenges of performing 
painful procedures on children, and the important role 
played by the intervention materials in making children 
less frightened of the clinics. A 40-year-old female nurse 
said: “... to know what is happening in the clinic is im-
portant—sometimes painful stuff like injections-but it is 
important for children to get the knowledge. For instance 
because there are these play kits, we can demonstrate 
that your child is sick, s/he must get an injection. It’s 
important that the child knows that sometimes an injec-
tion is needed in order to get better”. 
A few people were not enthusiastic about the child- 
friendly intervention. One 40-year-old female nurse re-
ported that even though the intervention was there, she 
sometimes forgot about it.... but when she remembered 
she tried to be friendly to children. She said: “I beg to 
differ. I don’t have the same views because we don’t 
have time for these children. I for instance, forget about 
them and find myself asking them: “Who are you by the 
way?” Because I’m seeing someone that is disturbing me 
while I’m busy and then I remember and I try to do 
damage control.” 
A 28-year-old female counsellor agreed and went on 
to say: I agree with [referring to Nurse] when they (chil-
dren) come we are really busy, I did not even know who 
they were. I just heard Igugu, but I did not know what 
Igugu was. I did not even attend to them because here at 
Clinic X it’s really busy. Things are turning upside down, 
and it’s not a child’s play. I don’t want to lie I have not 
entertained them (children).  
4. DISCUSSION 
This study demonstrated that providing training and 
simple tools for child-friendliness and health promotion 
in a resource-poor, high HIV prevalence area was well 
accepted by health workers and mothers. This interven-
tion was specifically aimed at the large group of HIV- 
uninfected but exposed children, on whom there is lim-
ited literature regarding their psychosocial support [18]. 
However, the child-friendliness approach that was intro-
duced has benefits for all children irrespective of their 
HIV status.  
Encouragingly, most health workers believed that 
child-friendliness was a good idea, an important step in 
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eliciting behaviour change [36,37]. Nevertheless, most 
admitted they had not considered this before the inter-
vention, an observation supported in the literature which 
suggests that health professionals lack awareness of the 
importance and benefits of child-friendliness [15]. In our 
study, health workers suggested activities to support 
child-friendliness, not all of which included purchasing 
materials or tools, but also recognising that they could 
draw on their instinctive caring and parental instincts to 
improve their communication with children during their 
consultations. Some suggested allocating specific people 
to attend to the children where possible, a model fre-
quently was adapted in resource-rich settings [6,32], but 
not feasible in many poorer settings. Indicators of child- 
friendliness in previous reports have included whether 
the environment was conducive for child play, whether 
toys and health promoting activities were provided, and 
whether someone had been allocated to lead play [10,11, 
32].  
Participants in the focus groups also appreciated the 
role of health promotion, despite the clinics being over-
whelmed with sick patients. Health promotion enables 
people to increase control over, and improve, their health 
[15], and participants were surprised by the knowledge 
of the relatively young children in this project around 
HIV issues, and their enthusiasm to learn more. Children 
of different ages and with different illnesses may need 
different types of health promotional support. Increasing 
opportunities for child participation in clinic visits may 
improve the quality of health care provider relationships.  
Many barriers to implementing child-friendliness were 
highlighted, mainly resulting from the great burden of 
HIV and tuberculosis at the clinics, leading to inadequate 
space for additional activities, and exhausted health staff 
[8,9]. These high levels of occupational stress have not 
only been reported in high HIV prevalence countries 
including South Africa [9] and Uganda [8] but also re-
source-rich settings including England [38]. The problem 
of dealing with painful procedures was also identified, 
with participants suggesting that children themselves can 
present barriers to engaging with health staff because of 
their innate fear of PHCs, something highlighted in pre-
vious research [10,21,22,24,39,40]. However, partici-
pants recognised the role of play in helping children un-
derstand about medical procedures. 
Participants expressed their appreciation of the chil-
dren’s responses to child-friendly activities, using words 
such as “fun”, “happy” and “enjoy” when describing 
their encounters with the children in this intervention. 
Often health workers in resource-poor settings are criti-
cised for their lack of motivation and poor attitude to 
patients [9], but the demands on them are immense. Pro-
viding training on child-friendliness appeared to be 
something that health workers appreciated, responded to, 
and found rewarding. An important point brought up by 
one participant was the clinic leader being a good role 
model. She explained that being friendly to all children, 
and in fact to all patients in her clinic was something that 
was easy to do as the sister-in-charge provided a loving 
and empathetic example. Placing more emphasis on the 
qualities of the person in charge of PHCs has the poten-
tial to change the overall quality of services provided. 
Further, interactions with children which are rewarding 
may help to re-sensitise busy over burdened nurses in 
their caring role.  
This was a small study in a specific geographic area. 
However, the findings are likely to resonate with other 
areas of southern Africa with similar problems. While 
some South African research exists to guide the use of 
play in health settings and the provision of psycho-social 
support for children [12,16,41,42], very little research 
has examined children’s own experience of health care 
services. The existing evidence base is limited to a few, 
mostly qualitative studies in Europe, Australia and North 
America [11,19,33,43]. It would be important to explore 
children’s experiences in future studies.  
In conclusion, ensuring child-friendly services at 
health facilities not only helps to establish a productive 
and trusting health care relationship but also prepares 
children for periods of illness and hospitalisation [10,33]. 
Although child-friendliness and health promotion are not 
priorities in PHCs in resource-poor settings, introducing 
them has the potential to improve the experience of 
health visits for children and their parents and be re-
warding for health workers. 
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 The Clinic Visit Guide for Clinic Staff 
Amagugu aims for the clinic visit:  
 To work together with clinic staff towards developing a more child 
friendly clinic 
 To extend children’s social support network 
 To familiarise children with clinics  
Guiding principle 
Children have a right to have access to information on health promotion and 
prevention and treatment 
Why do we want a child friendly clinic? 
 Most of our clinics are not child friendly 
 Clinics are extremely busy 
 Nurses are often focused on illnesses 
What is a child friendly clinic? 
A child friendly clinic puts children’s interests at its heart and does not 
discriminate. Children are then able to: 
 Visit clinics freely without fear 
 Feel loved and cared for at the clinic 
 Get good healthcare and health education at the clinic 
 Get a chance to laugh and play at the clinic 
 Feel better and valued when they leave the clinic 
Amagugu tools for making a child friendly clinic 
1. Child’s name tag 
2. Clinic visit checklist 
3. Marking pen 
4. Doll 
5. Body map (with stickers; red dots for HIV, spears and shields) 
6. Medical play kit (with stethoscope, BP machine, syringe for injection, 
thermometer, and ophthalmoscope). 
7. Amagugu poster 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
What is Amagugu Project requesting from the clinic staff? 
Amagugu child will present themselves to a clinic staff with the following: 
 Their name tag 
 A clinic visit checklist 
 A marking pen  
Why a name tag? 
 It has each child’s unique name so that the child can have a sense of 
belonging 
 The child can feel proud and have ownership of the clinic 
 The child can be easily identified when s/he comes to the clinic 
Why a clinic checklist? 
 It helps orientate a child to clinic surroundings 
 A child can move around the clinic and feel sense of ownership 
 A child can engage in conversations with other people in the clinic 
We request that the clinic clerk: 
 Be friendly to Amagugu children when they visit the clinic 
 Greet and introduce themselves to the child 
 Tell them the name of the clinic 
 Tell them the name of Sister-in-charge 
 Tell them the name of the doctor 
 Show them the clinic register and record their names on it 
 Tell them the telephone number of the clinic 
 
 
We request that the nurse: 
 Be friendly to Amagugu children when they visit the clinic 
 Greet and introduce themselves to the child 
 Play a quick card game with the child 
 Offer the child a play medical kit to play with and show the child what 
each tool is for 
 Examine the mother if she has come for a regular check-up or pretend 
to examine the mother if the mother has not come for a regular check-
up while the child plays with their kit 
“Today I will put a smile on a child’s face because s/he is the future” 
Thank you very much for your cooperation! 
                                                                                                                                                                         Study ID __________ 
                                                                                                                                                                                 Child No__________ 
V-3 February_25_ 2011                                                                                                                                                                             Page 1 of 6 
 
Africa Centre                     Amagugu Project (Family-Based Disclosure)                                                
 
Form 2: Baseline Information – BLI - Visit 1 
 
Form completion details 
 
  Form completion date                                Field worker                   Study ID 
Y Y Y Y M M D D 
 
   
 
   
 
 
 
1. Study child’s details 
Child 1 
     Surname                                                                                    Date of birth                            
 
 
Y Y Y Y M M D D 
 
 
  First name 
 
 
                 Second name 
 
 
Gender:  
 
O Female O Male 
 
 
2. Clinic details 
 Which is your nearest clinic? Please tick one of the following: 
          
O KwaMsane O Nkundusi O Madwaleni O Machibini O Other 
O Mpukunyoni O Gunjaneni O Hlabisa O Khula  If other, specify 
O Mtuba O Somkhele O  Cingci O Ezwenelisha ____________________ 
 
 Which clinic do you use most of the time?______________________________________ 
____________________ 
_____________________ 
 
 
 
3. Information about the father of the study child 
3a. Is the study child’s father still alive? O Yes O No  If No go to q4 
3b. Are you still in a relationship with him? O Yes O No If No, go to q 3d   
3c. Does he live with you? O Yes O No       If Yes go to  q3e  
3d. Where does he live? O Hlabisa 
district 
O Elsewhere O Don’t know 
3e. Does he provide for the child financially? O Yes O No 
 
4. Please tell me about the adults you live with.  Do you live with?  
(Interviewer:  This question refers to persons age 18 or older who live with the respondent)  
 Adult children(Children 18 or older) O Yes O No/ Not applicable O No response 
Your  siblings (sister/ brother) O Yes O No/ Not applicable O No response 
Husband O Yes O No/ Not applicable O No response 
Boyfriend O Yes O No/ Not applicable O No response 
Your father/ mother O Yes O No/ Not applicable O No response 
Relatives O Yes O No/ Not applicable O No response 
Friends or other adults  O Yes O No/ Not applicable O No response 
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5. Mother’s employment details  
Are you working? O Yes O No     If No go to q 5.1 
If yes, do you work full or part-time? O Full-time O Part-time 
 Do you work on: 
i. Saturday O Yes O No O Sometimes 
ii. Sunday O Yes O No O Sometimes 
iii. Public holidays O Yes   O No O Sometimes 
 
What time do you start work?    hour       min  What time do you finish work?    hour   min  
 
5.1 Other source of income 
Do you receive any social security grants? O Yes  O No 
What types of social security grants do you receive (please tick all that apply)  
  Old age  Disability  Social relief of distress 
 
  Child support    for how many children    
 
            Foster care    for how many children    
 
          Care dependency    for how many children    
 
Do you receive any remittance on a regular basis?    O Yes O No     
If Yes, from whom?____________________________ What amount? R_______________ 
 
Do you partake in any other income generating activities (selling snacks from home, frequent catering, etc)?  O Yes       O No 
If Yes, please describe:____________________________________________________________________________________ 
 
 
6. Mother’s physical assessment 
6a. Are you on ART?  O Yes O No If No go to q6c 
 
 6b.If yes, when was this commenced?   Y Y Y Y M M 
 
If can’t recall:- O ≤ 12 months  
 O > 12 months O Don’t know 
   
6c. Which clinics do you attend for your HIV treatment/ care?   
 
6d. What was your most recent CD4 count result?        O Don’t know O Not done If not done go to q7 
 
6e. When was it done?    Y Y Y Y M M        If can’t recall:- O ≤ 12 months        O > 12 months O Don’t know 
 
 
 
 
 
 
 
                                                                                                                                                                         Study ID __________ 
                                                                                                                                                                                 Child No__________ 
V-3 February_25_ 2011                                                                                                                                                                             Page 3 of 6 
 
7. Children 
How many biological children do you have in total? (All  children <18 and >18 years  
old)                                                                                                                                                                          
 Please list below children <18 years who are alive and 
deceased. 
Name of the child Gender Alive Dead Date of birth Name of the father Alive Dead DK 
1. O M   
O F 
O O 
 
Y Y Y Y M M D D 
 
 O O O 
  
2. O M   
O F 
O O Y Y Y Y M M D D 
 
 O O O 
 
3. O M   
O F 
O O Y Y Y Y M M D D 
 
 O O O 
 
4. O M   
O F 
O O Y Y Y Y M M D D 
 
 O O O 
 
5. O M   
O F 
O O Y Y Y Y M M D D 
 
 O O O 
 
6. O M   
O F 
O O Y Y Y Y M M D D 
 
 O O O 
 
7. O M   
O F 
O O Y Y Y Y M M D D 
 
 O O O 
 
8. O M   
O F 
O O Y Y Y Y M M D D 
 
 O O O 
  
9. O M   
O F 
O O Y Y Y Y M M D D 
 
 O O O  
      
10. O M   
O F 
O O Y Y Y Y M M D D 
 
 O O O  
 
 
8. Child feeding information 
How did you feed other children after Mamanengane child? (for first 6 months)    O Not applicable (N/A) 
Child category Name of child Feeding mode for first  6 months (indicate by the abbreviation 
of the feeding modes given below) 
1st child   
2nd child   
3rd child   
4th child    
5th child   
*Feeding modes:  
 1) Exclusive breast feeding (EBF)    2) Formula feed only (FFO)      3) Mixed breast feeding (MBF) 4) Other (OTH) 
5)  Exclusive breastfeeding < 6 months (BRF) 
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9. Study child’s school and care-giving arrangements 
 Please list all crèche and/schools your child has attended 
Name of crèche/school Grade Year 
   
   
   
   
Name of current school:_________________________________________ Current grade:___________________________ 
Do you have any travelling plans for the study child during school holidays over the next 6 months?   O Yes      O No  
If No, go to q10 
If yes, (i)When? _____________________________ ______(ii) For how long?   _____________________________________ 
 
 
10. Study child’s hospitalization 
Has the Mamanengane child been hospitalized since birth?   O Yes       O No.    If No, go to q11  
 If yes,  
(i) How many times  
(ii) What was the diagnosis given to you on each admission? 
_______________________________________________ 
_______________________________________________ 
_______________________________________________ 
_______________________________________________                                                                 
______________________________________________ 
 
11. Vaccination.  
Please tick vaccinations received. Use RTHC and Maternal recall 
Age of child Vaccines Tick appropriately 
At birth (a) BCG O Yes O No O Don’t know 
(b) OPV O Yes O No O Don’t know 
6 weeks (a) DTaP-IPV.HiB (1) O Yes O No O Don’t know 
(b) Hep B (1) Hepatitis B vaccine O Yes O No O Don’t know 
10 weeks (a) DTaP-IPV.HiB (2) O Yes O No O Don’t know 
(b) Hep B (2) Hepatitis B vaccine O Yes O No O Don’t know 
14 weeks (a) DTaP-IPV.HiB (3) O Yes O No O Don’t know 
(b) Hep B (3) Hepatitis B vaccine O Yes O No O Don’t know 
9 months (a) Measles vaccine (1) O Yes O No O Don’t know 
18 months (a) DTaP-IPV.HiB (4) O Yes O No O Don’t know 
(b) Measles vaccine (2) O Yes O No O Don’t know 
6 years (a) Td vaccine O Yes O No O Don’t know 
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Africa Centre                     Amagugu Project (Family Based Disclosure) 
 
Form 2: Baseline Information (BLI) – Twin 2 details – Visit 1 
 
1. Study child’s details – Twin 2 
 
Surname                                                                                         Date of birth                            
 
 
Y Y Y Y M M D D 
 
 
  First name 
 
 
 Second name 
 
 
Gender:  
 
O Female O Male 
   
 
 
2. Study child’s school and care-giving arrangements – Twin 2 
 Please list all crèche/schools your child has attended 
Name of crèche/school Grade Year 
   
   
   
   
Name of current school: 
Current grade: 
Do you have any travelling plans for the study child during school holidays over the next year?   O Yes    O No If No, go to q3 
If yes,   
(i)When? _______________________________________(ii) For how long?   ______________________________________ 
 
 
3. Child’s hospitalization – Twin 2 
Has the Mamanengane child been hospitalized since birth?   O Yes       O No.   If No, go to q 4 
If yes,  
(iii) How many times  
(iv) What was the diagnosis given to you on each admission? 
_______________________________________________ 
_______________________________________________ 
_______________________________________________ 
_______________________________________________                                                                 
_______________________________________________  
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4. Vaccination.  
Please tick vaccinations received. Use RTHC and Maternal recall  
Age of child Vaccines Tick appropriately 
At birth (c) BCG O Yes O No 
(d) OPV O Yes O No 
6 weeks (c) DTaP-IPV.HiB (1) O Yes O No 
(d) Hep B (1) Hepatitis B vaccine O Yes O No 
10 weeks (c) DTaP-IPV.HiB (2) O Yes O No 
(d) Hep B (2) Hepatitis B vaccine O Yes O No 
14 weeks (c) DTaP-IPV.HiB (3) O Yes O No 
(d) Hep B (3) Hepatitis B vaccine O Yes O No 
9 months (b) Measles vaccine (1) O Yes O No 
18 months (c) DTaP-IPV.HiB (4) O Yes O No 
(d) Measles vaccine (2) O Yes O No 
6 years (b) Td vaccine O Yes O No 
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Africa Centre                          Amagugu Project (Family-Based Disclosure) 
 
Form 17: Clinic visit follow-up and child experience  - Visit 6 
 
Form completion details 
 
   Form completion date                                  Field worker                    Study ID 
Y Y Y Y M M D D 
 
   
 
   
 
 
 
Child’s education 
 (Note for field worker: Before starting to ask the mother about the child clinic visit, check about child’s schooling)  
 
1. Name of school/crèche currently attending  
  
2. Current grade   
 
 
 
Mother’s experience of the clinic visit 
 
3. Did you take your child to the clinic visit? 
 
O  Yes (if yes to go q4) 
 
O  No 
 
If No, specify the reason(s) and stop the questionnaire here. (If child has not been to clinic, stop here and rebook 
the appointment for later date). 
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________ 
 
 
4. Which clinic did you go to?         Date           Y Y Y Y M M D D 
 
 
5. At what time?  H H M M 
 
     
6. Did the clinic visit reminder card help you to prepare for the health care visit?       O Yes         O No      O Don’t know  
 
7. Did your child wear his/her name tag?                                                                              O Yes        O No 
 
8. Did your child meet the clerk and complete the register?                                             O Yes        O No  If No, skip to q10 
 
9. How would you rate the friendliness of the clerk at the clinic? 
O  Very friendly   O  Neutral     O  Unfriendly  
 
 
10. Did your child complete his/her clinic checklist?                                                          O Yes      O No   
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  11. Did you see the Amagugu clinic poster at the clinic?                                    O Yes       O No 
 
12. How long did you wait to see the nurse for the health care visit? H H M M 
 
  13. Did your child see the nurse and complete the health care  visit?             O Yes       O No     If No, skip to q16 
 
  14. How would you rate the friendliness of the nurse who did your health care visit? 
 
      O Very friendly O Neutral  O Unfriendly  
 
  15. Did the nurse use any of the following in the demonstration? (tick those that were used by the nurse) 
 
□ Doll          □ Medical Play kit            □ Body map                      □ Posters 
 
     
  
 
 
Child’s experience of the clinic visit 
 
Ask the child: 
I understand that you went to the clinic with mum: 
 
16. Did you like going to the clinic with your mother?               O Yes          O No        O Don’t know 
 
17. Why do you think it is important for children to go to the clinic with their mothers? 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________
________________________________________________________________________________________________ 
 
 
18. What would make your clinic a nicer place for you to visit? 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________ 
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________ 
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Child competency on family support 
19. When we started Amagugu project, we did the family tree together. Can you tell me who helps mum look after you? 
Name Relationship 
  
  
  
  
  
  
  
  
  
  
 
Experience of the materials   
 
Instruction: Don’t prompt the child by naming any material: 
20. Mum did some fun things with you at home as part of this project.  Can you tell me what you remember doing? 
__________________________________________________________________________________________________ 
__________________________________________________________________________________________________ 
__________________________________________________________________________________________________ 
__________________________________________________________________________________________________ 
__________________________________________________________________________________________________ 
 
21. Remind the child of each material and ask them what they liked about each of them 
Activities                           Comments (can include no response/ don’t remember) 
a. Family life line _____________________________________________________________________ 
b. Body Map _____________________________________________________________________  
c. Playing cards _____________________________________________________________________ 
d. Disclosure hand _____________________________________________________________________ 
e. Story book _____________________________________________________________________ 
f. Clinic checklist 
g. Doll 
_____________________________________________________________________ 
_____________________________________________________________________ 
  
22. Which activity did you like best? (Please select only one option) 
O  Family life line 
O  Body Map 
O  Playing cards 
O  Disclosure hand 
O  Story book 
O  Clinic checklist 
O  Doll 
 
NOTE: PLEASE PHOTOGRAPH THE CLINIC CHECKLIST BEFORE YOU LEAVE 
 
 
1 
 
 
Amagugu Project Pre-Disclosure Training Questionnaire for Clinic Staff 
 
 
Form completion date 
Y Y Y Y M M D D 
Age 
  
Sex 
F M 
Number of biological children that are below 18 years 
  
Occupation……………………………………Role/responsibility (e.g. ART nurse)…………………................................................. 
 
Clinic………………………………………………………. 
 
 
1. In your role in this clinic approximately how many children do you see per day?.......................... 
 
2. Are children allowed to come and explore this clinic even if they are not sick?                 O Yes       O No 
 
If No why not?...................................................................................................................................................................... 
…………………………………………………………………………………………………………………………………………… 
………………………………………………………………………………………………………………………………………….…
……………………………………………………………………………………………………………………………………………. 
3. Do you have health promotion information that you distribute to children aged 6-10 in this clinic?      O Yes       O No 
 
If yes, what kind of health promotion information do you offer children?......................................................................... 
……………………………………………………………………………………………………………………………………… 
………………………………………………………………………………………………………………………………………. 
4. Have you given 6-10 year old children information about medical conditions such as HIV and TB?          O Yes       O No 
 
How do you feel about giving 6-10 year old children information about HIV and TB?......................................................... 
.………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………. 
5. When children come to consulting rooms, do you offer them anything to make them less nervous? 
 
O Yes      O No      O Not Applicable (I do not consult children) 
 
If Yes, what do you do or what do you offer them?…………………………………………………………………………… 
................................................................................................................................................................................................ 
……………………………………………………………………………………………………………………………………………. 
……………………………………………………………………………………………………………………………………………. 
6. Does this clinic have any play materials such as, books, crayons, paper and toys that are suitable for children between 
ages 6-10?         O Yes      O No 
 
If Yes, what kind of play material is there?....................................................................................................................... 
................................................................................................................................................................................................
................................................................................................................................................................................................ 
…………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………… 
 
P.T.O.  
2 
 
Child friendliness 
Below is Amagugu Project definition of child friendliness. Please read it before you answer questions that follow.  
Clinics can be made a fun place for children as opposed to scary. Friendly and welcoming clinic staff is what children need in 
order to feel free to approach clinics whether they are sick or are just seeking health information. In the clinics healthy living 
information can be presented in a fun way that children can easily understand. 
7. When you read the above definition of child friendliness, would you say this clinic is able to achieve this? 
 
O Yes      O No      If Yes why? If No why not?................................................................................................................. 
……………………………………………...................................................................................................................................
..........…………………………………………………………………………………………………………………………………… 
…………................................................................................................................................................................................ 
………………………………………………………………………………………………………………………………………….. 
 
Disclosure of mother’s HIV infection to children 
Many HIV-infected mothers are giving birth to HIV-uninfected children due to access to ARVs. One of the challenges faced by 
HIV-infected mothers from this community is whether to disclose their HIV infection to their children or not.  
 
8. Do you think it is important for HIV-infected mothers to disclose their HIV status to their children?         O Yes      O No
 
If Yes, why? If Not, why not?............................................................................................................................................... 
................................................................................................................................................................................................ 
…………………………………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………… 
 
 
9. In your opinion at what age should HIV-infected mothers disclose their HIV status to their children?............................. 
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Africa Centre                     Amagugu Project (Family- Based Disclosure) 
Form 20: Health update – Visit 7 
 
Form completion details 
 
  Form completion date                                     Field worker                    Study ID 
Y Y Y Y M M D D 
 
   
 
   
 
 
 
 
 
Introduction: When I interviewed you at the beginning of this project, I asked you about your health and now I want to 
check if anything has changed since then. 
 
1. At the start of the project, were you on ART?       O Yes (skip to q3)        O No  
 
2. Since then, have you started ART? 
                   
                  O Yes                              O No (skip to q4) 
 
 
  
3. Which clinic do you attend for your HIV treatment/ care?   
 
 
4. What is your recent CD4 count result?             O Don’t know     O Not done   (stop the questionnaire here) 
     
                                                                                                               
5. When was it done?    Y Y Y Y M M              
 
 
 
 
 
 
 
 
 
 
 
 
Amagugu Project Clinic Staff Focus Group Discussions Guide 
1. Child friendliness 
 What kinds of things do you think of when someone says a clinic should be child 
friendly? 
Would you say this clinic is child friendly? If yes why and if not why not? 
 Is being child friendly an easy thing to do? 
 Are there opportunities to show friendliness to the children at this clinic? 
 Are there any barriers to being friendly to the children that come to this clinic? If yes 
what are they? 
 What can be done to remove barriers to child friendliness in this clinic?  
 How do you feel about talking to 6-10 year olds about medical conditions such as HIV  
 
2. Maternal disclosure of HIV infection 
 What are the advantages and disadvantages of an infected mother disclosing her HIV 
status to a child? 
 What can be done to help mothers disclose their HIV status easily? 
 
 
RESEARCH OFFICE 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
 Westville Campus 
Govan Mbeki Building 
Private Bag X 54001  
Durban  
4000 
KwaZulu-Natal, SOUTH AFRICA 
Tel: 27 31 2604769 - Fax: 27 31 2604609 
Email: BREC@ukzn.ac.za  
Website: http://research.ukzn.ac.za/ResearchEthics/BiomedicalResearchEthics.aspx 
26 October 2010 
 
Dr Ruth Bland 
Africa Centre for Health and Population Studies 
PO Box 198 
Mtubatuba 
3935 
 
Dear Dr Bland 
 
PROTOCOL: Family Based Disclosure: A support programme for HIV-positive mothers, their 
children and families. The isiZulu name for this project is "Amagugu" which means 
"treasures". The title is hoped to capture the value and potential of each child, and our 
responsibility to do as much as we can to give them a good start in life. REF:BF144/010 
 
The Biomedical Research Ethics Committee (BREC) has considered the abovementioned 
application.  
 
The study was provisionally approved by a quorate meeting of BREC on 10 August 2010 
pending appropriate responses to queries raised. Your responses dated 27 September 2010 to 
queries raised on 31 August 2010 have been noted by a sub-committee of the Biomedical 
Research Ethics Committee.  The conditions have now been met and the study is given full 
ethics approval and may begin as from 26 October 2010.    
 
The following related study documents have been reviewed and approved: 
 
Amended Information Sheet 
Materials development reference group  
Clinical Care Intervention and Research Agenda family Based Disclosure 
Maternal assessment tools  
Child assessment tools  
Study Information sheets and Consent forms  
 
Please provide details regarding University of Witwatersrand PhD registration and 
approval as they become available.  
 
This approval is valid for one year from 26 October 2010.  To ensure uninterrupted approval 
of this study beyond the approval expiry date, an application for recertification must be 
submitted to BREC on the appropriate BREC form 2-3 months before the expiry date.  
 
Any amendments to this study, unless urgently required to ensure safety of participants, must 
be approved by BREC prior to implementation.  
 
Your acceptance of this approval denotes your compliance with South African National 
Research Ethics Guidelines (2004), South African National Good Clinical Practice Guidelines 
(2006) (if applicable) and with UKZN BREC ethics requirements as contained in the UKZN BREC 
Terms of Reference and Standard Operating Procedures, all available at 
http://research.ukzn.ac.za/ResearchEthics11415.aspx. 
BREC is registered with the South African National Health Research Ethics Council (REC-
290408-009). BREC has US Office for Human Research Protections (OHRP) Federal-wide 
Assurance (FWA 678). 
 
The following Committee members were present at the meeting that took place on 10 August 
2010:  
 
Professor V Rambiritch  Pharmacology (CHAIR) 
Professor D J Pudifin  Medicine 
Mrs P Naidoo  External 
Dr Z Khumalo KZN Health (External) 
Dr U Govind Private Pract. – Gen. Practitioner 
Ms J Hadingham External 
Mr R Moore  IPO – Research Office  
Prof Puckree Physiotherapy 
Dr M A Sathar  Medicine  
Professor S Collings  Psychology 
Prof R Bhimma Paediatrics and Child Health  
Dr S Paruk Psychiatry 
Ms T Esterhuizen Statistics 
Professor T E Madiba General Surgery  
Dr T Hardcastle  Surgery – Trauma  
 
We wish you well with this study.  We would appreciate receiving copies of all publications 
arising out of this study. 
 
Yours sincerely 
 
 
PROFESSOR D R WASSENAAR 
Chair: Biomedical Research Ethics Committee 
 
 
 



 
Amagugu - Africa Centre Family Based Disclosure Project 
AMAGUGU RESEARCH PROJECT - STUDY INFORMATION SHEET 
 
WHO ARE WE?  
We, Amagugu Team at the Africa Centre are doing research on disclosure of parents’ HIV status 
to their children.  
 
WHO WILL BE INVOLVED IN AMAGUGU AND HOW LONG WILL IT LAST? 
We are inviting you and your child/ren to participate in this research study. If you also want to 
include other members of your family you are welcome to do so, however, we would also like 
their permission. We would like to visit you in your home five times over a year. 
 
WHAT ARE WE TRYING TO LEARN? 
Research is just the process to learn the answer to a question. In this study we want to learn 
when, where and how mothers disclose their HIV status to their children.  
 
WHY IS THIS IMPORTANT? 
Some studies show that disclosure of maternal HIV infection may be beneficial to her child, 
helping the child to understand why the mother attends clinic, takes pills and sometimes has to 
go to hospitals. Therefore we want to help mothers before, during and after the disclosure 
process. 
 
WHAT WILL IT MEAN IF YOU PARTICIPATE IN AMAGUGU? 
We would like to visit you in your home five times over a year. During these visits will talk to you 
about the process of disclosing your own HIV status to your child/ren. We will not tell your child 
your HIV status, and many of these sessions will take place with you alone. We will provide you 
with materials, games, and activities to use with your child/ren which will help you to explain to 
them what HIV is. You will only be expected to disclose your HIV status to your child/ren if, and 
when, you feel ready. We will provide you with a cell phone so that you can contact your 
counsellor at any point if you wish for extra support. Part of the study involves a visit to your 
clinic nurse so that your child/ren can be introduced to them, learn more about the clinic and get 
to know at least one of the nurses at the clinic. In addition to talking to you about disclosure we 
will ask you and your child some questions during some of the visits, so that we can assess the 
effect of the support package.  
 
HOW MAY YOU AND YOUR CHILD BENEFIT FROM BEING IN AMAGUGU? 
We will work closely with the HIV Treatment and Care Programme leader, and coordinators, to 
ensure optimal care and support for you and your family. Any child found to be physically unwell 
will be offered referral to the family clinic, which is run by Dr Ruth Bland at one of the local 
government clinics. Further psychological help will be offered by senior psychologist, Ms 
Tamsen Rochat.  
 
IS THERE ANY DISADVANTAGE FROM BEING IN AMAGUGU? 
We realize that in some places HIV carries with it fear of stigma and discrimination. We will 
endeavour to keep all information relating to the project confidential, and we will not reveal your 
HIV status to others. 
 
WILL THERE BE ANY CHARGE FOR AMAGUGU? 
There will be no charge for participating in Amagugu.  
 
WHAT IF I CANNOT DECIDE NOW OR I CHANGE MY MIND LATER?  
Refusing to participate in the study or withdrawing at anytime will not result in penalty or loss of 
benefits. If you do not wish to decide now whether you want to participate we can come back 
later when you have had more time to think about this.  
 
WHO WILL SEE THE INFORMATION THAT WE COLLECT? 
All records will be kept completely confidential. Only senior members of the study team will have 
access to the information once it is collected. We would also like to access the information 
collected on you and your child in the original ‘Mamanengane’ or Vertical Transmission Study.  
 
WILL THE INFORMATION COLLECTED BE USED FOR ANYTHING ELSE? 
Yes some of the information collected will be used by one of the researchers for PhD (higher 
degree) purposes but confidentiality will still be maintained. 
 
 
WHO TO CONTACT IF YOU WANT TO KNOW MORE, OR IF YOU HAVE A PROBLEM AT ANY TIME? 
If you want more information on Amagugu before deciding on whether or not to participate, or if 
you participate in Amagugu and later have questions, please call: 
 
Dr. Ruth Bland Africa Centre, Mtubatuba, 
Tel: 035 550 7500 
 
Ms. Tamsen Rochat Africa Centre, Mtubatuba, 
Tel: 035 550 7500 
 
Ms. Ntombizodumo Mkwanazi 
Tel: 035 550 7500 Africa Centre, Mtubatuba, 
 
Contact details of BREC Administrator or Chair – for reporting of complaints/ problems: 
Biomedical Research Ethics, Research Office, UKZN, Private Bag X54001, Durban 4000 
Telephone: +27 (0) 31 260 4769 / 260 1074 
Fax:   +27 (0) 31 260 2384 
Administrator: Ms P Ngwenya  Email:  ngwenyap@ukzn.ac.za 
Chair: Email: Prof D R Wassenaar  c/o ngwenyap@ukzn.ac.za  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amagugu Project - Africa Centre  
CTP - Consent to participate in Family Based Disclosure Project 
 
I understand the benefits and difficulties of participating in Amagugu Project and also the 
implications for myself, my child/ren and my family. I understand that participation is voluntary 
and I am free to stop at any time. I understand that if I choose not to participate there will be no 
repercussions for my child/ren, myself, and my family. The study has been explained to me 
orally. I have been given a chance to ask questions and I know who to contact if I have 
questions later on. I also give permission for the study team to access the data collected on my 
child and myself in the original ‘Mamanengane’ or Vertical Transmission Study.  
 
Signature: _________________________________ 
 
 
Name: ____________________________________ 
 
 
Date: _______/ __________/ ______________ 
 
 
WITNESS 
 
Signature: _________________________________ 
 
 
Name: ____________________________________ 
 
 
Date: _______/ __________/ ____________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amagugu Project - Africa Centre 
CFFM - Consent for family member to participate in Family Based Disclosure 
Project 
 
I understand the benefits and difficulties of participating in Amagugu Project and also the 
implications for myself and my family. I understand that participation is voluntary and I am free to 
stop at any time. I understand that if I choose not to participate there will be no repercussions for 
myself and my family. The study has been explained to me orally. I have been given a chance to 
ask questions and I know who to contact if I have questions later on.  
 
 
Signature of family member: _________________________________ 
 
 
Name of family member: ____________________________________ 
 
 
Date: _______/ __________/ ______________ 
 
 
Signature of mother: _________________________________ 
 
 
Name of mother: ____________________________________ 
 
 
WITNESS 
 
Signature: _________________________________ 
 
 
Name: ____________________________________ 
 
 
Date: _______/ __________/ ____________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amagugu - Africa Centre Family Based Disclosure Project 
CFC CONSENT FOR CHILD  
 
I agree to allow my child/ren to participate in this family based disclosure study. I understand that 
I can give my child consent to participate but if my child does not want to participate he/she has 
the right not to take part in the activities without any repercussions to me or my child. My child 
will be asked if he/she would like to verbally assent to being involved in the study. The response 
will be recorded by my child or the researcher on the consent form. 
 
I understand that my child is participating freely and without being forced in any way to do so. I 
understand that my child can stop being involved at any time if s/he chooses. I understand that 
my child might like to take part in some activities and not others - s/he is free to do this. I also 
understand that I can stop any session at any point should I not want my child to continue and 
that this decision will not in any way affect me or my child negatively. 
 
I also give permission for the study team to access the data collected on my child in the original 
‘Mamanengane’ or Vertical Transmission Study.  
 
I have received the telephone number of a person to contact should I need to speak about any 
issues which may arise. 
 
 
………………………………………..   ………………………... 
Signature of mother      Date 
 
 
………………………………………..   ………………………... 
 
Verbal/written assent of child     Date 
 
 
…………………………………………   ………………………… 
Signature of translator (if applicable)   Date 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amagugu Project - Africa Centre  
Study Information Sheet for the interviews 
Greetings: Good day. Thank you for allowing us to visit you again.  
 
Introduction: You would remember that we have been visiting you for the Amagugu 
Study and filling in some forms with you. Now, we would like to interview you about 
your experience of participating in the Amagugu disclosure intervention.  
 
What is involved in the interviews? We would like to have in-depth interviews for 
approximately one hour with some of the mothers that were involved in the Amagugu 
study.  
 
What are we trying to learn? We would like to learn more about the mothers’ feelings 
regarding maternal HIV disclosure to HIV-negative children, their thoughts on the 
materials that they were provided with to help them disclose to their children. The 
information we will collect will be analyzed and used by Ntombizodumo Mkwanazi for 
her studies in the University of Witwatersrand.  
 
Why is this important? Some studies show that disclosure of maternal HIV infection 
may be beneficial to her child, helping the child to understand why the mother attends 
clinic, takes pills and sometimes has to go to hospital. Therefore, we want to understand 
the physical and psychological situation of mothers before, during and after they have 
taken part in the disclosure intervention so that future disclosure interventions may be 
designed better.  
 
Invitation to participate: We are inviting you to take part in the in-depth interviews. 
 
Risks of participating in the Amagugu Study in-depth interviews for you and your 
child: We realize that in some places HIV carries with HIV-related stigma and 
discrimination. We will endeavour to keep all information relating to the project 
confidential, and we will not reveal your HIV status to others. We do not foresee any 
difficulties if you participate in the interviews because you already participated in the 
Amagugu Study.  
 
Benefits of participating in the Amagugu Study in-depth interviews for you your 
child: We are working closely with the HIV Treatment and Care Programme leader and 
coordinators, to ensure optimal care and support for you and your family.  
 
Will there be any charge for participating in Amagugu Study in-depth interviews? 
There will be no charge for participating in the in-depth interviews. 
 
What if I cannot decide now or I change my mind later? Refusing to participate in the 
in-depth interviews or withdrawing at anytime will not result in any penalty or loss of 
benefits. If you do not wish to decide now whether you want to participate in the in-depth 
interviews we can come back later when you have had more time to think about this.  
 
Who will see the information that we collect? All recordings and transcripts of the 
interviews will be kept completely confidential. Only senior members of the study team 
will have access to the information once it is collected. Amagugu study numbers instead of 
names will be used to identify you and. However, if required by law we will have to 
disclose personal information.  
 
Who to contact if you want to know more, or if you have a problem at any time? 
If you want more information on Amagugu before deciding on whether or not to 
participate, or if you participate in Amagugu and later have questions, please call: 
 
Ms. Ntombizodumo Mkwanazi 
Tel: 035 550 7500 Africa Centre, Mtubatuba, 
 
Dr. Ruth Bland Africa Centre, Mtubatuba, 
Tel: 035 550 7500 
 
Dr. Tamsen Rochat Africa Centre, Mtubatuba, 
Tel: 035 550 7500 
 
Contact details of Wits Research Office– If you want to complain about the way the 
research is being conducted please contact Anisa Keshav, Wits Research Office, 10th 
Floor Senate House, East Campus at 011-717-1234 Fax: 011-717-1265 Email 
anisa.keshav@wits.ac.za  
 
Alternatively you can call Mduduzi Mahlinza at Africa Centre Community Engagement 
Office. Tel: 035 550 7500 Fax 035 550 7565. Email mmahlinza@africacentre.ac.za 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amagugu Project - Africa Centre  
Consent to participate in the interviews 
I understand the benefits and difficulties of participating in Amagugu Project interviews 
and also the implications for myself and my family. I understand that participation is 
voluntary and I am free to stop at any time. I understand that if I choose not to participate 
there will be no repercussions for myself and my family. The study has been explained to 
me orally. I have been given a chance to ask questions and I know who to contact if I 
have questions later on.  
 
Signature of mother: _________________________________ 
 
 
Name of mother: ____________________________________ 
 
 
Date: _______/ __________/ ______________ 
 
 
WITNESS 
 
Signature: _________________________________ 
 
 
Name: ____________________________________ 
 
 
Date: _______/ __________/ ____________ 
 
 
 
Amagugu - Africa Centre Family-Based Disclosure Project 
AMAGUGU RESEARCH PROJECT - STUDY INFORMATION SHEET FOR CLINIC STAFF 
 
WHO ARE WE?  
We, Amagugu Team at the Africa Centre are doing research on disclosure of parents’ HIV status 
to their children.  
 
WHO WILL BE INVOLVED IN AMAGUGU AND HOW LONG WILL IT LAST? 
We are inviting you to participate in this research study. We are asking you to complete the pre-
and post disclosure training questionnaire. We might ask you to participate in focus group 
discussions later.   
 
WHAT ARE WE TRYING TO LEARN? 
Research is just the process to learn the answer to a question. In this study we want to learn 
about your views on maternal disclosure of HIV status and child friendliness in the clinics.  
 
WHY IS THIS IMPORTANT? 
This is important because many HIV-infected mothers have HIV-uninfected children and we 
want children not to be frightened to come to the clinic for support.   
 
WHAT WILL IT MEAN IF YOU PARTICIPATE IN AMAGUGU? 
We would like to visit you complete a pre and post disclosure training questionnaire and also 
participate in a focus group discussion about mothers’ disclosure of HIV status to their children 
and clinic child friendliness.   
 
HOW MAY YOU BENEFIT FROM BEING IN AMAGUGU? 
We will provide you with training on maternal disclosure of HIV status to children and how to 
become a child friendly clinic.  
 
IS THERE ANY DISADVANTAGE FOR BE PARTICIPATING IN AMAGUGU STUDY? 
No. 
WILL THERE BE ANY CHARGE FOR PARTICIPATING IN AMAGUGU STUDY? 
There will be no charge for participating in Amagugu.  
 
WHAT IF I CANNOT DECIDE NOW OR I CHANGE MY MIND LATER?  
Refusing to participate in the study or withdrawing at anytime will not result in penalty or loss of 
benefits. If you do not wish to decide now whether you want to participate we can come back 
later when you have had more time to think about this.  
 
WHO WILL SEE THE INFORMATION THAT WE COLLECT? 
All records will be kept completely confidential. Only senior members of the study team will have 
access to the information once it is collected. 
 
WILL THE INFORMATION COLLECTED BE USED FOR ANYTHING ELSE? 
Yes some of the information collected will be used by one of the researchers for PhD (higher 
degree) purposes but confidentiality will still be maintained. 
 
 
 
 
 
 
WHO TO CONTACT IF YOU WANT TO KNOW MORE, OR IF YOU HAVE A PROBLEM AT ANY TIME? 
If you want more information on Amagugu before deciding on whether or not to participate, or if 
you participate in Amagugu and later have questions, please call: 
 
Ms. Ntombizodumo Mkwanazi 
Tel: 035 550 7500 Africa Centre, Mtubatuba, 
 
Dr. Ruth Bland Africa Centre, Mtubatuba, 
Tel: 035 550 7500 
 
Dr. Tamsen Rochat Africa Centre, Mtubatuba, 
Tel: 035 550 7500 
 
Contact details of BREC Administrator or Chair – for reporting of complaints/ problems: 
Biomedical Research Ethics, Research Office, UKZN, Private Bag X54001, Durban 4000 
Telephone: +27 (0) 31 260 4769 / 260 1074 
Fax:   +27 (0) 31 260 2384 
Administrator: Ms P Ngwenya  Email:  ngwenyap@ukzn.ac.za 
Chair: Email: Prof D R Wassenaar  c/o ngwenyap@ukzn.ac.za  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amagugu Project - Africa Centre  
CTP - Consent for clinic staff member to participate in Family-Based Disclosure 
Project 
 
I voluntarily agree to participate in the focus group discussions about making clinics child friendly 
and mothers’ disclosure of HIV status to their children. These discussions will be used for 
research conducted by Amagugu Project as well as for PhD studies by Ntombizodumo 
Mkwanazi. I understand that what is discussed in the talks will be kept confidential. I understand 
that I can stop being part of this research at anytime without any penalty or loss of benefits. I 
agree to have these discussions recorded. Research has been explained to me verbally and I 
was given a chance to ask questions. I know who to contact if I have questions at a later stage.  
 
CLINIC STAFF MEMBER 
 
Signature: _________________________________ 
 
 
Name: ____________________________________ 
 
 
Date: _______/ __________/ ___________ 
 
 
WITNESS 
 
Signature: _________________________________ 
 
 
Name: ____________________________________ 
 
 
Date: _______/ __________/ ___________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
